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The research presented in this thesis investigates the function of interferon gamma in 
vacuoles, namely Salmonella enterica serovar Typhimurium and Toxoplasma gondii. 
IFN-γ is a cytokine that functions in both the innate and the adaptive immune 
responses. IFN-γ is mainly secreted by T cells and natural killer (NK) cells and 
activates macrophages, promotes antigen presentation and enhances antiviral and 
antibacterial immunity. 
 
In the case of bacterial pathogens, such as S.Typhimurium, priming with IFN-γ leads 
to an inflammatory but controlled cell death mechanism known as pyroptosis, 
following bacterial invasion of the cytosol or experimental lipopolysaccharide (LPS) 
transfection. LPS is a major component of the outer membrane of Gram-negative 
bacteria and is sensed in the cytosol by human Caspase-4. The research described in 
Chapter 2 used a genome-wide CRISPR-Cas9 screen as an unbiased approach to 
identify new IFN-γ-induced genes that play a role in the cell death pathway. This 
viability screen enriched for cells resistant to LPS-mediated cell death after IFN-γ 
priming. Their sequencing generated a list of potential candidate genes including 
expected genes such as IFN-γ receptors (Ifngr) and novel genes such as Nckap1, 
Fip1l1, Srsf10, Safb. However, none of these additional candidates were validated 
because their deficiency did not provide significant resistance to the cell death 
phenotype. Overall, these results suggest that, in addition to the Caspase-4-
Gasdermin-D axis, the role of IFN-γ-induced genes in the cell death pathway 
triggered by cytosolic LPS remains to be investigated. 
 
This thesis also examined the role of IFN-γ in response to infection by the eukaryotic 
parasite Toxoplasma gondii, an apicomplexan that actively invades host cells and 
resides within a unique parasitophorous vacuole. The work presented in Chapter 3 
showed that with type II T.gondii (PRU strain), IFN-γ inhibits replication in an 
autophagy-dependent manner. This strain is coated by ubiquitin and by the individual 
subunits (HOIP, HOIL-1, and Sharpin) of the linear-ubiquitin assembly complex 
(LUBAC). Autophagy cargo receptors, such as NDP52, p62, and Optineurin, are also 
recruited to the type II, intracellular parasites. Although all these recruitments were 
IFN-γ-dependent, the role of LUBAC and the mechanisms for its recruitment remain 
unknown. This research further showed that PRU changes cytokine expression levels 
of infected cells: IL-1α, IL-6, and CCL5 expressions are induced upon infection and 
potentially in a LUBAC-dependent fashion. 
 
Overall, the work presented in this thesis provides new insights into the role of IFN-γ 
in antibacterial and antiparasitic cell-autonomous innate immunity. Further 
experiments could validate other candidate genes from the screen or investigate the 
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Chapter 1: Introduction 
This thesis presents two separate projects that investigate the role of IFN-γ not in 
stimulating immune cells but in regulating cell-autonomous pathways in response to 
pathogen infection. The first part of this introduction focuses on the organisation of 
the immune system and details cell-autonomous mechanisms that are relevant for the 
rest of the thesis such as ubiquitylation, inflammasome activation, cell death by 
pyroptosis and cytokine release. The second section highlights characteristics of the 
two pathogenic species investigated in this thesis, namely the Gram-negative bacteria 
Salmonella enterica serovar Typhimurium and the eukaryotic parasite Toxoplasma 
gondii. A comparison between the two organisms is made, in terms of the different 
host responses and the pathogenic strategies established during infection. 
 
 
1.1 Immune defence mechanisms against pathogens 
The immune system is composed of special organs, cells and molecules that constitute 
a network of multiple interconnected protection mechanisms meant to promote the 
survival of the host. It relies on a set of circulating and tissue-resident immune cells 
that survey the body for invading pathogens and damage. It is also crucial for 
maintaining homeostasis in eukaryotes, as exemplified by the severity of many 
immunodeficiency disorders and autoimmune diseases (van Dyke, 2011). Primary 
immunodeficiency disorders (PID) are mostly inherited defects in immune system 
development and/or function and affect both innate (e.g. phagocytes, NK cells…) and 
adaptive (e.g. T- and B-cells) immunity (McCusker & Warrington, 2011). The 
number of people affected by autoimmune diseases, such as type-I diabetes and 
multiple sclerosis (MS), has dramatically increased in the past decades (Rook, 2011). 
Patients with systemic lupus erythematosus (SLE) exhibit widespread inflammation 
and produce autoantibodies; more research is done to investigate the immune 
mechanisms of tolerance and autoimmunity (Singh et al., 2011). 
 
Vertebrates have adaptive and innate immune systems to protect them against threats 
such as pathogens (Boehm, 2012), and are based on the distinction between self and 
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non-self (Chaplin, 2010). The adaptive immune system targets previously recognised 
microorganisms or antigens. Any pathogen or toxin is recognised, via particular 
epitopes (antigens) it presents on its cell surface by specific receptors (Schatz & Ji, 
2011). These adaptive immune processes are characterised by highly specific 
mechanisms that require gene rearrangement in T- and B-cells, followed by clonal 
expansion. Thus, when a host is exposed to a new pathogen, adaptive responses are 
activated following faster-acting innate immune defence, which constitute the first 
line of defence against pathogens (Riera Romo et al., 2016) and are essential in the 
early stages of infection. 
 
The innate immune system, more ancient than the acquired immune response, has 
developed and evolved to prevent infection, eliminate invading pathogens and 
activate the adaptive immune system. Innate immunity is composed of physical 
barriers (skin, mucosa), phagocytes (i.e., neutrophils, monocytes, macrophages), cells 
that release cytokines and inflammatory mediators (i.e., macrophages, natural-killer 
cells) and includes recognition mechanisms and microbicidal capabilities.  
 
Cells outside immune lineages, such as the epithelial cells of the intestine, are often 
the first to encounter invasive pathogens. They have the ability to self-defend by 
detecting and tackling pathogens. Cell-autonomous immunity refers to any form of 
defences that do not require any other cells, and includes potent mechanisms 
inhibiting pathogen replication in the cytosol (Randow et al., 2013). A number of 
intracellular pathogens (such as Legionella, Salmonella, Mycobacteria) replicate in 
specialised vacuoles that provide a more hospitable environment to replicate (Frehel 
et al., 1986; Kagan and Roy, 2002; Portillo & Finlay, 1995; Steele-Mortimer, 2008) 
and that keep them isolated from the nutrient-rich cytosolic compartment (Hackstadt 
et al., 1997; Joshi & Swanson, 2011). Cell-autonomous immunity includes 
constitutive and IFN-induced processes (MacMicking, 2012; Moretti & Blander, 
2017), both of which are involved in microbial clearance (Randow et al., 2013). Cell-
autonomous processes regulate innate immune responses to microbes and the 
production of inflammatory cytokines. 
 
The first part of the introduction shows that the host defence against infections require 
recognition mechanisms of the threat (see paragraph 1.1.1), that trigger microbicidal 
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pathways (see paragraph 1.1.2) and activate the adaptive immune system by the 
production and release of effector molecules (see paragraph 1.1.3). A particular 
emphasis is made on cell-autonomous immune responses. 
 
 
1.1.1 Recognition mechanisms 
Within both immune and non-immune cells, cytosol-invading pathogens are 
recognised by the cell-autonomous immune system, which is defined by intrinsic cell-
dependent pathways activated in response to threats. 
 
1.1.1.1. Pattern-recognition receptors surveil both extracellular and 
intracellular compartments 
The innate immune system uses germline-encoded pattern recognition receptors 
(PRRs) in various cellular compartments to detect evolutionary conserved structures 
specific to pathogens (i.e. components of bacterial cell walls, of secretion systems, or 
effectors secreted by pathogens); these are known as pathogen-associated molecular 
patterns (PAMPs) (Janeway, 1989; Mogensen, 2009; Takeuchi et al., 2010). In 
addition, pathogen entry may cause disruptions in cellular homeostasis (Stuart et al., 
2013), such as mislocalised DNA outside of the nuclear or mitochondrial 
compartments, modified endogenous proteins or membrane damage. These 
disturbances act as danger-associated molecular patterns (DAMPs), which, through 
recognition by danger receptors, enable indirect detection of infections (Matzinger, 
1994). Sensing of both PAMPs and DAMPs by PRRs trigger multiple effector 
mechanisms and signalling pathways that interfere with pathogen growth and 
dissemination. Finally, Toll-like receptors (TLRs) surveil the extracellular 
compartment and endosomes whereas cytosolic NOD-like receptors (NLRs) are 
activated during proper infection. 
 
 
1.1.1.2. Inflammasomes are cell-autonomous sensing mechanisms 
Inflammasome activation is not a process exclusive to immune cells such as 
macrophages (LaRock & Cookson, 2013). It is also present in epithelial cells: NLRC4 
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canonical inflammasome and Casp11 non-canonical activation can be established 
during S.Typhimurium infection, restricting bacterial replication and spread (Sellin et 
al., 2014) and enabling shedding of the infected epithelial cells (Knodler et al., 
2014a). 
 
Inflammasomes play an essential role for controlling infections; however, aberrant 
inflammasome signalling results in human autoimmune and autoinflammatory 
diseases (Guo et al., 2015; Strowig et al., 2012) including neurogenerative diseases 
(multiple sclerosis, Alzheimer’s and Parkinson’s diseases) and metabolic disorders 
(atherosclerosis and type-2 diabetes). In the context of infection, excessive 
immunoinflammatory dysfunction is responsible for sepsis and causes morbidity 
(Bordon, 2012; Gao et al., 2018; Winters et al., 2010). 
 
Inflammasomes (Fig.1) are key components of cytosolic surveillance and are large 
multimolecular complexes that assemble in response to PAMP or DAMP detection 
(Rathinam et al., 2012; Broz & Dixit, 2016) by a subset of NLRs (nucleotide-binding 
domain and leucine-rich repeat containing proteins) and ALRs (AIM2-like receptors) 
(Takeuchi & Akira, 2010). Inflammasome activation is mediated by pro-inflammatory 
caspases and results in cytokine production (IL-1β and IL-18) and cell death by 
pyroptosis (Lamkanfi & Dixit, 2014). 
 
Canonical inflammasomes recruit human procaspase-1 by its CARD domain and 
convert it into the catalytically active enzyme (Martinon et al., 2002) mirroring the 
proximity-induced activation of Caspases-8 and -9 (Riedl & Salvesen, 2007). 
Canonical inflammasomes are activated in response to a broad range of stimuli 
including bacterial components (Miao et al., 2006; 2010) because numerous sensing 
molecules, such as NOD-like receptors (NLRC4, NLRP1, NLRP3) and AIM2 are able 
to induce CASP1 activation (Fig.1A). Both NLRC4 and NLRP1 interact directly with 
CASP1 via CARD-CARD binding. NLRP1 is activated by anthrax toxins (Chavarría-
Smith and Vance, 2013; Hellmich et al., 2012), whereas NLRC4 inflammasome is 
triggered by flagellin or bacterial T3SS and T4SS effectors (Kofoed & Vance, 2011). 
By contrast, AIM2 and NLRP3 inflammasomes require the adaptor and scaffold 
protein ASC, which binds CASP1 CARD by its N-terminal CARD and the sensing 
protein (AIM2 or NLRP3) by its C-terminal PYD. AIM2 is a Pyrin protein, which is 
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activated by cytoplasmic DNA (Fernandes-Alnemri et al., 2009; Hornung et al., 2009) 
and, during Francisella novicida infection (Man et al., 2015). AIM2-triggered 
inflammasome participates in antiviral and antibacterial defence (Rathinam et al., 
2010). Unlike the other NLRs, NLRP3 is a PRR that assembles inflammasomes in 
response to very diverse cues, including toxins and chemicals such as monosodium 
urate or, more particularly, DAMPs such as potassium efflux (Muñoz-Planillo et al., 
2013) or endogenous reactive oxygen species (ROS) (Zhou et al., 2011). 
 
Canonical activation of inflammasomes is driven by oligomerisation of NLR 
molecules for example, and results in cleavage of pro-caspase-1. By contrast, non-
canonical activation of inflammasomes (Fig.1B) is directly driven by either murine 
caspase-11 or human Caspases-4 or -5 themselves (Aachoui et al., 2013a; Kayagaki et 
al., 2013; Rathinam et al., 2012). Murine Casp11 and human CASP4 directly bind 
LPS in the cytosol, rendering this LPS activation of non-canonical inflammasome 
TLR4-independent (Casson et al., 2015; Kayagaki et al., 2013; Shi et al., 2014). 
Similar to CASP1, CASP4 oligomerises and is activated by autocleavage. Once 
activated, human Caspases-1 and -4, as well as caspase-11 have the ability to cleave 






Figure 1: Inflammasomes are activated by various stimuli 
Inflammasomes are divided into two categories depending on the inflammatory Caspase that 
is activated. (A) Canonical inflammasome assembly is triggered by a broad range of stimuli 
sensed by different inflammasome proteins. NLRC4 and NLRP1 interact directly with pro-
caspase 1 via CARD-CARD interaction, whereas AIM2 and NLRP3 require the adaptor ASC, 
which binds them with their PYD and pro-caspase-1 with its CARD domain. Oligomerisation 
drives the cleavage of pro-Caspase-1 in a proximity-dependent autoactivation model. Active 
Caspase-1 processes pro-IL-1β and pro-IL-18 in their mature forms, inducing inflammation. 
(B) Non-canonical inflammasome assembly is triggered by cytosolic LPS, which directly 
binds Caspase-4 (caspase-11 in mice) and leads to proximity-induced autoactivation of 
Caspase-4. Both Caspase-1 and Caspase-4 cleave Gasdermin-D, major effector of pyroptosis. 








1.1.1.3. Other mechanisms of intracellular detection 
Further detection occurs both directly, resulting in the deposition of ubiquitin on 
bacterial surfaces or parasitophorous vacuolar membranes (Lee et al., 2015; Selleck et 
al. 2015); and indirectly, when exposed glycans from damaged endomembranes are 
recognised by Galectin-8 (Birmingham et al., 2006; Thurston et al., 2012). Ubiquitin 
(Ub) and Galectin-8 (GAL8) are intracellular ‘eat-me’ signals for autophagy cargo 




Cells display complex glycoproteins and glycoplipids on the extracellular leaflet of 
the plasma membrane, but not on the cytosolic one. Consequently, these glycans are 
also found on the luminal leaflet of pathogen-containing vacuoles. Upon damage of 
vacuolar membranes, glycans become exposed to the cytosol where they are sensed 
by a number of cytosolic receptors known as galectins. Galectins were first found to 
be implicated in antibacterial autophagy when Galectin-3 was observed to accumulate 
on membrane remnants generated during cytosolic entry of Shigella flexneri (Dupont 
et al., 2009; Paz et al., 2010). Galectin-3, -8 and -9 are recruited to cytosol-invading 
bacteria, including S.Typhimurium, and bind to glycans exposed in the cytosol upon 
membrane rupture (Thurston et al., 2012). Galectins are therefore precise indicators of 
membrane damage and cytosolic entry of S.Typhimurium. Moreover, Galectin-8 




Both cytosolic bacteria and remnants of damaged membranes are ubiquitylated, 
thereby targeting Ub-bound substrates for proteasomal degradation (Hershko & 
Ciechanover, 1992) or autophagy. Ubiquitin is a well-conserved regulatory protein 
and its reversible conjugation to substrates (ubiquitylation) signals primarily for 
proteasomal degradation. It is also involved in numerous cellular processes such as 
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cell division and more specifically in intracellular pathogen degradation and immune 
signalling (Komander & Rape, 2012). Substrate ubiquitylation may be reversed by the 
action of deubiquitinases (DUBs), which are essential in ensuring cellular 
homeostasis (Fig.2). The ubiquitylation process requires three enzymes. The E1-
activating enzyme carries and transfers the Ub molecule to the E2-conjugating 
enzyme (Fig.2). The Ub-loaded E2 interacts with an E3-ligating enzyme. There are 
three classes of E3s, depending on the mechanism used for the transfer of Ub to the 
substrate: with the RING E3s, the ubiquitin molecule is directly transferred from the 
E2 to the substrate (Fig.2.1), whereas in both HECT (Fig.2.2) and RBR (Fig.2.3) E3-
ligases, Ub is transferred first to the E3 and subsequently to the substrate. 
 
 
Figure 2: The ubiquitylation cascade 
Conjugation of ubiquitin to a substrate takes several steps. Ubiquitin is first loaded on an E1-
activating enzyme in an ATP-dependent manner. The ubiquitin molecule is then transferred to 
an E2 ubiquitin-conjugating enzyme. The E2 then interacts with the E3 ubiquitn-ligating 
enzyme. E3 ligases are divided into three classes: (1) RING E3 is bound simultaneously to E2 
and the substrate and promotes direct transfer of ubiquitin from the E2 to the substrate; (2) 
HECT E3 helps ubiquitin transfer first from the E2 to the E3 and then from the E3 to the 
substrate; (3) RBR E3 binds the E2 through the RING1 domain, the substrate via the RING2 
(Rcat) domain, and catalyses the HECT-like ubiquitin transfer to the target. Deubiquitinases 






Ubiquitin is covalently attached to the substrate via an isopeptide bond between the 
C-terminus of the Ub and the substrate’s ε amino lysine residue. Mono-ubiquitin 
already impacts its substrate’s functions (Dikic & Dötsch, 2009); however, ubiquitin 
can be further modified and can form polyubiquitin chains (Hershko & Ciechanover, 
1998). Depending on the conjugation site – i.e. the seven internal lysines or the N-
terminal methionine of the Ub molecule – the various linkages exhibit different 
conformations and functions (Dikic et al., 2009). For example, K48-polyubiquitin 
chains target proteins to the 26S proteasome for degradation (Ciechanover, 2005); 
K63-linked ubiquitin targets T.gondii for endo-lysosomal degradation (Clough et al., 
2016); linear (M1) chains play a role in NF-κB signalling (Ikeda et al., 2011). 
 
The linear ubiquitin chain assembly complex (LUBAC) specifically synthesises linear 
(M1-linked) ubiquitin chains. LUBAC is a multimeric complex composed of three 
subunits – HOIP, HOIL-1, and Sharpin (Ikeda et al., 2011; Kirisako et al., 2006; 
Tokunaga et al., 2011) – of which HOIP is the catalytic subunit and acts as an E3 
ligase via its RBR domain (Smit et al., 2012). Maximal activity of HOIP requires both 
Sharpin and HOIL-1; the formation of the complex enhances the stability of each 
component (Elton et al., 2015; Tokunaga et al., 2011). Autosomal defects in LUBAC 
are associated with autoinflammation and immunodeficiency in humans, and 
additional disorders in mice (Boisson et al., 2015; Brazee et al., 2016). HOIL-1 
deficiency in mice is associated with increased susceptibility to Listeria 
monocytogenes, Citrobacter rodentium and Toxoplasma gondii (MacDuff et al., 
2015). During bacterial infection, LUBAC – the N-terminal double zinc-finger 
domain of HOIP – is recruited to cytosolic S.Typhimurium via initial ubiquitin 
deposited by upstream E3 ligases and produces linear ubiquitin chains on the bacterial 
surface (Noad et al., 2017) and thus amplifies the ubiquitin coat on cytosolic bacteria. 
This forms a signalling platform by recruiting the NF-κB activator NEMO and the 
cargo receptor Optineurin, thereby inducing pro-inflammatory signalling and 
targeting the bacteria to autophagy, respectively (Noad et al., 2017). Physiological 
effects of linear ubiquitylation are locally modulated and antagonised by the activity 
of deubiquitylating enzymes (DUBs) such as Ovarian tumor DUB with linear linkage 
specificity (OTULIN) or cylindromatosis (CYLD) (Takiuchi et al., 2014). OTULIN 
promotes bacterial proliferation in cells (van Wijk et al., 2017), is a negative regulator 
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of pro-inflammatory NF-κB signalling in mammals (Fiil et al., 2013; Schaeffer et al., 
2014), and critical for the maintenance of homeostasis. A homozygous hypomorphic 
mutation in human OTULIN, recapitulated in Otulin-deficient mice, is the underlying 
cause of ORAS (OTULIN-related autoinflammatory syndrome), a life-threatening 
autoimmune disorder characterised by spontaneous NF-κB activation in myeloid cells 
and chronic inflammation in multiple tissues (Damgaard et al., 2016). The LUBAC-
OTULIN interplay provides an example of the highly regulated balance between pro- 
and anti-inflammatory signalling necessary for the control of infections and for tissue 
and cell homeostasis. 
 
iii. Cargo receptors 
Ub and GAL8 are intracellular “eat-me” signals because they recruit autophagy cargo 
receptors in the context of bacterial infection: p62 and Optn only bind to Ub whereas 
NDP52 binds both Ub and GAL8 (Boyle & Randow, 2013). All three were shown to 
facilitate restriction of S.Typhimurium replication and other intracellular bacteria 
(Thurston et al., 2009; Wild et al., 2011; Zheng et al., 2009) via LC3 binding on 
developing autophagophores. Because of their role in antibacterial cell-autonomous 
defence mechanisms, they were studied in the case of Toxoplasma gondii infection. 
They were found to exhibit the following characteristics: 
 
NDP52 (nuclear dot protein 52) 
NDP52 (Fig.3) mediates immune defence against S.Typhimurium and potentially 
T.gondii (Haldar et al., 2015; Selleck et al., 2015). Its ability to specifically bind to 
LC3C via its CLIR motif (LC3C-interacting region) leads to recruitment of nascent 
autophagosomes (von Muhlinen et al., 2012) or other host membranes (Selleck et al., 
2015), resulting in the restriction of pathogen growth. NDP52 is recruited to broken 
vacuolar membrane remnants by binding to GAL8 (Fig.3) via a C-terminal region just 
upstream of the ubiquitin-binding zinc-finger (ZnF) that senses cytosolic bacteria 




p62 has been shown to direct autophagy towards bacterial pathogens (Mostowy et al., 
2011) including S.Typhimurium (Zheng et al., 2009). In the case of T.gondii infection, 
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IFN-γ induces ubiquitin conjugation and consequent p62 recruitment to the PVs (Lee 
et al., 2015). p62 recruitment is associated with the escort and deposition of GBPs on 
the PVs, a mechanism that does not occur in virulent strains (Haldar et al., 2015). 
Like NDP52, p62 has the ability to bind both the ubiquitin coat on cytosolic bacteria 
and LC3 proteins (via its C-terminal UBA and LIR domains, respectively) (Fig.3), 
thereby acting as a bridge between the bacteria and the autophagosomal membrane 
(Pankiv et al., 2007). 
 
Optn (optineurin)  
Optineurin restricts S.Typhimurium proliferation both in vitro and in vivo (Slowicka 
et al., 2016; Wild et al., 2011). The role and/or recruitment of Optn during T.gondii 
infection have not yet been investigated. 
Optn binds the surface of cytosolic bacteria through its UBAN and zinc-finger 
domains (Fig.3). Optn is an effector protein of LUBAC since it binds linear ubiquitin, 
unlike the other cargo receptors (Noad et al., 2017). Optn binding to LC3 is regulated 




Figure 3: Schematic illustration of the three autophagy cargo receptor proteins 
Characterisation of the different domains and binding partners of human NDP52, p62, 
and Optineurin. (C)LIR, LC3(C)-interacting region; ZnF, zinc-finger; UBA(N), Ub-






Moreover, NDP52, Optn, and p62 contribute to autophagic restriction against 
S.Typhimurium in a non-redundant manner. Although NDP52 and Optn binding 
colocalises, p62 is located on different microdomains on the bacteria, indicating that 
they recognise distinct ubiquitin linkage types (Cemma et al., 2011). The autophagic 
cargo receptor protein p62 also plays a role in the presentation of antigens against 
Toxoplasma gondii in an IFN-γ-dependent mechanism (Lee et al., 2015).  
 
Cargo receptors also bind LC3 on developing phagophores via their LIR domains and 
thus target cytoplasmic bacteria to autophagy (Boyle & Randow, 2013). In addition, 
cells induce their own death in response to cytoplasmic bacteria, in order to remove 
the bacteria’s replicative niche and expose them to phagocytes in the extracellular 
environment (Jorgensen et al., 2017). 
 
 
1.1.2 Microbicidal pathways 
One of the major roles of the innate immune system is to preserve the host integrity. 
When a threat has been identified and localised, not only systemic but also cellular 
defence mechanisms are triggered to avoid the spread of the infection. Several 
strategies can be employed by the cells to counteract the attack including autophagy 
and programmed modes of cell death. 
 
1.1.2.1. Autophagy 
Autophagy (“self-eating”) is a catabolic process that recycles cells’ cytoplasmic 
content and relies on engulfment of cytosolic cargos into double membrane 
autophagosomes (Fig.4). Nascent autophagosomes are recruited by cargo receptors 
and target their sequestered materials for lysosomal degradation (Gatica et al., 2018). 
Autophagy can be either general, for example in response to starvation (Hailey et al., 
2010), or selective, with cargo receptors targeting specific cargo such as ubiquitylated 





Autophagy is active under normal physiological conditions and maintains cellular 
homeostasis, regulates nutrient turnover and is induced in response to various stress 
stimuli (Levine & Kroemer, 2019; Mizushima & Komatsu, 2011; Rabinowitz & 
White, 2010). 
 
The autophagy process depends on no less than 35 autophagy-related (ATG) proteins, 
which assemble in several complexes for the initiation and formation of the 




Figure 4: Formation of the autophagosome 
The autophagy machinery relies on the establishment of an autophagosome. (1) 
Translocation of the activated ULK complex to the site of autophagosome initiation 
enables (2) activation of the VPS34 complex. (3) The class III phosphatidylinositol 3-
kinase (PI3K) promotes the accumulation of phosphatidylinositol 3-phosphate (PI3P) 
on the omegasome, recruiting PI3P-binding proteins (4) such as WIPI2 and the 
ATG12-ATG5/ATG16L1 complex. Elongation of the membrane proceeds via two 
conjugation systems. The ATG12-ATG5/ATG16L1 complex dimerises via ATG16, 
and (5), in concert with ATG3 and ATG10 catalyses conjugation of ATG8/LC3 to 
phosphatidylethanolamine (PE) present in the isolation membrane. (6) During 
selective autophagy, the targeting cargo (to be degraded) is associated to the 




The formation of the phagophore is initiated by the ATG1/ULK complex (Fig.4.1), 
which comprises a serine/threonine kinase ULK1 or ULK2 (uncoordinated 51 like 
kinase 1 or 2), and the partners ATG13 and FIP200 (focal adhesion kinase family 
interacting protein of 200kDa) and the scaffold protein ATG101 (Fig.4.1). Upon 
activation, ULK recruits and phosphorylates class III phosphatidylinositol 3 kinase 
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(VPS34), a main catalytic component of the second complex. This VPS34 complex 
(Fig.4.2) also contains Beclin-1 and ATG14L. Altogether, they participate in the 
accumulation of phosphatidylinositol-3-phosphate (PI3P) on the nascent omegasome 
(Fig.4.4) and thereby in the establishment of a crescent-shaped double-membrane 
structure derived from the endoplasmic reticulum (Axe et al., 2008; Obara & Ohsumi, 
2008; Simonsen & Tooze, 2009). Localised PI3P production (Fig.4.3) enables 
recruitment of WIPI2 (Fig.4.4), which attracts the ATG12-ATG5/ATG16L1 complex 
(Dooley et al., 2014; Mizushima et al., 2011; Tanida, 2011). The elongation process is 
driven by two ubiquitin-like conjugation systems based on either ATG12 or 
ATG8/LC3 (Sugawara et al., 2004). The ATG12-ATG5/ATG16L1 complex acts 
together with ATG10 and ATG3 (Fig.4.5) to catalyse conjugation of ATG8/LC3 to 
the phagophore membrane by lipidation with phosphatidylethanolamine (PE) (Kabeya 
et al., 2000). Conjugated LC3 promotes elongation of the autophagosomal membrane 
(Fig.4.6) and cargo selection (Pankiv et al., 2007; Tanida et al., 2004). 
 
The mechanism of closure for the engulfment of cytosolic content or a target substrate 
is thought to depend on components of the ECSRT (Endosomal Sorting Complex 
Required for Transport) machinery (Nguyen et al., 2016; Takahashi et al., 2018; 
Wang et al., 2016). Fusion with lysosomes to form a mature autolysosome allows 
degradation of the captured content and requires ATG8 and SNARE (SNAP 
receptors) proteins (Mizushima et al., 2011). 
 
Autophagy is crucial in bacterial restriction in eukaryotes, as demonstrated by 
mammalian cells deficient in FIP200, ATG5, ATG3, which fail to control intracellular 
proliferation of S.Typhimurium (Birmingham et al., 2006; Shun Kageyama et al., 
2011). The autophagy protein ATG5 is also involved in the IFN-γ-mediated 
parasiticidal effect against Toxoplasma gondii (Zhao et al., 2008). 
 
 
1.1.2.2. Cell death 
When pathogens are recognised as foreign and potentially harmful, they can be 
controlled by autophagy. In some instances, however, infected cells sacrifice 
themselves by triggering cell death in order to kill the pathogens and/or for the 
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extracellular exposition and detection of the threat, thereby activating professional 
immune cells and inducing adaptive immunity mechanisms. 
 
i. Programmed forms of cell death 
Cell death is essential for the survival and development of an organism (Fuchs & 
Steller, 2011; Schwartz, 1991), and there is increasing evidence that programmed cell 
death mechanisms contribute to immune protection against pathogenic infections as a 
form of cell-autonomous immunity (Jorgensen et al., 2017). Cell death results in the 
destruction of the pathogens’ replicative niche, exposing them to the extracellular 
environment where professional immune cells such as phagocytes may in turn target 
and destroy them. 
 
Apoptosis is a non-inflammatory and programmed mode of cell death. It can be 
initiated, for example, by DNA damage as a result of chemotherapy; in this case, 
apoptosis is mediated by the p53 pathway (Kemp et al., 2001). More generally, 
apoptosis is triggered either by extrinsic cues (death ligands binding to death 
receptors) or by intrinsic variations (Hengartner, 2000); for example, changes in the 
mitochondria can lead to the release of cytochrome c in the cytosol and subsequent 
assembly of the apoptosome and activation of Caspase-9 (Li et al., 1997). Apoptotic 
caspases initiate (Caspases-2, -8, -9, and -10) and execute (Caspases-3, -6, -7) this cell 
death mechanism (Cohen, 1997; Degterev et al., 2003); for example, the initiator 
caspase, Caspase-8 cleaves the effector caspase, Caspase-3, in the CD95 apoptosis 
pathway (Walczak & Krammer, 2000) (Fig.5). 
 
Contrary to pyroptosis and necroptosis, apoptosis is immunologically silent, forming 
apoptotic bodies that are cleared by efferocytosis. Efferocytosis refers to the 
engulfment of apoptotic bodies or necrotic debris by professional phagocytes, thereby 
preserving tissue homeostasis and standing as an antibacterial mechanism (Martin et 
al., 2012; Poon et al., 2010). 
 
As with apoptosis, pyroptosis results from the activation of caspases, but in this 
instance, they are inflammatory caspases in contrast to initiator or effector caspases in 
apoptosis (Fink et al., 2005). The activation of Caspases-4/-1 in humans and caspases-
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11/-1 in mice is mediated by the formation of inflammasomes, multimeric signalling 
platforms that favour proximity-induced auto-proteolysis of pro-caspases (Fig.1). 
 
Figure 5: Pyroptosis constitutes one of the multiple lines of defence against 
microbial infection 
In response to a microbial threat, several cell-autonomous defence mechanisms overlap in 
order to trigger cell death, thereby killing the pathogenic species. Human inflammatory 
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Caspases-4 and -1 are activated following the establishment of inflammasomes. CASP4 
directly binds cytosolic LPS whereas CASP1 is canonically activated in the NLRC4 or 
NLRP3 inflammasomes for example. Their activation allows maturation of interleukins and 
cleavage of GSDMD, essential for pyroptosis. Pyroptosis is a lytic form of cell death that 
triggers inflammation and enables cytokine release. The initiator caspase, CASP8 can also 
participate in NLRC4 inflammasome activation and is able to cleave GSDMD, although 
CASP8 is mostly known for its action upon effector Caspases-3 and -7 to trigger apoptosis. 
Moreover, CASP3 both benefits apoptosis and downregulates the pyroptotic pathway by 
cleavage of GSDMD in non-active fragments. Microbial infections induce production of type-
I or type-II IFNs, which in turn upregulate many genes involved in defence mechanisms; in 





Pyroptosis is a programmed but proinflammatory form of cell death. It was first 
characterised in macrophages infected with Shigella flexneri (Zychlinsky et al., 1992) 
and later named “pyroptosis” by Cookson & Brennan (2001). It is a non-homeostatic 
and lytic mode of cell death that requires the enzymatic activity of a dedicated set of 
cysteine-dependent proteases: Caspases-1, -4, or -5 in humans (Aachoui et al., 2013b; 
Cookson & Brennan, 2001; Kayagaki et al., 2011). Pyroptosis also occurs in non-
immune cells such as epithelial, endothelial and neuronal cells (Adamczak et al., 
2014; Cheng et al., 2017; Shi et al., 2014). Pyroptosis is morphologically distinct 
from apoptosis: cells dying by pyroptosis exhibit swelling, rupture of the plasma 
membrane and release of the cytoplasmic content, features that are shared with 
caspase-independent necroptosis (Bergsbaken et al., 2009; Lamkanfi, 2011) but lack 
the DNA fragmentation characteristic of apoptosis (Jorgensen et al., 2016). 
 
Active inflammatory caspases (Chang & Yang, 2000) can, in turn, cleave the 
downstream effector Gasdermin-D (GSDMD) releasing the inhibiting C-terminal part 
from the N-terminal pore-forming domain (Man & Kanneganti, 2015a; Liu et al., 
2018). The cytosolic presence of N-terminal GSDMD is sufficient to trigger 
pyroptotic cell death, even with artificial cleavage in the absence of active caspases 
(Kayagaki et al., 2015; Shi et al., 2015). N-terminal GSDMD (p30) proteins 
oligomerise and insert in the plasma membrane to form pore-like structures (Aglietti 
et al., 2016; Ding et al., 2016). This pore-forming ability is shared across the 
Gasdermin protein family as, for example, Gasdermin-A and Gasdermin-E form 
transmembrane pores in lipid membranes (Ding et al., 2016; Feng et al., 2018; Wang 
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et al., 2017). Overexpression of GSDMD, GSDMA, GSDMB, GSDMC or DFNA5 N-
terminal domains is cytotoxic in mammalian cells (Ding et al., 2016). The pore 
formation process is highly dependent on the membrane lipid composition: 
phosphatidylinositol (POPI) prevents GSDMD binding and cholesterol reduces 
GSDMD affinity to the membrane, whereas phosphatidylinositide (PI(4,5)P2) 
enhances binding and increases formation of slit- and ring-shaped oligomers 
(Mulvihill et al., 2018). Liposome-floating assays revealed that GSDMD p30 active 
form colocalises with mitochondria- and plasma membrane-like lipososmes (Chen et 
al., 2016). The active N-terminal domain of GSDMD can also bind to cardiolipin, a 
lipid moiety found in bacterial plasma membranes and mitochondrial inner 
membranes (Ding et al., 2016; Liu et al., 2016). 
 
The pores enable cytosolic contents to leak into the extracellular environment (Fig.5). 
Even though the specificity has not yet been fully characterised, previous work shows 
that mitochondrial cytochrome c, pro-caspase-3 and lysosomal cathepsin B are 
released through GSDMD pores (de Vasconcelos et al., 2019). Cytokines such as IL-
1β or IL-18 lack the signal peptide for the canonical secretion pathway via the 
endoplasmic reticulum and the Golgi compartment. They are secreted 
unconventionally, including passive release through the GSDMD pyroptotic pores 
(Heilig et al., 2017; Keller et al., 2007; Martín-Sánchez et al., 2016). Release of the 
inflammatory factor high mobility group box 1 (HMGB1) and IL-1α in the 
extracellular space (Fig.5) sustains the inflammatory and chemotactic responses 
(Vande Walle & Lamkanfi, 2016). 
 
In the case of pyroptosis, intracellular S.Typhimurium are enclosed in pore-induced 
intracellular traps (PITs) that ensure their destruction (Jorgensen et al., 2016); 
however recent work with Pseudomonas aeruginosa shows that infected macrophages 
trigger NLRC4 inflammasome-dependent pyroptosis and that P.aeruginosa escaped 






Contrary to autophagy, phagocytosis is a cell-mediated “eating” mechanism that 
protects an organism against foreign particles or organisms. Both phagocytosis and 
autophagy are highly conserved mechanisms involved in the removal and destruction 
of extracellular or cytosolic organisms, respectively. These two processes are linked 
since TLRs and ATG proteins play a role not only in autophagy (see paragraph 
1.1.2.1 “Autophagy”) but also in phagosome maturation and recruitment (Sanjuan et 
al., 2007). TLRs are indeed expressed on the surface of specialised cells from the 
innate immune system such as professional phagocytes (macrophages and 




1.1.3 Production and release of effector molecules makes up an 
integrated immune system 
The immune system is a highly connected network. Cytosolic immunity is integrated 
in organism-wide immune defences that induce inflammation in response to microbial 
attacks. Inflammatory signalling affects surrounding cells and tissues, promotes the 
recruitment of immune cells to the site of infection and regulates intrinsic cell-
autonomous defences. Some professional immune cells release effectors such as 
cytokines to signal and induce antimicrobial pathways; for example, helping the 
intestinal epithelium (Madara & Stafford, 1989) to stand as an efficient barrier against 
infection. 
 
In response to pathogens, inflammatory signalling can be activated downstream of 
PRRs (see paragraph 1.1.1.1). Immune effectors, such as Toll-like receptors (TLRs) 
survey the extracellular environment, whereas in the cytoplasm, intracellular PRRs 
such as NOD receptors, recognise opsonised pathogens (Takeuchi & Akira, 2010). 
Following recognition of a threat, a signal transduction cascade is initiated, thereby 
activating transcription factors including IFN response factors (such as IRF3) and 
dimeric nuclear factor kappa-light-chain-enhancer of activated B cells p65/p50 (NF-
κB). Once activated, these transcription factors enter the cell nuclei and upregulate 
Chapter 1 
 20 
transcription of a large number of genes that induce inflammation (Bouwmeester et 
al., 2004). 
Expression of NF-κB-controlled and/or IFN-induced genes is critical for the immune 
system to function efficiently and for the cooperation between several pathways 
linking innate and adaptive immunity (Cooney et al., 2010).  
 
For the immune system to collaborate, a feed-forward loop works through the 
activation of the NF-κB and IRF signalling pathways that lead to the transcription of 
key signalling molecules such as cytokines, chemokines, and interferons. They 
promote immune signalling cascades and are released to activate and recruit 
professional immune cells; these, in turn, produce additional signalling molecules for 




1.1.3.1. NF-κB signalling 
The nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) family 
contains dimeric transcription factors that bind to specific DNA sequences referred to 
as κB sites. These regulate a multitude of genes involved in immunity and for 
example, encode for cytokines and pro-proliferative or anti-apoptotic proteins 
(Wullaert et al., 2011). Many enteric pathogens, including S.Typhimurium and 
Shigella flexneri, are known to interfere with NF-κB signalling and to modulate 
inflammatory responses to promote bacterial pathogenesis (Kawai & Akira, 2007; 





Figure 6: NF-κB signalling 
The NF-κB signalling pathway activates target genes, presenting κB sites in their promoter 
region. The activation can be initiated following one of two pathways. The first pathway (A) 
is extracellular initiation, where TNF-α binds to TNF receptor 1 (TNFR1) inducing its 
oligomerisation and subsequent recruitment of TRADD and TRAF proteins. The second 
pathway (B) is initiated in the cytosol, where peptidoglycans of foreign origin bind to 
NOD1/2. Both pathways converge in the recruitment of RIP and the E3 ligase cIAP leading to 
ubiquitylation and recruitment of the kinase TAK1 and the E3 ligase LUBAC that synthesises 
linear ubiquitin chains and enables recruitment of NEMO and the IKK complex. The IKK 
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complex is activated by TAK1-mediated phosphorylation leading to removal of the inhibition 
exerted by Iκβα on the NF-κB dimer (commonly p65/p50), thereby allowing its translocation 




TNF-α binding to TNF-α receptor (TNFR) constitutes the canonical trigger for NF-κB 
signalling (Fig.6A). NF-κB signalling is also triggered by members of the TNF 
cytokine family, such as CD40 (cluster of differentiation 40), BAFF (B-cell-activating 
Factor) and lymphotoxin-β via a distinct non-canonical activation pathway (Hayden 
& Ghosh, 2012). 
Although, NF-κB signalling can be activated by multiple stimuli (Ting Liu et al., 
2017), the different pathways converge in the ubiquitinylation and subsequent 
proteasomal degradation of IκBα (Fig.6), releasing the inhibition on NF-κB. In resting 
cells, NF-κB dimers are inhibited by binding of IκB (inhibitor of NF-κB) and are 
consequently located exclusively in the cytosol (Beg et al., 1992). The degradation of 
IκBα results in nuclear translocation of NF-κB complexes where they act as 
transcription factors (Fig.6). This common signalling cascade starts with the synthesis 
of K63 Ub chains (Wertz & Dixit, 2010), which recruit LUBAC and TAB proteins 
(Besse et al., 2007; Haas et al., 2009; Kanayama et al., 2004). Linear Ub chains (M1-
Ub chains) synthesised by LUBAC recruit the IKK complex (Tokunaga & Iwai, 
2012), which is activated by TAK1 and thereby activates NF-κB. The IKK complex is 
composed of NEMO, which is specifically and directly recruited by M1-Ub chains 
(Fujita et al., 2014; Rahighi et al., 2009), in addition to the two IKKβ and IKKα 
subunits (Ea et al., 2006). TAB proteins recruit TAK1 for the phosphorylation and 
activation of the IKK complex (Karin & Delhase, 2000). In particular, the 
phosphorylation of the IKKβ subunit of the IKK complex mediates the 
phosphorylation of IκBα leading to its subsequent ubiquitylation (Karin & Ben-
Neriah, 2000) and degradation. 
 
RIP and TRAF proteins are involved in signalling upstream of the deposition of K63 
ubiquitin chains and independently of the NF-κB receptors (Fig.6). Extracellular 
induction of NF-κB signalling (Fig.6A) is canonically triggered by TNF-α (Hayden & 
Ghosh, 2014). Tumour necrosis factor receptor (TNFR) is activated by binding of 
TNF-α and oligomerisation, which allows recruitment of TRADD (TNF receptor-
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associated death domain protein). TRADD recruits RIP1 via death domain 
interactions (Ermolaeva et al., 2008; Hayden & Ghosh, 2012; Pobezinskaya et al., 
2008) and brings in TNF Receptor-associated factor 2 (TRAF2), which facilitates 
recruitment of cellular inhibitor of apoptosis proteins (cIAP1 and 2). cIAPs act as E3 
ubiquitin ligases and synthesise K63 Ub chains on RIP1 (Mahoney et al., 2008; 
Varfolomeev et al., 2008), thereby allowing LUBAC recruitment and NF-κB 
signalling as described above. 
 
In the cytosol (Fig.6B), nuclear oligomerisation domain proteins (NOD1 and NOD2) 
sense peptidoglycans from the bacterial cell wall (such as MDP), activate the 
transcription factor NF-κB (Girardin et al., 2003a and 2003b) and induce cytokine 
production in macrophages (Chamaillard et al., 2003). Oligomerisation of NOD 
receptors allows recruitment of the protein RIP2 (Cooney et al., 2010), which is then 
ubiquitylated by cIAP, by synthesising K63 chains. These K63 Ub chains are 
recognised by the TAK1 complex and LUBAC, leading to the downstream activation 
of the NF-κB dimers mentioned previously.  
 
Among the genes upregulated by NF-κB are pro-IL1β and pro-IL18, inactive forms of 
inflammatory cytokines, and NLRs such as NLRP3. Therefore, NF-κB activation can 
serve as the first signal for inflammasome formation. 
 
 
1.1.3.2. Interferon signalling 
Interferons (IFNs) are α-helical proinflammatory cytokines, which are classified into 
three groups according to the different receptors involved (Sadler & Williams, 2008). 
First, type-I IFNs, which include IFN-α and IFN-β, bind a receptor consisting of IFN-
aR1 and IFN-aR2 (Fig.7), which is expressed on all cell types. Second, type-II IFN 
also referred to as IFN-γ binds to a dimeric receptor made of IFNGR1 and IFNGR2 
(Fig.7), which is ubiquitously expressed (Platanias, 2005). Third, type-III IFNs 
include four homologous (IFN-λ1-4) proteins that bind to receptors containing 
IFNLR1 and IL-10R2 and trigger antiviral responses (Sadler & Williams, 2008; Wack 
et al., 2015). All interferons impact gene expression but their effect is different owing 




IFNs are produced in response to viral- or bacterial-induced PRR stimulation. 
Cytosolic IFN response factors (IRF) are activated by dimerisation upon 
phosphorylation by TBK1 (Fitzgerald et al., 2003; Sharma et al., 2003). Following 
nuclear translocation, IRFs bind to IFN-stimulated response elements (ISRE) found in 
promoter regions of genes upregulated by IRF signalling (Honda & Taniguchi, 2006). 
IRF target genes that include type-I IFNs (IFN-α/β) and other immunomodulatory 
cytokines (Honda & Taniguchi, 2006; Sharma et al., 2003). Once produced, type-I 
IFNs are secreted and can exert autocrine and paracrine effects by binding to IFN 
receptors on either the producer cell or neighbouring cells, triggering JAK-STAT 
signal transduction cascades (Fig.7) that upregulate hundreds of IFN-stimulated genes 
(ISGs) (Der et al., 1998; Samarajiwa et al., 2009).  
 
Screens have been performed to identify antiviral ISGs; depending on the study, these 
screens were designed to investigate virus entry, replication or virion budding. Host 
restriction effectors such as viperin, ISG20, IFITM2, IFITM3 and PKR were found to 
inhibit replicons of dengue and West Nile replicon-containing virus-like particles 
(Jiang et al., 2010). Guanylate-binding protein 1 (GBP1), an IFN-induced GTPase 
acts as a potent suppressor of classical swine fever virus (Li et al., 2016). Ifit2-
deficient mice are more severely infected by rabies virus than their wild-type 
counterparts (Davis et al., 2017). IFN-α-based drugs are used for the treatment of 
patients infected with hepatitis C virus and positive outcome is associated with 
elevated ISG levels in the liver (Sarasin-Filipowicz et al., 2008). 
 
Contrary to type-I IFNs, which are mainly associated with antiviral immunity 
(Schoggins & Rice, 2011), some proteins upregulated by IFN-γ also contribute to 
antibacterial immunity (Reljic, 2007; Rottenberg et al., 2002) and include cytosolic 
pathogen receptors. IFN-γ also plays a role in macrophage activation and immunity 
against a range of pathogens, including viruses, bacteria and parasites (Nathan et al., 
1983; Ohshima et al., 2014; Zhang et al., 2008). For instance, humans with defective 
type-II IFN signalling are highly susceptible to mycobacterial infections (Zhang et al., 
2008). 
Both IFN systems are non-redundant; for example, mice that are deficient in type-I 
IFN signalling are highly susceptible to viral infections but are able to control 
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bacterial infections such as L. monocytogenes (Müller et al., 1994; O'Connell et al., 
2004).  
 
IFN-γ requires further discussion for the benefit of this thesis, as it is characterised for 
its role in antibacterial and antiparasitic defences (Ohshima et al., 2014; Reljic, 2007; 
Rottenberg et al., 2002). IFN-γ is produced by NK cells, T cells, antigen-presenting 
cells and macrophages (Carnaud et al., 1999; Frucht et al., 2001; Gessani et al., 1998) 
and its production is controlled by cytokines such as IL-12 and IL-18 (Farrar and 
Schreiber, 1993; Fukao et al., 2000; Yoshimoto et al., 1998). IFN-γ antiparallel 
homodimer signals through the tetrameric receptor (IFGR) consisting of two IFNGR1 
chains and two IFNGR2 chains (Fountoulakis et al., 1992), resulting in activation of 
pre-associated JAK (Janus kinases) tyrosine kinases with the receptor (Fig.7). JAKs 
phosphorylate STAT-1 (signal transducer and activator of transcription 1) enabling 
STAT-1 to dimerise and form the IFN-γ activation factor (GAF). GAF enters the 
nucleus, where it binds GAS promoter elements and upregulates expression of IFN-γ-





Figure 7: Type-I and type-II interferon signalling 
IFNs are sensed by their specific receptors that are then activated and bind (I) TYK2 and 
JAK1 or (II) JAK1 and JAK2. Both IFN signalling pathways use the JAK-STAT signalling 
cascade for the phosphorylation of (I) STAT1 and STAT2 or (II) STAT1 only. Type I IFNs 
induce the formation of the IRF complex composed of STAT1, STAT2 and IRF9. The IRF 
complex translocates to the nucleus to bind ISRE motif located on promoters of target genes. 
IFN-γ (type II IFN) leads to the formation of the GAF complex, dimer of phosphorylated 




IFN-γ induces the Death associated protein (DAP)/DAP-kinase (DAPK) system 
genes. They are positive mediators of apoptosis and autophagy. Loss of DAPK 
expression (so far only found within epigenetic mechanisms) has been observed in 
multiple cancer types (Wei et al., 2010). 
 
Some IFN-γ-induced genes are involved in cell-autonomous immunity (MacMicking, 
2012). For example, guanylate-binding proteins (GBPs) are interferon-inducible 
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(Martens & Howard, 2006) and directly target intracellular bacteria and promote 
inflammasome activation in response to bacterial infection (Haldar et al., 2015; Man 
et al., 2017; Santos & Broz, 2018). In addition, certain upregulated proteins, such as 
nitric oxide synthase, mediate the production of bactericidal reactive oxygen and 
nitrogen species for the killing of pathogens (Denkers & Gazzinelli, 1998; Haraga et 
al., 2008).  
 
Interferons are used as treatment against particular disorders; for example, 
recombinant human IFN-γ (Actinmune – IFN-γ1b) is used in chronic granulomatous 
disease. It delays the progression in severe malignant osteopetrosis but has been 
shown to be ineffective and may increase mortality in patients with idiopathic 
pulmonary fibrosis (Brunton et al., 2011). 
 
 
1.1.3.3. Cytokine production 
Proinflammatory cytokines play an important role during the inflammation process, 
and they participate in the interactions of the cells involved not only in the innate 
immune response but also in the establishment of acquired immunity. 
Proinflammatory cytokines, such as TNF-α, IL-1, and type I IFNs, participate during 
the activation and effector phases of the innate immune response. Other cytokines 
also play a role during the establishment of the innate immune response, but the 
aforementioned ones deserve special attention in the context of this thesis. 
 
i. Interleukins 
Interleukins (ILs) are a subgroup of cytokines that are classified into four major 
families; the classification is based on structural features, since interleukins share little 
sequence homology as a consequence of constant evolutionary pressure between the 
host’s immune system and infectious agents (Brocker et al., 2010). By binding to 
high-affinity cell-membrane receptors, interleukins initiate paracrine or autocrine 
responses to multiple stimuli with a variety of effects, including modulation of cell 
proliferation, cell activation, or cell differentiation (Commins et al., 2010). The 
human genome encodes more than 50 interleukins and related proteins, of which three 
quarters are either characterised or annotated (“Cytokine Tutorial”, Univ. of Arizona; 
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Lippincott, 2007). Only a few interleukins are highlighted here because they are 
mentioned later in this thesis (see Chapter 3, paragraph 3.3.2) and include IL-6 and a 
few members of the IL-1 superfamily such as IL-1α, IL-1β and IL-18. The focus is 
placed on their role in anti-microbial immunity. 
 
Interleukin 1 has two isoforms, α and β, which both participate in the regulation of 
immune responses, inflammatory reactions and hematopoiesis (Mochizuki et al., 
1987; Sims et al., 1988). IL-1β production is enhanced in response to bacterial 
infection after detection of the pathogens via PRRs (Brubaker et al., 2015; Takeuchi 
& Akira, 2010). More generally, in resistance mechanisms against intracellular 
pathogens, IL-1β is required for IL-12-dependent, NK cell-mediated IFN-γ production 
(Hunter et al., 1995). Inflammasome activation results in processing of IL-1β and IL-
18 by CASP1 and IL-1α by Caspases-11/-4 (Casson et al., 2015; Kayagaki et al., 
2011; Martinon et al., 2002) eventually promoting inhibition of S.Typhimurium 
growth (Thurston et al., 2016). IL-18 belongs to the IL-1 superfamily and is produced 
by macrophages, but is also constitutively expressed in non-hematopoietic cells such 
as intestinal epithelial cells. IL-18 was first described to induce the production of IFN-
γ (Nakamura et al., 1989), but it has also been characterised to upregulate NK cell 
activity and to modulate both innate and adaptive immunity (O’Neill et al., 2016; 
Yoshimoto et al., 1998). Dysregulation of IL-18 is associated with cancer, 
autoimmune diseases and inflammatory diseases (Fabbi et al., 2014; Yasuda et al., 
2019). 
 
IL-6 is a glycosylated soluble mediator that plays a role in inflammation, immune 
response and hematopoiesis (Kishimoto, 1989). IL-6 expression is highly regulated; 
for example, in response to IL-1R/TLR stimulation, inhibitor of NF-κB (IκB) kinase 
(IKK) complex phosphorylates regnase-1 and thereby controls IL-6 mRNA stability 
(Iwasaki et al., 2011). In hepatocytes, the decreased expression or lack of Homeobox 
containing 1 (HMBOX1) upregulates the expression of inflammatory factors such as 
IL-6 and TNF-α (Zhao et al., 2018). However, increased level of IL-6 and TNF-α in 
cultured HAECs following LPS treatment is independent of HMBOX1 (Ma et al., 
2019). IL-6 also has various effects on lymphocytes, as it promotes differentiation of 
CD4+ T cells and is required for Th17 differentiation in combination with 
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transforming growth factor (TGF)-β (Bettelli et al., 2006). IL-6 is, therefore, a bridge 
between innate and adaptive immunity (Tanaka et al., 2014). 
 
ii. TNF-α 
TNF-α is a pro-inflammatory cytokine (Carswell et al., 1975) synthesised by 
macrophages as a membrane-associated 26kDa protein that is cleaved from the 
membrane in the extracellular domain to produce a mature 17kDa cytokine (Palladino 
et al., 2003). Both membrane-bound and secreted forms of TNF-α require 
trimerisation to be active. Along with IL-10, IL-12 and IFN-γ, TNF-α is an important 
mediator of host survival during primary infection with Toxoplasma gondii (Scanga et 
al., 2002; Sukhumavasi et al., 2008). 
 
iii. Adhesion molecules  
Pro-inflammatory cytokines and chemokines all have the ability to induce chemotaxis 
and cell adhesion molecule (CAM) expression in both endothelium and leucocytes. 
These CAMs include selectins, integrins, immunoglobuline-like superfamily 
molecules and cadherins. Expression of these CAMs allows interaction between 




1.1.4 Immunity relies on multiple cross-talks to function as a fully 
integrated system 
Various defence mechanisms, including cell death pathways, constitute a multi-
layered immunity against invading pathogens. Cross-talk is therefore essential to 
regulate and produce the most appropriate and efficient response. 
 
Caspases seem to play several roles in diverse immune pathways (Man & Kanneganti, 
2015b). Although CASP8 is defined as an apoptotic caspase, it can cleave GSDMD 
leading to pyroptosis in murine macrophages (Chen et al., 2019; Gram et al., 2019; 
Orning et al., 2018). A consequence of CASP8-mediated pyroptosis is the activation 
of the NLRP3 inflammasome (Fig.5). In the apoptotic pathway, activated CASP8 
cleaves CASP3; however, CASP3 was found to process GSDMD and generate the 
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p43 and p20 fragments from the full-length protein and not the pore-forming p30 N-
terminal fragment (Chen et al., 2019). This suggests that CASP3 inhibits pyroptosis 
and favours apoptosis (Fig.5). In conclusion, several cell death pathways operate, but 
in a non-exclusive way. 
 
Many inflammatory caspases such as CASP1, CASP4, and Casp11 are upregulated by 
type-I and/or type-II interferons (Kayagaki et al., 2015; Ramirez & Salvesen, 2018). 
In addition to inflammatory caspases, NLR proteins and GSDMD are also IFN-
induced, promoting inflammasome-mediated activation of CASP1 and pyroptosis, 
which in turn releases IL-18 (also known as interferon-γ-inducing factor), promoting 
inflammation (Fig.5). GSDMD is a downstream effector of mouse Casp11- and 
human CASP4-induced pyroptosis; however, pyroptosis following prolonged CASP1 
activation is GSDMD-independent (Kayagaki et al., 2015). The absence of GSDMD 
combined with the absence or prolonged activation of CASP1 results in the activation 
of CASP8 via ASC specks and consequent apoptosis (Pierini et al., 2012). 
 
Occasionally, cells release IL-1β/18 without lysis and consequent death, meaning that 
some membrane repair mechanisms might be in play (Jimenez et al., 2014; McNeil & 
Kirchhausen, 2005). The endosomal sorting complexes required for transport 
(ESCRT) membrane repair machinery has an anti-inflammatory function by 
negatively regulating pyroptosis (Rühl et al., 2018).  
 
 
1.2 Two model organisms to study cell-autonomous 
immunity: Salmonella Typhimurium and Toxoplasma 
gondii  
Cell-intrinsic immunity includes self-defence mechanisms that most nucleated cells 
activate against viruses, bacteria and eukaryotic parasites (Randow et al., 2013).  
Although S.Typhimurium and T.gondii are respectively prokaryotic and eukaryotic 
pathogens, their life cycle and the clearance or restriction mechanisms established by 
the infected cells display similarities, which are presented in this section. For instance, 
both pathogens reside within a vacuole. In rare cases, they become exposed in the 
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cytosol where sensors and receptors detect the foreign pathogenic elements and can 
lead to cell death (Jorgensen et al., 2017). Some of these host effectors are IFN-
inducible (MacMicking, 2012). For example guanylate-binding protein 1 (GBP1) 
expression is highly increased in macrophages exposed to IFN-γ. GBP1 is recruited to 
cytosolic S.Typhimurium and is required for the breakage of T.gondii parasitophorous 
vacuole. GBP1 promotes the assembly of supramolecular organising centres, which 
act as signalling platforms and is required for cell death following S.Typhimurium 
and T.gondii infections (Fisch et al., 2019b). 
 
After introducing the pathogenesis and the organisational characteristics of the two 
organisms, this section focuses not only on host defense mechanisms against 
S.Typhimurium and T.gondii but also highlights strategies that these two pathogens 





Both the bacterium S.Typhimurium and the parasite T.gondii infect humans and can, 
under different circumstances, be life-threatening. 
 
Bacteria are ancient unicellular organisms that are highly adaptable to changing 
environments by selection of spontaneous mutants and thereby have evolved traits 
that make them ubiquitous. Even though they appear simple as they lack a nuclear 
membrane, they are metabolically active and multiply by a process called binary 
fission (Davies et al., 1996). 
Bacteria are divided into two categories depending on the composition and structure 
of their cell wall: Gram-positive and Gram-negative; except for Mycobacteria (e.g. 
M.tuberculosis or M.leprae), whose cell wall has unique properties (Brennan, 2003). 
Gram-positive bacteria have one thick cell wall composed of a periplasmic space 
comprised between the cytoplasmic lipid membrane and several peptidoglycan layers 
(Weidel & Pelzer, 1964). In Gram-negative bacteria, the organisation is more 
complex: the cell wall, similar to the one in Gram-positive with a thinner single layer 
of peptidoglycans, is surrounded by an outer membrane. The outer membrane 
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contains phospholipids and lipopolysaccharides (LPS), respectively on the inner and 
outer leaflets. Chapter 2 deals with the immunogenicity of LPS as an endotoxin. 
 
Salmonella enterica are a species of facultative anaerobic Gram-negative bacteria that 
cause diseases in many organisms, including humans (Haraga et al., 2008). 
Salmonella infections are orally acquired via the consumption of contaminated food 
or water. The Salmonella enterica species consists of several serovars, such as 
Typhimurium or Typhi. Both strains cause highly inflammatory gastroenteritis, which 
is associated with water loss, and may be life threatening for the elderly and children 
under the age of five. Together, they account for three million deaths each year 
worldwide (Coburn et al., 2007). S.Typhi specifically infect humans and cause more 
severe systemic typhoid fever, whilst in some instances, S.Typhimurium may enter 
the bloodstream and potentially lead to lethal sepsis and meningitis (Feasey et al., 




Toxoplasma gondii is an obligate intracellular protozoan parasite. Humans become 
infected by the consumption of the oocytes present in contaminated water or food, or 
by ingestion of the tissue cysts present in undercooked or raw meat (Liu et al., 2015). 
In comparison to other species from the phylum Apicomplexa, T.gondii can infect any 
nucleated cell (Khan & Grigg, 2017) of warm-blooded animals including humans 
(Hill & Dubey, 2002), whereas Plasmodium spp. and Cryptosporidium spp. invade 
red blood cells and intestine enterocytes respectively (Sibley, 2004).  
Members of the Felidae family (cats and relatives) are the definitive hosts of T.gondii 
whereas many birds and mammals – including humans – serve as intermediate hosts 
(Frenkel, 1973). T.gondii infections greatly affect livestock (e.g pigs, sheep, and 
goats), having a dramatic economic impact on the farming industry and being a 
sanitary risk by constituting a source of infections for humans (Stelzer et al., 2019).  
It is estimated that anywhere from 500 million people worldwide (Denkers & 
Gazzinelli, 1998) to a third of the world’s population are chronically infected (Khan 
& Grigg, 2017). In most cases, people do not show any symptoms; however, in 
immune-compromised individuals (Kasper & Buzoni-Gatel, 1998; Furtado et al., 
2011), T.gondii infections can potentially cause fatal encephalitis, myocarditis, 
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pneumonitis (Liu et al., 2015), or can lead to severe mental and/or behavioural 
disorders, such as schizophrenia (Fuglewicz et al., 2017). Congenital toxoplasmosis – 
that is, infection of pregnant women and transmission to the foetus through the 
placental barrier (Wujcicka et al., 2018) – can lead to miscarriage or severe 
neurologic damage in the newborn (Hill & Dubey, 2002). 
 
T.gondii can be found at three different infectious stages that are sporozoites, 
tachyzoites and bradyzoites (Dubey et al., 1998). The route of contamination common 
to all intermediate hosts is via sporulated oocysts. Sporozoites are contained in 
oocysts, whose structure is similar to tachyzoites but which contain increased 
numbers of effectors such as micronemes and rhoptries (Lycke et al., 1975). 
Tachyzoites are found as groups or clones and multiply rapidly in any cell of 
intermediate hosts or all but intestinal cells of the final host. Fast-growing tachyzoites 
are responsible for the acute phase of the infection and then turn into bradyzoites or 
tissue cysts in response to host immune defence to become dormant and hence 
constitute the basis for chronic T.gondii infection. (Boyle & Radke, 2009; Sibley, 
2011). Bradyzoites grow slowly in tissue cysts that constitute a source of infection for 
humans and definitive hosts. Intact tissue cysts can persist for the entire life of the 
host without triggering any inflammatory response.  
Tachyzoites and bradyzoites divide by endodyogeny (Ferguson & Hutchison, 1987), 
which means that the two daughter cells are formed within the mother cell that 
eventually pops open.  
As a eukaryotic single-cell organism, T.gondii has common organelles such as 
nucleus, endoplasmic reticulum, Golgi apparatus, mitochondria. It is also a polarised 
cell that contains secretory vesicles such as micronemes and the rhoptry bulb, in the 
apical end (Dubey et al., 1998).  
 
 
1.2.2 Entry and establishment of the vacuole 
Intracellular bacterial pathogens either exploit host membrane trafficking to create 
protective niches called vacuoles or are cytosol-dwellers, such as Shigella flexneri and 
Listeria monocytogenes, which proliferate in the cytosol and often spread to 
neighbouring cells (Di Russo Case & Samuel, 2016). In the host cell cytosol, both 
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S.Typhimurium and T.gondii reside within vacuoles. However, the boundary between 
these distinct intracellular phenotypes is tenuous and may depend on the timing of 
infection and on the host cell type. For example, Listeria monocytogenes which has 
long been a model for cytosolic pathogens, now emerges as a bacterium also capable 
of residing in vacuoles, in a slow/non-growing state (Bierne et al., 2018). On the 
contrary, the vacuolar membrane surrounding S.Typhimurium sometimes breaks 
open, exposing the bacteria to the cytosolic compartment (Knodler et al., 2014b). 
 
This section presents the mechanisms of cellular entry for both pathogens – i.e. 
S.Typhimurium and T.gondii – and the processes involved in the establishment of 
their vacuole. 
 
Following ingestion, S.Typhimurium reach the gut epithelium where they 
preferentially invade microfold cells (M-cells) in Payer’s patches (Jones et al., 1994) 
before infecting neighbouring epithelial or macrophage cells (Müller et al., 2012) 
(Fig.8A and 8C). S.Typhimurium entry in non-phagocytic host cells (e.g. enterocytes) 
is mediated by effectors translocated into the cytosol through their type III secretion 
systems (T3SS). S.Typhimurium pathogenicity islands 1 and 2 (SPI1 and SPI2) 
encode two needle-like (Kubori et al., 1998) T3SSs (Hansen-Wester & Hensel, 2001; 
Ochman & Groisman, 1996; Shea et al., 1996) that penetrate the cellular membrane 
and release up to 30 bacterial molecules into the target cell. SPI1 T3SS and SPI2 
T3SS are required for biogenesis and maturation (Fig.8A and 8B) of the Salmonella-
containing vacuole (SCV), respectively (Laughlin et al., 2014). S.Typhimurium reside 
inside SCV within the cytoplasm of host cells and establish a replicative niche. The 
T3SS-1 effector SopB participates in the rearrangement of the actin cytoskeleton 
enabling membrane ruffling and bacterial uptake into an SCV (Takeuchi, 1967). 
Maturation of the SCV is driven by a switch from SPI-1 to SPI-2 T3SS activity 
allowing the acquisition of lysosomal markers such as RAB7 and LAMP1 to 
transform the SCV into a late endosome-like compartment permissive to bacterial 
replication (Madan et al., 2012; Méresse et al., 1999). However, SCVs avoid 
lysosomal fusion and instead interact with endomembrane compartments and localise 
in close proximity to the Golgi and its secretory vesicles in order to source nutrients 
(Fig.8B) and additional membrane to enhance bacterial replication (Alix et al., 2011; 




Occasionally, the SCV membrane is ruptured, resulting in S. Typhimurium to enter 
the nutrient-rich cytosol (Knodler et al., 2014b); this holds true for approximately 
10% of intracellular S.Typhimurium in tissue culture cells. In vivo work on the 
NAIP/NLRC4 inflammasome claims that SCVs become leaky or rupture and exposed 
ligands to cytosolic NAIPs (Sellin et al., 2014). 
 
 
Figure 8: Life cycle of Salmonella Typhimurium 
(A) S.Typhimurium preferentially infect microfold cells (M-cells), which undergo membrane 
ruffling and actin rearrangement in a SPI1-dependent fashion. S.Typhimurium can migrate 
through the M-cells to reach their basolateral membrane and infect neighbouring epithelial 
cells. (B) However, epithelial cells are also directly infected at their apical membrane in a 
SPI1-dependent fashion. S.Typhimurium typically reside in vacuoles (SCVs) that become 
localised in proximity to the Golgi for sourcing nutrients and express SPI2 effectors for 
maturation. In approximately 10% of the cases, S.Typhimurium enter the cytosol where they 
either proliferate or are restricted by cell-autonomous immune defences. (C) S.Typhimurium 
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also infect macrophages in the lamina propia facilitating bacterial spread and systemic 




Parasites have evolved various strategies to invade host cells (Sibley, 2004) and 
establish their replicative niche. In contrast to S.Typhimurium entry mechanism, 
T.gondii actively enter host cells relying on the parasite’s own cytoskeleton, 
actomyosin system and calcium-dependent secretory pathway to create a 
parasitophorous vacuole (Clough & Frickel, 2017). 
T.gondii use a unique mode of motility referred to as gliding (Heintzelman, 2015), 
which is a substrate-dependent locomotion mechanism to penetrate target cells 
(Sibley, 2004). In order to form the parasitophorous vacuole (PV), which is derived 
from the host cell membrane but excludes many host proteins (Charron & Sibley, 
2004), the parasite membrane enters in contact with the cell membrane and 
establishes a moving junction (Mordue et al., 1999; Besteiro et al., 2011). The highly 
regulated secretion of microneme, dense granule proteins and rhoptries, plays a 
critical role in substrate attachment, host cell invasion and the establishment of the 
PV. These effector proteins are secreted in a timely fashion at the apical (anterior) tip 
of the parasite (Carruthers, 1999). T.gondii compartimentalises its secretory proteins 
according to their function.  
Microneme proteins include adhesins (e.g. TgMIC2) and escorters (e.g. TgMIC6), are 
involved in trafficking and storage of ligands (MICs) to be coupled to the gliding 
motility and host-cell invasion steps (Soldati et al., 2001).  
Rhoptry proteins appear to facilitate PV formation and association to host organelles 
(Fig.9A) such as mitochondria, the endoplasmic reticulum or the Golgi (Jones & 
Hirsch, 1972). The parasitophorous vacuole is also surrounded by host microtubules 
(Melo et al., 2001) and vimentin-type intermediate filaments (Halonen & Weidner, 
1994), structures in close proximity of the host cell nucleus (Boyle & Radke, 2009). 
Dense granule proteins may promote intracellular replication by transporting and 
processing nutrients from the host cell. The Golgi (Fig.9A) provides a source of 
sterols that are taken up by the parasites and used particularly for replication (Boyle & 
Radke, 2009; Sonda et al., 2001; Yoshifumi et al., 2011). At the tachyzoite stage in 
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intermediate host cells, T.gondii undergo asexual cell division and formation of many 
parasites (Radke et al., 2001) within the vacuole, is more likely to occur (Fig.9B). 
 
The establishment of the PV (Fig.9A) is critical for T.gondii survival by avoiding 
both phagocytic engulfment upon entry (Coppens, 2017) and lysosomal destruction, 
because the PV is rendered nonfusogenic with the host endolysosomal system 
(Clough & Frickel, 2017).  
 
 
Figure 9: Life cycle of Toxoplasma gondii 
(A) T.gondii infect cells via an active mechanism called gliding that requires effectors and 
segregation of host membrane proteins out of the forming vacuole. The parasitophorous 
vacuole containing living parasites interacts with several host organelles (mitochondria, ER, 





Although cellular entry mechanisms differ between S.Typhimurium and T.gondii 
infections, both pathogens establish a vacuole within the host cytosol. In both cases, 
the formation of this protective environment and its maturation to avoid lysosomal 
fusion and promote pathogen replication is highly regulated by pathogenic effector 
proteins. Host organelles, such as the Golgi, are used by the pathogens as a source of 





1.2.3 Host cell-autonomous immunity directed against 
S.Typhimurium and T.gondii 
Cytosolic S.Typhimurium can be targeted by potent intrinsic immune mechanisms, 
which restrict bacterial proliferation and growth (Birmingham et al., 2006); this 
makes S.Typhimurium a valuable model organism. Cell-autonomous defence 
mechanisms directed against pathogens have been mostly studied in the case of viral 
infections, to a smaller extent with bacteria and this thesis (Chapter 3) investigates 
whether similar pathways apply in the case of parasite (e.g. with Toxoplasma gondii) 
infection. 
 
S.Typhimurium enter the cell via bacterial-mediated phagocytosis (Fig.8) and invade 
host cells, residing in a SCV. In some instances, the rupture of the SCV enable 
S.Typhimurium to enter the cytosol. Multiple detection mechanisms are present in the 
cell to counteract infection. For example, autophagy (see paragraph 1.1.2.1 
“Autophagy”) is mediated by the recruitment of LC3 proteins. After the rupture of the 
SCV, cytosolic Galectin-8 (GAL8) detects the exposed glycans from the broken 
vacuole membrane, recruits NDP52, which binds LC3C (Fig.10.1), and thereby 
targets the damaged membrane and associated bacterial cargo to autophagy (Ravenhill 
et al., 2019; Thurston et al., 2012). Cytosolic bacteria also get ubiquitylated and the 
ubiquitin deposited on S.Typhimurium is detected by NDP52, p62, and Optineurin 
(Fig.10.2). The three autophagy adaptors bind LC3 on the autophagosome to target 
their ubiquitylated cargo (the bacteria) to autophagy (von Muhlinen et al., 2012; Wild 
et al., 2011; Zheng et al., 2009). The M1-linkage type specifically synthesised by 






Figure 10: Antibacterial pathways targeting intracellular Salmonella 
Typhimurium 
S.Typhimurium enter cells in a SPI1-dependent phagocytosis and reside in vacuoles. (1) 
Galectin-3, -8 and -9 detect glycans exposed on the damaged membrane of the SCV. 
Galectin-8 recruits NDP52, which interacts specifically with LC3C conjugated to the 
autophagosomal membrane, targeting the damaged membrane and associated bacterial cargo 
to autophagy. (2) Ubiquitin deposited on cytosolic S.Typhimurium is detected by NDP52, p62 
and Optineurin. The three autophagy adaptors bind LC3 on the autophagosome to target their 
ubiquitylated cargo to autophagy. (3) Ubiquitin deposited on cytosolic S.Typhimurium is 
bound by LUBAC, which synthesises linear ubiquitin chains recruiting the cargo receptor 
Optn and via interaction with LC3 target the bacteria for autophagy. Alternatively, M1-Ub 




Despite the multiple strategies by which host cells attempt to contain and clear 
bacterial infection, a minor fraction of cytosolic S.Typhimurium escape autophagy 
and can replicate extensively. Infected cells also detect the presence of Gram-negative 
bacteria via lipopolysaccharides (LPS) present on their outer membrane. Gram-
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negative bacteria constitutively produce outer-membrane vesicles (OMVs), small 
spherical bilayered nanostructures (Fig.11.1) that reflect the composition of the 
parental cell membrane and the periplasm (Rüter et al., 2018; Yoon, 2016) and 
therefore carry LPS, a major constituent of the bacterial outer membrane (Whitfield & 
Trent, 2014). OMVs are involved in intra- and inter-species communication as well as 
regulation of inflammation. They act as a delivery system either by direct contact or at 
a distance (Yoon, 2016) and provide a protected environment for the transport even of 
hydrophobic components to their target (Bonnington & Kuehn, 2014). OMVs can be 
taken up into host epithelial cells via clathrin-mediated endocytosis and LPS becomes 
exposed in the cytosol (Vanaja et al., 2016) likely upon early endosome membrane 
rupture (Fig.11.1), even though the exact mechanism is unknown (Broz, 2016) and 
consequently activates the non-canonical inflammasome. In the case of uptake of 
living S.Typhimurium (Fig.11.4) within the host cell, the SCV may break open and 
release the bacteria and their associated LPS in the cytosol (Finethy et al., 2017). 
There is also increasing evidence suggesting that IFN-γ-induced guanylate-binding 
proteins (GBPs) participate in the lysis of the vacuole (Meunier et al., 2014), control 
intracellular detection of LPS (Santos et al., 2018) and promote LPS-mediated 





Figure 11: Infection with Gram-negative bacteria results in LPS becoming 
cytosolic 
LPS can access the cytosolic compartment through different mechanisms. (1) Gram-negative 
bacteria produce outer-membrane vesicles (OMVs) in the extracellular environment and these 
OMVs can be endocytosed. Free extracellular LPS molecules can either (2) bind to HMGB1, 
followed by the complex interacting with RAGE or be delivered to CD14 by LBP, promoting 
the recognition by the MD2-TLR4 complex. In both (2) and (3) the receptors are taken up into 
endosomes. LPS-containing endosomes (scenario 1, 2 or 3) may release LPS in the cytosol, 
most likely before fusion with lysosomes and degradation. (4) Gram-negative bacteria also 
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enter cells and reside in vacuoles, which occasionally break open, exposing the LPS to the 




Extracellular LPS can be internalised following two distinct pathways (Fig.11.2 and 
11.3). The alarmin HMGB1 released by hepatocytes binds to LPS and triggers its 
uptake by macrophages via the receptor RAGE (Deng et al., 2018). The complex 
LPS-HMGB1 destabilises the endosomal membrane leading to the release of LPS in 
the cytosol (Rathinam et al., 2019) (Fig.11.2). Finally, extracellular LPS triggers 
immune response in a TLR4-dependent fashion (Fig.11.3). LPS-binding protein 
(LBP) is secreted by gastrointestinal tract epithelial cells and its expression is induced 
upon infection to act as an acute phase serum glycoprotein (Hansen et al., 2009; 
Vreugdenhil et al., 2000). LBP binds LPS micelles and has the ability to remove LPS 
molecules from either OMVs or the bacterial surface (Miyake et al., 2006; Steimle et 
al., 2016). LBP transfers individual LPS molecules to soluble or GPI-anchored CD14 
and/or directly to MD2. Both LBP and CD14 act as catalysts for the transfer of LPS to 
the heterodimeric complex MD2-TLR4 (Fenton & Golenbock, 1998; Ryu et al., 2017; 
Tsukamoto et al., 2018). Upon delivery of LPS to MD2, two MD2/TLR4 dimers 
oligomerise to form the active signalling complex. The CD14-LPS-MD2/TLR4 
complex is then internalised (Zanoni et al., 2011) and potentially leads to cytosolic 
release of LPS (Fig.11.3). The downstream, LPS-triggered, TLR4-mediated responses 
may vary between cell types: e.g. induction of cytokine production in intestinal 
epithelial cells or promotion of T cell adhesion to prevent chemotaxis. LBP also 
induces NF-κB signalling and cytokine production by enhancing TRIF-TRAF6 
association, and inflammatory response by stimulating ERK and p38 MAPK 




T.gondii are protected in vacuoles which, although they do not display many host 
proteins to be recognised by the host cell, can still be targeted and initiate host 
defence mechanisms. TLR signalling pathways provide the first line of defence 
against pathogens. The TLR adaptor molecule MyD88 (Scanga et al., 2002) 
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association with TLR11 (Yarovinsky et al., 2005) was shown to be critical for the 
production of IL-12 following T.gondii infection in mouse dendritic cells. Moreover, 
TLR7 and TLR9 can sense RNA and DNA, respectively, from T.gondii in mice 
(Andrade et al., 2013). Overall, T.gondii infection induces the production of many 
cytokines such as IL-12, IL-6, IL-1, TNF-α (Deckert-Schlüter et al., 1995), resulting 
in activation of NK and T cells, as well as the subsequent release of IFN-γ (Gazzinelli 
et al., 1993). Activated human cytotoxic T cells release granulysin to destroy the 
PVM and pore-forming perforins that allow secretion of granzymes leading to the 
activation of caspases in infected cells (Krishnamurthy et al., 2017). Additionally, the 
production of chemokines leads to the migration of neutrophils and monocytes to the 
location of infection (Biswas et al., 2015). 
 
In addition to eliciting signalling pathways, parasitophorous vacuoles of T.gondii also 
recruit autophagy-related proteins. The TNF-α-dependent conjugation of LC3 enables 
restriction of T.gondii infection in vitro and in vivo (Choi et al., 2014) and fusion of 
the PV with lysosomes (Krishnamurthy et al., 2017). The autophagy cargo receptor 
p62 is also recruited to T.gondii by K48-Ub chains. P62 partially participates in 
TRAF6 and TRIM21 recruitment and is required for the delivery of GBPs to the PV 
(Haldar et al., 2015; Saeij & Frickel, 2017), promoting host survival (Foltz et al., 
2017). 
 
In IFN-γ treated cells, ubiquitylated PVs are engulfed in LC3-decorated bilayered 
vacuoles (Selleck et al., 2015). IFN-γ-primed MEF cells require IRG proteins and the 
E3 ligase TRAF6 for the ubiquitylation of the T.gondii PVM. In addition, IFN-γ 
promotes restriction of T.gondii replication (Haldar et al., 2015). IRG proteins can 
directly lyse the PV thereby exposing the parasites into the cytosol to autophagy-
mediated clearance (Ling et al., 2006). In human cells, the IFN-γ-dependent K63-
linked ubiquitylation results in endo-lysosomal fusion of the PV and impaired 
T.gondii replication (Clough et al., 2016). Furthermore, the IFN-γ- and GBP1-
dependent PV lysis in THP-1 cells (Fig.12.B) results in loss of integrity of the PVM 





Figure 12: Host immune proteins target Toxoplasma gondii 
(A) The parasitophorous vacuole can be ubiquitylated and recruits the autophagy cargo 
receptor p62, as well as LC3 proteins. (B) In IFN-γ primed cells, the vacuole is targeted by 




During either S.Typhimurium or T.gondii infections, host cells trigger multiple 
processes to restrict proliferation and clear the pathogens. Initially, the pathogenic 
threat is detected: TLR signalling pathways are activated to promote cytokine 
production. The TLR4/MD-2 dimer detects the presence of bacterial LPS, whereas 
T.gondii is sensed by TLR11/MyD88 system. Both the SCV and the PVM are 
targeted by autophagy-related proteins and recruit LC3 proteins and cargo receptors. 
In both types of infection, the vacuole can be ruptured to expose the pathogen to the 
host cell cytosol, where additional detection processes and clearance mechanisms take 
place – e.g. ubiquitylation. Vacuole lysis seems mostly driven by IFN-γ-induced 
GBPs. IFN-γ, NF-κB and TNF-α signalling pathways are critical to promote 
microbicidal mechanisms and cytokine production for the recruitment of professional 
immune cells and activation of adaptive immunity. 
 
Many human immune defence mechanisms against infections can be modelled and 
studied in mice. However, some drastic interspecies differences can be noticed. For 
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example, humans cope with T.gondii infections and most people are asymptomatic 
whereas the parasite makes mice lose fear of cats to reach their definitive host. 
 
 
1.2.4 Microbial effectors for a successful host invasion 
Most pathogens secrete effectors not only to enter the host cell but also to subvert host 
cell mechanisms and to inhibit cell defence mechanisms. This section presents 
strategies employed by S.Typhimurium and T.gondii to establish infection. 
 
S.Typhimurium do not possess genes that encode for ubiquitin. Nevertheless, they 
have E3 ligase-like effectors that hijack the host’s ubiquitylation machinery to their 
own advantage. This modulates inflammatory signalling, suggesting that 
inflammation is an important component of both bacterial pathogenesis and 
antibacterial immunity. For example, the S.Typhimurium effector SopA, a HECT-like 
E3 ligase (Fig.2), modulates host inflammation (Zhang et al., 2006) by ubiquitylating 
TRIM56 and TRIM65, two host E3 ligases involved in the production of the pro-
inflammatory cytokine IFNβ (Fiskin et al., 2017; Kamanova et al., 2016). 
S.Typhimurium also produces novel E3 ligases (NEL), such as SspH1 or SspH2 
(Quezada et al., 2009). Their catalytic activity is achieved by a single conserved 
cysteine residue that is essential for the formation of a HECT-like ubiquitin-E3 
intermediate; this is also the case with the Shigella flexneri effector IpaH9.8, the 
SspH1 homolog (Rohde et al., 2007; Singer et al., 2008; Zhu et al., 2008). SspH1 
seems to reduce inflammation by inhibiting NF-κB-induced genes, whereas SspH2 
activates inflammation via NOD-1 signalling (Bhavsar et al., 2013; Haraga & Miller, 
2006). Bacterial pathogenesis is possible by both promoting and dampening pro-
inflammatory responses in order to both antagonise and benefit bacterial growth, 
thereby sparing or hijacking the host. Another effector, SipB, adds to the 
inflammatory state by activating Caspase-1, thereby inducing production of pro-
inflammatory cytokines IL-1β and IL-18 (Hersh et al., 1999). 
 
S.Typhimurium pathogenicity islands (SPI) encode needle-like structures that 
penetrate the cellular membrane and secrete bacterial effector molecules into the host 
(Kubori et al., 1998), some of which are essential for vacuolar uptake and maturation. 
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Release of SopB in the cytosol, for example, recruits the Ras-related protein RAB5 
that promotes fusion of early endosomes to the SCV (Mallo et al., 2008). Other 
proteins ensure that SCV maturation down the endolysosomal pathway is stalled 
(Garcia-Del Portillo & Finlay, 1995; Méresse et al., 1999), to prevent fusion with 
lysosomes and bacterial degradation (Goren, 1977). 
 
 
T.gondii also release effectors to build the vacuole and hijack pathways in the host 
cell. Despite sharing a common organisation and structure, numerous strains of 
T.gondii have been identified and classified into three clonal lineages: type I (e.g. RH 
or GT-1), type II (e.g PRU of ME-49), and type III (e.g CEP or VEG). They differ 
genetically by no more than 1% but show substantial differences in terms of virulence 
– growth rate, migration ability – and variations in their effectors repertoires, which 
lead to various changes in the host’s metabolism as a strategy for T.gondii to survive, 
spread, and/or kill the host cell (Saeij et al., 2005). 
 
Regardless of the strain, T.gondii discharge micronemal proteins, such as dense 
granule proteins (GRAs) and rhoptry proteins (ROPs) from apical secretory organelles 
in the host cytoplasm. The micronemal proteins play a major role in stimulating 
immunity (Scorza et al., 2003; Weilhammer & Rasley, 2011) and therefore are 
considered as vaccine therapies (Rezaei et al., 2019). ROP17, ROP5, and GRA3 (for 
example), were shown to be implicated in virulence differences in murine infection 
(Jones et al., 2017). Type I and type III T.gondii strains produce ROP16, which can 
phosphorylate STAT-3 (Yamamoto et al., 2009) and STAT-6 (Ong et al., 2010), 
thereby inducing IL-4 and IL-6 production, which results in IL-12 inhibition. ROP16 
is not the only means by which T.gondii avoid host immune defence: infection 
disrupts IFN-γ signalling via blockade of Stat-1 (Kim et al., 2007) and also prevents 
cell death in order to preserve the replicative and nutrient-rich environment for the 






This thesis describes a project directed towards the investigation of the molecular 
basis of cell-autonomous immune response to infection by pathogenic 
microorganisms and using genetic screens to identify some of the proteins involved. 
Specifically, the research focuses on the function of interferon gamma (IFN-γ) in 
mediating the cell-autonomous immune response to two major human pathogens, 
namely Salmonella enterica serovar Typhimurium and Toxoplasma gondii.  
IFN-γ is a cytokine that regulates multiple signalling pathways for both the innate and 
the adaptive immune responses and that modulates many genes involved in anti-
pathogenic mechanisms. IFN-γ is required for the restriction of T.gondii growth and 
in antibacterial processes, such as upregulation of inflammasome proteins and 
inflammatory caspases. This project investigates the IFN-γ-induced protein 
recruitment on T.gondii by studying the nature and the function of this recruitment. 
This thesis also intends to unravel the IFN-γ-dependent cell death mechanism that 
occurs in the presence of cytosolic S.Typhimurium LPS in human cells. The CRISPR-
Cas9 technology was employed to this end and is discussed in detail below. 
 
 
The specific aims of this research project are to: 
 
1. Identify IFN-γ-induced genes required for cell death in response to cytosolic 
lipopolysaccharide (LPS) using a whole genome CRISPR screen in human HeLa 
cells. 
2. Investigate the recruitment and role of the LUBAC complex and autophagy 
cargo receptors during Toxoplasma gondii infection in IFN-γ-stimulated mouse 
embryonic fibroblasts. 
 
The results of these two aims are covered in Chapters 2 and 3 respectively. Chapter 4 






Chapter 2: A genome-wide screen to identify 
IFN-γ induced genes required for cell death in 
response to cytosolic LPS 
2.1 Introduction  
This introductory section presents some background on how an immune response to 
LPS occurs in both mice and humans and discusses the role of IFN-γ in that response 
mechanism. This is important because this chapter details a new methodology to 
investigate the cell death pathway triggered by cytosolic LPS in IFN-γ primed human 
cells. 
 
2.1.1 Immune responses to cytosolic lipopolysaccharide (LPS) 
Cytosolic LPS is recognised by murine caspase-11 and human Caspase-4 and, to a 
lesser extent by Caspase-5 (Shi et al., 2014). Human Caspase-4 is expressed 
constitutively (Shi et al., 2014) whereas in most murine cells caspase-11 is induced by 
proinflammatory signals (Russo et al., 2018); the promoter region of the caspase-11 
gene contains NF-κB and STAT1 binding sites (Schauvliege et al., 2002). Depending 
on whether the species is mouse or human, there are also some differences in terms of 
binding and cell death activation: for example, CASP4 can bind tetra-acylated LPS, 
whereas Casp11 cannot (Lagrange et al., 2018). The caspase-11-activating form of 
LPS is the hexa- or penta-acylated Lipid A (Hagar et al., 2013).  
 
Both Casp11 and CASP4 mediate cell death following transfection or electroporation 
of LPS, whereas CASP5 only plays a role in infection itself (Shi et al., 2014). Binding 
of caspases (-11 or -4) to LPS activates the non-canonical inflammasome resulting in 
cell death by pyroptosis (Kayagaki et al., 2015). Caspases are activated by auto-
proteolysis in an induced-proximity model (Salvesen & Dixit, 1999). Oligomerised 
and active caspases process their target substrates, such as GSDMD leading to 




Casp11 was shown to protect mice against infection but is also responsible with 
GSDMD for LPS-induced endotoxic shock (Hagar et al., 2013). Both Casp11 and 
GSDMD are required, respectively for the non-canonical activation of the NLRP3 
inflammasome (Kayagaki et al., 2011), and the secretion of mature IL-1β and IL-18 
following Caspase-1-mediated cleavage of their pro-IL forms. 
 
 
2.1.2 The role of IFN-γ 
Cell death was observed when murine bone marrow derived macrophages (BMDMs), 
or human THP-1 or HeLa cells, were incubated with outer membrane vesicles 
(OMVs) from E.coli. OMVs act as LPS transporters from the extracellular 
compartment to the cytosol (Vanaja et al., 2016). Pyroptosis is triggered by free 
cytosolic LPS in human and murine macrophages and non-monocytic cells. It seems 
that IFN-γ potentiates the inflammatory immune response to infection, and somewhat 
to LPS transfection, at least in macrophages (Shi et al., 2014; Yang et al., 2015).  
 
When human monocyte cell lines such as U937 and THP-1 were electroporated with 
E.coli LPS, cell viability was significantly reduced when compared to non-treated 
cells or to cells electroporated with bacterial cell wall fragment muramyl dipeptide 
(MDP). This LPS-triggered cell death was also observed in other human cell lines 
such as HaCaT or HL60. It was also noticed that priming with IFN-γ in mouse 
macrophages enhanced cell death upon LPS electroporation (Shi et al., 2014). 
 
Electroporation provides an artificial means of introducing LPS directly into the 
cytosol. In a more physiological situation, LPS can be exposed in the cytosol 
following infection with Gram-negative bacteria. LPS is indeed a major component of 
Gram-negative bacteria’s outer membrane. For example, S.Typhimurium enter the 
host cells triggering their own phagocytosis, residing in Salmonella-containing 
vacuoles (SCV), which in some instances break open exposing the bacteria to the 
cytosol, exhibiting their outer membrane and hence their LPS. 
It is not known whether infection with living bacteria lead to activation of the non-




It is worth further investigating the requirement of IFN-γ in triggering cell death in the 
case of either LPS transfection or infection with living S.Typhimurium. This chapter 
will address the role of IFN-γ in the LPS-triggered cell death pathway as it might have 
been previously overlooked. 
 
 
2.2 Results: A novel role for IFN-γ in LPS-triggered cell 
death 
This section covers preliminary experiments that led to investigate in more details the 
IFN-γ-dependent, LPS-triggered cell death pathway in human HeLa cells. 
Observations and conclusions drawn from these experiments pointed out the 
incomplete understanding and knowledge about this cell death mechanism. 
 
2.2.1 Cytosolic LPS triggers cell death 
This first paragraph focuses on the phenomenon which will become the subject of 
investigation for the entire chapter, namely LPS-triggered cell death in IFN-γ-primed 
cells. It shows that studying the impact of cytosolic LPS can be an appropriate model 
for S.Typhimurium infection. 
 
2.2.1.1. S.Typhimurium triggers cell death in IFN-γ-primed HeLa cells 
Infections with living S.Typhimurium rarely leads to cell death because 
S.Typhimurium-triggered cell death requires both IFN-γ and for the S.Typhimurium 
to be cytosolic.  
 
To test whether priming with IFN-γ enhances cell death, HeLa cells were transfected 
with LPS and bacterial lysate – both from S. Typhimurium – or infected with the 
bacteria (Fig.1A). Propidium iodide (PI), a red, membrane-impermeable, DNA 
intercalating dye (fluorescent upon DNA binding) was used as a marker of cell death 
because it is only taken up by dead or dying cells. After 5h, the number of dead cells 
(those with PI-positive nuclei) was counted by microscopy. There was hardly any cell 
death produced by either bacterial infection or lysate and LPS transfections. However, 
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in cells primed with IFN-γ overnight, cell death reached 12%, when infected with 
living S. Typhimurium, and 11% and 5% when transfected with lysate and LPS, 
respectively. Even though percentages of dead cells were lower when transfecting 
cells with lysate or LPS, it seemed that both S. Typhimurium lysate and LPS could 
reproduce (to a limited degree) the IFN-γ dependent cell death phenotype observed 
upon S. Typhimurium infection. 
 
 
Figure 1: Treatment with S. Typhimurium, Gram-negative bacterial lysates or 
LPS lead to cell death in IFN-γ-primed HeLa cells  
HeLa cells were (A) either infected with live S. Typhimurium or transfected with either 
S.Typhimurium LPS, or lysate or (B) transfected with commercial E.coli LPS, or bacterial 
lysates from different bacterial strains - including Gram-negative and Gram-positive bacteria. 
Cell death was measured by microscopy counting of PI-positive nuclei at 5h post-
infection/transfection. Data are shown as Mean ± S.E.M of three coverslips and show cells 
primed overnight with IFN-γ (+) compared to cells grown in standard conditions (-). 





This experiment indicates that LPS alone could model S. Typhimurium infection 
when investigating the IFN-γ-induced cell death pathway, in contrast to earlier work 
showing that IFN-γ was not required for cell death upon E.coli LPS electroporation 
(Shi et al., 2014). Certainly, the work using E.coli LPS (Shi et al., 2014) employed 
electroporation (physical method), whereas in this experiment, S.Typhimurium lysate 
or LPS were transfected (requiring the use of chemicals like Lipofectamine). Because 
the bacterial strains (E.coli or S.Typhimurium) used were different, the question of 
bacterial species specificity is addressed in Section 2.2.1.2 with regards to triggering 
cell death in IFN-γ-primed HeLa cells. 
 
 
2.2.1.2. Cell death following bacterial lysate transfection is specific to 
Gram-negative strains 
The previous experiment used lysates and LPS from S. Typhimurium; however, the 
cell death phenotype had been reported for other bacterial species such as E.coli (Shi 
et al., 2014). The investigation was therefore extended to include a broader range of 
bacterial lysates to investigate whether this cell death pathway is specific to 
S.Typhimurium. To test the species specificity of this cell death phenotype, cells were 
transfected either with LPS from E.coli or with lysates from Gram-negative or Gram-
positive bacteria (Fig.1B). These lysates originated from both invasive bacteria (e.g. 
Shigella flexneri, Salmonella enterica, Listeria monocytogenes, Streptococcus 
pyogenes) and non-invasive bacteria (e.g. ΔSPI S.Typhimurium, EPEC, Listeria 
innocua). 
 
At 5h post-transfection, cells were stained with PI and cell death was assessed, by 
using microscopy to count the number of PI-positive nuclei (indicative of dead cells) 
within each sample. In the absence of IFN-γ priming, no cell death was observed 
(Fig.1B). However, when cells were treated overnight with IFN-γ, transfection with 
E.coli LPS or Gram-negative lysates led to a degree of cell death. A dose-response 
was observed with the two amounts of E.coli LPS used: increasing the LPS quantity 
by 5-fold (from 2μg/mL to 10μg/mL), led to a 3-fold increase (from 8% to 24%) in 
cell death. All lysates from Gram-negative bacteria showed a cell death phenotype 
with between 17% and 24% of PI-positive nuclei in cells primed overnight with IFN-
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γ. By contrast, none of the cells transfected with lysates from Gram-positive bacterial 
strains died, even following IFN-γ treatment.  
 
In summary, with either LPS or Gram-negative bacterial lysates, the cell response 
shows a pronounced cell death phenotype when primed with IFN-γ. However, Gram-
positive bacterial lysates did not show a similar effect and cells appeared to be non-
responsive to those strains, even when primed with IFN-γ. Because Gram-positive 
bacteria do not display any LPS on their membrane, this experiment confirms the 
hypothesis that the trigger is LPS itself, and also shows that IFN-γ priming is required 
for the cell death to occur. 
 
 
2.2.1.3. The LPS O-antigen is not necessary to trigger cell death 
It is possible that the length of the LPS chains present on bacteria was an important 
factor in triggering the cell death pathway. LPS is a polymer of sugars bound to Lipid 
A, and so the number or location of these sugar subunits could be important for 
recognition and initiation of the cell death pathway. 
 
To explore this further, lysates of S.Typhimurium mutants that lacked a range of 
enzymes required for LPS biosynthesis (and hence expressing LPS of various lengths 
on their outer membrane) were tested (Fig.2A). The LPS chains were truncated in 
order to identify a minimal fragment sufficient to trigger cell death. HeLa cells were 
then transfected with the range of bacterial lysates containing different lengths of LPS 
using Lipofectamine2000.  
At 5h post-transfection, cells were trypsinised and stained with propidium iodide. PI-
negative cells were counted by flow cytometry to express the percentage of surviving 
cells after the treatment (Fig.2B). In comparison to the control cells (no transfection), 
commercial LPS and all the lysates triggered significant (p-value < 0.01) cell death 
when cells were primed with IFN-γ. LPS and lysate from wild-type bacteria resulted 
in 40% cell death, whereas transfection with the various lysates with LPS having 
truncated sugar chains led to higher cell death, averaging 60% (p-value < 0.05), when 
cells were primed with IFN-γ.  
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No major difference in the cell death was noticed as the LPS chain length decreased 
from ΔrfaL to ΔrfaF mutants (Fig.2A). This suggests that the region of the LPS 
required for recognition and for triggering the cell death signalling pathway lies 
within the shortest chain type: namely, that produced by the ΔrfaF mutant strain. It 
has been shown previously that even Lipid A itself (Kayagaki et al., 2013) is 
sufficient to bind murine caspase-11 (homologous to human Caspases-4 and -5), 
which is thought to be the effector of cell death (Yi, 2017).  
 
 
Figure 2: The O-antigen and most of the external sugars of LPS are not required 
to trigger cell death in IFN-γ-primed HeLa cells  
(A) Mutant bacteria lacking the indicated enzymes produce LPS of different lengths, and their 
lysates were used to transfect HeLa cells. (B) The percentage of surviving cells was 
calculated based on the number of PI-negative cells detected by flow cytometry at 5h post-
transfection. Data are shown as Mean ± S.E.M of two independent experiments each run in 
duplicates. *P<0.001, **P<0.0001, one-way ANOVA with Dunnett’s multiple comparisons 






In summary, the O-antigen and most of the external sugars of the outer core do not 
appear to be necessary for IFN-γ-dependent, LPS-triggered, cell death in Hela cells. 
Instead Lipid A associated with the two keto-deoxyoctulosonate (Kdo) and one 
heptose (Hep) were sufficient to trigger cell death when transfected into HeLa cells 
primed with IFN-γ. 
 
 
2.2.2 Further characterisation of the LPS-triggered cell death 
phenotype 
This section collates additional background observations and exhibits key 
characteristics of the pathway, essential to understand the project. It emphasises the 
essential role of IFN-γ priming for the cell death to occur and explains the choice of 
HeLa cells as the study model. 
  
2.2.2.1. Measuring LPS-triggered cell death 
Two different methods were used to assess cell death in the wells. The first one relied 
on propidium iodide (PI) staining. PI is a DNA stain which binds to double-stranded 
DNA by intercalating between base pairs without sequence specificity. As it is 
membrane impermeable, it is normally excluded from viable cells. Counting the 
number of PI-negative cells in a given population allowed quantification of the 
percentage of surviving cells. However, this protocol required a lot of handling, 
pipetting and transfer of cells, which could lead to loss of cells and decreased 
accuracy in the results. Moreover, conditions were tested in a single 24-well in each 
experiment, not favouring reproducibility. Because of this lack of reproducibility, 
another method measuring the number of surviving cells was employed instead. 
 
The second method used CellTiter Glo reagent (Promega), which generates a 
luminescence signal when reacting with adenosine triphosphate (ATP). The signal is 
linearly related (Fig.3A) to the level of ATP produced – an indicator of metabolically 
active cells – which allows the percentage of viable cells to be quantified. CellTiter 
Glo reagent reacts within a few seconds and the luminescence signal produced is 
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stable for at least 20 minutes. Each condition was performed in triplicate. Figure 3B 
shows the percentage of surviving cells when seeded at different densities and 
analysed at either 5h post-transfection or on the day following transfection (i.e. 
overnight). As expected, cell death was observed only in cells treated with both IFN-γ 
and LPS. Following cell priming with IFN-γ, LPS transfection resulted in 65% or 
60% cell death with respectively 0.5x103 or 1.0x103 cells seeded in 96-well plates, 
when cells were analysed on the day after transfection and using the CellTiter Glo 
reagent. Result significance was assessed by calculating the p-value using ANOVA: 
CellTiter Glo detected significant (*p<0.001 and **p<0.0001) drops in cell survival 
when cells were primed with IFN-γ overnight and transfected with LPS on the next 
day. 
For the highest cell densities assayed (10x103 in 96-well plate format), the cell 
survival increased significantly and LPS transfection was no longer efficient in 
triggering cell death, even in IFN-γ primed cells. When the concentration of cells in a 
well was high, the transfection efficiency was likely decreased; additionally, it is 
unlikely that the IFN-γ priming was homogenous, meaning that not all cells were 
equally targeted. Because both LPS and IFN-γ are necessary to cause cell death, either 
of these problems could result in higher cell survival. 
 
Overall, the results obtained favoured the use of the CellTiter Glo reagent as an 
analysis method in order to obtain the most reproducible results (Fig.3A). Moreover, 
figure 3B shows that LPS-triggered cell death is cell density-dependent. For that 
reason, in future experiments 0.8-1.0x103 cells were seeded in a 96-well plate and 






Figure 3: The luminescence signal generated by Cell Titer Glo varied linearly 
with the number of live cells  
Cells were seeded at three different densities in a 96-well plate. Cells were ± primed with 
IFN-γ overnight followed by ± transfection with LPS the next day. After 5h, cells were either 
analysed (5h) directly with CellTiter Glo or grown overnight before analysis (o/n). (A) The 
luminescence signal was recorded for the different conditions and data from a representative 
experiment performed in triplicates are shown as Mean ± S.D. (B) The percentage of cells 
surviving after LPS transfection was calculated at 5h or overnight (o/n). Data from one 
representative experiment performed in triplicate are shown as Mean ± S.D. *P<0.001, 
**P<0.0001, one-way ANOVA with Dunnett’s multiple comparisons test comparing + IFN-γ 




A likely reason for the better reproducibility of the data obtained using the CellTiter 
Glo reagent (Promega), when compared to using PI staining, is probably a result of 
the experimental protocol. CellTiter Glo data were acquired based on technical 
triplicates within one experiment, whereas PI staining was performed with a single 
sample for each condition. This difference is a result of the large amount of handling 
and pipetting required for PI staining followed by flow cytometry analysis, which 
makes reproducibility increasingly difficult as the number of conditions and samples 
increases. Since the CellTiter Glo kit involved fewer steps of washing and pipetting, 
and since it could also accommodate internal replicates, the results were more 
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reproducible. As a result, validation experiments following the screen, were carried 
out using the CellTiter Glo protocol. 
 
Furthermore, the timing of the analysis impacts the measure of cell death. Using 
microscopy, at 5h post-transfection, only 5% of the cells transfected with 
S.Typhimurium LPS after overnight priming with IFN-γ and fixed and PI-stained 
were counted PI-positive (i.e. dead) (Fig.1A). By contrast, analysis with CellTiter Glo 
at 5h post-transfection showed 30% cell death (Fig.3B). This difference could be 
attributed to the timing of the analysis, as equilibrium might not have been reached at 
5h post-transfection. It was additionally observed that, independent of the method 
used to analyse the samples, the percentage of surviving cells was always lower when 
cells were washed at 5h post-transfection but analysed on the next day (overnight) 
rather than directly after the 5h-transfection period. For example, when 0.5x103 cells 
were seeded per well, primed with IFN-γ, transfected with LPS and analysed using 
CellTiter Glo: 70% of the cells were alive after 5h whereas only 35% survived 
overnight (Fig.3B). 
 
In summary, cell death was highest if measured after overnight incubation and 
showed more substantial differences with the controls. In addition, the signals 
obtained with CellTiter Glo were linear with the number of cells seeded initially 
(Fig.3A) and the linearity of the signal was retained after either IFN-γ priming or LPS 
transfection. In all four experimental conditions and at both analysis time points (5h 
or overnight), the luminescence intensities were linearly proportional to the number of 
viable cells in the wells. Consequently, in all the following experiments, cells were 
washed, and the medium changed at 5h post-transfection with the analysis using 
CellTiter Glo performed on the following day. 
 
2.2.2.2. Cell death is IFN-γ dependent 
Although electroporation of E.coli LPS did not require priming with IFN-γ to elicit 
cell death in macrophages (Shi et al., 2014) in the system investigated in the present 
study, LPS was introduced into the cytosol by lipid-mediated chemical transfection 
for entry of LPS in HeLa cells. The role of IFN-γ was therefore addressed with this 
experimental design. In contrast to the results obtained by electroporation, IFN-γ-
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priming was completely required in the case of either LPS transfection or bacterial 
infection (Fig.1A) to trigger cell death and it substantially enhanced cell death 
following lysates transfection (Fig.2B). In these experiments, HeLa cells were 
transfected with LPS after being primed overnight with IFN-γ (+ +) to ensure the 
requirement of both IFN-γ and cytosolic LPS for triggering cell death. As controls, 
cells were treated only with either Lipofectamine2000, either in the absence (- -) or 
presence (+ -) of IFN-γ priming, or with LPS (- +). The results demonstrate that the 
effect of LPS on cell survival in HeLa cells is indeed IFN-γ dependent (Fig.4). 
CellTiter Glo was used to assess cell survival after allowing cells to recover overnight 
after LPS-transfection. At 24h post-transfection, 50% cell death was recorded; by 
contrast, no cell death was observed in the presence of either IFN-γ alone or LPS 
alone (Fig.4). Only pre-treatment with IFN-γ elicited the LPS-induced cell death in 
HeLa cells and IFN-γ treatment on its own did not induce lethality (Fig.4). Moreover, 
LPS transfection did not produce a cell death phenotype in HeLa cells that were not 
primed with IFN-γ. Therefore, Lipofectamine was not the cause of mortality and it 




Figure 4: LPS-triggered cell death depends on both IFN-γ and cell line  
Human (HeLa, HFF, HCT116, 293ET) and mouse (MEF) cells were seeded in 96-well plates 
in the presence or absence of IFN-γ (human or mouse, as appropriate for the cell line). Next 
day, half were transfected with LPS. On the following day, both transfected and non-
transfected cells were analysed with CellTiter Glo. Data are shown as Mean ± S.D from a 






2.2.2.3. Cell death occurs only in certain cell lines 
Several human and one mouse cell lines were tested to explore whether the IFN-γ-
induced, LPS-triggered cell death was indeed cell-type dependent. Infectious bacteria 
initially encounter skin and mucous, which constitute the first immune barrier against 
pathogenic threats in susceptible organisms; therefore, HeLa (human cervical cancer 
cell line), HFF (human foreskin fibroblasts), and HCT116 (human colon cancer cell 
line) were chosen because they are cell types that make up physical barriers against 
pathogens and are thus physiologically relevant. 293ET (human embryonic kidney 
cells) and MEF (mouse embryonic fibroblasts) were also added to the panel for 
testing to provide insights on tissue- and species-specificity, respectively. 
  
All cells were seeded at similar densities and the same transfection conditions were 
used in each case. HCT116, HFF and HeLa cells showed an increasing response to 
LPS transfection with 20%, 30%, and 50% cell death respectively (Fig.4) when 
primed overnight with IFN-γ. However, no cell death was observed with 293ET and 
MEFs cells and there was no decrease in luminescence signal when cells were 
transfected with LPS, even after IFN-γ priming. It is important to note that the 
cultured cell lines originated from different initial stocks and could lose various 
pathways, including sensing of IFN-γ or LPS and/or certain cell death mechanisms. 
These differences might explain the observation that IFN-γ induced, LPS-triggered 
cell death is cell type dependent and that, within the cell lines tested, cell death 
occurred predominantly in HeLas. Consequently, all further experiments were 
performed using HeLa cells. 
 
In conclusion, Shao (Shi et al., 2014; Yang et al., 2015) showed cell death upon 
electroporation of LPS. However, in the experimental system used in the present 
study, in which LPS was instead transfected using a lipid-based reagent, IFN-γ was 
required for cell death (thought to be pyroptosis). Electroporation most likely allows 
transfection of monomeric LPS molecules in the cytosolic compartment, whereas 
lipid-based transfection creates LPS agglomerates delivering LPS in the cytosol in a 
less accessible form for recognition and binding of partner proteins. 
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In addition, S.Typhimurium-triggered cell death in IFN-γ-primed cells could be 
recapitulated by transfecting either Gram-negative bacterial lysates or purified LPS. It 
was also observed that different cell lines behaved differently in response to cytosolic 
LPS: IFN-γ-primed 293ET and MEF cells were found to be resistant whereas IFN-γ-
primed HCT116, HFF or HeLa exhibited increased cell death following LPS 
transfection. These results indicate that additional experiments are needed to unravel 
the mechanism of cell death following the cytosolic presence of LPS. Experiments 
described in Section 2.2.3 already give an indication on the role of Caspase-4 in the 
pathway, and Section 2.3 details a genome-wide genetic screening method employed 




2.2.2.4. LPS-triggered cell death occurs at similar levels in population and 
clones 
As shown earlier, different cell lines respond differently to LPS-transfection when 
primed with IFN-γ. HeLa cells were chosen because they exhibited most cell death, 
likely because they are the most sensitive to factors provoking cell death among all 
the cell lines tested. It was, however, thought prudent to check whether the lab stock 
of HeLa cells would behave differently than a clonal population that had been derived 
from a single cell. This was because even maximising the number of cells dying upon 
the combined treatment of IFN-γ and LPS transfection by optimising cell density, 
together with the amount of Lipofectamine2000 and LPS added to the well, was still 
not sufficient to get 100% cell death. This indicated that there was always at least 
20% of HeLa cells surviving the treatment. 
 
To investigate whether there was a genetic reason for this resistant population, cells 
derived from a single HeLa clone were tested (Fig.5). HeLa cells are indeed known to 
bear several copies of particular chromosomes and are polyploid rather than diploid. 
As a population, HeLa cells are genetically somewhat diverse and individual cells can 
contain several copies of genes. For that reason, it was thought that it might be more 
prudent to use a clonal population of cells with the aim of having a more homogenous 
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IFN-γ induced response to LPS transfection and, more importantly, a cell death 
greater than 80%. 
 
 
Figure 5: LPS similarly triggers cell death in IFN-γ-primed HeLa clones or 
population  
A population of HeLa cells or cells derived from individual clones were seeded in 96-well 
plates in the presence or absence of pre-treatment with IFN-γ. The following day, the cells 
were ± transfected with LPS and then analysed with CellTiter Glo on the next day. Results are 
shown as Mean ± S.D from a representative experiment run in triplicate for each condition. ns 
(not significant), using one-way ANOVA with Dunnett’s multiple comparisons test 





LPS transfection alone led to an average 20% cell death in the HeLa and all the clonal 
populations. As expected, this phenotype was aggravated by IFN-γ priming which led 
to 80% cell death, without any significant difference between the four cell lines 
tested. Only three clones are shown here because they are representative of the initial 
ten clones tested. All exhibited approximately 20% of surviving cells following IFN-γ 
priming overnight and LPS transfection. These resisting cells could be explained by 
insufficient transfection efficiency, which would limit the amount of LPS becoming 




In conclusion, employing a clonal population seemed unnecessary because none of 




2.2.3 Role of Caspase-4 and Gasdermin-D in the IFN-γ-dependent, 
LPS-triggered cell death pathway 
From previous studies, Caspase-4 (CASP4) and Gasdermin-D (GSDMD) appear to be 
promising candidates required in the IFN-γ-dependent cell death pathway triggered by 
LPS. Looking at the LPS-triggered cell death mechanism, F. Shao (Shi et al., 2014; 
Yang et al., 2015) showed that human CASP4, which is the homolog of murine 
caspase-11, binds to LPS and is required to generate cell death. V. M. Dixit 
demonstrated that caspase-11 cleaves GSDMD, leading to pyroptosis (Kayagaki et al., 
2015), which is an inflammatory but programmed form of cell death. In the Shao 
laboratory, characteristic pyroptotic features were indeed recognised in the cell death 
occurring after LPS treatment. 
 
To determine whether CASP4 and GSDMD were IFN-γ inducible, HeLa cells were 
grown overnight in the presence or absence of IFN-γ. Cells were then analysed by 
western-blotting to compare expression at the protein level. Figure 6 shows blots for 
CASP4 (Fig.6A) and GSDMD (Fig.6B). CASP4 expression was increased in cells 
primed with IFN-γ compared to controls: this is in accordance with previous work 
(Lin et al., 2000). In the case of GSDMD, the induction by IFN-γ was much more 
pronounced than was seen with CASP4. Treatment with siRNA was able to knock-
down the expression of GSDMD, irrespective of whether cells were primed with IFN-





Figure 6: IFN-γ induces both CASP4 and GSDMD 
Expression levels of Caspase-4 (A) and Gasdermin-D (B) were assessed by western-blotting 
comparing expression levels upon IFN- priming. For CASP4, untransfected HeLa cells were 
tested; for GSDMD, HeLa cells transfected with either non-targeting siRNA (siCtrl) or 




CASP4 binds to LPS (Shi et al., 2014) and GSDMD proteins assemble and form 
pores (Broz & Monack, 2011) in the plasma membrane. This, combined with the fact 
that they are both induced by IFN-γ treatment, suggested to examine their precise role 
in the IFN-γ-induced, LPS-triggered cell death pathway.  
 
 
2.2.3.1. Caspase-4 is necessary for LPS-triggered cell death upon IFN-γ 
priming 
To test whether CASP4 was required in the cell death pathway, it was first knocked-
out using three different guides (gRNA 1B-1D) in Cas9-expressing HeLa cells. Since 
cell death is IFN-γ dependent, the IFN-γ receptor 1 (IFNGR1) was chosen as a 
positive control because interference with upstream signalling should prevent cell 
death. IFNGR1 was knocked-out using four different gRNAs (gRNA 5A-5D). The 
role of GSDMD was also tested at the same time and was knocked-out by four guides 
(gRNA 3A-3D).  
The extent of the knockouts of CASP4 and GSDMD were established using western-
blots (Fig.7A) and showed variable levels of success depending on the gRNA used. 
IFNGR1 knockouts were not tested as the specific antibody was not available. Full 
knockouts (i.e. total absence of protein on the western-blot) were obtained with 
gRNAs 1B, 1C and 3C for CASP4 and GSDMD, respectively; the GSDMD western-
blot indicated that knockout with guides 3A, 3B, 3D were incomplete as shown by the 
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residual band. All stable Cas9-expressing cell lines treated with gRNAs against 
CASP4, GSDMD and IFNGR1 were challenged with LPS (+/- IFN-γ priming). Cell 
death was assessed using the CellTiter Glo reagent and comparing cell survival in 
knockouts with cells stably expressing Cas9 as a negative control.  
In the control population, approximately 38% of the cells survived (Fig.7B). By 
contrast, IFNGR1 knockout cells were substantially more resistant to IFN-γ-induced, 
LPS-triggered cell death, with 90% of these cells surviving the combined treatment. 
CASP4 knockout cells (gRNAs 1B and 1C, Fig.7A) also showed significant increased 
survival, with respectively 90% and 70% of IFN-γ-primed cells surviving, following 
LPS-transfection. For GSDMD, gRNA 3C led to 60% of cells surviving, which was 
statistically, a non-significant effect.  
 
In conclusion, only CASP4 appeared to be necessary for the IFN-γ-induced, LPS-
triggered pyroptotic cell death pathway because the resistance to cell death provided 
by the two knockouts was significant when compared with the control cells. This is in 
contrast with GSDMD, for which the knockout did not show a statistically significant 










Figure 7: Following priming with IFN-γ, Caspase-4 contributes to LPS-triggered 
cell death  
Three genes – IFNGR1, CASP4 and GSDMD – were either knocked-out using CRISPR-Cas9 
and multiple gRNAs or knocked-down using pooled siRNAs. The efficiency of the knockouts 
(A) and knock-downs in cells treated with IFN-γ overnight (C) were assessed by western-
blotting. Knockout (B) and knock-down (D) cells were treated by ± priming with IFN-γ 
overnight and ± LPS transfection on the next day, and cell survival was assessed with 
CellTiter Glo on the following day. Results shown are from two experiments, each performed 
in triplicate, and are shown as Mean ± S.E.M in (B) and (D). *P<0.05, **P<0.005, 
***P<0.0002, ****P<0.0001, ns (not significant), one-way ANOVA with Dunnett’s multiple 
comparisons test comparing with the control condition (Cas9-cells for knockouts and non-




To complement these results and gain confidence in the results obtained with 
knockouts, a different method – RNA interference – was used to disrupt protein 
expression. The same genes, that is, IFNGR1, CASP4 and GSDMD were knocked-
down using pooled siRNAs – a mix of four siRNAs targeting a single gene – 
(Dharmacon). The negative control employed was a non-targeting siRNA, referred to 
as siControl (siCtrl). The efficacy of the CASP4 and GSDMD knock-downs in cells 
primed with IFN-γ was checked by western-blotting (Fig.7C). The levels of both 
CASP4 and GSDMD proteins were successfully abbrogated, as shown by the absence 
of the bands corresponding to these proteins compared with the control cells. With the 
combined treatment of IFN-γ and LPS, 35% of control cells survived. By contrast, 
85%, 75% and 50% survived in the IFNGR1, CASP4 and GSDMD knock-downs, 
respectively (Fig.7D). As expected, the resistance to cell death was more pronounced 
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in the IFNGR1 than in the CASP4 or GSDMD knock-down cells. CASP4 knock-
down showed a 2-fold increased survival (p<0.05), whereas GSDMD knock-down did 
not significantly improve cell survival compared with the non-targeting control. 
However, GSDMD knock-down cells exhibited death upon IFN-γ treatment alone 
(yellow bar) and no further increase in cell death was observed when transfecting LPS 
in these IFN-γ-primed cells. In this regard, the lack of GSDMD seems to have a 
protective role for the cytosolic LPS-triggered cell death, in IFN-γ-primed HeLa cells. 
 
Taken with the conclusions drawn from Figure 7A-B, these results suggest that 
IFNGR1 and CASP4 are both required for the IFN-γ induced, LPS-triggered cell 




2.2.3.2. Neither CASP4 nor GSDMD is sufficient to trigger pyroptosis in 
response to LPS transfection 
CASP4 is necessary for IFN-γ-induced cell death following LPS transfection. Τo test 
whether the upregulation of CASP4 or GSDMD would be sufficient to trigger LPS-
induced cell death (and hence to replace the IFN-γ induction), HeLa cells 
overexpressing various constructs for these two proteins were investigated.  
 
HeLa cells were first transduced and then cells were selected for their stable 
overexpression of three different CASP4 constructs that coded for wild-type (WT), 
impaired LPS-binding (K19E) and catalytically dead (C258A) CASP4 (Sollberger et 
al., 2012). These constructs were chosen to enable differentiation between the two 
main functions of CASP4: namely, LPS binding and catalytic activity. In addition, 
two different cell lines were constructed that expressed FLAG-tagged GSDMD with 
the tag located at either the N- or C-terminus of the GSDMD protein. These two 
constructs were tested to ensure the tag did not alter the protein’s behaviour. Because 
all the CASP4 and GSDMD constructs contained a FLAG tag, the levels of 
overexpressed proteins were assessed by western-blotting (Fig.8A) using a FLAG 
antibody. All constructs were expressed and the level of the CASP4 constructs on one 
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hand and the GSDMD constructs on the other hand were similar when normalised to 
their respective actin expression level. 
 
These five cell lines were tested in the LPS-transfection assay. Fresh medium was 
added at 5h post-transfection and samples were analysed with CellTiter Glo after 
overnight incubation. Wild-type HeLa cells were used as a negative control and 25% 
of the cells survived (Fig.8B). Overexpression of neither of the GSDMD constructs, 
the wild-type CASP4 nor the CASP4 mutant deficient for LPS-binding (K19E) 
significantly increase cell death in cells primed with IFN-γ when comparing with 
untransfected cells. The catalytically dead mutant CASP4 (C258A) showed a 
significant (p-value<0.05) increase in resistance to LPS transfection with 40% of cells 
surviving compared to only 25% in the control. 
 
In the absence of IFN-γ priming, overexpression of the C-terminal flag-tagged 
GSDMD led to a significant increase in cell death following LPS transfection, with 
40% cell death compared to 20% in the control. This was expected because GSDMD 
is strongly induced by IFN-γ and overexpressing it in cells essentially recapitulates 
IFN-γ upregulation. However, this effect on cell death only occurred when the C-
terminal tagged protein was overexpressed. In cells, the C-terminal part of GSDMD 
has an autoinhibitory effect (Ding et al., 2016) and when the protein undergoes 
cleavage by CASP4, the free N-terminal part oligomerises to form pores (Liu et al., 
2016; Chen et al., 2016) in the membrane and that results in pyroptotic cell death (Shi 
et al., 2015). A tag on the N-terminal part of the protein could therefore prevent 
oligomerisation and alter GSDMD function in the cell. The catalytically impaired 
CASP4 mutant (C258A) reproducibly displayed a minor dominant negative effect 
showing an increase in the percentage of surviving cells compared to the control. This 
observation is in line with the requirement of the catalytic activity of CASP4 in the 
IFN-γ-dependent cell death pathway initiated by LPS transfection. 
 
These results indicate that upregulation of CASP4 alone is not sufficient to generate 
cell death following LPS transfection and is unable to replace IFN-γ priming. 
GSDMD did not accentuate cell death in the presence of IFN-γ. However, in the 
absence of IFN-γ priming, overexpression of C-terminal tagged GSDMD was 
sufficient to induce cell death after transfection with LPS, and in levels comparable to 
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IFN-γ-primed control cells. This result demonstrates the requirement of GSDMD for 
LPS-induced pyroptosis. Neither of these two candidates – CASP4 and GSDMD – 
individually, fully accounts for the requirement of IFN-γ to trigger pyroptosis upon 
LPS transfection, indicated that, there must be other IFN-γ-induced genes needed in 
the LPS-triggered cell death pathway. 
 
 
Figure 8: Caspase 4 is not sufficient to trigger cell death following transfection 
with LPS 
A range of Flag-tagged CASP4 (WT - wild-type, C258A - catalytically dead, and K19E - 
impaired for LPS binding) and Flag-tagged GSDMD (at the N- or C-terminus) constructs, 
were expressed in HeLa cells. (A) Overexpression of the desired proteins (CASP4 or 
GSDMD) was confirmed by western-blotting using a Flag antibody. Cells overexpressing 
either CASP4 or GSDMD were subjected to ± priming with IFN-γ overnight followed by ± 
LPS transfection on the next day and cell death was assessed with CellTiter Glo at 18h post-
transfection; (B) Cell death from three separate experiments performed in triplicate are shown 
as Mean ± S.E.M. Results compared with the control condition (non-transfected HeLa cells) 
were evaluated using one-way ANOVA with Dunnett’s multiple comparisons test with 
*P<0.05 and ns (not significant). For each cell line, the effect of LPS transfection on cells 
(comparison between black and grey bars) and the effect of IFN-γ with LPS transfection (grey 
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and blue bars) were evaluated using one-way ANOVA with Dunnett’s multiple comparisons 
test with *P<0.05, **P<0.005, ****P<0.0001, ns (not significant).  




In summary, CASP4 and GSDMD were investigated as genes required in the IFN-γ-
induced, LPS-triggered cell death pathway because CASP4 is a receptor of free 
cytosolic LPS and GSDMD is an effector in pyroptosis. CASP4 was shown here to be 
necessary in the IFN-γ-induced, LPS-triggered cell death pathway although its 
overexpression failed to replace the IFN-γ induction. This was to be expected because 
both CASP4 knockout and knock-down only showed partial inhibition of pyroptosis. 
The function of GSDMD was not as straightforward. On the one hand, GSDMD 
knockout or knock-down displayed a limited effect in the LPS-induced pyroptosis of 
IFN-γ-primed cells: the increase in survival compared to control cells was not 
significant compared to effects seen with CASP4 or IFNGR-1 knockouts. On the 
other hand, LPS transfection in C-terminal FLAG-tagged GSDMD overexpressing-
cells resulted in cell death without IFN-γ priming and overexpression of GSDMD 
replaced the effect of IFN-γ. GSDMD is a known IFN-γ inducible protein (ratio of 
1.38 in the microarray performed by M. Wandel, Table 2) that is processed and 
cleaved to separate the N-terminal active region from the C-terminal inhibitory region 
of the protein (He et al., 2015; Shi et al., 2015); it was indeed observed that 
overexpression gave different results depending on the location (N- or C-terminal) of 
the FLAG tag.  
 
 
This entire section was dedicated to show the limitations of our knowledge about the 
IFN-γ-dependent, LPS-triggered cell death pathway in human HeLa cells. The next 
section of this chapter presents a new approach to investigate this mechanism further 





2.3 Results: Genetic screen to identify new genes in the 
IFN- dependent, LPS-triggered cell death pathway 
In order to investigate the IFN-γ-dependent, LPS-triggered cell death pathway, an 
unbiased genetic screen was set-up using the CRISPR-Cas9 technology. 
 
Identifying genes that influence a phenotype of interest is frequently achieved through 
genetic screening, a process by which individuals are tested to find out if they carry 
mutations in genes associated with a certain known phenotype. Genetic selection 
refers to a type of genetic screening that is designed so that only the desired mutants 
survive. Multiple techniques are available, and several strategies can be applied to 
perform a genetic selection assay, depending on the biological question under 
investigation (Shemesh et al., 2007; Yamamoto et al., 2009). 
 
Genetic screens are a powerful tool to investigate signalling pathways and understand 
molecular mechanisms. The immune system is a highly complex and connected 
network, and an approach that uses a genome-wide forward CRISPR screen permits 
the study of particular pathways of interest. 
 
 
2.3.1 Designing a genome-wide CRISPR screen 
This section presents the strategy that was used – genome-wide genetic screen - and 
justifies the technical choices made during the project – CRISPR-Cas9 in human 
HeLa cells - by comparison with other screening methods. It also shows the rationale 
of the design and some preliminary optimisations that were essential to check the 
feasibility of that study. 
 
2.3.1.1. Mutagenesis was achieved using the CRISPR-Cas9 technology 
To genetically investigate specific phenotypes, gene expression must be modified. 
Many techniques are available, and they all present advantages and drawbacks. In this 
case, the screen required the use of a targeted and highly specific method that could 




i. Targeted approaches 
In contrast to non-targeted approaches, targeting requires prior knowledge of the 
target sequence or genomic region. RNA interference (RNAi) offers a sequence-
specific, high-throughput knock-down method (Ngo et al., 2006) that could be applied 
on a genome-wide scale and causes loss-of-function in diploid cells, including human 
cells (Berns et al., 2004; Zuber et al., 2011). Gene expression is impaired post-
transcriptionally targeting mRNAs for degradation. RNAi efficiency is independent of 
gene copy number and does not create dominant negative mutants. However, the 
efficiency of a knock-down depends on the timing, the delivery method and the 
design of the si/shRNA (Maine, 2001); the RNAi technology suffers from high off-
target effects and potential incomplete knock-down (Boutros & Ahringer, 2008), 
which may cause residual protein expression and a low signal-to-noise ratio 
(Echeverri et al., 2006) making it hard to interpret results. 
 
In order to circumvent the disadvantages of RNAi and ensure protein loss-of-function, 
knockout methods using programmable nucleases have been developed and have 
recently undergone a revolution with the discovery of the CRISPR-Cas9 system. 
Programmable nucleases enable targeted genetic modifications and rely on site-
specific DNA double-strand breaks paired with cellular DNA repair mechanisms; 
consequently, the efficiency of both the homologous recombination (HR) and the non-
homologous end-joining (NHEJ) mechanisms is greatly enhanced (Rouet et al., 1994). 
In the absence of donor DNA, the error-prone NHEJ mechanism is predominant and 
thus creates site-specific gene disruption, deletion, and chromosomal rearrangements 
(Kim & Kim, 2014). 
 
ii. Programmable nucleases 
Irrespective of their type, programmable nucleases were developed and are now used 
to disrupt not only protein-coding genes but also non-coding elements. They all create 
site-specific DNA double-strand breaks (DSBs). Their specificity is based on 
sequence recognition, mechanism subject to off-target effects. 
 
Zinc-finger nucleases (ZFNs) consist of DNA-binding ZFPs (zinc-finger proteins), 
which contain a nuclease domain derived from the restriction enzyme FokI (Kim et 
al., 1996). Their activated dimer form can bind 9-18bp of the targeted gene (Fig.9.1), 
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depending on the number (3-6) of zinc-fingers (Wolfe et al., 2000); but ZFNs have 
overall a poor targeting density: all 64 combinations of triplet sites are not readily 
available in zinc-fingers assembly (Kim & Kim, 2014). Moreover, the rules 
explaining binding to the targeted DNA sequence are still to be resolved; the selection 
of a library cannot be done in silico.  
 
Transcription activator-like effector (TALE) are also DNA-binding proteins and are 
associated with a FokI-derived nuclease to form TALEN (Miller et al., 2011). TALEs 
contain amino acid repeats in which a pair of amino acids is responsible for the 
recognition of a specific nucleotide (Fig.9.2). It is possible to design TALENs in 
order to target specific sequences (Kim et al., 2013), but this becomes very time-
consuming. TALENs are the nucleases of choice for targeting small DNA sequences 
but require a thymine at the 5’ end of the target sequence (Lamb et al., 2013) and 
cannot cleave methylated DNA (Bultmann et al., 2012). 
 
RNA-guided engineered nucleases (RGENs) include, but are not restricted to, the 
Cas9 protein (Fig.9.3). Clustered regularly interspaced small palindromic repeats 
(CRISPR) are DNA fragments of invading phage or protospacers found integrated in 
the genome of bacteria or archaea (Barrangou et al., 2007). When armed with the 
RNA produced from the CRISPRs, RGEN – an essential component of adaptive 
immunity in these organisms – targets invading DNA. Cas proteins are activated by 
conformational change following the formation of a complex with cr-RNA and tracr-
RNA ((trans-activating) CRISPR RNA). They function as nucleases and the target 
specificity is carried by 20bp on the cr-RNA. The target sequence (20bp) is followed 
by the 3bp of the PAM sequence (protospacer adjacent motif), which is recognised by 





Figure 9: Three types of programmable nucleases 
Programmable nucleases are used for genome editing and can target coding or non-coding 
DNA sequences. Zinc-finger nucleases (1. ZFN) and transcription activator-like effector 
nucleases (2. TALEN) use the same enzyme FokI but the sequence recognition is mediated by 
either zinc-finger repeats (ZFP) or amino acid sequences (TALE). RNA-guided engineered 
nucleases (3. RGEN) require Cas9 and a sgRNA to generate a DNA double-strand break 




Generally, TALENs cleave non-methylated DNA regions with almost 100% 
efficiency in mammalian cells, similar to the success rate obtained with RGENs (Kim 
& Kim, 2014). However, mutation frequencies are very variable and range overall 
from 1% to 79% in cultured mammalian cells, with RGENs on the higher side of the 
window. In terms of specificity, all three methods rely on sequence recognition and 
are therefore subject to off-target effects (Fu et al., 2013; Mussolino et al., 2011; 
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Pattanayak et al., 2011). Because ZFNs are activated by dimerisation, they are 
expected to be more specific. RGENs are the most modular with respect to the variety 
of potential targets available, since it is easier to synthesise RNA than it is to 
modulate the number and nature of either ZnF for ZFNs or TALE in the case of 
TALENs (Kim & Kim, 2014). That is why although ZFNs and TALENs result in 
targeted mutagenesis at high frequencies, these techniques are not appropriate for 
genetic screens, lacking versatility and high-throughput in their application. 
 
 
2.3.1.2. The CRISPR-Cas9 technology 
The CRISPR-Cas system is an essential component of adaptive immunity against 
viruses and plasmids, widespread in bacteria and archaea. Prokaryotes have indeed 
evolved a small RNA-based detection and silencing mechanism targeting foreign 
nucleic acids whereby specificity is dictated by the CRISPR spacer content while the 
resistance is provided by the Cas enzymatic machinery (Barrangou et al., 2007). 
Following viral and plasmid challenges, short fragments of foreign nucleic acids are 
integrated in the host genome at one end of a repetitive element known as CRISPR. 
These repetitive loci provide resistance to subsequent phage infection in a sequence-
specific; phage sensitivity is dictated by the CRISPR composition (Wiedenheft et al., 
2012). 
 
CRISPR elements are transcribed and processed into a library of short CRISPR RNAs 
(crRNAs). When the Cas protein is associated with the two-RNA complex containing 
crRNA and trans-activating crRNA (tracrRNA), it acts as an endonuclease and 
generates double-strand breaks (DSBs), cleaving foreign nucleic acid sequences and 
hence protecting the host (Cho et al., 2013). The CRISPR-Cas machinery causes 
small, frameshifting insertions and deletions around the target sequence by means of 
error-prone non-homologous end joining (NHEJ) repair of the DSBs. 
 
To apply this system as a targeted mutagenesis tool, the two RNA elements were 
replaced by a chimeric single guide RNA. Association with the Cas9 protein led to 
cleavage in vitro (Jinek et al., 2012) and was further used as a sequence-specific 
genome-editing technique in mouse and human cell lines (Cong et al., 2013; Hart et 
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al., 2015; Wang et al., 2014) and even in vivo, e.g in bacteria, zebrafish (Jiang et al., 
2013; Hwang et al., 2013). 
 
The CRISPR-Cas methodology has been optimised for mammalian genetics and 
especially to carry out genome-wide screens in human cells (Shalem et al., 2014; 
Wang et al., 2014) to discover and study genes involved in cell fitness (Hart et al., 
2015), proliferation (Wang et al., 2014), viability of cancer or pluripotent stem cells, 
drug resistance (Shalem et al., 2014) or genes having an influence on the immune 
response (Parnas et al., 2015). 
 
The design of such a large-scale experiment requires careful planning and essential 
decision-making about the type of CRISPR single guide RNA (sgRNA) library to use 
(whole genome vs focused), the format of the screen (pooled or arrayed), the cell line 
to use to perform the screen (Miles et al., 2016).  
 
i. Pooled vs arrayed screens 
To perform a genome-wide screen, the layout preference is for a pooled library, rather 
than an arrayed library, of sgRNAs. Arrayed screens are run in plates where each well 
contains one or several guide(s) against a single gene, making the readout high 
throughput in the case of either positive or negative screens. By contrast, a pooled 
library allows sequencing of the collected population and is therefore easier to 
implement for a positive screen, provided the phenotype is selectable. Genome-wide 
CRISPR screens are theoretically possible with both types of assays (Agrotis & 
Ketteler, 2015); but in practice, cells are meant to express both Cas9 and one single 
gRNA at a time, and each gene needs targeting with multiple gRNAs. Consequently, a 
large number of cells is easier to handle than a large number of wells, rendering 
pooled libraries preferable. However, when the phenotype is not selectable for, 
arrayed assays (Kim et al., 2018) will then be used. 
 
ii. Genome-wide library 
In order to investigate a specific phenotype in an unbiased manner, a genome-wide 
pooled library is preferable. It targets the whole coding genome and allows more 
novel discoveries. A targeted library, by contrast, is narrower and biased by the choice 
of genes to be mutated. Multiple genome-wide human gRNA libraries have been 
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developed; these can differ by the number of genes they target, the number of guides 
targeting each gene, and whether the Cas9 protein is encoded by the same plasmid as 
the sgRNA. For instance, the sgRNA library described by Wang et al. (2014) includes 
73,151 guides targeting 7,114 genes (≈35% of the human protein-coding genome) and 
100 non-targeting controls. 
 
To reduce biases due to differences in sequence targeting and mutation efficiency 
between gRNAs, the library should contain a minimum of four gRNAs per gene. 
Adding more sgRNAs is primarily beneficial to decrease the off-target effect (Hart et 
al., 2017) and to gain statistical power when processing the data, resulting in higher p-
value. The design of gRNAs is limited by the PAM sequence (NGG or NAG) that is 
recognised by the nuclease (Cas protein) and is at the 3’ end of the 20bp from the 
targeted sequence. The presence or the addition of a guanine residue at the 5’ end of 
the target sequence in the gRNA increases its transcription because it enhances RNA 
polymerase III recruitment – the gRNA sequence being under the control of the U6 
promoter (Kuscu et al., 2014). More generally, gRNAs are preferentially designed to 
target early exons in genes for a higher chance of synthesising a non-functional or 
truncated protein. They are also designed to target the maximum number of isoforms 
for a higher knockout efficiency (Mohr et al., 2016). Chemical groups can be 
covalently bound to add variety in the gRNAs, thereby affecting the specificity or the 
stability of the Cas9-gRNA complex (Moon et al., 2019). Because Cas proteins 
tolerate mismatches of up to five nucleotides (Hsu et al., 2013), it is possible to alter 
the sequence to avoid unwanted off-target activity. Modifications in the core of the 
gRNAs can be made as well: modifying the lengths of the spacer or the scaffold 
regions can be beneficial and can improve specificity (Cho et al., 2014; Grissa et al., 
2007). In order to further improve CRISPR as a genome-editing tool to achieve high 
on-target specificity, efficiency, and low off-target effects (Cui et al., 2018), the 
nuclease can be modified. More high-performance effector nucleases such as Cas12a, 
Cas13a or newly engineered forms of Cas9 are available. 
 
iii. Human HeLa cells as the experimental working model 
Over the history of genetics, multiple model organisms have been developed, 
increasing the level of complexity of the system. The use of yeasts allowed easy 
manipulations in eukaryotic organisms (Forsburg, 1999) and this work was further 
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extended with Caenorhabditis elegans (Ankeny, 2001; Brenner, 1974) and 
Drosophila melanogaster (Golic & Lindquist, 1989; Rubin & Lewis, 2000) to 
investigate developmental processes, behavioural changes, neurodegeneration and 
inheritance. More recently, mouse models have emerged to become the first multi-
cellular organism where genes could be targeted by homologous recombination 
(Thomas & Capecchi, 1986; Thomas et al., 1986). Forward dominant genetic screens 
were performed, looking at visible phenotypes (Nolan et al., 2000). Furthermore, 
crossing and study of the offsprings (generations 2 and 3) revealed recessive effects 
(Nelms & Goodnow, 2001; Simon et al., 2015). Recessive screens are also possible 
using chromosome engineering approaches (Ramirez-Solis et al., 1995; Zheng et al., 
1999) and provide a non-biased way for phenotype-driven genetic screens. As 
mammals, mice could mimic human diseases and provide a better understanding of 
human biology. However, the implementation of screens on the organism level in 
mammals has proven difficult.  
 
Mammalian cultured cells provide a reductionist and simpler model to perform 
genetic experiments compared to a whole organism. Moreover, many human genes do 
not have homologs in yeast including in pathways such as apoptosis, or cell 
differentiation (Goffeau et al., 1996; Grimm, 2004). There are indeed multiple 
advantages in using cultured mammalian cells: coming from a common source cell 
lines usually display uniform genetic and phenotypic backgrounds, which are known 
and help with the consistency of the interpretation. In addition, cells are kept in 
known and specific growth conditions (e.g. medium composition, temperature are 
controllable) and are stable (do not differentiate) in the absence of induction. Some 
cell lines are preferred due to their ease of handling and introducing genetic material, 
others for their ability to grow in certain conditions or for displaying the phenotype 
studied (Grimm, 2004; Wang, 2006). 
 
The evolution of CRISPR has made it possible to use this technology in mammalian 
cells (Jinek et al., 2012) and the development of human CRISPR knockout screens 
has led to research in many different fields including genomics (Aguirre et al., 2016) 
as well as identification of biomarkers or cancer vulnerabilities (Hart et al., 2015) and 




For an efficient CRISPR-mediated knockout, it is important to ensure that the cell line 
used is equipped with DNA repair pathways and, more specifically, the error-prone 
NHEJ (Jackson & Bartek, 2009). For the implementation of the screen, cells are 
chosen so that they must be affected by the selection pressure too. Figure 4 highligted 
that IFN-γ-primed HeLa cells died the most after transfection with LPS, compared to 
other cell lines tested. 
 
 
2.3.2 Justification of the project and rationale of the experiment 
2.3.2.1. Optimisation of the cell death assay 
The signalling pathway being investigated addresses the impact of cytosolic LPS in 
IFN-γ-primed HeLa cells. To study the LPS-triggered cell death pathway, cells were 
transfected with commercially available S.Typhimurium LPS purified from bacterial 
outer membrane. To recapitulate in vitro the presence of LPS inside the cells, a 
transfection protocol was designed and optimised to induce LPS-caused cell death as 
efficiently as possible in HeLa cells primed with IFN-γ. Both the transfection reagent 
and the amount of LPS were optimised to reach the highest cell death specifically due 
to introducing LPS into the cytosol of IFN-γ-primed cells. 
 
The concentration of LPS (7.5μg/mL in a 96-well plate format) was kept constant 
while a range of reagents for the transfection of LPS was tested (Fig.10A). The same 
volume (0.2μL in a 96-well plate format) of different transfection reagents was added 
to the reaction to keep total volumes constant (total of 220μL in a 96-well plate 
format) across conditions, hence the concentrations of these reagents varied. 
Lipofectamine2000 (Baker et al., 2015) or Fugene (Casson et al., 2015) had already 
been used to transfect LPS. Liposome-mediated transfection had also been used, 
although this was mostly for hydrophobic molecules such as Lipid A (Lagrange et al., 
2018; Steimle et al., 2016). A broader range of transfection reagents was tested since 
most of these reagents were available in the lab and straightforward to test in the 
assay. These transfection reagents were chosen following a literature search (Rahimi 




In summary, the choice of reagent for LPS transfection was based on the highest 
percentage of dying cells obtained in IFN-γ-primed HeLa cells. Conditions were 
likely not optimal for all the reagents tested because the same volume, hence not the 
same concentration of reagent was added to the cultured HeLa cells. Only RNAiMax 
and Lipofectamine2000 generated substantial and detectable cell death. Since only 
0.2μL of transfection reagents were diluted in OptiMEM medium, it is possible that 
there was not a sufficiently high concentration of other reagents to effectively 
transfect LPS and generate cell death. Oligofectamine (0.6μL) and PEI (0.4μL) were 
previously tested using PI staining as the readout and both gave 20% cell death. By 
contrast, 0.2μL of either Lipofectamine2000 or RNAiMax gave 80% and 65% death 
respectively (data are not shown). Another possible hypothesis is that these reagents 
simply did not bind or interact with LPS and so the transfection was not effective. 
 
Only the combined treatment of IFN-γ and LPS (Fig.10A, blue bar, + +) contributed 
to any cell death. Neither priming with IFN-γ overnight (yellow bar, + -) nor LPS 
transfection alone (grey bar, - +) generated an increase in cell death in comparison to 
control cells that were only treated with the corresponding transfection reagent (black 
bar, - -). RNAiMax and Lipofectamine2000 respectively generated 50% and 75% cell 
death, whereas none of the other transfection reagents gave any cell mortality in the 
conditions tested here. In the case of Lipofectamine2000, the concentration of reagent 
used was not lethal and no cell death was observed in the presence of the transfection 
reagent only (in the absence of LPS). Overall, the highest specific cell death due to 





Figure 10: Lipofectamine 2000 was the most efficient LPS transfection reagent to 
trigger cell death 
(A) Following overnight priming of HeLa cells with IFN-γ, eight transfection reagents were 
evaluated to determine which was able to transfect LPS most efficiently to promote cell death. 
Results are shown as Mean ± S.E.M for two independent experiments, performed in triplicate, 
in 96-well plates, using 0.2μL of transfection reagent and 1.5μL of LPS per well. Cell death 
was assessed using CellTiter Glo. (B) LPS was titrated using 1μL of Lipofectamine 2000 per 
well for the transfection. Results are shown as Mean ± S.E.M for three independent 






To further optimise the assay, a titration of LPS was performed using a constant 
concentration of Lipofectamine2000 as transfection reagent (Fig.10B). Based on the 
results of the previous experiment, 2μg/mL (1μg in a 24-well plate format) of 
Lipofectamine2000 was used. Increasing the amount of LPS from 10ng to 5μg per 
well (i.e. 20ng/mL to 10μg/mL) increased cell death from 10% to 85% of the IFN-γ-
primed HeLa cells. Adding up to 10μg LPS (20μg/mL) did not further increase cell 
death; it appeared to have reached a plateau. This was consistent with saturation: for 
the amount of transfection reagent (Lipofectamine2000) available, no more LPS could 
be transfected. 
 
Following these tests, 3μg of LPS along with 1μL of Lipofectamine2000 in a total 
volume of 100μL OptiMEM were added to a 24-well already containing 500μL of 
medium (final concentrations of 5.0μg/mL of LPS and 1.67μg/mL of Lipofectamine) 
to transfect LPS into HeLa cells. This ratio was maintained throughout the 
experimental design and amounts were adjusted appropriately when well sizes were 
changed. 
 
Future knockout experiments using the CRISPR-Cas9 technology were therefore 
performed in a population of HeLa cells. Overall, as a result of these studies, the LPS-
triggered cell death assay had now been optimised to give a maximum cell death upon 
IFN-γ priming. This protocol could therefore be used to find IFN-γ-induced genes 
required in the cell death pathway triggered by the presence of cytosolic LPS. 
 
 
The cell-death phenotype investigated here naturally leads to the implementation of a 
loss-of-function screen. Although the inactivation of both copies of a gene in diploid 
cells (e.g. human cells) has proven difficult, it became possible with the CRISPR-Cas 
system (Wang et al., 2014). In order to identify genes required in the IFN--induced, 
LPS-triggered cell death pathway, a genome-wide loss-of-function genetic forward 
screen was performed, using the CRISPR-Cas9 technology. For the screen to be 
successful, the selection pressure needs to be sufficiently strong to kill nearly all 
normal cells, to ensure enrichment of cells specifically carrying genes providing 
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resistance to IFN--dependent, LPS-triggered cell death, when they are mutated (non-
functional). Consequently, it was necessary to optimise transfection conditions and 
assay readout to ensure that these conditions were fulfilled. 
 
 
2.3.2.2. Validation of the enrichment strategy 
As shown above (Fig.4), HeLa cells died upon LPS transfection when they were 
primed with IFN-γ. IFNGR1 acts as sensor of IFN-γ and thereby is required for the 
cell death to occur. CASP4 was also shown to be necessary, although not sufficient, in 
the pathway. There are clearly other players – yet to be identified – required in the 
IFN-γ-induced, LPS-triggered cell death pathway. In order to perform the genetic 
screen to identify new genes required in the LPS-triggered, IFN-γ-dependent cell 
death pathway, the assay had been optimised to give the highest selection pressure 
possible to select only cells which are resistant to LPS-triggered cell death when 
primed with IFN-γ. However, for the screen to be successful, the proposed enrichment 
strategy needed to be validated. 
 
i. CrmA inhibits LPS-induced cell death in IFN-γ-primed HeLa 
cells 
Serine proteinase inhibitor 2 (CrmA) is a cowpox-encoded serpin, which inhibits host 
caspases, thereby modulating cell death responses to viral infection. CrmA was tested 
for its ability to inhibit LPS-triggered cell death. A construct was created to 
overexpress GFP-tagged CrmA in HeLa cells. Expression of the protein was checked 
by western-blotting (Fig.11A) and cells were treated by LPS transfection following 
IFN-γ priming. On average, 60% of untransfected HeLa cells died under these 
conditions, whereas none of the HeLa cells overexpressing the GFP-CrmA protein 
died (Fig.11B). This result confirms that CrmA provides resistance to IFN-γ induced, 
LPS-triggered cell death, and hence CrmA-overexpressing cells mimic the behaviour 
of cells being mutated, in the future screening process, in genes involved in the LPS-





Figure 11: Overexpression of CrmA provides resistance to LPS-triggered cell 
death  
(A) GFP-tagged CrmA was transduced in HeLa cells and expression was assessed by 
western-blotting. (B) CrmA-expressing cells, together with controls (untransduced), were 
primed overnight with IFN-γ, and then transfected with LPS. Cell death was assessed using PI 
staining and flow cytometry to determine the percentage of cells surviving relative to cells 
that had also been primed with IFN-γ, but which had only been treated with the transfection 
reagent Lipofectamine 2000 (no LPS). 




ii. Proof of concept using CrmA-overexpressing cells 
Overexpression of CrmA was sufficient to give resistance to LPS-triggered cell death 
in IFN-γ-primed HeLa cells. These cells could therefore be used to test the screening 
enrichment strategy to see whether a mutant/resistant population would be enriched 
and then isolated in the screen. 
GFP::CrmA-overexpressing HeLa cells were mixed together with HeLa cells in a 
1:10,000 ratio. This population was submitted to several rounds of treatment 
consisting of IFN-γ priming followed by LPS transfection (Fig.12A). After each 
round, surviving cells were analysed for their content in GFP-positive cells. CrmA 
cells were both resistant to the treatment and expressed GFP, and so their proportion 
was expected to increase. The enrichment in GFP-positive cells in the surviving 
population was followed over the course of the successive rounds of selection by flow 
cytometry (Fig.12B). In the input population, 0.01% of cells were GFP-positive. After 
the first round, 3.5% of cells were found GFP-positive; this percentage continually 
increased to reach about 75% after the fifth round (Fig.12C). The population was 
therefore substantially enriched in resistant cells. These results indicate that the 
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selection strategy is successful and could be applied to a pool of cells mutated with 
the CRISPR-Cas9 technology. 
 





Figure 12: CrmA cells are enriched in a mixed population following LPS 
transfection  
(A) HeLa cells overexpressing GFP::CrmA were mixed with untransduced HeLa cells and the 
population was subjected to several rounds of treatment (involving IFN-γ priming followed 
by LPS transfection). The enrichment in GFP-positive cells was assessed by flow cytometry 
(B) and quantified for each round of enrichment (C). Flow cytometry plots are from one 





Since CASP4 and GSDMD are not sufficient to explain the influence of IFN-γ in the 
LPS-dependent cell death phenotype, the mechanism required more detailed 
investigation. To do this, a genetic screen was used to identify new genes required in 
the LPS-triggered, IFN-γ-dependent cell death pathway. In this scenario, IFN-γ 
priming followed by LPS transfection would provide a selection pressure that would 
selectively enrich for cells resistant to the treatment. 
 
 
2.3.3 Implementing a genome-wide CRISPR screen in human cells 
Despite variations in screening conditions that depend on the biological question and 
the strategy implemented, three main steps characterise any CRISPR screen (Fig.13): 
1) delivery of the components into the cells, 2) the screening process itself, and 3) the 
data analysis, complemented by the confirmation of the ‘hits’ from the screen (see 
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paragraph 2.3.4 “Validation of the hits”), which indicates how trustworthy the results 
from the screen are. 
 




In order to select a mutated population based on a specific phenotype, lentiviruses expressing 
either the Cas9 or the gRNA library are produced. HeLa cells are then transduced and 
selected successively for the expression of Cas9 (hygromycin) and the gRNA library 
(puromycin). Mutated cells are submitted to the selection pressure (here the treatment 
required IFN- priming overnight followed by LPS transfection). In the case of a viability 
screen, DNA from surviving cells is extracted, purified and amplified before sequencing. Data 




2.3.3.1. Delivery of the components in the target cells 
The CRISPR-Cas9 methodology requires two essential components: a CRISPR-
associated endonuclease (Cas protein) and a sgRNA targeting the desired gene to 
mutate. Having a single vector to deliver Cas9 and a sgRNA into cells allows the 
simultaneous delivery of both components of the CRISPR system, eliminating the 
need to generate cell lines expressing Cas9 (Shalem et al., 2014). However, having 
the nuclease and the sgRNA on two separate plasmids can be advantageous for 
controlling the level of Cas9 expression. The introduction of Cas9 into cells can be 
followed by selection of one cell to be expanded in a clonal population. The clone 
may be chosen for its high expression of the Cas9 protein (within the limit of long-
term cytotoxicity). The resulting clonal population would express a homogenous high 
level of Cas protein ensuring efficient and consistent knockouts. Having the gRNA 
library on a distinct plasmid also allows determination of the library titre for ensuring 
delivery of no more than one gRNA per cell (Koike-Yusa et al., 2014; Wang et al., 
2014). 
 
The Cas9 protein can be directly delivered into the cytosol and, because proteins are 
rapidly degraded, this can reduce the off-target effects. Mammalian cells can also be 
transfected with non-replicating plasmid DNA that will transiently express Cas9 and 
gRNAs (Cong et al., 2013; Mali et al., 2013) and, although transient expression of 
Cas9 has shown to be sufficient to perform successful CRISPR in living organisms 
(Jiang et al., 2014), constitutive expression increases Cas9-mediated knockout 
efficiency and does not impact the number of off-target cleavages (Koike-Yusa et al., 
2014). The use of lentiviral vectors (Fig.14) offers the possibility of constitutive 
expression of both Cas9 and/or gRNAs (Shalem et al., 2014; Wang et al., 2014). 
Adding enrichment cassettes on the plasmids allows subsequent selection of 
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transduced cells (Koike-Yusa et al., 2014). 
 
The lentiviral delivery of the CRISPR-Cas9 system (Aregger et al., 2019; Piccioni et 
al., 2018) is also used in primary cell lines, in cell lines difficult to transfect, or even 
in vivo (Aubrey et al., 2015). It has become a very attractive strategy for gene therapy 
applications (Chandrasekaran et al., 2018). 
 
In this research project, a 2-plasmid system (Wang et al., 2014) was used (Fig.14): 
this procedure relied on the stable expression of the Cas9 protein being achieved 
before transducing the cells with the sgRNA pool to generate mutants and hence 
knockouts by producing DNA double-strand breaks. The sgRNA library targeted the 
whole human coding genome (18,543 genes) to provide an unbiased approach. The 
sgRNA library was designed without the Cas9 gene on the coding plasmids; therefore, 
Cas9 was expressed stably in the cells before they were transduced with the sgRNA 
library. Having a 2-plasmid system provided two key advantages. First, Cas9 
expression and gRNA transduction could be successively selected with hygromycin 
and puromycin, respectively. Second, lentiviral supernatants generated for the gRNA 
library were titrated separately. Lentiviral supernatants were used for the transduction 
of cells and expression of both Cas9 and the gRNA library. 
 
 
Figure 14: CRISPR screen using a 2-plasmid system 
The CRISPR technology is based on two main components: (A) an endonuclease - Cas9- and 
(B) guide RNAs (gRNAs) that have a common scaffold and a specific sequence targeting the 
gene of interest.  
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The Cas9 gene was cloned into the pHRSIN vector by Dr. Jessica Noad and the gRNA library 




i. Stable expression of Cas9 
HeLa cells were first transduced with lentiviruses expressing Cas9 using a high titre 
(1:2 dilution of viral supernatant) to ideally transduce all the cells, even with several 
copies of Cas9. A high level of expression of the Cas9 protein will ensure more 
efficient knockouts. Notwithstanding the high lentivirus titre, cells were still subjected 
to selection with hygromycin following transduction, to remove non-transduced cells 
(cells not expressing Cas9). The expression of the Cas9 protein was evidenced by 
western-blotting (Fig.15A): a specific band was detected at the expected size (MWCas9 
= 163.5 kDa) in the transduced and selected population. 
 
To ensure that the expressed protein was functional, a test was performed using a 
gRNA against β2-microglobulin (Fig.15B). This guide was validated by Stuart Bloor 
(Paul Lehner’s lab, Univ. of Cambridge). β2M is a major component of MHC Class I 
receptors and is required for their expression on the cell surface. Absence of 
expression or expression of a non-functional β2M would translate into impaired MHC 
Class I receptors synthesis and hence a decreased number of MHC Class I receptors 
on the cell surface. Probing for these receptors using a specific antibody (Parham et 
al., 1979), it was possible to visualise the extent of the β2M knockout. For this assay, 
Cas9-cells were transduced with the β2M guide and selected with puromycin. They 
were then stained for MHC I receptors. As expected, cells only expressing Cas9 but 
not the gRNA (blue curve) were positive for MHC Class I (Fig.15C). In addition, 
there was no background staining – unspecific binding – from the secondary antibody, 
since cells were negative for MHC I (orange and red curves) in the absence of the 
primary antibody (Alexa488 only). When Cas9-HeLa cells were treated with the β2M 
guide, two distinct populations of cells could be seen (green curve). At 5 days post-
gRNA-transduction, the majority of the cells had an intermediate level of MHC Class 
I receptors, between the positive and negative controls. At 10 days post-gRNA-
transduction, the main population overlapped with the negative population. The shift 
was time-dependent, and it appeared that knockout was properly established at 10 
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days post-gRNA-transduction. Targeting β2-microglobulin (β2M) resulted in 
progressive loss of this protein’s expression. Some proteins have long half-life and, 
even in the case of an efficient knockout, they might still be present after many days. 
Although experiments were performed to try to assess the rate of MHC I turnover, the 
results were inconsistent and durations varied considerably with cell types, activation 
states, and even isotypes (Prevosto et al., 2016). The kinetics of protein turnover was 
visualised by the peak (green curve) moving to lower intensities and thus decreased 
expression of MHC Class I receptors (Fig.15C).  
 
Even after 10 days, however, a residual fraction of cells was still MHC-positive. A 
slow turnover of MHC Class I receptors could not account for the presence of this 
positive population at 10 days post-gRNA transfection. By contrast, non-targeted cells 
still expressed MHC Class I receptors and thereby were stained during the experiment 
and could account for (part of) the residual peak of high intensity. There is also a 
possibility that the sequence of interest was effectively targeted and mutated but with 
in-frame indels, generating cells positive for the expression of MHC Class I receptors. 
 
Because these MHC class I-positive cells survived puromycin selection, they should 
have been successfully transduced with β2M gRNA. However, it was possible that 
some DNA repair mechanisms were activated and successfully corrected the damage, 
enabling the protein to be expressed. Another explanation is that the DNA double-
strand break created caused a non-deleterious mutation (e.g. in frame indels) and the 
functional β2M protein was still produced. Alternatively, these cells might not have 
expressed sufficient Cas9 to generate the targeted DNA double-strand break in the 
β2M gene. Another possibility is that, since HeLa cells frequently carry multiple 
copies of genes, the knockout could have only been partial and not target all the 
copies of the β2M gene present. These cells likely give a partial phenotype, i.e. 
decreased expression compared to wild-type. 
Unfortunately, this resistant population constituted a pool of cells that could not be 
avoided. A higher number of cells would be necessary during the screen to 





Figure 15: Cas9 was expressed and was functional  
(A) The expression of Cas9 was confirmed by western-blotting. (B) Plasmid schematics for 
the expression of Cas9 and a gRNA targeting β2M. (C) After either 5 or 10 days of gRNA 
transduction, MHC Class I receptors were immunostained, and the cells analysed by flow 
cytometry to assess the extent to which the MHC Class I receptors had been removed from 
the cell surface. Controls (red and orange curves) were cells incubated only with the 
secondary antibody to measure any non-specific fluorescence signal; cells expressing only 
Cas9 (cyan curve) were stained by the antibody as they carry MHC Class I receptors on their 
surface, providing a positive control to compare with; over time, the number of MHC Class I 
receptors decreased in cells transduced with both the Cas9 protein and the gRNA targeting 
2M (green curve). 
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The Cas9 plasmid was generated by Dr. Jessica Noad and the #1861 gRNA-containing vector 




Overall, these experiments indicated that the screen, and any other experiment 
requiring knockouts, should commence at least 10-12 days after transduction with the 
gRNA library in Cas9-expressing cells in order to allow sufficient time for the 
knockouts to achieve maximum efficiency. Waiting more than a week was also a way 
to lose essential genes, thus eliminating cells that carried deleterious mutations that 
would not survive for this length of time. Accordingly, the background population of 
cells that was sequenced as reference was sampled at the start of the screen to 
maximise its being representative of the initial population going into the screening 
process. 
 
ii. The gRNA library 
To knockout cells in a “random” and unbiased way, a genome-wide human gRNA 
library was used (Park et al., 2016). Because of the 2-plasmid system, the transduction 
of gRNA was performed into Cas9-expressing cells at a MOI of 0.36, so that cells 
were targeted by only a single gRNA and so would be mutated in only one gene. 
  
The gRNA library contained a total of 187,536 gRNAs targeting the whole human 
genome. This corresponds to an average of 10 guides per gene; the number of human 
protein-coding genes is estimated to be around 20,000 (Wang et al., 2015). The gRNA 
library was received as three aliquots and was split into three sub-libraries (hL1nC9, 
hL2nC9, hL3nC9) approximately containing 90,000, 90,000 and 5,000 guides, 
respectively. These three sub-pools were transformed and expanded separately, and 
the resulting plasmids were purified. The three sub-pools of purified plasmids were 
then carefully quantified by qPCR and mixed, based on their individual concentration 
and the ratio (18:18:1) of the number of guides in each to be sequenced on the MiSeq. 
Sequences were aligned to the reference provided by the supplier. Overall, 1.025 
million reads could be aligned, representing 64% of the total number of reads 
produced by the analysis (Fig. 16A). Among the sequences known to be in the library, 
10.16% of them could not be found in the sequenced sample (missing guides). By 
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contrast, the supplier performed a more comprehensive analysis leading to 4.324 
million aligned reads and resulting in only 0.94% of guides missing. The guide 
distribution in the transformed library was assessed (Fig.16B) by looking at the 
contribution of each gRNA – percentage of representation – to the total gRNA count. 
The transformed library was not excessively skewed as the initial slope of the curve 
(Fig.16B) was close to the ideal representation (black dashed line), whereby every 
guide contributes the same to the overall library. In addition, the curve reached a 
plateau, meaning that some gRNAs were not represented. This was expected given 
that 10.16% of the guides were missing (Fig.16A), which corresponds to a total of 
168,482 guides being present (Fig.16B).  
 
The overall number of reads per guide was established to be on average 5.7 (Fig. 
16A) following the sequencing on the MiSeq, compared to 23.1 in the data provided 
by the supplier, which paralleled the total number of reads (and hence the depth of the 
analysis). However, increasing the number of reads per guide exponentially decreases 
the percentage of missing guides in the analysis (Fig.16C). Sequencing experiments 
were performed with three different gRNA libraries. For each library, various 
numbers of reads were simulated, and, in each case, the randomised results were 
aligned to the reference and the percentage of missing guides was calculated. For the 
same sample, the calculated representation of the overall library depended strongly on 
the number of reads per guide available to assess the percentage of missing guides. 
For all three libraries tested, increasing the number of reads per guide from 2 to 8 
(Fig.16C) did, in turn, significantly decrease the percentage of missing guides from 






Figure 16: Comparison between the transformed and the reference gRNA 
libraries 
After transformation, the gRNA library was sequenced on the MiSeq. Sequences were 
demultiplexed (pools 1-3) and aligned to the list given as reference (hL1-3nC9). (A) 
Comparison of the read counts and proportion of missing guides in the entire library with the 
NGS data from the supplier. (B) The entire library was plotted on a cumulative curve after 
ranking all the guides by decreasing abundance. (C) Three other gRNA libraries of various 
sizes were subjected to high-depth sequencing, and the results were randomly sampled for an 
increased depth of analysis, looking at a particular number of reads and evaluating the 
percentage of missing guides in the overall library. For each gRNA library, the same initial 
samples were used, but the analysis was done differently. For multiple average numbers of 
reads per guide, the percentage of missing guide in the entire library was calculated based on 
the comparison to the supplier’s data. Experiments performed and data collected by Dr. 
Patrycja Kozik to generate the data in this panel of the figure (C). (D) The three individual 
sub-pools (pool1, pool2, pool3) were also plotted to compare them to the reference (hL1nC9, 






The sequencing data could also be compared to the supplier’s in a sub-library specific 
manner (Fig.16D). It was possible to demultiplex the sequences and identify for each 
sequence the sub-pool to which it belonged. The three sub-pools (pools 1, 2, 3) were 
individually compared to the data from the supplier (hL1nC9, hL2nC9, hL3nC9 
respectively). To assess the extent to which the distributions matched, multiple 
numbers of reads per guide were simulated to randomly generate lists of analysed 
sequences. With only a few counts per guide, the diversity of the selected sequences 
(and hence the number of unique guides – i.e. newly seen in the analysis) was the 
greatest. Increasing the number of reads per guide allowed the identification of a few 
more new guides, but mostly contributed to increase the numbers of guide counts 
(Fig.16D). Curves for pools 1-3 were much shorter than the curves drawn for the 
reference, but this was expected and was consistent with the much lower number of 
reads (1,025,868) obtained compared to the supplier (4,324,256). For each subset, the 
two curves – from the transformed library and the reference – almost overlapped. The 
curves from the reference reached plateaus corresponding to the total number of 
different guides in each sub-pool, 90,000, 90,000 or 5,000 respectively. Curves 
obtained for the transformed library sub-pools did not reach these plateaus since the 
numbers of reads per guide generated were not sufficient. However, based on the 
relationship between number of reads per guide and percentage of missing guides 
described above (Fig.16C), the transformed library was considered to be 
representative of the initial library and hence suitable for use in future experiments. If 
the sequencing had been deeper (more total reads) and of better quality (more aligned 
sequences) leading to a higher number of reads per guide, the percentage of missing 
guides would decrease in the analysis. 
 
Because the transformed gRNA library was deemed satisfactory in terms of 
representation and identity to the template, the three sub-pools were then used to 
create knockouts. 293ET cells were used to produce lentiviruses expressing the gRNA 
library. The lentiviral supernatant was titrated (Fig.17A) in order to establish the 
dilution to use to transduce the Cas9 cells. It was important that no more than one 
gRNA entered a single Cas9-expressing cell, since cells used for the screen must be 
mutated only in one target gene by a single gRNA. Having two or more guides 
knocking out several genes in one cell would prevent identification of the gene 
responsible for resistance to IFN-γ-induced, LPS-triggered cell death in the screen. 
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Also, cells without guides (i.e. non-transduced cells) would be discarded during the 
puromycin selection. Thus, the transduction should aim for a multiplicity of infection 
(MOI) of 0.36, which corresponded to 30% infected cells (Fig.17B). 
 
The titration was performed by transducing cells with a range of dilutions of lentiviral 
supernatant, followed by selection with puromycin. Cell death was measured by using 
PI staining and analysed by flow cytometry. This led to a percentage of surviving 
cells (PI-negative) compared to non-transduced cells which all died (0%). A MOI = 
0.36 would be achieved for 30% of Cas9-expressing cells being transduced with the 
gRNA library, which translated in 30% puromycin-resistant cells (Fig.17B). This 
proportion was achieved for a 1:500 dilution of the virus (Fig.17A). Therefore, the 
cell population for the screen was transduced with a 1:500 dilution of lentiviral 
supernatant for the gRNA library. This would enable the generation of mutant cells 
using the CRISPR-Cas9 technology in which the entire human genome had been 
targeted. In addition, the strategy of the screen based on the ability of enriching for a 
population of cells resistant to death upon LPS transfection and after IFN-γ priming 
was validated with CrmA-expressing cells. 
 
 
Figure 17: Titration of the guide RNA library  
293ET cells had been transfected to generate lentiviral supernatant coding for the gRNA 
library. Cas9-expressing HeLa cells were then transduced with a range of quantities of 
lentiviral supernatant. The titer was assessed by looking at cell death following puromycin 
selection three days after gRNA transduction in HeLa cells. Cell death was analysed by flow 
cytometry using PI staining. (A) The percentage of surviving (transduced) cells was 
calculated relative to cells that were not transduced (0%) and cells transduced with non-
diluted supernatant (100%). (B) Graph used as a reference for the conversion between 






2.3.3.2. Screening process 
This genetic screen aims to unravel the mechanism behind LPS-triggered cell death 
upon IFN-γ priming, by identifying new genes that are essential in the cell death 
pathway triggered by cytosolic LPS in IFN-γ-primed cells using CRISPR. 
 
Two IFN-γ inducible genes (CASP4 and GSDMD) that play a role in the LPS-
triggered cell death pathway were tested as candidates (see paragraph 2.2.3. “Role of 
Caspase-4 and Gasdermin-D in the IFN-γ-dependent, LPS-triggered cell death 
pathway”), but it was clear that other genes were also involved in this pathway. 
CASP4 is a homolog of the mouse caspase-11, which has been described to bind 
directly to LPS and trigger a non-canonical inflammasome resulting in cell death. 
GSDMD is an effector in pyroptosis, an inflammatory but regulated form of cell 
death. However, neither CASP4 nor GSDMD was sufficient to account for the IFN-γ-
dependent, LPS-triggered cell death pathway. Although IFNGR1, CASP4 and 
GSDMD are all required in the IFN-γ-induced, LPS-triggered cell death pathway, 
none of them adequately explain IFN-γ-induced, LPS-triggered cell death.  
 
An unbiased forward genetic screen using the CRISPR-Cas9 technology was used in 
order to find new genes involved in the IFN-γ dependent cell death pathway triggered 
by cytosolic LPS. Cells were mutated using a human genome-wide gRNA library and 
then challenged with the selection pressure; that is priming with IFN-γ followed by 
transfection with LPS. The objective was to isolate mutants that were resistant to cell 
death; these cells should carry mutations either in the cell death pathway and thus be 
required in one of the steps between detection of the LPS as a trigger and the cell 
dying or in the IFN-γ signalling pathway. DNA sequencing of resistant cells would 
allow identification of the gRNAs carried by these mutants and that should enable 
identification of the genes necessary for cell death to occur. 
 
The selection pressure on the cells was provided by LPS transfection after IFN-γ 
priming overnight. This killing method did not give 100% cell death with the control 
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cells; therefore, the cells that survive after a single transfection might be interesting 
mutants, but could conversely contain cells that would have escaped from the 
selection, i.e. cells that were not affected by the treatment. For that reason, several 
rounds of LPS transfection were performed with the aim of enriching more stringently 
for genuinely resistant mutants (Fig.18). 
 
 
Figure 18: Forward genetic screen based on LPS-transfection  
Scheme of the strategy laid out for isolating CRISPR-mutated and IFN-γ-primed cells 
resistant to LPS-triggered death. Cells were subjected to several rounds of selection, each 




i. Keeping the gRNA representation 
The library representation is defined by the number of molecules of each sgRNA 
present at any time during the screen: the higher the representation, the more robust 
the screen (Strezoska et al., 2012). A low library representation results in high 
background noise and either identification of false positives due to random depletion 
in the case of negative selection (Schuster et al., 2019), or increased loss of positive 
‘hits’ in positive selection. Certain screen conditions create a natural bottleneck, 
which is expected in positive screens and leads to decreased library representation. In 
this case, starting with a library exhibiting a 500-1000-fold representation is necessary 
(Joung et al., 2017). The library representation is assessed at each step of the screen 
and is largely dependent on the number of cells used in the screen. When the number 
of cells to handle becomes problematic, it is advisable to limit the library size rather 
than compromise on the representation. 
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In this project, the representation of the library was, at all times, maintained over 500-
fold the number of guides; at each step during the screen, a minimum of 108 cells 
were used. 
 
ii. Selection process and timeline 
A period of at least a week shall be left after sgRNA transduction before starting the 
screen to allow time for selection of transduced cells and recovery from selection and 
cell expansion (see paragraph 2.3.3.1. “Delivery of the components in the target 
cells”). The knockout generated using CRISPR-Cas9 has been found to be optimal 
(most efficient) seven days after gRNA transduction (Joung et al., 2017). In case of 
constitutive expression of Cas9, one should ensure that the cells tolerate prolonged 
expression of the nuclease. The duration of viability screens is dictated by the 
population doubling time because a certain number of mitoses is necessary to observe 
the phenotype.  
 
In this project, HeLa cells were mutated using the CRISPR technology with a 
genome-wide human gRNA library. The screen was carried over a time period of a 
month because a total of five rounds of enrichment were performed (Fig.19A). One 
round of selection consisted of overnight IFN-γ priming followed by LPS 
transfection, after which surviving cells were carried on to the next round. By the end 
of this procedure, the population should contain cells that carry a mutation in genes 
required in the IFN-γ-induced, LPS-triggered cell death pathway. 
 
Throughout the entire process, efforts were made to provide adequate coverage of the 
entire gRNA library (Hart et al., 2017) and keep the representation throughout the 
screen by using appropriate numbers of cells (Schuster et al., 2019). It was assumed 
that initially having 100-fold coverage, that is 100 times more cells than the number 
of gRNAs in the library, would ensure significant signal over noise during the 
sequencing analysis. The sgRNA library (Park et al., 2016) contained 1.87x105 
gRNAs, indicating that a population of 2x107 cells should be maintained to keep this 
100x coverage. However, getting 20 million mutated cells retrospectively meant that 
at least 60 million cells had to be transduced, since the MOI was chosen to target only 




In the experiment, 80 million Cas9-expressing cells were transduced with the gRNA 
library lentiviral supernatant, used at 1:500 dilution according to the titration 
performed previously (Fig.17A). After 48h, cells were submitted to puromycin 
treatment to select for cells transduced with a gRNA. Cells were grown under 
puromycin selection for five more days, after which the cells were grown under 
selection conditions with both hygromycin and puromycin, in order to maintain a 
population expressing both Cas9 and a gRNA, respectively. Twelve days after gRNA 
transduction and 15 days after Cas9 transduction, 320 million cells were primed with 
IFN-γ overnight. Of this total amount, 100 million (500-fold coverage) were treated 
only with Lipofectamine2000, whereas the other 220 million (1100-fold coverage) 
were transfected with LPS. On the following day, the control cells (those treated only 
with transfection reagent) were harvested, pelleted down, and frozen. They 
constituted the starting point of the screen; thenceforward, their genetic information 
would serve as the reference (‘- cells’). 
 
Only 5.4% of the LPS-challenged cells survived the first round (Fig.19B), but they 
were expanded again to 200 million cells. On day 20 after gRNA transduction, they 
were primed with IFN-γ. On the following day, 120 million (600-fold coverage) were 
transfected with LPS while the other 80 million (‘+ cells’) were treated only with 
Lipofectamine2000. 
 
This time and for the subsequent rounds, the cells treated only with Lipofectamine 
(but already selected on previous rounds) were grown alongside the selected 
population. Therefore, at the end of the screen, five different batches of cells (‘+ cells’ 
to ‘5+ cells’) were grown at the same time (Fig.19C). They came from the successive 
(1 to 5) rounds of enrichment. They were all pelleted and frozen down at the same 





Figure 19: The five rounds of enrichment were performed over a month 
(A) A rough timeline showing the first few rounds of enrichment in the screen that lasted 28 
days. For each round of selection, the number of cells used was calculated and the amount of 
cell death was estimated by comparing cell numbers to non-treated cells (B). After each round 
of enrichment, cells were kept in culture to be frozen at the same time point at the end of the 




The initial Cas9- and gRNA-transduced cells were frozen down at the very start of the 
screen. In this respect, they represented the initial population that was submitted to the 
first round of selection. They provided a population that could be used to assess the 
efficiency of the gRNA transduction. Based on the sequencing of that sample, 
information was obtained concerning the representation of the whole library in the 
cellular context rather than at the plasmid level (Fig.16). Because the sequencing of 
the ‘- cells’ yielded more reads than the MiSeq data first generated on the transformed 
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plasmid library, it appeared that only 3.3% of the guides were missing compared to 
the original plasmid library. This result was obtained from the total percentage of 
missing guides (13.3%) by subtracting the 10% of sgRNAs in the library that target 
essential genes. After 10 days, cells mutated in essential genes would have been lost 
following natural selection.  
By contrast, all the populations of cells challenged by one or multiple LPS 
transfection(s) were kept and maintained throughout the duration of the screen. This 
was done with the aim of having more comparable samples with cells having had the 
same life span.  
 
 
2.3.3.3. Data analysis 
Cells are collected and, following DNA amplification for enrichment of the barcodes 
tagging the gRNAs, the DNA is sequenced using next-generation sequencing (NGS) 
to identify the gRNAs (Fig.13). The readout is based on the relative abundance of the 
various sgRNA calculated from the number of reads for each guide. To ensure robust 
analysis, the number of reads must be within the 30-300 window. Analysis software 
such as MAGeCK (Li et al., 2014) generates a ranking of all the genes and potential 
‘hits’ can then be further validated. 
 
i. Preparation of the samples for sequencing 
Cell pellets (see paragraph 2.3.3.2. “Screening process”) were thawed, and the 
genomic DNA was extracted before being purified. DNA was subjected to several 
steps of genomic amplification (Fig.20A) before analysis by sequencing. Purified 





Figure 20: Several PCRs were needed to prepare the samples for sequencing  
(A) Scheme of the successive sample preparation steps necessary to perform new-generation 
sequencing on genomic DNA extracted after the experiment (i.e. from resistant cells to the 
IFN-/LPS transfection treatment): (B) genomic DNA was amplified (PCR1 and PCR2) and 
gRNA sequences (green and yellow) were flanked, in PCR2, with Illumina adaptors (red and 
purple) that are necessary for sequencing before precise quantification by qPCR and 




The full protocol is detailed in Chapter 4, paragraph 4.9.2. “gRNA amplification and 
sample barcoding”. In summary, qPCR0 (see Chapter 4, Fig.2) was performed to 
make sure that the primers designed for PCR1 bound and amplified the expected 
fragment of genomic DNA at the concentration of the purified sample. The primers 
tested were amplifying as expected and were used in PCR1. Following PCR1, crude 
products were taken onto qPCR1 in which PCR2 conditions were tested to determine 
the appropriate number of cycles needed (see Chapter 4, Fig.4). The PCR2 was 
therefore run with 20 cycles of amplification. PCR2 products were purified (see 
Chapter 4, Fig.5) and then quantified by qPCR (see Chapter 4, Fig.6). Samples 
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submitted to sequencing can contain several different cell batches, provided they are 
individually barcoded in PCR2 and individually quantified in qPCR.  
 
The number of different cell batches in one sample could vary depending on the 
sequencing depth required. In this case, only two cell batches were submitted in one 
lane to obtain at least 100x coverage of the entire library that contained 2x105 
gRNAs. At first, samples from cells frozen before any LPS transfection (‘- cells’) and 
cells having been through three rounds of enrichment (‘3+ cells’) were submitted for 
sequencing. The second sequencing submission contained cells challenged with one 
or two LPS transfection(s), ‘1+ cells’ and ‘2+ cells’ respectively. 
 
 
ii. Sequencing results  
The sequences generated by the HiSeq were sorted into two lists: sequences were 
assigned to the sample from which they originated (demultiplexing), based on the 
barcode they carried: ‘- cells’ (initial population that had not experienced LPS 
transfection) or ‘3+ cells’ (cells that had experienced three rounds of selection). The 
step of demultiplexing was followed by alignment of the trimmed sequences to the 
reference library. Each gRNA present in the library was attributed the number of 
copies of their sequences that were found in the analysis. The initial population (‘- 
cells’) was treated with IFN-γ overnight and mock transfected with medium 
containing Lipofectamine2000, although without adding LPS. The sequencing of this 
population showed the representation of the gRNA library in cells (Fig.21A, red 
curve), as opposed to the previous MiSeq data (Fig.16B) performed at the plasmid 
level.  
 
The curve (Fig.21A) shows the representation of the library: it is a cumulative plot for 
which contributions of each gRNA are added up according to decreasing abundance. 
The initial slope accounts for the most abundant gRNAs: the steeper the slope, the 
more enriched the first few gRNAs. Since the screen was designed to enrich genes 
playing a role in the IFN-γ-induced, LPS-triggered cell death pathway (i.e. gRNAs), it 
was expected that the most abundant gRNAs contributed progressively more as the 
number of enrichment rounds increased. Indeed, comparing the library representation 
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for all four samples (Fig.21A), the initial slope grew steeper as an increasing number 
of enrichments was performed and the top ranked gRNAs significantly outnumbered 
the other gRNAs. The curve eventually reaches a plateau in all cases, indicating that 
some gRNAs did not contribute to the representation and hence were depleted from 
the sample. This plateau was reached earlier as the number of enrichment rounds 
increased because selection was depleting many gRNAs. 
Overall, some gRNAs were depleted while some others became further enriched, 
validating the selection pressure and the screening process. 
 
The median number of guide counts for each gene was determined and each round of 
enrichment was plotted to visualise whether some genes were enriched (Fig.21B). As 
expected, non-targeting guides (orange dots) were not enriched over the course of the 
successive selection rounds. These dot plots, which compare median gRNA counts for 
each gene, showed that ‘- cells’ already had a significant number of enriched genes 
known in the IFN-γ signalling pathway such as JAKs 1 and 2, IFNGR1 and STAT-1. 
This observation makes sense since ‘- cells’ were primed overnight with IFN-γ, even 
though they were not treated subsequently with LPS. The first round of enrichment 
(‘+ cells’) showed further enrichment of CASP8 and also JAK1 and IFNGR1. The 
second selection round (from ‘+ cells’ to ‘2+ cells’) was the most successful in 
enriching for genes; all the genes in the IFN-γ signalling pathway (JAK1, STAT-1, 
IFNGR1, JAK2, IFNGR2) stood out (Fig.21B). Other genes, such as CASP4 and 
GSDMD were also expected to be enriched and were indeed distinct from the 
majority of the other genes. CASP8 was also isolated in this second round. In the third 
and final round of enrichment (from ‘2+ cells’ to ‘3+ cells’), genes for IFNGRs (1 and 
2), JAKs (1 and 2), CASP4 and -8, were enriched and were very clearly separated 
from the rest.  
 
Although GSDMD did not segregate out as a potential ‘hit’ from the screen, the 
observation that most genes in the IFN-γ signalling pathway were enriched gave 





Figure 21: Progressive enrichment for resistant cells during the screen 
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(A) The gRNA libraries sequenced after the four distinct stages of the screen: before 
treatment (red) or sampled at each round of enrichment (1:green, 2:blue, 3:purple) were 
plotted on a cumulative curve after ranking all the guides by decreasing abundance to show 
progressive depletion in gRNAs and loss of diversity. (B) For the three rounds of enrichment, 
the median number of gRNA counts for each gene was represented showing whether the 
genes were enriched or depleted (respectively higher or lower than the diagonal) over the 




In all the plots (Fig.21B), blue and dark green dots represent enriched and depleted 
genes (respectively), as calculated by the enrichment fold: that is, the measure of the 
difference in the representation of a gene and/or gRNA in the selected population 
compared against a reference population. Since the goal of the screen was to find 
genes involved in the IFN-γ-induced, LPS-triggered cell death pathway, the genes in 
the successive rounds of enrichment (‘3+’, ‘2+’ or ‘1+ cells’) were all compared to 
their counterpart in the initial population (‘- cells’, never treated) in order to calculate 
their enrichment ratios. The sequencing data were processed to score the genes using 
the MAGeCK algorithm (Li et al., 2014) which considers the library size, the count 
distribution and the 10 gRNAs available for each gene, generating a ranking of all the 
genes tested (if found in the sequencing data). After the third round of selection (LPS 
transfection of IFN-γ primed cells), cell death on a population level had decreased 
significantly compared to the first two: 25% of surviving cells compared to 5.4% or 
8.8%, respectively (Fig.19B). The percentage of surviving cells continued to increase 
in subsequent rounds (50% in round 4); however, resistant cells could be mutated in 
genes favouring hyperproliferation. This could give them a survival advantage not 
specific to LPS-triggered cell death and may result in them outnumbering the true 
‘hits’. ‘3+ cells’ were chosen as a suitable compromise that comprised both a majority 
of resistant cells and allowed sampling early enough in the screen to avoid false 
positives.  
 
Table 1 shows the first 50 genes in the ‘hit’ list comparing the fold enrichment seen 
in the ‘3+ cells’ compared to ‘- cells’. Three different analytical methods were used: 
MAGeCK (Li et al., 2014), RSA (König et al., 2007) and “5th guide” using Fisher’s 
and Wilcoxon tests to calculate p-values (Prabhakaran, S., 2016-2017). The screen 
identified genes (Table 1) potentially playing a role in the IFN-γ induced, LPS-
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triggered cell death phenotype. Some highly ranked genes, such as interferon-γ 
receptors (IFNGR1 and IFNGR2), Janus kinases (JAK1 and JAK2) and STAT-1 were 
expected because they are major genes in the IFN-γ sensing and signalling pathways. 
Since the screen identified ‘hits’ but did not demonstrate directly that they were 
required in the IFN-γ-induced, LPS-triggered cell death pathway, candidates from the 
‘hit’ list were selected for validation (green). Among the expected ‘hits’, only 
IFNGR1 and STAT-1 were carried on to validation experiments to serve as positive 






Table 1: List of the top 50 genes obtained from the sequencing 
Sequencing data from the ‘3+ cells’ were compared to ‘- cells’ to calculate the enrichment 
fold of each gRNA; values that were then used to rank the genes contained in the library. 
Genes were ranked using three different statistical methods: MAGeCK which was developped 
with the advent of CRISPR, RSA already used mostly in the case of RNAi screens and “5th 
guide” which considers the rank of the 5th guide (median) for each gene when all guides are 
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ranked according to their enrichment fold. In each list, genes in the IFN-γ signalling pathway 





iii. Interpretation of the data  
After the validation experiments, results from either the third round or the first three 
rounds combined were represented using volcano plots. This gives a graphical 
visualisation of the genes that were enriched (blue) or depleted (dark green) in the 
screen. In both plots, ‘hits’ with the highest confidence (-log p-value > 4) were genes 
expected because they are key players in the IFN-γ signalling pathway, namely JAKs 
(1 and 2), IFNGRs (1 and 2), STAT-1. Caspases-4 and -8 were also clearly identified 
as positive regulators in the IFN-γ-induced, LPS-triggered cell death pathway. 
Focusing on the third round of enrichment (Fig.22A), the candidates chosen for 
validation (BID, NCKAP1 and SAFB, see paragraph 2.3.4 “Validation of the hits”) 
were also significantly enriched (-log p-value > 3). Additionally, SMAD4, LCORL, 
EXOC2, and CHD8 showed similar enrichment confidence and should be considered 
in further validation experiments. SMAD4 (Mothers against decapentaplegic homolog 
4) is involved in the transforming growth factor (TGF) signalling pathway in which it 
acts in conjunction with either DPC4 (Liu et al., 1997), PDK1 (Seong et al., 2007), or 
FBI-1 (Yang et al., 2015) functioning as negative regulators and making the SMAD4 
gene more likely to be a false positive in the screen because its mutation could 
provide a growth advantage to the cells. Ligand-dependent nuclear receptor co-
repressor-like protein (LCORL) has not yet been characterised. Exocyst complex 
component 2 (EXOC2) is part of the exocyst complex, an octameric protein assembly 
that controls vesicle trafficking, vesicle fusion and exocytosis (Wu & Guo, 2015; Mei 
& Guo, 2018). Chromodomain-helicase-DNA-binding protein 8 (CHD8) recruits 
histone H1 to suppress p53/TP53-mediated apoptosis in early embryogenesis 
(Nishiyama et al., 2009). CHD8 is also recruited to CTNNB1 responsive genes and 
negatively regulates them (Thompson et al., 2008). This may be why CTNNBL1 was 
also identified as a potential candidate. 
CXCR4 was also highly enriched in the results of both the third round of enrichment 





Figure 22: The genes expected as positive controls were significantly enriched 
during the screen 
Volcano plots showing the p-value calculated for the enrichment fold of each gene either for 
(A) the third enrichment round (‘3+ cells’) or (B) for the three rounds of enrichment 






Examining the ‘hits’ (-log p-value > 3) when the sequencing analyses of all three 
enrichment rounds were combined (Fig.22B), SAFB and CXCR4 were present 
together with TNFRSF11B, ZNF619, PPP4R4. Tumor necrosis factor receptor 
superfamily member 11B (TNFRSF11B) seems to be mostly associated with 
osteoclastogenesis and bone homeostasis (Tsuda et al., 1997). More recently, 
polymorphisms in TNFRSF11A and TNFRSF11B genes have been studied in the 
context of infections (Jingjing et al., 2019). TNFRSF11B also acts as a receptor for 
RANKL (receptor activator of nuclear factor kappa-B ligand), the expression of 
which is substantially changed during Porphyromonas gingivalis infection 
(Yamaguchi et al., 2017). By contrast, Zinc finger protein 619 (ZNF619) and 
Serine/threonine-protein phosphatase 4 regulatory subunit 4 (PPP4R4) have not been 
studied extensively to date. 
As mentioned, these graphs (Fig.22) were generated only after the validation 
experiments were done and therefore these latter considerations were not taken into 
account in the choice of candidates to validate. 
 
RNA-seq data (Table 2) comparing RNA levels in cells either with or without 
priming with IFN-γ, were used to provide additional information about whether the 
high ranked genes were IFN-γ inducible. Known functions of the candidate genes 
were also considered. 
Candidates to follow-up in validation experiments were high ranked in the ‘3+ cells’ 
sample with higher confidence (-log p-value > 3). Most of these were subsequently 
found to be also highly ranked in the ‘2+ cells’ sample. However, amongst the IFN-γ 
inducible genes and highly ranked in the screen (Table 2), only CTNNBL1 stood out 
as new (non-expected as a positive control); STAT-1 is a direct downstream effector 
of the IFN-γ signalling pathway; CASP4 and IFNGR1 were shown to be necessary for 
the IFN-γ induced, LPS-triggered cell death; CASP8 is known as an essential 




Table 2: Enrichment ratio upon IFN-γ treatment for the genes chosen for 
validation 
Genes were partly chosen based on their expression being IFN-γ inducible; RNA-seq was 
performed by M. Wandel by treating HeLa cells with IFN-γ and measuring mRNA levels in 
both the primed and unprimed cells. The enrichment ratio of mRNA level upon IFN-γ 
treatment was calculated for each gene. Genes are ranked by alphabetical order. N/A: non-





2.3.4 Validation of the ‘hits’ 
Candidates selected from the screen results (Table 3) were validated using genetic 
techniques – CRISPR-Cas9 (knockouts) and/or RNA interference (knock-downs) – in 
follow-up experiments. Because the gene list was generated in a screen experiment, it 
was important to try to reproduce the observed phenotype (resistance to IFN-γ-
induced, LPS-triggered cell death) on an individual basis. It was expected that, 
following mutation of one of the genes in the list of candidates, fewer (or no) cells 
would die following the challenge of IFN-γ priming and LPS transfection relative to 









Table 3: Characterisation of the genes chosen from the screen results 
Genes chosen for validation were searched mostly using UniProt in order to indicate along 
with the gene name, the full name of the coded protein, their main known functions and the 




2.3.4.1. Validation using knockouts 
Cas9-expressing cells were transduced with gRNAs targeting 12 genes selected from 
the list of potential ‘hits’, including positive (CASP4, STAT-1, IFNGR1) and 
negative (Cas9-expressing cells ± β2M-transduced) controls. Each gene was tested 
using three or four different targeting gRNAs (Fig.23A); for each gene, two of the 
guides were selected from the original library for their high enrichment ratio whereas 
the other guides were newly designed. As expected, cells mutated in CASP4, STAT-1 
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or IFNGR1 showed significant resistance to LPS transfection: cell death occurred in 
respectively 20%, 10% and 12% of IFN-γ-primed cells, compared to 65% in cells 
transduced with the β2M guide (Fig.24B). These percentages were determined on a 
gene level by combining the results generated by all the different gRNAs used for 
each gene, albeit similar observations were obtained for individual guides (Fig.24A). 
In the cases of GSDMD and CASP8, the resistance phenotype was more partial (35% 
cell death) and significant only in the case of GSDMD. In the case of CASP8, there 
was greater variability between the different guides (Fig.24A): guides 2A and 2B 
gave respectively 40% and 65% cell death whereas 2C and 2D showed 30% and 25% 
cell death, respectively.  
 
 
Figure 23: Knockout and knock-down experiments were performed to validate 
the ‘hits’ obtained  
To perform validation experiments for genes chosen among the ‘hits’ identified in Table1 and 
further characterised in Table3, (A) three or four gRNAs were synthesised to target 12 of 
them and (B) pooled siRNAs were ordered to target 23 genes. All genes for which gRNAs 






Looking at the other seven candidates, none of the guides (Fig.24A, lower panel) 
showed a significant reduction in cell death for any of the genes tested, when 
compared with Cas9-cells (negative control). Even when averaging the different 
guides for one gene (Fig.24B), no candidate stood out as successfully able to 
reproduce the phenotype for which they were selected: i.e. resistance to cell death 
triggered by LPS upon IFN-γ priming. 
 
The observation that not a single new gene could be validated was surprising; 
especially because positive controls (IFNGR1, STAT-1) convincingly exhibited the 
desired result, showing hardly any cell death in IFN-γ-primed cells following LPS 












Figure 24: Knockout experiment for the validation of potential ‘hits’  
Cas9-expressing HeLa cells were transduced with gRNAs directed against specific genes 
(Fig.23A) and selected accordingly (hygromycin for Cas9 and puromycin for the gRNAs). On 
day 6 after gRNA transduction, cells were primed with IFN-γ overnight and transfected with 
LPS on the next day (blue). For each knockout cell line, controls were carried out: no 
treatment (black); transfection with LPS without priming with IFN-γ (grey), priming with 
IFN-γ but no transfection (yellow), meaning that a total of four conditions were set-up. Cells 
were analysed with CellTiter Glo on the day after LPS transfection to measure the number of 
live cells in each condition. The percentages of survival were calculated for each gRNA (A) 
for the 12 genes tested taking the unprimed and untransfected cells (black) as reference 
(100%). (B) shows the averages of guides for each gene. Upper graphs show genes for which 
resistance to cell death was expected, whereas the lower panel investigated new candidates. 
Results from seven independent experiments, all performed in triplicate, are shown as Mean ± 
S.E.M. Statistics were calculated for each gene knockout cell line (B) on the one hand, cell 
death following combined treatement by both IFN-γ and LPS (blue bar) was compared to the 
control cells (Cas9-expressing cells or cells transduced with β2M guide) and evaluated using 
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one-way ANOVA with Dunnett’s multiple comparisons test: *P<0.05, **P<0.005, 
***P<0.0002, ****P<0.0001, ns (not significant); on the other hand, the effect of LPS 
transfection was evaluated in cells primed with IFN-γ (yellow and blue bars) using unpaired t 
test, without assuming a consistent SD: *P<0.05, **P<0.005, ***P<0.0002, ****P<0.0001, 




2.3.4.2. Use of RNA interference as an alternative validation method 
An alternative method of validation was provided in case the candidate genes had not 
been successfully knocked-out in the previously described method. In this alternative 
method, the same genes and others chosen from the top-ranked in the screen list were 
knocked-down using RNA interference. HeLa cells were transfected with pooled 
siRNAs (a mix of four siRNAs for each gene) against 23 genes (Fig.23B), including 
all the genes previously tested in the gRNA experiment. The additional candidate 
genes were chosen for being highly ranked with the MAGeCK algorithm (Table 1), 
having a p-value higher than 3 and picked amongst the more IFN-γ inducible genes 
(Table 2).  
Two different siRNA controls were used as reference (negative controls) in order to 
compare the amount of cell death with the knock-downs. Pooled siRNAs targeting 
CASP4, STAT-1, and IFNGR1 were used as positive controls. Cells knocked-down 
for each of the three, showed significant resistance to cell death after IFN-γ priming 
followed by LPS transfection. Control cells died by 70%, whereas only 15% and 10% 
of cells died when knocked-down for IFNGR1 and STAT-1, respectively. CASP4 
showed a milder phenotype with 25% of cells dying (Fig.25, upper graph).  
Amongst all the candidates tested (Fig.25), only SAFB knock-down cells 
demonstrated a significant increase in survival (p=0.03). SAFB was not noticed as an 
IFN-γ inducible gene and is a member of the family of RNA-/DNA-binding proteins. 
SAF proteins are multifunctional (Norman et al., 2016) and are implicated in cell 
growth and death processes and are characterised as tumour suppressors via their 





Figure 25: Knock-down experiments for the validation of potential ‘hits’ 
Pooled siRNAs against 23 genes (Fig.23B) were transfected into HeLa cells to generate 23 
knock-down cell lines. At 48h post-siRNA transfection, the 23 cell lines were primed with 
IFN-γ overnight before transfection with LPS (blue). For each knock-down cell line, controls 
were carried out: no treatment (black); transfection with LPS without priming with IFN-γ 
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(grey), priming with IFN-γ but no transfection (yellow), meaning that a total of four 
conditions were set-up. Cells were analysed with CellTiter Glo on the day after LPS 
transfection to measure the number of live cells in each condition. The percentages of survival 
were calculated for each gene tested taking the unprimed and untransfected cells (black) as 
reference (100%). Experimental conditions were tested in triplicates. Data are shown as Mean 
± S.E.M from the triplicates of four independent experiments. For each gene knock-down, 
cell survival following combined treatement by both IFN-γ and LPS (blue bar) was compared 
to the control cell line (cells transfected with non-target siRNA: si-ctrl) and evaluated using 
one-way ANOVA with Dunnett’s multiple comparisons test: *P<0.05, **P<0.005, 
***P<0.0002, ****P<0.0001, ns (not significant). In each gene knock-down, the effect of 
LPS transfection was evaluated in cells primed with IFN-γ (yellow and blue bars) using 




In summary, when mutated using CRISPR and silenced by siRNA, none of the new 
genes identified in the screen gave a significant reduction in cell death when IFN-γ 
treated cells were transfected with LPS. None of the putative target genes were able to 
reproduce the resistance phenotype to LPS transfection upon IFN-γ-priming, for 
which they were initially selected. Consequently, no new gene could be validated and 





The work in this chapter used the CRISPR technology to establish a novel strategy to 
identify additional components in the IFN-γ-induced, LPS-triggered cell death 
pathway. This strategy was based on using an unbiased genetic screen to identify 
genes that play a role in the pathway. 
 
The presence of LPS in the cytosol leads to cell death in IFN-γ-primed HeLa cells. 
This is a mechanism by which the host protects against pathogenic infections, through 
restricting bacterial proliferation and potential spread to neighbouring cells. In human 
cells, cytosolic LPS is recognised by CASP4, which is activated in a proximity-
induced fashion. The active form of CASP4 cleaves GSDMD, the main effector of 
pyroptosis, which is a programmed but pro-inflammatory form of cell death (Fig.26). 
Expression of both CASP4 and GSDMD is induced by IFN-γ. However, 
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overexpression of neither CASP4 nor GSDMD individually was sufficient to 
recapitulate the effect of IFN-γ on cell death triggered by cytosolic LPS (Fig.8). 
 
 
Figure 27: Schematic illustration of how cytosolic sensing of LPS triggers 
pyroptotic cell death  
Cytosolic LPS is bound by CASP4 that is then activated by proximity-induced proteolysis. 
Active CASP4 cleaves GSDMD to release the inhibitory C-terminal part and to enable N-
terminal GSDMD to oligomerise and form pores in the plasma membrane. These pores not 
only allow the release of signalling molecules such as interleukins, but also result in 




This project would require further optimisation before performing at least one 
additional screen repeat to make sure that the results are reproducible and to gain 
deeper understanding of the multiple redundant mechanisms at stake. In order to 
follow up on results that challenge the current published views on the topic, the role 





2.4.1 Repeating the screen to achieve reproducibility 
The screen was undertaken based on the observation that CASP4 and GSDMD only 
had partial effects on the IFN-γ-induced, LPS-triggered cell death in HeLa cells: 
neither of these two candidates were able to explain completely the mechanism by 
which LPS promoted cell death in cells treated with IFN-γ (Fig.8). It was therefore 
reassuring to find CASP4 highly enriched by the successive rounds of selection 
(Fig.21). However, GSDMD was not identified in the first 100 genes in the ‘hit’ list. 
This means either that the screen design was not completely suitable or that other cell 
death mechanisms are redundant with the GSDMD-driven pyroptosis pathway. 
 
Using the CRISPR-Cas system as the genetic screening technique for the project 
detailed in this chapter was novel and came with a number of challenges. Several 
methodological points warrant discussion and would need to be improved for future 
implementations to be successful; in particular, the choice of cell line and the design 
of the gRNA library are crucial for the implementation of such a screen. Robust data 
analysis is also required and clear definition of criteria to select genes to be validated 
are also essential. 
 
To gain confidence in the results previously generated, repeating the screen is 
necessary. The same methodology could be applied again; alternatively, changes 
could be implemented to make the screen more robust. The time points for sampling 
the selected cells and the number of enrichment rounds to perform are discussed in 
paragraph 2.4.1.1. (“Loss of essential genes and slow-growing mutants”). The data 
analysis pipeline could also be improved in terms of choice of enrichment rounds to 
consider, the processing of the data (as multiple programmes are available), and the 
ways of representing the results to show clearly the potential ‘hits’ to be validated. 
 
 
2.4.1.1. Loss of essential genes and slow-growing mutants 
To ensure protein depletion (i.e. knockout), Cas9-expressing HeLa cells were 
expanded for 10 days after gRNA transduction before starting the screen. Although 
cells knocked-out in essential genes (i.e. regulating cell cycle, replication, 
metabolism) died during this waiting time, the loss of essential genes is not critical for 
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the result of the screen. The analysis did not consider genes that were lost but rather 
identified genes that were enriched over time. 
 
The successive enrichment rounds were compared to the reference (‘- cells’): HeLa 
cells that had undergone overnight priming with IFN-γ. IFN-γ-regulated genes 
providing a survival advantage would be present in the starting pool and selected for 
by this first incubation. This was a deliberate choice for the reference, to avoid 
generating false positives. Consequently, when calculating gene enrichment ratios 
after the different enrichment round(s), these genes would not show any positive 
enrichment as the screen selected for genes involved in the cell death mechanism 
triggered specifically by cytosolic LPS. Therefore, if any essential gene were to be 
involved in the IFN-γ-induced, LPS-triggered cell death pathway, the method used 
was not relevant to identify such a gene. 
 
Two different strategies could be applied to determine the sampling time points for 
cells from each enrichment round. The first strategy, which was implemented for the 
screen detailed in this thesis, assumes that cells are more genetically comparable if 
they are grown for the same duration. Therefore, cells of the different enrichment 
rounds were kept in culture for the entire duration of the experiment and eventually 
individually pelleted and frozen. This approach favours fast-growing clones, which 
will outgrow slow-growing mutants, thereby introducing a bias in the analysis. The 
second strategy would be based on the possibility that some genes, enriched in the 
early rounds, could be lost at later time points if they were detrimental to cell viability 
in the long-term. However, by isolating and saving the cells immediately after each 
enrichment round, these short-lived and enriched mutants resistant to IFN-γ-induced, 
LPS-triggered cell death could be identified. 
 
The screen described here was carried over five rounds of selection (i.e priming with 
IFN-γ followed by LPS transfection) and DNA from the cells isolated after the first 
three rounds was sequenced. Because the treatment after the fifth round did not seem 
to produce any additional cell death (Fig.19), it might prove insightful to consider the 
cells isolated after this stage of enrichment (‘5+ cells’). However, this last batch of 
cells was initially disregarded because it would contain hyperproliferative mutants 
that might not be specific to the selection pressure – IFN-γ priming followed by LPS 
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transfection – to which they had been exposed. To build a dataset that can be trusted 
and avoid the identification of false-positives, sequencing the ‘4+’ and ‘5+ cells’ 
batches would allow combining data from all five enrichment rounds and get 
additional information. 
 
To follow-up on this project, the screen needs to be repeated, ideally sampling the 
cells directly after each round of selection and then sequencing them, allowing dataset 
combinations as desired. 
 
 
2.4.1.2. Using a robust pipeline for the result analysis 
Irrespective of the computational algorithm used to rank the genes, the enrichment 
fold for each gRNA was calculated. Data processing methods differed in the way they 
rank the genes based on the information from each individual gRNA. 
 
Despite the absence of GSDMD in the top ranked genes, the screen seemed to have 
functioned effectively because the genes of the entire IFN-γ signalling pathway: IFN-
γ receptors (IFNGR1 and 2), STAT-1, JAKs (1 and 2) knockout cells were strongly 
(high enrichment fold) and robustly (high -log p-value) enriched in the screen, as 
expected. However, none of the new genes identified by the screen and chosen for 
validation showed even partial resistance to LPS-triggered cell death upon IFN-γ 
priming when knockout and/or knock-down individually. 
 
The candidates selected for validation were chosen based on the rankings obtained 
with the MAGeCK algorithm for the successive rounds of enrichment. Two other 
algorithms were used to rank the genes after the screen: RSA and “5th guide”. A more 
robust approach would consider genes highly ranked in the three different analysis 
methods (MAGeCK, RSA and “5th guide”) for selecting candidates to validate. The 
rankings shown in Table1 were generated from the ‘3+ cells’ batch. For example, 
SAFB was ranked 39, 13 and 17 with MAGeCK, RSA and “5th guide” analysis 
methods, respectively. Although no more time was allocated to undertake additional 
experiments, other ‘hits’ with a similar or higher ranking should be considered. This 
would include QRICH, LTK, PISD, LRIG1, and ECD. Chemokine receptor 4 
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(CXCR4) has been identified as a mediator of LPS-initiated inflammatory response 
(Triantafilou et al., 2001) and was ranked 16 and 18 using RSA and “5th guide” 
methods, respectively, suggesting that it would be a promising candidate to test too. 
Unlike other CDKs, cyclin-dependent kinase 9 (CDK9), which was ranked 23, 24, 
and 19 acts as a regulator of transcription and not of the cell cycle. CDK9 
heterodimerises with CyclinT1 to form the positive transcriptional elongation factor b 
(P-TEFb), complex shown to play a key role in signalling cascades (Brasier, 2008) 
such as TNF-inducible NK-κB activation (Nowak et al., 2008) and IL-6-inducible 
STAT3 (Hou et al. 2007) and so could be a potential target for anti-inflammatory 
therapy (Wang & Fischer, 2008). 
 
In addition to using the three algorithms, it would be interesting to consider other 
enrichment rounds individually or to combine the data of several stages. For example, 
to check whether top-ranked genes overlap between enrichment rounds and whether 
‘hits’ specific to ‘1+ cells’ or ‘2+ cells’ could be validated. That will potentially lead 
to the identification of both stage-specific and common ‘hits’; the latter definitely 
constituting a pool of candidates for validation. 
In order to make such analysis easier, the genes’ enrichment fold were represented on 
volcano plots (Fig.22), which provide a clearer view of the enriched genes in the 
screen, and a way of comparing either individual enrichment rounds (e.g. ‘3+ cells’, 
Fig.22A) or combined results from the three sequenced samples (Fig.22B).  
 
Criteria could be defined to select genes for validation experiments using volcano 
plots displaying data from the screen. Results from either the screen already 
performed and/or new repeats and processed by the three different ranking methods 
could be compared. Furthermore, candidates for validation could be chosen 
considering one or multiple enrichment rounds. In addition, the cut-off in terms of 
confidence was set to -log p value > 3. 
 
More comprehensive analysis of the results generated by the screen have identified 
several additional candidates (CXCR4, CDK9, LCORL, EXOC2, CHD8, 
TNFRSF11B, ZNF619 and PPP4R4) as putative members of the IFN-γ-induced, LPS-
triggered cell death pathway and so would be attractive targets for future validation 
studies. These new genes were identified based on their p-value (confidence in the 
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enrichment fold comparing to the initial population) in analysis done considering only 
the ‘3+ cells’ or the three enrichment rounds together (‘1+’, ‘2+’ and ‘3+ cells’). 
 
2.4.1.3. A more systematic approach for validation of the candidates 
Once chosen, candidates are tested in validation experiments and it is usually 
preferable to follow-up a CRISPR screen by again using CRISPR in the validation 
procedure. In this way, if the potential candidate does not pass the test, it is assumed 
that it was a false positive in the ‘hit’ list. As discussed above, the knockouts in the 
validation experiments performed might not have been complete and this would likely 
be due to intrinsic redundancy in HeLa cells, which usually carry multiple copies of 
the same gene and often have more than two alleles. In the future, the absence of the 
target proteins should be checked by western-blotting. 
However, even if the phenotype is reproduced on an individual basis using knockouts, 
the candidate gene still needs to go through further confirmations, characterisations, 
and functional experiments to demonstrate that it is required in the pathway. 
 
In addition to knockouts, alternative validation techniques such as knock-downs using 
siRNAs could generate more information on potential candidates. Reproducing the 
resistance phenotype in these experiments validates further the genes as true positives. 
However, when the knock-down cells did not show any phenotype, it was hard to 
know whether the knock-downs were incomplete or whether the tested genes were 
simply false positives. It would thus be worth following up the work on SAFB since it 
was the only gene to produce a significant resistance to cell death (Fig.25). During the 
screen, cells were selected following multiple rounds of LPS transfection: because of 
this, cells mutated in a single gene might not show a difference in survival with only a 
single round of applying the selection pressure. Therefore, it might be useful to test 
again the knockout / knock-down cells, assessing their survival after multiple 
selections. In addition to the number of selection rounds to apply, the timing of 
analysis (measure of cell death) might play a role in the validation of a candidate 
gene: analysing cells, even when using the same technique, showed increased cell 
death over time (Fig.3B). This might be explained by the existence of concomitant 
cell death pathways being activated but triggered or responding to the LPS challenge 
at various time points after the treatment. Whether the response is produced directly 
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by IFN-γ or, alternatively, by LPS and the nature of the proteins involved, will dictate 
the time required for the cell to die. It has been shown that GSDMD-dependent 
pyroptosis is generally a faster process than apoptosis (Bergsbaken et al., 2009). This 
may account for both Caspases-4 and -8 becoming enriched during the screen as a 
consequence of their representing the pyroptotic and the apoptotic cell death 
pathways, respectively. A delay in cell death might also be due to membrane repair 
mechanisms led by the ESCRT complex (Rühl et al., 2018). 
 
In order to test these hypotheses and also because of the absence of candidates from 
the screen that could be validated in subsequent experiments, a focused screening 
approach might be best. 
 
 
2.4.1.4. Focusing the screen to investigate beyond redundancy 
The screen can be biased in different ways: either by limiting the gRNA library or by 
performing it in knockout cell lines.  
Repeating the screen using a focused sgRNA library might help identify true 
candidates for further validation, in addition to the positive controls (IFNGRs, STAT-
1, JAKs). Using a genome-wide library in a CRISPR screen allows for an unbiased 
approach when it comes to a biological question. However, it may be worth 
introducing a bias by using a targeted screen (Wang et al., 2014). To investigate the 
IFN-γ-dependent and LPS-triggered cell death pathway, libraries specifically 
targeting subsets of genes known to be either IFN-γ-regulated or known for their 
involvement in cell death pathways or LPS sensing would be appropriate choices 
(https://www.synthego.com/crispr-libraries); a library designed based on the results of 
the first genome-wide screen and targeting, for example, the first 1000 ‘hits’ found 
could be another option. 
 
CASP4 and GSDMD were expected to be in the ‘hit’ list generated by the screen 
because CASP4 acts as a direct receptor for cytosolic LPS (Shi et al., 2014) and 
GSDMD is the principal effector in pyroptosis (Rühl & Broz, 2016). The requirement 
of these two proteins in the IFN-γ-induced, LPS-triggered cell death pathway was 
tested: the absence of CASP4 resulted in decrease of cell death, whereas 
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overexpression of GSDMD partially induced cell death in the absence of IFN-γ 
priming. However, the combined effect of CASP4 and GSDMD was not addressed. It 
would be interesting to look at double knockout or knock-down HeLa cells to see 
whether the absence of both proteins completely abrogates LPS-triggered cell death 
upon IFN-γ priming. Similarly, simultaneous overexpression of CASP4 and GSDMD 
could recapitulate the effect of IFN-γ priming; i.e. the cell death observed when 
transfecting LPS would be the same in the absence or presence of IFN-γ. 
 
Working in CASP4-deficient cells could allow deeper understanding in the cell death 
pathway and overcome possible pathway redundancy. CASP4 knockdown in human 
MDMs (monocyte-derived macrophages) or in intestinal epithelial cells showed 
decreased level of IL-1α processing after infection with L.pneumophila (Casson et al., 
2015) and IL-18 secretion as well as increased bacterial load upon infection with 
enteropathogenic E.coli or S.Typhimurium (Knodler at al., 2014). These findings also 
suggested involvement of CASP1, which could be investigated in CASP4-deficient 
cells. Such a cell line could be generated by using CRISPR-Cas9 to knockout CASP4 
in HeLa, hence providing a different genetic background for a new screen. 
 
In the case of S.Typhimurium infection, the autophagy machinery is recruited to 
cytosolic bacteria for the degradation of the pathogen (Boyle & Randow , 2013). 
Projects in the Randow laboratory have demonstrated the ubiquitylation of LPS 
chains on cytosolic bacteria following infection and rupture of the SCV membrane. 
Ubiquitin constitutes a signal for the recruitment of the autophagy machinery. 
Therefore, autophagy might also play a role when cells are transfected with LPS. To 
address the possible redundancy of cell death pathways, it would be best to silence 
(e.g. use of ATG5-knockout cells) or inhibit the autophagy pathway (e.g. with small 
molecules inhibitors such as wortmannin, bafilomycin, chloroquine or MG-132) 
during the screen. This might impact the percentage of cell death by changing the way 
LPS is sensed in the cytoplasm. 
 
Inflammasomes, autophagy, and cell death are innate immune defence mechanisms 
that the host set up to control pathogenic infections. All three interact with each other 
to preserve host viability by pathogen clearance (Krakauer, 2019). The autophagy 
protein family Beclin-2 (BCL-2) contains several members known to control 
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mitochondrial membrane integrity (Chipuk et al., 2010) and to regulate the release of 
cytochrome c in the cytosol. Cytochrome c indirectly promotes caspase-9 activation 
and subsequent apoptosis by cleavage of caspases-3 and-7 (Riedl & Salvesen, 2007). 
Hence autophagy and apoptosis are closely linked. Similarly, necroptosis (believed to 
actually be pyroptosis) is negatively related to autophagy. Under starvation condition, 
autophagy is activated in order to prevent necrosis (Bell et al., 2008; Farkas et al., 
2011). 
 
Because of these interconnections between pathways, it would also make sense to 
prevent apoptosis from happening (either by using caspase inhibitors or by making 
knockout cell lines) and assess the impact on the IFN-γ-dependent, LPS-triggered cell 
death. This cell death mechanism was hypothesised to be pyroptosis (Jorgensen & 
Miao, 2015), but a decrease in the percentage of non-apoptotic cells dying following 
the treatment would suggest that part of the cell death is due to apoptosis. Such a 
result would also explain why GSDMD was not part of the top ‘hits’ in the list 
resulting from the screen. 
 
 
2.4.2 Role of IFN-γ in LPS sensing 
The sensing mechanisms, and thereby downstream effects, are impacted differently 
depending on whether LPS is attached to the bacteria or displayed as a free molecule 
in the cytoplasm. Introducing LPS into cells by electroporation or cationic chemical 
transfection leads to different phenotypes regarding cell death and could explain the 
extent to which IFN-γ is required. Variations between species (mouse vs human) and 
cell lines (macrophage-derived vs non-immune) will also be discussed in the 
following sections. 
 
2.4.2.1. Impact of the delivery method for LPS 
It was shown that LPS from Gram‐negative bacteria delivered to the cytosol by 
transfection or electroporation is sufficient to induce caspase‐11 activation (Hagar et 
al., 2013; Kayagaki et al., 2013). However, depending on the technique used, LPS 
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molecules are most likely sensed differently by the cell. Electroporation or chemical 
transfection are usually used for introducing nucleic acids (DNA or RNA) into cells. 
Electroporation is a direct physical method based on the induction of pore formation 
by applying an electric field. The hydrophilic pores are lined by phospholipid 
headgroups, facilitating the introduction of polar and charged molecules in cells 
(Tieleman, 2004). Two distinct models try to explain the mechanism by which the 
electroporated substrate gets into the cell. One suggests the formation of large stable 
pores in the plasma membrane allowing transport through it without much interaction 
(Smith et al., 2004). The other claims that small pores provide flexibility to the 
plasma membrane allowing structural modifications for the translocation of the 
payload (Sukharev et al., 1992). 
Because this method is a direct transfer, LPS molecules would most likely not be 
affected and would instead remain aggregated in micelles or vesicles, since they are 
naturally in aqueous solution. 
 
Transfection is a chemical method relying on successive interactions to deliver the 
desired molecule into cells. The transfection reagent Lipofectamine2000 is a mixture 
of lipid subunits that assemble as liposomes in aqueous environment and entrap the 
transfection payload, that is, LPS in the experiments described in this chapter. Two 
major uptake mechanisms are involved: clathrin-dependent endocytosis and/or 
transmembrane transport of lipoplexes by a caveolae-dependent pathway into the cell 
membrane channels. A correlation between clathrin-mediated or caveolae-dependent 
endocytosis and lipoplexes transfection was convincingly supported by several pieces 
of evidence, including the use of inhibitors of endocytosis, co-localization with 
pathway-specific markers and defective in clathrin-mediated endocytosis (Cui et al., 
2012). The uptake of lipoplexes in HEp-2 cells was mediated via both the clathrin- 
and the caveolae-dependent pathways, although it is not definite which is the main 
mechanism. 
 
Lipofectamine, contrary to alternative formulations, is able to efficiently avoid active 
intracellular transport along microtubules and the subsequent entrapment and 
degradation of the payload within acidic/digestive lysosomal compartments. This 
result is achieved by random Brownian motion of Lipofectamine-containing vesicles 
Chapter 2 
 136 
within the cytoplasm (Cardarelli et al., 2016). In this way, LPS is released in the 
cytoplasm upon vesicle membrane rupture or fusion. 
 
The introduction of LPS into the cell cytoplasm via either electroporation of chemical 
transfection influences the shape and the aggregation or assembly of LPS molecules. 
Therefore, there is a chance that cells recognise cytoplasmic LPS through different 
pathways depending on the transfection mechanism. Furthermore, similar 
considerations apply regarding LPS being either bound at the surface of Gram-
negative bacteria (alive or in lysates) or free in solution. It was indeed shown (Fig. 
1A) that infection with living S.Typhimurium produces more cell death compared to 
infection with S.Typhimurium lysates or transfection with S.Typhimurium LPS in 
IFN-γ-primed HeLa cells. In the absence of IFN-γ, the delivery of LPS into cells by 
cationic lipids using Lipofectamine2000 transfection reagent (Fig.3) has no effect on 
the viability of cells (Eldstrom et al., 2000), and provided an appropriate way of 
investigating acute actions of LPS in the intracellular compartment of human cells. 
 
In addition, responses to the presence of cytosolic LPS may differ between cell types, 
especially comparing with professional immune cells. The extent to which IFN-γ is 
required for the detection and sensing of LPS, and for cell death to occur depends on 
the cell lines used. 
 
 
2.4.2.2. Differences between cell lines 
When infected by Gram-negative bacteria, epithelial cells in the lungs, the intestinal 
or urinary tracts are the first line of defence against the pathogenic threat. Both 
murine (Hornef et al., 2002; Knodler et al., 2014a) and human intestinal epithelial 
cells are responsive to LPS. The activation of immune responses is generally 
mediated by the binding of extracellular LPS to the cell surface receptor TLR4. 
However, it was also shown that the recognition of intracellular LPS is enhanced by 
IFN-γ in human intestinal epithelial cells (Suzuki et al., 2003). 
In this project, HeLa cells derived from a cervical cancer specimen were used as a 
model to investigate the IFN-γ-induced, LPS-triggered cell death pathway, which is a 
cell line dependent mechanism. IFN-γ-primed embryonic cells (293ET and MEF) did 
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not die following transfection with LPS whereas 50% of HeLa cells died in the same 
conditions (Fig.4). This particular cell death process was also noticed in HFF and 
HCT116 cells (Fig.4), albeit to a lesser degree than in HeLa cells. This could be 
because the same conditions (i.e. amounts of Lipofectamine2000 and LPS) – that had 
been optimised to produce the greater percentage of cell death in HeLa cells – were 
used to transfect LPS across the different cell lines and transfection efficiency can 
significantly vary between different cell types (Chu et al., 1987; Yamano et al., 2010). 
In addition, there was always a pool of HeLa cells resistant to the treatment: around 
20% of the cells did not die. The percentage of resistant cells in the population was 
not reduced when cells cloned from a single starter cell were employed to attempt to 
obtain a more homogenous population. One way forward could be to put greater effort 
in obtaining a population in which complete cell death (100%) was achieved 
following LPS transfection, as this would have the potential to generate a 
considerably more robust selection pressure for the screen. Lipofectamine2000 was 
chosen as the transfection reagent because it led to the highest cell death among the 
transfection reagents tested (Fig.10A). It is possible that an increased amount of 
Lipofectamine or other transfection reagents could increase the percentage of cell 
death, but this hypothesis was not thoroughly investigated. The titration of LPS 
indeed showed saturation of the transfection capacity (Fig.10B) indicating that this 
variable could be further optimised. As performed in earlier experimentation, any 
future optimisation experiments will include conditions without adding LPS and/or 
IFN-γ to control for the absence of cytotoxicity originating from either the 
transfection reagent or IFN-γ: the screen selection relies on cell death triggered 
specifically by LPS. 
 
HeLa cells were used for primarily technical reasons: they are relatively easy to 
transduce and have a relatively fast doubling time, thereby shortening the overall 
duration of the screen. More importantly, HeLa cells displayed the phenotype being 
studied: that is, LPS-triggered cell death upon IFN-γ priming. HeLa cells respond to 
IFN-γ priming as shown by RNA-Seq (experiments performed by M. Wandel) by 
inducing many genes and hence protein expression. According to the Protein Atlas 
Database (available at http://www.proteinatlas.org, Uhlen et al., 2015), HeLa cells 
express both CASP4 and GSDMD in contrast to, HEK293 (293ET) cells, for 
example. However, higher mRNA levels for both CASP4 and GSDMD were found in 
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THP-1 cells, a myeloid cell type. This leads to a consideration of the role of 
macrophages during infection and their relevance in the experimental system 
employed. Most of the earlier studies showing pyroptosis resulting from the presence 
of cytosolic LPS and which identified caspase-11 as a direct LPS binding partner 
(Demon et al., 2014; Shi et al., 2014) were performed in macrophages. Macrophages 
and monocytes are highly sensitive to IFN-γ because they display a high 
concentration of IFN-γ receptors on their surface (Valente et al., 1992). The TLR4-
independent activation of the non-canonical inflammasome by intracellular LPS was 
originally showed in macrophages (Kayagaki et al., 2013). This one-step non-
canonical inflammasome was similarly activated in response to LPS in human 
monocytes (Viganò et al., 2015) requiring Caspases-4 and -5. These experiments were 
carried out in BMDM (bone-marrow derived macrophages) isolated from mice, which 
were knocked-out in crucial genes such as caspase-11, TLR4, or GSDMD. 
 
Repeating the selection process in a different cell line such as immortalised 
macrophages might be more effective in giving further insight in the IFN-γ-induced, 
LPS-triggered cell death pathway. New optimisation experiments would need to be 
performed to address any limitation in the ability of these cells to 1) sense IFN-γ, 2) 
be transfected with LPS, and 3) trigger cell death in response to cytosolic LPS when 
primed with IFN-γ. Additional experiments will be necessary to identify conditions 
that could be used to produce a suitable selection pressure in a viability assay. Using 
macrophages would also have the potential to direct the focus away from innate 
immunity in non-immune cells to that in dedicated phagocytes. 
 
Finally, the choice of the model cell line for the experiment considers the species-
specific differences. As mentioned earlier, MEF cells did not die when transfected 
with LPS, even when primed with murine IFN-γ. In vivo data suggest that rodents 
such as mice and rats are less susceptible to sepsis when receiving a LPS dose, 
compared to chimpanzees or even humans. Physiological changes were noticed with a 
dose of 1-5ng/kg in humans whereas similar effects were observed in mice with a 
105-fold higher dose of 0.5mg/kg (Vaure & Liu, 2014). This study was consistent 
with the results obtained here and, to some extent explains the absence of cell death in 




In conclusion, the CRISPR screen successfully performed and described in this 
chapter, did not allow the robust identification of novel regulators or mediators in the 
cell death pathway following LPS challenge and enhanced by IFN-γ. However, 
several technical changes would be implemented in future repeats of the screen. In 
addition, multiple hypotheses were discussed: investigating possible redundancy 
between cell death pathways or cell line-specific LPS sensing mechanisms and 
downstream responses. Further experimental work would be necessary to address 





Chapter 3: Host responses to Toxoplasma 
gondii: Recruitment of host immune proteins 
and production of cytokines in an IFN-γ 
dependent manner 
3.1 Introduction 
This chapter investigates the innate immune defence against pathogens in non-
immune cells; more specifically, the cell-autonomous defence against the parasite 
Toxoplasma gondii. This work complements work done in the Randow laboratory on 
cytosol-invading pathogens such as Shigella flexneri or Salmonella enterica serovar 
Typhimurium. 
 
3.1.1 The restriction of pathogens 
3.1.1.1. Role of ubiquitylation 
Ubiquitylation is a versatile post-translational modification that has various effects 
depending on the length and the linkage types of the synthesised polyubiquitin chains 
(Kulathu & Komander, 2012). Ubiquitin conjugation acts as an immune signal in the 
case of infections. For example, K63-linked ubiquitin chains drive IFN-γ-dependent 
endo-lysosomal fusion of the parasitophorous vacuole (PV) that mediates killing of 
T.gondii in HeLa cells (Clough et al., 2016). In IFN-γ-primed cells, the deposition of 
ubiquitin chains on the parasitophorous vacuole membrane (PVM) is essential for the 
recruitment of sequestosome-1 (p62) that transports guanylate-binding proteins 
(GBPs) in proximity of the PVM. In mouse cells, GKS proteins (subfamily of IRGs, 
including Irga6, Irgb6) target the PVM (Haldar et al., 2013; Hunn et al., 2008) and 
facilitate GBP coating on the PV, but hypervirulent strains of T.gondii (type I) 
produce ROP18, which can inhibit GKS proteins by phosphorylating them (Steinfeldt 
et al., 2010).  
 
During S.Typhimurium infection, M1-linked Ub is required for the restriction of 
S.Typhimurium proliferation (Noad et al., 2017; van Wijk et al., 2017). M1-linkage 
type recruits the NF-κB essential modulator (NEMO) leading to NF-κB activation 
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(Noad et al., 2017). However, it is currently unknown whether or not M1-linked 
polyubiquitin coats T.gondii in MEF cells. This chapter will therefore investigate the 
presence of linear polyubiquitin chains on T.gondii and the recruitment mechanism of 
LUBAC and its three constitutive subunits (HOIP, HOIL-1, Sharpin), because it 
specifically synthesises linear ubiquitin chains (M1-linkage type).  
 
 
3.1.1.2. Cargo receptors are the link to autophagosome 
The ubiquitin coat on bacteria acts as a recruitment platform for cargo receptors such 
as NDP52, p62 and Optn, ultimately leading to the recruitment of the autophagy 
machinery for degradation of the ubiquitylated substrate (Cemma et al., 2011; 
Thurston et al., 2009; Wild et al., 2011; van Wijk et al., 2017; von Muhlinen et al., 
2012; Yoshikawa et al., 2009). Both NDP52 and p62 were also shown to be recruited 
to T.gondii or its PVM in IFN-γ-primed human cells (Selleck et al., 2015). However 
little is known about the mechanisms by which they are recruited and whether they 
are recruited in mouse cells. Therefore, the requirement of IFN-γ will be addressed in 
this chapter, together with T.gondii strain specificity. 
 
 
3.1.2 Immune signalling during T.gondii infection 
3.1.2.1. Τhe protective role of IFN-γ 
IFN-γ plays an essential role in defence against T.gondii infection. Following T.gondii 
infection with non-virulent strains, mice devoid of IFN-γ died of Toxoplasmosis 
whereas wild-type mice developed chronic T. gondii infection (Suzuki et al., 1988). 
IFN-γ was also shown to restrict T.gondii growth (Selleck et al., 2015) and, in some 
instances, to kill the pathogens (Zhao et al., 2008; Sasai et al., 2018). In human 
fibroblasts, IFN-γ triggers cell death upon T. gondii infection, thereby limiting 





3.1.2.2. T.gondii infection induces chemokine production 
T. gondii infection in vivo triggers IFN-γ production by NK cells as a result of IL-12, 
TNF-α, and IL-1β production in macrophages. Furthermore, IFN-γ is also regulated 
by IL-10 (Hunter et al., 1994; Hunter et al., 1995; Gazzinelli et al., 1996). An 
extensive study (Aviles et al., 2008) characterised the variations in chemokine and 
cytokine levels during T.gondii infection, to show that proinflammatory cytokines and 
their receptors induce T.gondii tachyzoites conversion to bradyzoites preventing 
replication and protecting the host. Furthermore, the NF-κB signalling is activated by 
the T.gondii effector GRA15 (Sangaré et al., 2019); and NF-κB activation is known to 
induce the production of, for example, IL-6 in macrophages (Liu et al., 2017) or upon 
LPS activation (Yamamoto et al., 2004) and of IL-8 (Keusekotten et al., 2013).  
 
In order to understand the immune response against T.gondii in greater detail, the role 
played by IFN-γ was investigated using a targeted approach that considered proteins 
related to autophagy such as the linear ubiquitin-binding assembly complex (LUBAC) 
and cargo receptors such as NDP52, Sequestosome-1 (p62) and Optineurin (Optn). 
The recruitment mechanisms of these proteins to the parasite were investigated using 
microscopy (see paragraph 3.2). The potential relationship of LUBAC with the 




3.2 Results: Protein recruitment to T.gondii  
One of the principal goals of this study was to investigate the recruitment of proteins 
to the vicinity of T.gondii, i.e. either to the parasitophorous membrane or to the 
parasite itself, that might be associated to the cellular immune response to this 
pathogen. Following infection, cytosolic S.Typhimurium are targeted by host proteins 
of the autophagy machinery, resulting in either degradation of the pathogens or 
restriction of their replication (Wang et al., 2018a). Similarly to cytosolic bacteria and 
even though T.gondii is a eukaryotic parasite, it (or its parasitophorous vacuole 
membrane – PVM) has been shown to be coated by ubiquitin (Coers & Haldar, 2015).  
In order to investigate whether either T.gondii or its PVM behaves as an immune 
signalling platform, MEF cells were infected with the parasite. Because the precise 
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location of the recruitment was not addressed in this study, the word T.gondii, as used 
throughout the chapter, probably refers to the PVM since it is the likely target of such 
host proteins.  
In case there was a difference between T.gondii strains, two different strains were 
used: type I – RH – which is more virulent than type II – PRU (Zajdenweber et al., 
2007). Both strains were engineered to express Td-tomato fluorophore and could 
therefore be used in microscopy and imaging experiments. 
 
 
3.2.1 Type II T.gondii is targeted by host proteins 
3.2.1.1. Cytosolic exposure of type II T.gondii is IFN-γ-independent 
Galectin-8 (GAL8) is an early marker of cytosolic entry of S.Typhimurium because it 
binds exposed intravesicular glycans, hence colocalising with membrane remnants of 
the broken vacuoles (Randow et al., 2013). GAL8 recruits cargo receptors such as 
NDP52 (Li et al., 2013), which associates with “eat-me” signals (Randow & Youle, 
2014) for the targeting of bacteria to xenophagy (Thurston et al., 2012).  
 
To determine whether GAL8 was recruited to T.gondii, MEF cells seeded on 
coverslips were infected with type II (PRU) T.gondii for 1h, before being fixed with 
PFA and later immunostained with the GAL8 antibody. Although the fluorescence 
levels were low and therefore recruitment events challenging to detect (Fig.1A), 34% 
of intracellular T.gondii were counted positive for GAL8 in the absence of IFN-γ, 
whereas 22% were positive following IFN-γ priming (Fig.1B). However, this 
difference was not considered to be statistically significant (p > 0.05). 
 
This experiment demonstrated that IFN-γ priming did not induce a difference in the 
recruitment of GAL8, shortly after active invasion of type II T.gondii parasites. This 
result suggested an IFN-γ-independent entry mechanism of T.gondii in the cytosol of 
the host cells. This is an unexpected result and may possibly be the result of non-





Figure 1: Galectin-8 is localised to type II T.gondii 
MEF cells were infected with type II (PRU) Toxoplasma gondii strain in 4:1 ratio compared 
to the number of cells seeded on coverslips. Cells were incubated with IFN-γ overnight before 
infection. At 1h post-infection, cells were washed and fixed with 4% PFA. Coverslips were 
stained using Galectin-8 as primary antibody followed by Alexa488 as secondary antibody. 
(A) Images of PRU-infected cells were taken on a Zeiss-780 microscope using a 63x oil-
immersion objective. Scale bar is 20μm. (B) At least 100 T.gondii were counted for each 
coverslip and the number of GAL8-positive T.gondii was recorded. Data are shown as Mean 
± S.E.M from four independent experiments, all performed in duplicate. ns (not significant), 
unpaired t test without assuming a consistent SD scoring for the difference of GAL8-coating 




It was indeed noticed that the antibody stained a few extracellular T.gondii. Even 
though only intracellular parasites were counted, it is possible that the GAL8 antibody 
recognises T.gondii irrespective of their location. An alternative method relying on 
the overexpression of GFP-tagged GAL8 in MEFs could be used to validate this 
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interpretation. GFP-GAL8-overexpressing MEFs would then be infected with 
T.gondii to look at GAL8 specific recruitment to intracellular T.gondii. In this way, 
the requirement of IFN-γ or its effect on inducing T.gondii cytosolic entry would be 
addressed. 
 
Following cytosolic entry and escape from the SCV, S.Typhimurium is 
ubiquitinylated by multiple E3 ligases, including LUBAC (Noad et al., 2017). 
Ubiquitin chains act as anchors for autophagy cargo receptors (von Muhlinen et al., 
2012; Wild et al., 2011; Zheng et al., 2009). To establish whether similar events 
happen in the case of T.gondii infections, other microscopy-based experiments were 
performed and are detailed in the next paragraphs. 
 
 
3.2.1.2. Ubiquitin coats T.gondii in MEFs 
Initially, MEF cells seeded on coverslips were infected with either type I (RH) or type 
II (PRU) T.gondii for 1h, before being fixed with PFA and later immunostained with 
the FK2 antibody, which recognises all ubiquitin chains. FK2-positive parasites were 
counted among the infectious T.gondii, defined as intracellular parasites, which were 
typically located close to the nucleus (Denkers et al., 2004).  
 
Very few events (3%) were recorded with the type I (RH) T.gondii strain; whereas, in 
cells infected with the PRU (type II) strain, 12% of T.gondii were FK2-positive in the 
absence of IFN-γ priming (Fig.2A). Moreover, ubiquitin conjugation was greatly 
enhanced, increasing from 12% to 56% of the parasites, when cells were primed 
overnight with murine IFN-γ (Fig.2B). This indicates that ubiquitin was primarily 
attached to type II T.gondii and was significantly (p<0.0001) induced by priming with 
IFN-γ. 
 
The presence of Ub chains in the vicinity of T.gondii suggests the recruitments of one 
or multiple E3-ligase(s) for the synthesis of these chains and of downstream effectors 
such as autophagy cargo receptors. Both questions were subsequently addressed 




Figure 2: Ubiquitin is conjugated to type II T.gondii parasites 
MEF cells were infected with type II (PRU) or type I (RH) T. gondii strains in 4:1 ratio 
compared to the number of cells seeded on coverslips (MOI of 4:1). Cells had been incubated 
with IFN-γ overnight before the infection. At 1h post-infection, cells were washed with PBS 
and fixed with 4% PFA. Coverslips were immunostained for ubiquitin chains with the FK2 
antibody, followed by Alexa488. At least 100 parasites were counted for each coverslip and 
the number of FK2-positive T.gondii was recorded (A), data are shown as Mean ± S.E.M 
from five independent experiments, all performed in duplicate. **P<0.0001, unpaired t test 
without assuming a consistent SD scoring for the difference of Ub-coating in the presence or 
absence of IFN-γ priming. (B) Images of PRU-infected cells were taken on a Zeiss-780, 






3.2.2 LUBAC colocalises with type II T.gondii 
The linear ubiquitin assembly complex (LUBAC) acts as an E3-ligase that 
specifically synthesises linear (M1-linked) ubiquitin chains (Kirisako et al., 2006). 
Linear ubiquitin chains are detected by FK2 staining, as would K63, K48, and all the 
other ubiquitin linkage types (except for K6) without distinction (Noad et al., 2017; 
Wandel et al., 2017; Zheng et al., 2009). Because ubiquitin coats type II T.gondii, the 
presence and role of LUBAC were assessed during T.gondii infection.  
 
3.2.2.1. LUBAC is recruited to the PRU in an IFN-γ-dependent manner 
LUBAC is a heteromultimeric complex containing the proteins HOIP, HOIL-1, and 
Sharpin. It induces NF-κB signalling and thereby promotes inflammation and inhibits 
apoptosis (Brummelkamp et al., 2003; Gerlach et al., 2011; Ikeda et al., 2011; 
Tokunaga et al., 2011). Since ubiquitin was conjugated with type II T.gondii (Fig.1), 
GFP-tagged human HOIP, HOIL-1, and Sharpin were overexpressed in MEF cells 
(Fig.3Α) to investigate their recruitment to both strains of T.gondii. Both strains of 
T.gondii, engineered to express the Td-tomato fluorophore, were used to infect IFN-γ-
primed MEFs. Cells were imaged using microscopy, (Fig.3B) and recruitment of each 
individual LUBAC subunit was counted manually. 
 
At 1h post-infection, MEFs infected with RH (type I strain) did not show recruitment 
of any of the LUBAC subunits (Fig.3C, right graph). By contrast, infection with PRU 
led to recruitment of all three LUBAC subunits in an IFN-γ-dependent manner. HOIP, 
HOIL-1, and Sharpin were recruited to less than 10% of the parasites without IFN-γ, 
but colocalisation was significantly (p<0.05, p<0.05 and p<0.0001 respectively) 
increased when cells were primed overnight with IFN-γ to reach respectively 25%, 
21%, 42% of intracellular T.gondii (Fig.3C, left graph). This 2-fold difference in 
recruitment between HOIP, HOIL-1 on the one hand (~ 20%) and Sharpin on the 
other hand (~ 40%) might be explained by Sharpin being recruited by both HOIP and 
HOIL-1; and also by HOIL-1 and HOIP recruitments being exclusive.  
This experiment demonstrated that only the PRU strain was targeted by HOIP, HOIL-






Figure 3: LUBAC subunits are recruited to PRU T.gondii parasites in an IFN-γ-
dependent manner  
MEF cells overexpressing GFP-tagged human LUBAC subunits (HOIP, HOIL-1, Sharpin) 
were infected with type II (PRU) or type I (RH) Toxoplasma gondii strains (MOI of 4:1). 
Cells were incubated with IFN-γ overnight before the infection. (A) Expression levels of all 
three LUBAC subunits were assessed by western-blotting probing for GFP. (B) At 1h post-
infection, cells were washed with PBS and fixed with 4% PFA. Images of PRU-infected cells 
were taken on a Zeiss-780 microscope, using a 63x oil-immersion objective. Scale bar is 
20μm. (C) At least 100 T.gondii were counted for each coverslip and the number of GFP-
positive T.gondii was recorded. Results from three independent experiments, all performed in 
duplicate, are shown as Mean ± S.E.M. *P<0.05, ****P<0.0001, multiple unpaired t-test 
without assuming a consistent SD scoring the difference of protein recruitment in the 
presence or absence of IFN-γ priming. 
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Constructs for the expression of GFP-tagged wild-type HOIP, HOIL or Sharpin were 




The next experiments will address the requirement of each individual LUBAC subunit 
for the recruitment of the others. 
 
 
3.2.2.2. Kinetic analysis of the recruitment of HOIP, HOIL-1 and Sharpin  
In the previous experiment, infected cells were fixed at 1h post-infection. Analysis by 
microscopy showed that: first, all three proteins (HOIP, HOIL-1, Sharpin) were 
recruited specifically to the PRU strain; and second, their recruitment was enhanced 
when cells were treated with IFN-γ overnight before infection. To see whether 
recruitment of the different proteins changed over time, IFN-γ-primed MEF cells 
overexpressing GFP-tagged wild-type HOIP, HOIL-1, and Sharpin were infected with 
type II T.gondii (PRU strain). Cells were then fixed not only at 1h post-infection but 
also at 2h and 6h post-infection.  
The recruitment kinetics of these three proteins was different. HOIL-1 did not show a 
significant change in recruitment over these three time points, as 18% at 1h and ~13% 
at both 2h and 6h of the intracellular T.gondii parasites were counted positive. 
However, HOIP and Sharpin showed the highest percentages of recruitment at 1h 
post-infection, after which their recruitment to type II T.gondii was reduced over time 
(Fig.4). For example, Sharpin was recruited to 37% of T.gondii at 1h, but then only to 
27% at 2h and to 20% at 6h post-infection. This decrease could be due to parasites 
dying over time. Using a vacuole marker, for instance, will help addressing this 
question assuming that opened and broken parasitic vacuoles account for dead 
parasites. An alternative strategy will be to employ death dyes that could be 





Figure 4: Kinetics of recruitment of LUBAC subunits to PRU  
MEF cells overexpressing GFP-tagged human LUBAC subunits (HOIP, HOIL-1, Sharpin) 
were infected with type II (PRU) Toxoplasma gondii strain (MOI of 4:1). Cells were 
incubated with IFN-γ overnight before the infection. At 1h post-infection, cells were washed 
with PBS and fixed with 4% PFA. At least 100 T.gondii were counted for each coverslip and 
the number of GFP-positive T.gondii was recorded. Results from three independent 
experiments, all performed in duplicate, are shown as Mean ± S.E.M. *P<0.05, **P<0.005, ns 
(not significant), unpaired t test without assuming a consistent SD, scoring for the difference 
of recruitment at 2h and 6h compared to the 1h time point, for each construct. 
Constructs for the expression of GFP-tagged wild-type HOIP, HOIL or Sharpin were 




Of the time points tested, 1h post-infection appeared to produce the highest levels of 
protein recruitment to type II T.gondii. Consequently, all subsequent experiments 
were performed using only the PRU strain, priming cells overnight with IFN-γ and 
fixing cells at 1h post-infection. However, it is worth bearing in mind that other 
proteins may have different (slower or faster) kinetics. 
 
 
3.2.2.3. HOIP, HOIL-1, and Sharpin are recruited independently from 
each other 
In the case of S.Typhimurium, LUBAC recruitment is HOIP-dependent. HOIL-1 and 
Sharpin both require the presence of the HOIP subunit to be recruited to these bacteria 
(Noad et al., 2017). In order to determine whether the same recruitment mechanism 
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takes place with T.gondii, GFP-HOIP, -HOIL-1, and -Sharpin were overexpressed in 
MEFs. These cells were transfected with siRNA to knock-down the expression of the 
other two LUBAC subunits (Fig.5A); e.g. in GFP::HOIP-overexpressing MEFs, 
HOIL-1 and Sharpin were knocked down. These cells were infected with type II 
T.gondii (PRU strain) after overnight priming with IFN-γ. HOIP, HOIL-1 and Sharpin 
were respectively counted on 35%, 20% and 30% of T.gondii, in both the control and 
the double knock-downs cell lines (Fig.5B).  
 
 
Figure 5: The LUBAC subunits are recruited independently of each other 
MEF cells overexpressing GFP-tagged human subunits of LUBAC (i.e HOIP, HOIL-1 and 
Sharpin) were transfected with either control siRNA (siCtrl) or with a combination of both 
siRNAs targeted the other two subunits of the complex. For example, GFP-HOIP 
overexpressing MEFs were transfected with siRNAs against HOIL-1 and Sharpin. (A) 
Efficiency of the individual knock-downs was assessed by western-blotting for HOIP and 
HOIL-1 and by qPCR for Sharpin. (B) At 48h after siRNA treatment, cells were primed with 
IFN-γ overnight before infection with type II (PRU) Toxoplasma gondii strain (MOI of 4:1). 
At 1h post-infection, cells were washed and fixed with 4% PFA. At least 100 T.gondii were 
counted for each coverslip and the number of GFP-positive T.gondii was recorded. Results 
from three independent experiments, all performed in duplicates are shown as Mean ± S.E.M. 
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ns (not significant), one-way ANOVA with Dunnett’s multiple comparisons test comparing 
with the control condition (siCtrl). 
Constructs for the expression of GFP-tagged wild-type HOIP, HOIL or Sharpin were 




This experiment suggests that the three LUBAC subunits bind independently to 
T.gondii. The residual expression of the different LUBAC subunits in the case of the 
double knock-downs might be sufficient for the recruitment of the other subunit. To 
test that hypothesis, the same experiment would need to be performed in knockout 
cells, ensuring the complete absence of the proteins. 
To explore whether the three subunits each recognise different ligands or bind the 
same ligand but using three distinct binding modes, experiments were performed to 
understand the recruitment mechanism of HOIP (see paragraph 3.2.2.4 “HOIP is 
recruited via two distinct mechanisms”). 
 
 
3.2.2.4. HOIP is recruited via two distinct mechanisms 
In order to further investigate the recruitment mechanism of LUBAC, a range of 
constructs expressing GFP-tagged truncations or mutated versions of human HOIP 
(Fig.6A) were tested for recruitment to type II T.gondii in IFN-γ primed MEFs. 
Expression of each construct was confirmed by western-blotting with a GFP antibody 
(Fig.6B).  
 
To determine whether some specific domains were necessary and/or sufficient for 
HOIP recruitment, protein truncations were used. Both N-terminal fragments 
containing the PUB domain either alone (residues 1-294; N294) or also containing the 
triple zinc-finger (residues 1-438; N438) were recruited to a level similar to that 
observed for the wild-type protein. Threonine360 and Arginine375 are essential for 
binding to Ub chains and recruiting NEMO respectively (Fujita et al., 2014). 
Additionally, mutating the second zinc-finger at these two residues (T360A or 
R375A) in the N-terminal fragment (N438) did not alter the recruitment compared to 
wild-type (Fig.6C). This indicates that the PUB domain is sufficient to bind to type II 
T.gondii in IFN-γ-primed cells and that the recruitment of N-terminal part of HOIP is 
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independent of Ub and NEMO. To support this hypothesis, C-terminal truncations 
lacking the PUB domain: ΔN294, ΔN438, and ΔN527 were observed to be impaired 
in their recruitments and respectively colocalised with 13%, 7% and 3% of T.gondii 
compared to 25% for the wild-type. Further investigation into the recruitment 
mechanism showed that, by contrast, the UBA domain was not required for binding 
because overexpression led to significant drop in recruitment (5%), similar to other C-
terminal constructs (Fig.6C). However, the UBA domain is required for the 
interaction with endogenous HOIL-1 and together with the RBR domain, has been 
shown to be essential for recruitment of HOIP to S.Typhimurium (Noad et al., 2017). 
In summary, these experiments indicate that neither the catalytic activity (RBR 
domain) nor HOIL-1 is required for HOIP binding to T.gondii (PRU strain). 
 
Interestingly, the full-length protein mutated in the ubiquitin-binding residue (T360A) 
showed a significant (p<0.0001) decrease in its ability to recruit to T.gondii. Only 8% 
of intracellular T.gondii recruited the mutated protein compared to 25% for the wild-
type protein. This suggests that in the context of the full-length protein, Zn finger 2 is 
necessary for recruitment. Following up on this observation, constructs expressing the 
individual Zn fingers and combinations of the three ZnFs were used to study the 
extent to which they were required for HOIP recruitment. All the individual ZnF 
domains on their own, as well as the triple ZnF fragment, were recruited to T.gondii to 
similar levels as those seen with wild-type HOIP. This indicated that, in addition to 
the PUB domain, any zinc-finger domain in HOIP was sufficient to bind to T.gondii. 
Overexpression of a pair of successive ZnF – i.e. ZnF1+ZnF2 or ZnF2+ZnF3 – 











Figure 6: The 2-mode recruitment mechanism of HOIP 
(A) Schematic of human HOIP with the various domains and mutated sites. MEF cells 
overexpressing GFP-tagged constructs of mutated and truncated forms of human HOIP were 
primed with IFN-γ overnight before infection with type II (PRU) Toxoplasma gondii strain 
(MOI of 4:1). (B) Overexpression of the constructs was checked by western-blot probing for 
GFP. (C) At 1h post-infection, cells were washed and fixed with 4% PFA. At least 100 
T.gondii were counted for each coverslip and the number of GFP-positive T.gondii recorded. 
Results from three independent experiments, all performed in duplicate, are shown as Mean ± 
S.E.M. *P<0.005, **P<0.0002, ***P<0.0001, ns (not significant), one-way ANOVA with 
Dunnett’s multiple comparisons test comparing with the wild-type. (D) Schematic of the 
hypothetical recruitment mechanisms of HOIP to T.gondii. The full-length protein is mostly 
bound through the triple zinc-finger domain; by contrast, the N-terminal part can also bind via 
the PUB domain, freed from the inhibition exerted by the C-terminal part of HOIP. 
Constructs for the expression of GFP-tagged mutated or truncated HOIP were generated by 




In conclusion, HOIP appears to be recruited to type II T.gondii in IFN-γ-primed 
MEFs through two distinct mechanisms (Fig.6D). First, in the full-length protein, the 
UBA and/or RBR domain(s) exert(s) an inhibitory effect on the PUB domain. Binding 
Chapter 3 
 157 
to T.gondii is then mediated by the zinc-finger domain, especially ZnF2. Such a 
scenario is not surprising because HOIP exists in an auto-inhibited form, where the 
UBA domain represses the catalytic activity by blocking the RBR domain (Kirisako et 
al., 2006; Smit et al., 2012). The requirement of the catalytic activity should be 
addressed in future experiments. Second, the recruitment of N-terminal HOIP is 
mainly driven by the PUB domain.  
 
Through its binding to NEMO (Arg375), Ub (T354/F355) (Fujita et al., 2014) and 
OTULIN via the PUB domain (Elliott et al., 2014; Schaeffer et al., 2014), HOIP is 
essential for the activation of NF-κB signalling: for example, it regulates immune and 
inflammatory responses in response to PAMPs. During apoptosis, HOIP can undergo 
cleavage by effector caspases at Asp390 (Joo et al., 2016) releasing the N- and C-
terminal fragments separately, consequently separating HOIP’s functions. Although 
the C-terminal part retains its catalytic activity, linear ubiquitylation of the substrate 
NEMO is decreased (Goto & Tokunaga, 2017). Moreover, phosphorylated OTULIN 
(at Tyr56) bound to HOIP’s PUB domain negatively regulates HOIP ubiquitylation 
(Elliott et al., 2014; Schaeffer et al., 2014). This latter role of OTULIN could explain 
the double recruitment mechanism of HOIP to T.gondii: the presence of the catalytic 
domain (hence the full-length model) provides substrates to OTULIN requiring the 
PUB domain to be available for binding, and thus HOIP recruitment is mediated by 
the zinc-finger. In the cleaved form of HOIP, PUB recruitment to T.gondii is then 
favoured. 
 
Future experiments should also investigate the recruitment mechanisms of HOIL-1 
and Sharpin to determine whether, for example ubiquitin binding is required. 
Within the scope of this project and because T.gondii is ubiquitinylated and recruits 
LUBAC, the recruitment of autophagy cargo receptors was addressed next (see 
section 3.2.3 “Recruitment of autophagy cargo receptors”), following the comparison 





3.2.3 Recruitment of autophagy cargo receptors 
Cargo receptors act as intermediates between cargo proteins and autophagosomal 
membranes. They are recruited to their partners by binding to their Ub coats or other 
‘eat-me’ signals (Birgisdottir et al., 2013; Boyle & Randow, 2013; Stolz et al., 2014; 
Thurston et al., 2012). These receptors include Calcium-binding and coiled-coil 
domain-containing protein 2 (NDP52), Sequestosome-1 (p62) and Optineurin (Optn) 
(see Chapter 1, Fig.4), factors that are known to bind the ubiquitin coat of cytosolic 
bacteria and to play a role in restricting bacterial proliferation (Thurston et al., 2009; 
Wild et al., 2011) and to be essential for targeting bacteria to autophagy (Zheng et al., 
2009; Mostowy et al., 2011). Because NDP52 (Xie et al., 2015), p62 (Seibenhener et 
al., 2004) and Optn (Wild et al., 2011) can bind ubiquitin, together with the fact that 
type II T.gondii was coated with ubiquitin (Fig.2), the recruitment of NDP52, p62 and 
Optn to PRU was investigated further in IFN-γ-primed MEF cells. 
 
 
3.2.3.1. NDP52, p62 and Optn recruitment to type II T.gondii is IFN-γ-
dependent 
MEF cells overexpressing GFP-tagged wild-type human NDP52, p62 or Optn 
(Fig.7A) that had been primed with IFN-γ overnight were infected with both strains of 
T.gondii. Coverslips were then imaged (Fig.7B) and the extent to which each cargo 
receptor protein was recruited, was manually counted on the microscope. 
 
Infection with the type II strain (PRU) resulted in all three cargo receptor proteins 
being recruited, although only in cells that had been primed overnight with IFN-γ. 
Thus, NDP52, p62, and Optn were recruited to less than 2% of the parasites in cells 
grown in standard conditions. NDP52, p62 and Optn colocalisation was significantly 
(p<0.05, p<0.0001, p<0.0002, respectively) increased when cells were primed 
overnight with IFN-γ to reach respectively 15%, 36%, and 28% of intracellular 
T.gondii (Fig.7C, left graph). By contrast, none of these proteins were recruited to RH 
(type I strain) in MEFs (Fig.7C, right graph). This experiment demonstrated that 
NDP52, p62, and Optn target only the PRU strain and that IFN-γ priming is required 





Figure 7: Cargo receptors are recruited to PRU parasites in an IFN-γ-dependent 
manner  
MEF cells overexpressing GFP-tagged human cargo receptor proteins (NDP52, p62, Optn) 
were infected with type II (PRU) or type I (RH) Toxoplasma gondii strains (MOI of 4:1). (A) 
Expression levels of these three overexpressed proteins were assessed by western-blotting. 
Cells were incubated with IFN-γ overnight before infection. At 1h post-infection, cells were 
washed and fixed with 4% PFA. (B) Images of PRU-infected cells were taken on a Zeiss-780 
microscope, using a 63x oil-immersion objective. Scale bar is 20μm. (C) At least 100 T.gondii 
were counted for each coverslip and the number of GFP-positive T.gondii was recorded. 
Results from three independent experiments, all performed in duplicates are shown as Mean ± 
S.E.M. *P<0.05, ***P<0.0002, ****P<0.0001, multiple unpaired t-test without assuming a 
consistent SD scoring the difference in protein recruitment in the presence or absence of IFN-
γ priming. 
Constructs for the expression of GFP-tagged wild-type Optn and p62 were generated by Dr. 






The recruitment of these three cargo receptors was initially investigated because they 
bind to ubiquitin. This hypothesis could be tested in follow-up experiments targeting 
ubiquitin chains for degradation using deubiquitinases (DUBs), after which 
recruitment events would again be counted. This protocol could be used to assess 
whether M1-ubiquitin linkages are necessary for NDP52, p62 or Optn recruitment by 
overexpressing OTULIN – a DUB specific for linear ubiquitin chains (Keusekotten et 
al., 2013) – and hence removing specifically LUBAC-synthesised ubiquitin chains. 
Because overexpression of deubiquitinases could be detrimental for the cells, the 
overexpression of autophagy cargo receptors deficient in Ub-binding would be 
preferred. 
 
Next, in order to investigate NDP52, p62, and Optn recruitment mechanisms to type II 
T.gondii, GFP-tagged truncations or mutants of these three cargo receptors were 
expressed in MEFs. The experiments are detailed and the results explained in 
paragraphs 3.2.3.2 for NDP52, 3.2.3.3 for p62 and 3.2.3.4 for Optn. 
 
 
3.2.3.2. NDP52 recruitment is independent of GAL8-binding 
NDP52 (Fig.8A) is an essential protein in the autophagy targeting S.Typhimurium. It 
is recruited to broken SCVs via GAL8 (Thurston et al., 2009, 2012) and leads to 
autophagophore formation via binding to LC3 (Slobodkin & Elazar, 2013). In more 
recent research, there has been evidence for NDP52 forming a heterotrimer by 
binding both FIP200 and SINTBAD/NAP1 via its SKICH domain and through them, 
recruiting respectively the ULK and TBK1 complexes that are crucial in the first steps 
of autophagosome formation (Ravenhill et al., 2019). The role and, more specifically, 
the recruitment mechanism of NDP52 were therefore investigated in this project. 
 
First, three GFP-tagged full-length mutants were overexpressed in MEFs (Fig.8B). 
Their overexpression was checked by western-blotting using a GFP antibody. Only 
the D439K mutant in the ZnF domain showed a band higher than expected (79.2kDa). 
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The sample did not migrate in a fashion similar to that observed with the wild-type 
and the other mutants: this could be due to protein aggregation. Sequencing the 
construct confirmed that there was only the D439K missense point mutation. If 
analysis had been performed by western-blotting with a NDP52 antibody, this might 
have excluded the possibility that this band represented the expression of a different 
protein. To avoid misinterpretation, D439K mutant-expressing cells were not 
considered during the analysis. However, this mutant is worth investigating because it 
prevents NDP52 binding to Ub and cytosolic S.Typhimurium recognition is abrogated 
with D439R mutation (Xie et al., 2015).  
The L374A single point mutant – which eliminates the ability of binding to GAL8 – 
was recruited to 13% of type II T.gondii; this is a result very similar to the 16% 
obtained with the wild-type protein (Fig.8C). This suggests that NDP52 recruitment 
to PRU is GAL8-independent. The inability of NDP52 to bind LC3C, as a 
consequence of the V136S mutation, significantly (p<0.05) increased recruitment of 
mutated NDP52 to 32% of T.gondii compared to 16% with the wild-type protein. 
LC3C interaction might hinder NDP52 binding to T.gondii. 
Two additional mutants located in the shorter ΔSKICH version of NDP52 (Fig.8A) 
were used and their overexpression was checked by western-blotting (Fig.8B). The 
ΔSKICH truncations of NDP52 did not form aggregates, therefore giving a more 
diffuse cytosolic GFP staining than with the full-length (Appendix1). In the absence 
of the SKICH domain, binding to FIP200 and SINTBAD/NAP1 was also impaired. 
Deletion of the SKICH domain (ΔSKICH), even with an additional L374A mutation, 
did not significantly change the recruitment of the V136S mutant (respectively 43% 










Figure 8: Gal-8 binding is not required for NDP52 recruitment  
(A) Schematic of human NDP52 with the various domains and mutated sites. MEF cells 
overexpressing GFP-tagged constructs of mutated and truncated forms of human NDP52 were 
primed with IFN-γ overnight before infection with type II (PRU) Toxoplasma gondii strain in 
4:1 ratio compared to the number of cells seeded on coverslips. (B) Overexpression of the 
constructs was checked by western-blot probing for GFP. (C) At 1h post-infection, cells were 
washed and fixed with 4% PFA. At least 100 T.gondii were counted for each coverslip and 
the number of GFP-positive T.gondii recorded. Results from three independent experiments, 
all performed in duplicate, are shown as Mean ± S.E.M. **P<0.005, ns (not significant), one-
way ANOVA with Dunnett’s multiple comparisons test compared with the wild-type. (D) 
Schematic of the potential recruitment modes of NDP52 whether it is bound or not to LC3C. 
Constructs for the expression of GFP-tagged wild-type, truncated or mutated NDP52 were 




In summary, NDP52 binding to GAL8 is not required for colocalisation to T.gondii 
(Fig.8D). Testing NDP52 mutant for Ub-binding (D439K) would help determine 
whether the recruitment mechanism is similar to S.Typhimurium infection. However, 
LC3C binding seems to impair recruitment to T.gondii, as CLIR-mutated NDP52 
(V136S) showed enhanced recruitment. In conclusion, these experiments show 
NDP52 exhibiting a new recruitment mechanism that requires either Ub or an 
unknown ligand on T.gondii. To address the hypothesis that NDP52 could be 
recruited by both GAL8 and ubiquitin in a redundant fashion, the L374A+D439K 





3.2.3.3. PB1 and UBA domains are required for p62 recruitment to 
T.gondii 
The recruitment of p62 (Fig.9A) to T.gondii was further investigated, using the same 
strategy as for NDP52, because Sequestosome-1 (p62) promotes NF-κB activation 
(Sanz et al., 2000) and facilitates proteasomal degradation of ubiquitylated substrates 
(Pankiv et al., 2007; Seinbenhener et al., 2004).  
Several GFP-tagged mutants and truncations (Fig.9B) of p62 were tested for their 
colocalisation with type II T.gondii in MEFs primed overnight with IFN-γ. The 
objective of these experiments is, for example, to determine whether ubiquitin binding 
was required for p62 recruitment. 
 
P62 preferentially binds to K63-polyubiquitin chains and the two lysine residues 
K406 and K417 in the UBA domain have been shown to be essential for this binding 
(Seinbenhener et al., 2004). However, individual (K406V and K417V) and double 
mutations (K406V+K417V) to valine did not influence the recruitment of p62 to 
T.gondii (Fig.9C) compared to wild-type. LC3 family members also bind the p62 LIR 
motif (residues 336-341) (Pankiv et al., 2007) linking p62 to the autophagy 
machinery. Two constructs mutated in the KIR domain were tested but neither 
showed a difference in recruitment to T.gondii (34%, 31%) compared to wild-type 
(35%). Neither LC3 nor Ub binding seemed to be required for p62 recruitment to type 
II T.gondii. This hypothesis was further validated using the N-terminal fragment 
(N165) of p62 which, despite the absence of both the UBA and the LIR domains, was 
recruited to T.gondii (29%) in similar levels to the wild-type (35%). 
 
The PB1 domain has been shown to interact with the proteasome (Seinbenhener et al., 
2004), but the K7A/D69A double mutation specifically prevented p62 polymerisation 
(Lamark et al., 2003). Recruitment of the double mutant (K7A+D69A) to T.gondii 
(37%) was, however, indistinguishable from the wild-type protein (Fig.9C). The 
truncation mutant (ΔN165) lacking PB1 and ZnF further demonstrated the 
dispensability of PB1 domain for recruitment to T.gondii. 
 
Removing both the N-terminal PB1 and the C-terminal UBA domain decreased the 
extent to which p62 was recruited to T.gondii. Only 22% of these T.gondii were 
positive, compared with 35% in the wild-type. This result suggests that PB1 and UBA 
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are redundant in driving the recruitment of p62 to T.gondii. However, since removing 
both of them did not completely abrogate the binding, there must be another binding 
site which remains to be characterised. Further experiments could address this 
question by overexpressing individual domains and looking at recruitment to see 
whether any of them was sufficient. Alternatively, the mutations in the UBA domain 
could be transferred in the ΔN165 fragment to see whether it recapitulates the loss of 










Figure 9: The PB1 and UBA domains of p62 are required for recruitment 
(A) Schematic of human p62 with the various domains and mutated sites. MEF cells 
overexpressing GFP-tagged constructs of mutated and truncated forms of human p62 were 
primed with IFN-γ overnight before infection with type II (PRU) Toxoplasma gondii strain in 
4:1 ratio compared to the number of cells seeded on coverslips. (B) Overexpression of the 
constructs was checked by western-blot probing for GFP. (C) At 1h post-infection, cells were 
washed and fixed with 4% PFA. At least 100 T.gondii were counted for each coverslip and 
the number of GFP-positive T.gondii recorded. Results from three independent experiments, 
all performed in duplicate, are shown as Mean ± S.E.M. ns (not significant), *P<0.05 one-
way ANOVA with Dunnett’s multiple comparisons test compared with the wild-type. (D) 
Schematic of the potential recruitment mechanism of p62 via the zinc finger and the TRAF6-
binding domain. 
Constructs for the expression of GFP-tagged wild-type, truncated or mutated p62 were 




3.2.3.4. The recruitment of Optineurin 
Optineurin interacts with ubiquitin and LC3 to induce autophagy in response to 
bacterial infection, for example (Gomes & Dikic, 2014). To investigate the 
recruitment mechanism of Optineurin (Fig.10A), full-length mutants and truncations 
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of the protein were overexpressed (Fig.10B) and their recruitment to T.gondii was 
compared to that observed with overexpressed GFP-wild-type Optn.  
The N-terminal fragment (residues 1-555; N555) that lacks the ZnF domain showed 
recruitment comparable to wild-type, suggesting that the ZnF domain of Optn is not 
required for binding. 
 
Optn binds to linear ubiquitin chains via its UBAN domain (Wagner et al., 2008). The 
D474N mutant has been characterised by its failing to recruit to ubiquitylated 
S.Typhimurium (Noad et al., 2017). By contrast, this mutant protein accumulated on 
22% of T.gondii (Fig.10C), a non-significant decrease compared to the 27% observed 
for the wild-type protein. Another mutant in the UBAN domain, the natural variant 
E478G that has been shown to be implicated in ALS (Amyotrophic Lateral Sclerosis) 
pathogenesis and to activate NF-κB signalling (Maruyama et al., 2010), was also 
investigated. In this case, the mutant’s limited reduction in recruitment to T.gondii 
was calculated to be statistically significant (p<0.05), suggesting that this glutamic 
acid residue is necessary for binding. 
 
Phosphorylation by TBK1 on S473 enhances LC3B affinity for Optn (Wild et al., 
2011; Rogov et al., 2013). Mutating the serine residue (S473A) disrupts TBK1-
mediated phosphorylation and hence prevents enhanced recruitment of the autophagy 
machinery. The S473A mutant was recruited to 18% of T.gondii (Fig.10C), which 
gave a similar level of recruitment (27%, a non-significant decrease) to that observed 





Figure 10: Optn recruitment is mediated by ubiquitin  
(A) Schematic of human Optn with the various domains and mutated sites. MEF cells 
overexpressing GFP-tagged constructs of mutated and truncated forms of human Optn were 
primed with IFN-γ overnight before infection with type II (PRU) Toxoplasma gondii strain 
(MOI of 4:1). (B) Overexpression of the constructs was checked by western-blot probing for 
GFP. (C) At 1h post-infection, cells were washed and fixed with 4% PFA. At least 100 
T.gondii were counted for each coverslip and the number of GFP-positive T.gondii was 
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recorded. Results from three independent experiments, all performed in duplicate, are shown 
as Mean ± S.E.M. *P<0.05, one-way ANOVA with Dunnett’s multiple comparisons test 
compared with the wild-type. 
Constructs for the expression of GFP-tagged wild-type and E478-mutated Optn were 
generated by Dr. Ben Ravenhill; the other truncations and mutants used here were made by 




Overexpression of the UBAN domain was sufficient for it to be recruited to T.gondii 
and altering the nearby phosphorylation site did not influence this recruitment. This 
observation strongly suggests that Optn recruitment is driven by ubiquitin via the 
UBAN domain, and that it is M1-linked ubiquitin independent as the D474N mutant 
is recruited fine. However additional experiments testing a shorter N-terminal 
fragment lacking the UBAN domain (N473) and UBAN constructs mutated at 
residues 474 and 478 would be required to confirm this hypothesis, particularly since 
full-length D474N recruitment was not reduced compared to wild-type. Based on the 
observation that LC3 can also bind Optn at the LIR domain (Birgisdottir et al., 2013) 
and mutation at residue 177 inactivates LC3 binding (Noad et al., 2017), the triple 
F177S+D286N+L493S mutant in which LC3C binding is impaired, was expressed 
and was also recruited (25%) similar to wild-type Optn. This was expected if there 
was redundancy. Future work studying recruitment of the N473-LIR mutant would be 




3.2.4 Interpretation of the microscopy experiments 
A few remarks need to be made concerning the microscopy experiments carried out in 
this thesis. Further discussion will follow (see section 3.4 “Discussion”) but these 
technical disclaimers need to be clarified. 
 
Firstly, all quantitation was performed manually and in a blinded fashion to avoid bias 
based on the knowledge of the protein and the particular mutant or truncation 
considered. Positive events – recruitment of the GFP-protein to T.gondii – were 
counted based on internal controls: a first positive event compared to background was 
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defined; and subsequently, other events with similar intensity were counted as 
positives. The intensity threshold for counting positive events was therefore variable 
between constructs. Secondly, no construct expressing the GFP protein on its own 
was used as negative control for recruitment. It might be prudent to include this in 
future experiments to ensure that recruitment is specific to the protein of interest and 
not due to the GFP-tag. 
 
In addition, one coverslip for each construct was counted on the same day, ensuring 
standardised criteria for judging positive events. Experiments were repeated three 
times and always performed in duplicate so that six coverslips were examined for 
each construct to assess the reproducibility of the data. However, because of the great 
number of constructs used in these experiments and given the somewhat surprising 
results, the question of using automated counting as opposed to manual counting 
should be considered for future work. Automated counting appears to be a more 
impartial way of determining positive events based on computationally calculated 
intensity levels, and can help avoid human errors (Fisch et al., 2019c). 
 
Finally, in the case of Optn, background fluorescence was relatively high, making it 
harder to distinguish between noise and true positives. In order to obtain better results 
and reduce the level of background fluorescence, cells could be permeabilised with 
saponin to leak out the cytosol and remove all cytosolic proteins not bound to 




3.3 Results: IFN-γ restricts type II T.gondii replication 
and induces cytokine production upon T.gondii infection 
 
According to the recruitment experiments previously described, overnight IFN-γ 
priming is required for the significant recruitment of any of the LUBAC subunits or 
cargo receptors such as p62, NDP52 or Optn in MEFs infected with type II T.gondii. 
In the following experiments performed using IFN-γ-primed MEF cells, immune 
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responses in terms of T.gondii killing are addressed with both type I and type II 
strains, whereas cytokine production is investigated only with the PRU strain, because 
the role of LUBAC – recruited only to type II T.gondii parasites – is also considered. 
 
 
3.3.1 IFN-γ antagonises type II T.gondii  
3.3.1.1. Restriction of T.gondii infectivity 
The results presented above (Fig.3 and 7) showed that proteins were recruited to 
T.gondii when cells were primed with IFN-γ. Consequently, the impact of IFN-γ on 
parasite entry in cells was studied. 
 
MEF cells – either primed overnight with IFN-γ or not – were infected with type I 
(RH) or type II (PRU) strains of Td-tomato-expressing T.gondii. At 1h post-infection, 
cells were washed and fresh medium was dispensed in the wells, keeping IFN-γ 
treatment in the wells originally primed. At 2h, the cells were fixed, and all samples 
were analysed at the same time using flow cytometry. Cells harbouring T.gondii were 
visible by flow cytometry (Fig.11) as the parasites express the fluorescent protein Td-
tomato. Cells were individually measured for their brightness, which provided a 
measurement of the cell burden in T.gondii (assuming that all parasites were 
expressing similar levels of the fluorophore). Several gates were set up to analyse the 
samples, and this workflow could be applied systematically in future experiments to 
facilitate reproducibility. The first gate was designed in order to leave the debris out 
of the analysis (Fig.11, left column) and this population was further selected to keep 
only single cells (Fig.11, middle column). On this single-cell population, the next gate 
was drawn to analyse the T.gondii-positive cells; that is infected cells (Fig.11, right 
column). The same gating was used for all samples run on the same day. In term of 
fluorescence, the addition of IFN-γ did not alter uninfected cells. However, in the 
presence of IFN-γ, fewer cells were infected as 25.8% of IFN-γ-primed cells were 
T.gondii positive compared to 40.5% of control cells for a same dose of parasite 





Figure 11: Infected cells are detected as a separate population by flow cytometry  
MEF cells were infected with type II (PRU) Td-Tomato-expressing Toxoplasma gondii strain 
in 1:1 ratio compared to the number of cells seeded in wells. Cells were incubated with IFN-γ 
overnight before the infection. At 1h post-infection, cells were washed, and fresh medium 
was added, keeping IFN-γ if required. At 2h cells were analysed by flow cytometry. 
Representative plots are shown for uninfected and infected cells and whether they were 
primed with IFN-γ or not.  
From left to right, gate on cells to remove debris from the analysis (side scatter vs forward 
scatter); gate on the cell population for single cells (side scatter horizontal vs side scatter); 
plot of the single cell (side scatter vs Tomato-T.gondii) for their parasite burden, the gate is 






To summarise, IFN-γ priming decreases susceptibility and hence protects MEF cells 
against type II T.gondii infection; it could also be that parasites invaded the cells but 
were killed soon after entry. 
 
Indeed, IFN-γ has been shown to inhibit T.gondii growth in human fibroblasts 
(Pfefferkron & Guyre, 1984) and even to kill the parasites in haematopoietic and non-
haematopoietic cells (Clough et al., 2016). 
 
3.3.1.2. IFN-γ-primed cells restrict PRU replication 
To determine whether IFN-γ promotes immune defence mechanisms against T.gondii, 
parasite replication was followed over time. Cells were infected either with PRU or 
RH strain and samples were fixed at the three different time points of 2h, 24h, and 
48h. These time points were chosen to ensure that T.gondii had time to replicate, since 
a replication cycle lasts between 6h and 12h. The 2h time point was used as the 
control condition for entry level, i.e. infectivity in the different conditions. In all 
conditions, cells were infected with the same concentration of parasites and the gating 
on the flow cytometry plots was applied to all samples from the same experiment. In 
control cells, type II T.gondii replicate over time. The infected population shifted to 
higher fluorescence intensities (Fig.12A), which was expected: as the parasitic burden 
increased over time, vacuoles contained more parasites and thus cells were detected as 
brighter overall. By contrast, IFN-γ-primed cells did not exhibit this shift (Fig.12A). 
IFN-γ most likely prevents T.gondii from replicating in cells. 
 
The absence of a shift in IFN-γ-primed cells was well captured by chromatograms 
showing the intensity distribution of the population of infected cells (Fig.12B). These 
curves clearly demonstrate that restriction of replication is IFN-γ-dependent and 
occurs only with the type II strain (PRU). In the case of infection with the RH (type I) 
strain, curves in the presence (cyan) or absence (red) of IFN-γ overlap (Fig.12B) for 
the three time points indicating that IFN-γ did not induce restriction of T.gondii 
replication in this strain. Both curves shifted towards higher fluorescence intensities 









Figure 12: IFN-γ prevents type II T.gondii from replicating  
MEF cells were infected with type II (PRU) or type I (RH) Tomato-Toxoplasma gondii 
strains in 1:1 ratio compared to the number of cells seeded in wells. Cells were incubated with 
IFN-γ overnight before the infection. At 1h post-infection, cells were washed with PBS and 
fresh medium was added. At 2h, 24h and 48h post-infection, cells were fixed with 4% PFA 
and cells harvested at the three different time points were analysed by flow cytometry at the 
same time. (A) shows representative scatter plots of PRU-infected Cas9-MEFs primed or not 
with IFN-γ. (B) shows chromatograms of PRU- or RH-infected Cas9-expressing MEFs, 
primed (cyan) or not (red) with IFN-γ. (C) Mean intensities of the red signal (measure for the 
abundance of T.gondii parasites) in the infected population were calculated and (D) the ratios 
between cells primed or not with IFN-γ were calculated for each sample. Data are shown as 
Mean ± S.E.M from three independent experiments, all performed in duplicate. *P<0.05, 
****P<0.0001, ns. (not significant) one-way ANOVA with Dunnett’s multiple comparisons 






In order to quantify and visualise changes in cell intensity due to modifications in 
T.gondii infectivity and/or replication, means of intensity were calculated and plotted 
as histograms. Even though the distribution is not a Gaussian, the variations observed 
with mean intensities were significant and representative of what was seen on the 
curves.  
For example, the fluorescence signal in siCtrl cells is measured to be 4,000 at 2h post-
infection, 11,000 after 24h and then 23,000 at 48h post-infection in unprimed cells; 
this is in contrast with levels of 3,000, 3,000 and 7,000 at 2h, 24h and 48h 
respectively, in IFN-γ-primed MEF cells (Fig.12C). In the absence of IFN-γ, T.gondii 
replicated over time and to a greater extent with the PRU strain (Fig.12C). In the 
presence of IFN-γ, the PRU strain was prevented from replicating and, in both the cell 
lines tested the mean signal intensity did not increase significantly over time. By 
contrast, infection with type I strain (RH) still showed increased mean signal intensity 
of the infected population, even in cells primed with IFN-γ (Fig.12C). To better 
visualise the effect of IFN-γ on the mean intensity of infected cells and hence on the 
replication of T.gondii, mean signal intensities of infected cells primed with IFN-γ 
were normalised to infected cells not treated with IFN-γ (Fig.12D) for each time 
point. At 2h, ratios were therefore close to 1.0 because there was little difference in 
terms of parasite burden between conditions. Changes were therefore expected to be 
seen at later time points. In the case of PRU, for both cell lines tested, there was a 
significant reduction (p<0.0001) in the intensity ratio from 1.0, at 2h down to 0.4, at 
24h, and this ratio was maintained at the 48h time point. This reduction indicated 
either prevention of T.gondii replication or death of some of the parasites. In the case 
of RH, there was a significant (p<0.05) reduction from 1.0, at 24h, down to 0.8, at 
48h, for the Cas9-expressing cells. The reduction was also observed with cells 
transfected with siRNA control (Fig.12D) for which the ratio was decreased to 0.7, at 
24h, although it was not maintained at the 48h time point. 
 
In summary, the PRU (type II) strain was more sensitive to IFN-γ treatment than the 
more virulent RH (type I) strain, as priming with IFN-γ prevented type II T.gondii 





3.3.1.3. Atg5 is required for T.gondii restriction 
Next, the potential role of autophagy in this restriction process was investigated. Atg5 
is a key protein in the defence against pathogens (Chen et al., 2012) either functioning 
in the autophagy pathway or more generally in innate immunity (Zhao et al., 2008; 
Sibley, 2011). Atg5 was shown to have an impact on resistance to T.gondii 
(Niedelman et al., 2013; Choi et al., 2014) and so was tested as a positive control in 
the restriction of T.gondii. It was expected that the absence (by knock-down or 
knockout) of Atg5 would show higher ratios of mean intensity at 24h and 48h 
compared to the control. MEFs were successfully knocked out for Atg5 as shown by 
western-blotting (Fig.13).  
 
 
Figure 13: Atg5 is required in the IFN-γ-dependent restriction of PRU 
MEF cells expressing Cas9 and knockout for Atg5 (western-blot) were infected with type II 
(PRU) or type I (RH) Tomato-Toxoplasma gondii strains in 1:1 ratio compared to the number 
of cells seeded in wells. Cells were incubated with IFN-γ overnight before infection. At 1h 
post-infection, cells were washed with PBS and fresh medium was added. At 2h, 24h and 48h 
post-infection, cells were fixed with 4% PFA and later analysed by flow cytometry. Mean 
intensities of the T.gondii signal were measured and the ratios between cells primed or not 
with IFN-γ were calculated for each sample. Data are shown as Mean ± S.E.M from three 
independent experiments, all performed in duplicate. *P<0.005, ***P<0.0001, ns (not 
significant) one-way ANOVA with Dunnett’s multiple comparisons test comparing to the 2h-
time point of Cas9 cells. *P<0.05, **P<0.005, ****P<0.0001, unpaired t test without 
assuming a consistent SD, comparing ratios between control cells and Atg5-KO cells at a 






Cas9-expressing cells (control) or knockout for Atg5 (Atg5-KO) were infected with 
type II T.gondii (PRU) and ratios of the mean intensity (Appendix2) of the infected 
population were calculated comparing cells primed with IFN-γ with non-primed cells. 
Atg5-KO cells showed a statistically significant (p<0.005) reduction of the intensity 
ratios at 24h and 48h with values of 0.78 and 0.76, respectively compared with 1.1 at 
2h (Fig.13). These decreases, however, were not as pronounced (p<0.0001) as the 
ones obtained with Cas9-expressing MEFs, where the ratios were 0.99, 0.36, and 0.32 
at 2h, 24h, and 48h respectively. Indeed, statistics comparing Cas9-MEFs to Atg5-KO 
MEFs showed that ratios at both 24h and 48h were significantly (p<0.0001 at 24h and 
p<0.005 at 48h) different between the two cell lines. This means that the Atg5 
knockout counteracted the effect of IFN-γ priming in the resistance to type II T.gondii 
infections. These results highlight the role of Atg5 in restricting T.gondii upon IFN-γ 
priming and suggest that Atg5 plays a major role downstream of IFN-γ. However, the 
knockout of Atg5 did not completely abrogate resistance to T.gondii and therefore it 
can be concluded that there must be an additional pathway to autophagy acting in the 
IFN-γ-dependent restriction of T.gondii replication. 
 
On the one hand, Atg5 is a major protein in the autophagy machinery. On the other 
hand, LUBAC has been shown to play a role in autophagy: by ubiquitinating 
substrates it indirectly signals for proteasome degradation and mediates the 
recruitment of the autophagy machinery (Ji & Kwon, 2017). 
 
 
3.3.1.4. Restriction of T.gondii replication is LUBAC-independent 
Next, the role of LUBAC in resistance to T.gondii in IFN-γ-primed cells was 
investigated. Although it was shown above that LUBAC (Fig.3) and cargo receptors 
such as NDP52, p62, and Optn (Fig.7) are recruited to type II T.gondii in the presence 
of IFN-γ, their precise role remains unclear and their functions have not been 
characterised.  
By synthesising linear ubiquitin chains, LUBAC is likely to induce recruitment of 
other proteins. Cargo receptors usually contribute to the cellular defence machinery 
by targeting substrates for autophagy or proteasomal degradation (Ji & Kwon, 2017). 
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They are therefore expected to either recruit other proteins, directly signal for the 
destruction of the parasites or, for the release of signalling molecules such as 
cytokines, inducing downstream events on the T.gondii. The results presented above 
confirmed that Atg5 plays a role in the IFN-γ-dependent resistance to T.gondii. Since 
LUBAC is another autophagy-related protein complex, its role in restricting type II 
T.gondii replication in IFN-γ-primed cells was also investigated. 
 
MEF cells in which HOIP or HOIL-1 had been knocked-out or which were deficient 
in Sharpin (Fig.14A and B) together with their wild-type control were generated and 
kindly provided by Henning Walczak. These cells were infected with type II T.gondii 
(PRU). Knockouts of HOIP and HOIL-1 were assessed by western-blotting 
(Fig.14A): cells knocked-out for HOIL-1 and HOIP exhibited a strong reduction in 
protein expression (HOIL-1 and HOIP, respectively), similar to the knock-downs 
obtained with siRNAs. However, despite repeating the experiment multiple times, it 
was not possible to account for full knockouts and complete absence of the desired 
proteins. Discussion with Dr. Walczak led to the hypothesis that either the antibody 
used is not as specific as the in-house one they use, or that the cells were cultured for 
too long, explaining genetic instability.  
 
The deficiency for Sharpin was determined at the transcriptional level by measuring 
relative amounts of mRNA using qPCR. The ΔΔCt method was used to analyse these 
data, using actin as the reference gene. Levels of HOIP, HOIL-1, and Sharpin were 
compared between wild-type (black bars) and deficient cell lines (red bars). Atg5-KO 
MEFs were compared to Cas9 MEFs and as expected, transcriptional levels of all 
three LUBAC subunits were similar in both cell lines (Fig.14B). Sharpin-deficient 
MEFs (cpdm) exhibited reduced levels of Sharpin as expected but also showed 
reduced levels of both HOIP, HOIL-1, suggesting some sort of stabilisation mediated 
by Sharpin for the expression – or at least transcription – of HOIL-1 and HOIP. 
 
For each cell line, ratios of mean intensity were calculated as intensity of IFN-γ-
primed cells over intensity of unprimed cells (Fig.14C). Cas9-expressing MEFs were 
used as a negative control. IFN-γ induced restriction of T.gondii replication (Fig.12); 
by contrast, Atg5-KO cells partially lost this ability, and the ratio was increased to 
0.78, at 24h or 48h, compared to 0.37 in the Cas9-cells. None of the other wild-type 
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cell lines – HOIP-WT, HOIL-1-WT, Sharpin – showed a phenotype similar to the 
control. These cells do not seem to be sensitive to IFN-γ treatment. The knockout and 
deficient cell lines did not exhibit any difference from their respective wild-type 
(Fig.14C). Because the wild-type did not show any response to IFN-γ priming during 
T.gondii infection, no conclusion could be drawn from this experiment. In addition, it 
would have been hard to make sense of the data as the knockouts could not be 
confirmed either. The use of these HOIP or HOIL or Sharpin deficient cell lines was 
not fruitful. 
 
To address the role of LUBAC in T.gondii resistance, MEF cells were knocked-down 
for the individual LUBAC subunits using siRNA. Single knock-downs were not 
confirmed by western-blotting (Fig.14A) as a residual band was visible after long 
exposure of the membrane. These “knock-down” MEFs for either one, two or all three 
LUBAC subunits were infected with the PRU strain. Ratios of mean intensity were 
calculated (Fig.14D) and for each cell line the 2h time point was compared with both 
24h and 48h time points. MEFs transfected with siCtrl showed a substantial decrease 
(p<0.0001) from 0.78, at 2h down to 0.25, at 24h and 48h. In the single “knock-
downs”, ratios also dropped significantly (p<0.0001) and ratios, at 24h and 48h, were 
similar to the control except for the 48h time point of the HOIL-1 “knock-down”, for 
which the drop was accentuated at a ratio of 0.13. In the double or triple “knock-
downs”, the drops were less substantial (p<0.005), especially for the 24h time point 
where the ratio was 0.45 (compared to 0.25 for the control). Moreover, in the 
HOIP+Sharpin double “knock-down”, the 24h and 48h ratios reached 0.43 and 0.37 
respectively, a non-significant decrease from the 0.72 ratio at 2h. This behaviour was 
not, however, replicated in the triple (entire LUBAC) “knock-down” and a significant 
difference was not observed relative to the control cells or any of the “knock-down” 
cells. Nonetheless, decreases in intensity ratio were lower in the cases of double (two 









Figure 14: None of the LUBAC subunits is individually required for T.gondii 
restriction  
MEFs either knockout or knock-down for HOIP, HOIL-1 or Sharpin or Atg5-KO along with 
their individual controls (respectively wild-type for the knockouts and siCtrl for the knock-
downs) were infected with type II (PRU) Tomato-Toxoplasma gondii strain (MOI 1:1). Cells 
were incubated with IFN-γ overnight before infection. At 1h post-infection, cells were 
washed with PBS and fresh medium was added. At 2h, 24h and 48h post-infection, cells were 
fixed with 4% PFA to be then analysed by flow cytometry. (A) Knock-downs were validated 
by western-blotting, whereas knockouts were checked both by western-blotting (A) and qPCR 
(B). Mean intensities of the T.gondii signal were measured and the ratios between cells 
primed or not with IFN-γ were calculated for each sample (C and D). Data are shown as 
Mean ± S.E.M from three independent experiments, all performed in duplicate. *P<0.05, 
**P<0.005, ***P<0.0002, ****P<0.0001, ns (not significant) one-way ANOVA with 






In conclusion, LUBAC appeared at best, to play only a minor role and/or to be part of 
redundant pathways in restricting T.gondii replication in IFN-γ-primed MEFs. These 
results should be considered with care because knock-downs were incomplete and 
residual protein expression might be enough to drive the effect, thereby explaining the 
absence of any major and reproducible changes between the different cell lines. 
 
The recruitment of LUBAC to type II T.gondii in IFN-γ-primed MEF cells could not 
directly be linked to restriction of parasite replication or growth. However, LUBAC 
could signal directly or act as upstream effector for the release of signalling molecules 
such as cytokines, inducing downstream events on the T.gondii. 
 
 
3.3.2 T.gondii infection induces production of cytokines and 
adhesion proteins  
As an obligate parasite, T.gondii establishes a niche to develop, replicate, and spread 
in the form of tachyzoites (Radke et al., 2001). Differentiation into bradyzoites, which 
form latent cysts (Radke et al., 2003), is a mechanism thought to enable the parasite to 
evade host cell defence mechanisms (Hunter & Sibley, 2012); however, more recent 
work showed that bradyzoites are not entirely quiescent: the cyst burden is also 
controlled by the host immune system (Watts et al., 2015). In order to grow, T.gondii 
induces changes in the host cell metabolism (Hargrave et al., 2019) to increase its 
survival by reprogramming key metabolic pathways such as glycolysis or lipid and 
sterol metabolism (Nelson et al., 2008). Cells have several mechanisms to counteract 
infections, however: for example, IFN-γ prevents T.gondii growth (Suzuki et al. 1988) 
and favours the degradation of tryptophan (Pfefferkorn, 1984), an essential amino 
acid for T.gondii. In response to T.gondii effectors, namely rhoptries and dense 
granule proteins (Sibley, 2004), host cells produce pro-inflammatory cytokines such 
as IL-12 (Denkers, 2003) and TNF-α or activate the NF-κB signalling pathway 





3.3.2.1. The expression profile of signalling molecules is modified 
following T.gondii infection 
Cells rely not only on intracellular proteic adaptors to recognise and bind pathogens 
or danger factors but also on signalling molecules (Meissner et al., 2013) to activate 
an immune response either intrinsically or in the neighbouring cells (respectively 
autocrine and paracrine effects). These somewhat redundant mechanisms provide a 
multi-layered cell defence against pathogens (Randow et al., 2013). 
 
To determine whether infection with PRU of IFN-γ-primed MEFs was changing 
expression levels of signalling molecules, qPCR was performed with primers 
amplifying interleukin-1alpha (IL-1α), interleukin-6 (IL-6), C-C motif chemokine 
ligand 4 (CCL4) and 5 (CCL5), tumour necrosis factor (TNF-α), vascular cell 
adhesion protein-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) as 
potential signalling molecules involved in inflammation and/or immune response. 
GAPDH and actin were used as control genes. The pro-inflammatory cytokines IL-1α, 
IL-6, and TNF-α were shown to have their expression greatly modified to establish 
immune responses upon T.gondii infection in pregnant women (Wujcicka et al., 
2018), but also in some cell lines such as astrocytoma cells (Pelloux et al., 1994). A 
study in cats (Levy et al., 2004) linked the decreased levels of IL-12, IL-6, IL-2, and 
IFN-γ with an increase susceptibility to T.gondii infection and replication. 
Chemokines CCL4 and CCL5, among others, activate chemokine receptors to build 
an immune response. Both secreted CCLs in the plasma of mice and mRNA 
expression in the brain were measured overtime and showed increased levels 
following infection with a mild-infectious strain (ME49) of T.gondii (Aviles et al., 
2008). Cell adhesion proteins VCAM-1 and ICAM-1 are both NF-κB-dependent 
(Nowak et al., 2008) and their surface expression is enhanced by TNF-α (Li et al., 
2000). ICAM-1 expression is increased following ME49 T.gondii infection in rats 
(Pastre et al., 2019). VCAM-1 also indirectly induces IFN-γ production in mice 
infected with T.gondii (Suzuki et al., 2011). VCAM-1 is indeed known to bind the 
α4β1 integrin on CD8+ T cells, hence driving the recruitment of the T cells into the 
brain during the chronic stage of T.gondii infection (Wang et al., 2007; Silva et al., 
2010). VCAM-1 and ICAM-1 promote cell-cell recognition and adhesion for the 
recruitment of monocytes and lymphocytes to the site of inflammation (Carman & 




For these experiments, all cells were primed overnight with IFN-γ and half the wells 
were then infected (MOI 4:1) with the PRU (type II) strain. At 1h post-infection, cells 
were washed and at 24h post-infection, cells were lysed, and their RNA purified. The 
ΔΔCt analysis method was used to normalise mRNA levels to the endogenous gene 
GAPDH. Expression levels of signalling molecules were compared between 
uninfected (black) and PRU-infected MEFs (Fig.15). Actin levels were unchanged by 
the infection (data not shown), which was expected because actin is usually also used 
as control gene. By contrast, levels of IL-6 (p<0.0001), CCL4 (p<0.05), CCL5, and 
ICAM-1 (p<0.005) were significantly increased by 90-, 2-, 5- and 5-fold, 
respectively, following infection with T.gondii (Fig.15). IL-1α was not detected in the 
uninfected samples, but it was measured at reasonable levels in infected cells.  
In summary, infection with T.gondii in IFN-γ-primed MEFs induced transcription of 
IL-1α, IL-6, CCL4, CCL5, and ICAM-1. 
 
 
Figure 15: T.gondii induces cytokine expression in MEF cells  
MEFs were all primed with IFN-γ and on the next day, cells were infected or not with type II 
(PRU) Tomato-Toxoplasma gondii strain (MOI of 4:1). At 1h post-infection, cells were 
washed with PBS and fresh medium was added. At 24h post-infection, cells were collected, 
lysed and their RNA was purified. Following reverse transcription, mRNA levels were 
quantified by qPCR and analysed using the ΔΔCt method with GAPDH as the reference gene. 
Data are shown as Mean ± S.E.M from three independent experiments, all performed in 
triplicate. *P<0.05, **P<0.005, ****P<0.0001, ns (not significant), unpaired t test without 





3.3.2.2. Cytokine expression is regulated by LUBAC 
ICAM-1 expression (Nowak et al., 2008) and pro-inflammatory cytokine synthesis 
(Merline et al., 2011; Bryant et al., 2015) are NK-κB-dependent. LUBAC induces 
NF-κB signalling (Tokunaga et al., 2011), thereby controlling apoptosis (Ikeda et al., 
2011) and activating the autophagy machinery to restrict cytosol-invading bacteria 
(Noad et al., 2017). LUBAC was recruited to T.gondii in IFN-γ-primed cells (Fig.3). 
Consequently, the role of LUBAC in the increased production of immune-related 
molecules (Fig.15) was addressed. 
 
The function of LUBAC in generating signalling molecules was examined in cells 
transfected with siRNA targeting one of the LUBAC subunits or the entire complex 
(triple knock-down). Knock-downs of HOIP, HOIL-1, and Sharpin were individually 
tested by western-blotting (Fig.16A) for the single knock-down cell lines and for the 
LUBAC (triple) knock-down; however levels of expression were decreased but not 
completely abrogated by any of the siRNA. Cells transfected with siHOIP especially 
showed protein, even though the triple knock-down was clear of any HOIP. Given 
this result, further interpretation about the cytokine levels will be closely paired with 
the observations from the western-blot. 
 
Results from the qPCR (i.e. cytokine transcript levels) were normalised to GAPDH. 
The graph featuring actin (Fig.16B) is shown as an additional internal control: actin 
levels were similar across all the knock-down cell lines and to the control, validating 
direct comparisons between cell lines. Each signalling molecule, which previously 
showed induction upon T.gondii infection (Fig.15) was analysed individually 
(Fig.16B) and expression levels were compared across cell lines primed with IFN-γ 
and infected with type II T.gondii. In all the cell lines tested, IL-1α expression was 
dramatically increased following T.gondii infection. The increase in IL-1α expression 
was lower when either HOIP or the whole LUBAC complex were knocked-down; 






Figure 16: HOIL-1 is required for IL-6 and CCL5 induction upon T.gondii 
infection  
MEFs were transfected with siRNA either control, or targeting one of the three LUBAC 
subunits (HOIP, HOIL-1 or Sharpin), or the entire complex (triple knock-down). 48h after 
siRNA transfection, cells were all primed with IFN-γ overnight and on the next day, cells 
were infected with type II (PRU) Tomato-Toxoplasma gondii strain in 4:1 ratio compared to 
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the number of cells seeded in wells. Samples from the different knock-down cell lines 
produced were isolated and later analysed by western-blotting (A) to assess the expression 
levels of the three targeted proteins (HOIP, HOIL-1, Sharpin). At 1h post-infection, cells were 
washed with PBS and fresh medium was added. At 24h post-infection, cells were collected, 
lysed and their RNA purified. After reverse transcription, mRNA levels were quantified by 
qPCR and analysed using the ΔΔCt method (B) with GAPDH as the reference gene. Data are 




IL-6 induction following T.gondii infection was reduced in the HOIL-1 knock-down 
and to a smaller extent in the LUBAC knock-down. Regarding CCL4, induction by 
T.gondii was significant (p-value < 0.05) (Fig.15) and no major change was observed 
in any of the knock-downs (Fig.16B). mRNA levels of CCL5 were significantly 
reduced with cells knocked-down for HOIL-1 and reduced to a similar level in the 
triple knock-down. Finally, ICAM-1 levels were increased during T.gondii infection 
(similar to CCL5 induction, p-value < 0.005) in the control, but ICAM-1 transcripts 
were induced to lower levels in the absence of HOIL-1. However, this decrease in 
mRNA level was not recapitulated by the triple knock-down. 
 
In summary, HOIL-1 seems required for the induction of IL-6 and CCL5 upon 
T.gondii infection whereas IL-1α induction might be partly HOIP-dependent. On the 





There is increasing literature about the balance that T.gondii initiate to settle in cells, 
making use of cellular resources but evading immune responses in order to replicate 
and grow. T.gondii releases a number of effectors that impact the cell metabolism and 
signalling. Some of those changes were considered in this chapter and more 
particularly in relationship with IFN-γ. However, hosts have multiple mechanisms of 
defence to fight against infections, including cell-autonomous pathways such as 
autophagy. In the case of S.Typhimurium, the host response is multi-layered but 
requires autophagy to restrict bacterial growth and eventually destroy the pathogens 
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(Randow et al., 2013). In order to potentially draw a parallel with T.gondii infection, 
this chapter investigated the role of autophagy and, more particularly the roles of 
LUBAC and cargo receptors.  
 
3.4.1 Role of autophagy in T.gondii clearance 
The role of LUBAC and the autophagy receptors in the case of T.gondii infection was 
considered based on the comparison with cell-autonomous defence mechanisms 
exhibited against S.Typhimurium (see Chapter 1, Fig.10). 
The results obtained showed that all LUBAC subunits and three major cargo receptors 
(NDP52, p62, and Optn) were recruited to type II T.gondii in IFN-γ-primed MEF 
cells. These results also suggest a range of experiments that could be employed in the 
future to obtain additional information about this process.  
 
 
3.4.1.1. Is LUBAC involved in the restriction of the parasite? 
Although LUBAC components are constitutively expressed, the complex is recruited 
to T.gondii in an IFN-γ-dependent manner, which suggests upstream IFN-γ-induced 
recruitment machinery that requires further experiments to be identified.  
All LUBAC subunits, namely HOIP, HOIL-1 and Sharpin were recruited individually 
and independently of the other LUBAC subunits. This contrasts with the results 
obtained from bacterial infections where, in the case of S.Typhimurium, endogenous 
levels of HOIL-1 enable HOIP to be recruited, and, in a feed-forward loop, recruit 
HOIL-1 and Sharpin to the ubiquitylated cytosolic bacteria (Noad et al., 2017). 
Moreover, the two distinct mechanisms of HOIP recruitment (Fig.6D) to T.gondii are 
novel but require further experiments to identify the precise ligands involved. 
 
To identify ligands more precisely, in vitro binding assays could be performed with 
purified T.gondii and cell lysates containing the tagged protein of interest. Lysates 
from cells either primed or not with IFN-γ overnight could be compared for their 
ability to bind to T.gondii. Both strains of T.gondii (RH and PRU) should also be 
used. The isolation of the parasite from HFF cells, in which they replicate within 
vacuoles would be critical to obtain either naked or vacuolar T.gondii, thereby 
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influencing the results of the pull-down assay. The proteins identified would belong 
either to the parasite membrane or to the PVM, respectively. 
 
Further investigation of the recruitment mechanisms would have the potential to 
identify ligands and discriminate between the parasitophorous vacuolar membrane 
(PVM) and the parasite itself as the target (Jones & Hirsch, 1972; Kimata & Tanabe, 
1987; Bradley et al., 2002). Using confocal microscopy was sufficient to count 
recruitment events; however, using super-resolution microscopy would enable a more 
detailed picture to be developed and might reveal whether recruitment is to the PVM 
or onto the parasite itself. Also, looking at intensity profiles across an image would 
have the potential to see to what extent the fluorescence signals overlap and hence 
identify colocalisation of tagged-proteins with T.gondii. 
 
To investigate further the recruitment mechanisms and test whether LUBAC subunits 
are bound directly to T.gondii, an in situ proximal biotinylation could be employed. 
The ascorbate peroxidise enzyme APEX fused to a resident protein, in this case the 
LUBAC subunits (HOIP, HOIL-1 and Sharpin), allows proximity-dependent 
biotinylation in cells pretreated for 30 minutes with 500μM biotin-phenol to enable 
sufficient uptake as biotin-phenol has poor membrane permeability. The addition of 
1mM H2O2 enables the production of phenoxyl radicals which biotinylate proximal 
proteins on electron rich amino acids, in particular tyrosine. APEX has been used to 
identify resident proteins in the mitochondrial matrix or to specifically label resident 
proteins in the mitochondrial intermembrane space (IMS), despite it being connected 
to the cytoplasm (Hung et al., 2016; Rhee et al., 2013). Since the half-life of phenoxyl 
radicals is very short (<10ms), this approach preferentially labels proteins located in 
close proximity (radius of 20nm) to the APEX-fused protein (Lam et al., 2015) for 
subsequent identification by TMT mass spectrometry. For the follow-up experiment, 
different infection conditions will be compared, that is: no infection, or infection with 
either type I (RH) or type II (PRU) T.gondii. In addition, for each of these infection 
conditions, cells primed or not with IFN-γ overnight would be used. Results obtained 
from cells primed with IFN-γ overnight and infected with the PRU T.gondii strain 
should facilitate identification of true binding partners. This experimental method 
should help identify binding partners, which could be host molecules or targets on 
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either the parasite or the PVM segregating binders of the T.gondii itself, or the 
parasitophorous membrane. 
 
LUBAC constitutively restrict bacterial proliferation (Noad et al., 2017). Moreover, 
its action is not known to be antagonised by any S.Typhimurium effectors but is 
regulated by the deubiquitinase (DUB) OTULIN (Fill et al., 2013; Keusekotten et al., 
2013). More specifically, because LUBAC synthesises linear ubiquitin chains, using 
the deubiquitinase OTULIN would help determine the extent to which LUBAC is 
(indirectly) required for the recruitment of cargo receptors such as NDP52, p62 and 




3.4.1.2. How and why are autophagy cargo receptors recruited to the 
parasite? 
The proximal biotinylation strategy described above would be applicable to studying 
NDP52, p62, and Optn in order to determine whether binding to T.gondii requires 
partners and/or complex formation. For instance, the PB1 domain of p62 was shown 
to be necessary for recruitment (Fig.9C) and is known to interact with the proteasome 
(Haldar et al., 2015; Seibenhener et al., 2004), the atypical protein kinase C (aPKC), 
and the dual specificity mitogen-activated protein kinase kinase 5 (MEK5) (Moscat & 
Diaz-Meco, 2000). Any of these could act either as downstream effectors or upstream 
baits of p62. Additionally, p62 has been shown to participate in the immune response 
against T.gondii: in conjunction with IFN-γ stimulation, p62 activates CD8+ T cells 
that recognise T.gondii-derived antigens originally present in the parasitophorous 
vacuole (Lee et al., 2015). 
 
Both p62 and Optn required functional ubiquitin-binding domains (UBA and UBAN) 
to be recruited efficiently (Fig.9 and 10). Overexpressing a range of DUBs would 
provide an additional method for testing the precise way in which ubiquitin chains 
facilitate the recruitment of p62 and Optn to T.gondii. By removing ubiquitin from 
multiple host and external parasitic targets, it is to be expected that the recruitment of 




Live imaging (Niedelman et al., 2013) would be useful to determine the extent to 
which there is a time-sequence for the protein recruitment events on T.gondii. In the 
present study, patterns of proteins around the parasite – or its vacuole – were 
observed. Depending on the constructs, the shapes of recruitment events differed, 
even within one coverslip. In some instances, the GFP coat was observed to be either 
fully or partially surrounding the parasite; whereas, in other instances, a “tail” could 
be observed, as if the recruitment was onto the broken vacuole, with the T.gondii 
escaping or moving away from the membrane remnants. Live microscopy could help 
enrich the understanding of the time course of these recruitment events and would 
help establish whether recruitment is progressive and how sudden or stable it is. In 
addition, investigating the timeline will lead to know how early proteins are recruited 
after infection.  
 
In summary, live imaging would provide further insight on the sequence of 
recruitment events, potentially revealing the necessary presence and/or function of 
LUBAC for the downstream recruitment of cargo receptors. Furthermore, looking at 
both host proteins and parasite effectors during infection will increase the knowledge 
of how the balance between host resistance and parasite virulence is established. 
 
 
3.4.2 Host signalling could be silenced by T.gondii effectors 
T.gondii has evolved mechanisms to antagonise host cell signalling pathways to avoid 
destruction (Zhao et al., 2009). For example, the effector ROP18 – present in virulent 
strains – phosphorylates IRGs, inhibiting their association with the PV and thereby 
protecting the parasite against clearance (Fentress et al., 2010; Steinfeldt et al., 2010). 
 
3.4.2.1. Impacts of IFN-γ on the cell response 
IFN-γ seems to play a role at the different stages of the infection process, namely cell 




Flow cytometry experiments (Fig.11) showed that IFN-γ reduced the infectivity of 
type II T.gondii by almost half. Priming cells with IFN-γ seems to protect them 
against parasite infection.  
 
Following T.gondii infection, members of the immunity-related GTPase (IRG) and 
guanylate-binding protein (GBP) families, which are IFN-γ inducible (Martens & 
Howard, 2006) adhere specifically to the parasitophorous vacuole (PV). GBPs recruit 
antimicrobial protein complexes that include the inflammasome and the autophagy 
machinery (MacMicking, 2012), whereas IRG proteins have the ability to lyse the PV 
membrane, exposing the parasites to the cytosol for targeting by autophagy (Ling et 
al., 2006).  
 
As a marker of cytosolic entry for S. Typhimurium (Thurston et al., 2012), the 
presence of GAL8, following T.gondii infection, was assessed using antibody staining 
(Fig.1). Microscopy experiments need to be repeated using overexpressed 
fluorescently-labelled GAL8 to avoid unspecific staining. In addition, because 
T.gondii makes its own vacuole by releasing rhoptries and using lipids from the 
plasma membrane, the PVM content is species-specific. Moreover, upon rupture, the 
PVM might not expose any ligand being recognised as extracellular or foreign and 
therefore not targeted by GAL8. 
 
Parasite replication was also assessed by flow cytometry looking at mean intensity in 
cells infected with fluorescent T.gondii. As mentioned, the mean intensity was used to 
measure either T.gondii growth or restriction of replication. However, curves showing 
the different cell populations based on the single cells’ intensity (i.e. T.gondii load) 
are more bimodal than Gaussian, making the use of mean of intensity questionable for 
the data analysis. Performing plaque assays to more precisely count the number of 
parasites per cell and even looking at the distribution of the number of T.gondii per 
vacuole would provide a clearer picture of the mechanism and would discriminate 
between restriction of replication and/or killing of T.gondii. 
 
The results presented in this chapter have demonstrated that IFN-γ drives restriction 
of type II T.gondii in MEFs (Fig.12), thereby confirming previous observations 
(Selleck at el., 2015). Priming with IFN-γ has also been shown to be required for the 
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recruitment of LUBAC and the autophagy cargo receptors NDP52, p62 and Optn to 
type II T.gondii (most likely to the PVM). No connection was made so far between 
their recruitment and the restriction of replication or killing of the parasites. Because 
T.gondii restriction may be promoted or activated by the production of cytokines (e.g. 
IL-1α, IL-6) and the upregulation of certain adhesion proteins (e.g. VCAM-1 or 
ICAM-1), several candidates were tested and their mRNA level was assessed by 
qPCR showing that indeed, IFN-γ-primed cells produced increased levels of IL-1α, 
IL-6 and CCL5, in a potentially HOIP, HOIL-1 and HOIL-1 dependent manner, 
respectively. 
 
Analysing the changes in the synthesis and production of both adhesion and signalling 
proteins, either individually or together, would give a better understanding of their 
relationship with IFN-γ. Inhibiting or inducing some of them to try to recapitulate 
effects on infectivity, parasite replication and cell death, will shed light on the 
mechanisms by which IFN-γ impacts the cell response to T.gondii infections. 
 
 
3.4.2.2. Signalling conflicts between host cytokines and parasite effectors 
During an infection, the parasites deliver a set of effectors to invade the host cells, 
replicate, and establish tissue cysts. Even though the parasites try to use the host cell 
resources, some defence mechanisms are also set-up by the hosts on a cellular level to 
fight against the infection. 
 
As shown by the qPCR experiments, infection with T.gondii alters cytokine levels 
such as IL-1α or IL-6 (Fig.15). It would be interesting to broaden the spectrum of 
signalling molecules tested in order to see whether more are affected upon T.gondii 
infection. For example, interleukin-12 (IL-12) was shown to play a critical role in 
controlling T.gondii growth in cells (Suzuki et al., 2011; Hargrave et al., 2019). The 
cytokine IL-10 was shown to be anti-inflammatory (Wujcicka et al., 2018) and 
increased levels of IL-10 were observed in enhanced T.gondii infection and 
replication (Levy et al., 2004). IL-10 protects mice against T.gondii (Gazzinelli et al., 




All transcript analyses were initially performed with IFN-γ-primed MEF cells; using 
unprimed cells might reveal different cytokine profile changes. Additionally, type I 
and III T.gondii were shown to antagonise IL-12 by activating signal transducer and 
activator of transcription 3 and 6 (STAT3 and STAT6) (Boyle & Radke, 2009) via the 
release of rhoptry protein 16 (ROP16) (Ong et al., 2010). Experiments investigating 
modifications in mRNA levels could be performed again using the type I T.gondii 
strain (RH), because changes in transcription levels of signalling molecules might be 
different than those seen with the PRU (type II) strain and perhaps explained by the 
differences between the effector molecules released by the two distinct strains, linking 
it to virulence. 
 
By synthesising linear ubiquitin chains, LUBAC activates NF-κB signalling to restrict 
cytosolic bacteria (Noad et al., 2017). High content microscopy was used to measure 
p65 nuclear translocation upon T.gondii infection. As a positive control, cells were 
treated with TNF-α (Hayden & Ghosh, 2014). As a negative control, the supernatant 
from the pelleted T.gondii after harvest and cell lysis was added to the cells. 
Automated analysis did not allow segregation between the different treatment 
conditions: levels of p65 nuclear translocation were already high in the negative 
control and even the addition of TNF-α did not show a significantly higher number of 
p65 translocation events. Thus, the effect of T.gondii infection on NF-κB signalling 
could not be addressed. This assay needs further optimisation and/or development of 
alternative methods such as ELISA, to measure NF-κB activation upon T.gondii 
infection. 
 
T.gondii also subverts the host cell metabolism. Arginine metabolism was identified 
to be reprogrammed in the case of T.gondii infection (Hargrave et al., 2019). Arginine 
is converted in ornithine or proline rather than in toxic nitric oxide species (NOS) 
(Adams et al., 1990). T.gondii also affects host glycolysis by modulating seven 
enzymes (Nelson et al., 2008) resulting in up-regulation of the anabolic pathway. This 
increase translates to higher production of ATP providing energy and, more 
importantly, pyruvate that generates even more ATP by entering the oxidative 
phosphorylation route (Ainscow & Brand, 1999). Other metabolic cascades are 
probably modified (Blader et al., 2001) by T.gondii infection, whether it serves the 
T.gondii directly for growth or by silencing immune responses to protect T.gondii for 
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survival. Experiments testing whether LUBAC subunits or other cargo receptors (p62, 
Nemo, NDP52) are involved in directing the modifications in these pathways could be 
performed to get a better understanding of these mechanisms. 
 
Although some work has also been done in human or mouse macrophages (Ling et al., 
2006; Zhao et al. 2008; Clough & Frickel, 2017), it might be worth looking at other 
human epithelial or intestinal cell lines, which would be more physiologically 
relevant. Humans get infected most commonly through contaminated food or water 
(Hoffmann et al., 2012) before the infection migrates to the brain where bradyzoites 
establish cysts (Denkers & Gazzinelli, 1998). Since the human immune system is 
more efficient in fighting T.gondii infections than the murine one, the pathogenicity is 
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Appendix 1: Recruitment of HOIP, NDP52, p62 and Optn constructs to type II 
T.gondii 
MEF cells overexpressing GFP-tagged constructs were primed overnight with IFN-γ and 
infected with type II T.gondii (PRU), in a 4:1 ratio compared to the number of cells seeded on 
the coverslips. At 1h post-infection, cells were washed with PBS and fixed with 4% PFA. 
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Appendix 2: Chromatograms showing the T.gondii-infected population 
Wild-type, Cas9-overexpressing and Atg5-KO-MEF cells were incubated with IFN-γ 
overnight before infection with type I (RH) or type II (PRU) Tomato-Toxoplasma gondii 
strains in 1:1 ratio compared to the number of cells seeded in wells. At 1h post-infection, cells 
Appendices 
 208 
were washed with PBS and fresh medium was added. At 2h, 24h and 48h post-infection, cells 
were fixed with 4% PFA and cells collected at all time points were analysed by flow 
cytometry at the same time. Data analysis using FlowJO enables the visualisation of 
chromatograms for the three cell lines infected with both the RH and PRU strains, and either 
primed (cyan) or not (red) with IFN-γ. 
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Chapter 4: Materials and methods 




Restriction enzymes all 






Histidinol dihydrochloride Sigma 









Interferon-gamma (IFN-γ) Human and murine BD Pharmingen 
PCR grade water Distilled water Life Technologies 
Propidium iodide 
Cell death assays 
Sigma 
Cell Titer Glo 2.0 Promega 
Primers All sequences Sigma 
Sequencing 
For plasmids GATC (Eurofins) 
For gRNA library MiSeq in the LMB 





4.1.2.1. Primary antibodies 
Antibody Cat. no Source Application 
Mouse monoclonal α-Flag M2  F1084 Sigma WB (1:2000) 
Mouse α-GFP (JL8) 632381 Clontech WB (1:2500) 
Rabbit α- βActin ab8227 Abcam WB (1:5000) 
Mouse α-MHC class I (W6/32) sc-32235 Santa Cruz FC (1:50) 
Mouse monoclonal α-CRISPR-Cas9 ab191468 Abcam WB (1:1000) 
Mouse α-CASP4 M029-3 MBL WB (1:1000) 
Mouse α-CASP8 9746 CST WB (1:1000) 
Rabbit α-GSDMD NBP2-33422 Novus Bio WB (1:500) 




Goat polyclonal α-HOIL sc-49718 Santa Cruz WB (1:1000) 
Rabbit polyclonal α-Otulin ab151117 Abcam WB (1:1000) 
Mouse monoclonal α-Ubiquitin FK2 
BML-PW8810-
0500 
Enzo IF (1:400) 




Rabbit polyclonal α-NF-κB p65 (C-
20) 
sc-372 Santa Cruz IF (1:1000) 
Mouse monoclonal α-LPS 
(S.Typhimurium) 
8210-0407 Bio-Rad IF (1:1000) 
WB: western-blot; IF: Immunofluorescence; FC: Flow cytometry 
 
4.1.2.2. Secondary antibodies 



















4.2.1 Primers used for sequencing 
Vector ID Sequence Ori 
M6P 
Flx 190 5’-TAGACGGCATCGCAGCTTGGA-3’ F 
Trx 109 5’-TCAAGATCCGCCACAACATCG-3’ F 
Flx 561 5’-ACGCACACCGGCCTTATTCCA-3’ R 
Flx 211 5’-CTGGTGATATTGTTGAGTCA-3’ R 
pET-11 
T7 5’-TAATACGACTCACTATAGGG-3’ F 
pET-RP 5’-CTAGTTATTGCTCAGCGG-3’ R 
gRNA 
library 
PCR2 5’-TTAGCTCACTCATTAGG-3’  
M13FP 5’-TGTAAAACGACGGCCAGT-3’ F 
scr15 5’-GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAG-3’ F 
scr16 5’-GGTGTTTCGTCCTTTCCACAAGATATATAAAGCC-3’ R 
ID: primer identification reference; Ori: orientation; F: forward; R: reverse 
 
In all the subsequent tables, sequences are all written in their 5’ → 3’ orientation. 
 
 
4.2.2 Primers for Illumina sequencing – samples from the screen 































4.2.3 Primers used for qPCR 
Gene Species ID Sequence Ori 
CASP4 Human 
scr140 TGGAATCCCTGGGCAAAGAT F 
scr141 GGTCCAGCCTCCATATTCGG R 
CASP8 Human 
scr146 AGGAGCTGCTCTTCCGAATT F 
scr147 ACCTCAATTCTGATCTGCTCAC R 
GSDMD Human 
scr156 CCAGAAGAAGACGGTCACCA F 
scr157 CCTCTGCTTCTTATCCGGGA R 
STAT-1 Human 
scr164 TGATCTCCAACGTCAGCCAG F 
scr165 CCAACATGTTCAGCTGGTCC R 
IFNGR1 Human 
scr166 TACCAGATCATGCCACAGGT F 
scr167 CCTGGCTTTAACTCTGACCC R 
NCKAP1 Human 
scr172 ACTGCTGTCTCGAATTGAAGA F 
scr173 GCTATGGGGTACAAATTCTTCCA R 
SRSF10 Human 
scr180 AAGACTTGCGGCGTGAATTT F 
scr181 GCCGTCCACAAATCCACTTT R 
ALG12 Human 
scr186 GGTCATCTGTCCCTACACCA F 
scr187 GAGAACACTGCGATCACCAC R 
FIP1L1 Human 
scr196 TGGTTATGATAGTCGTTCTGCAC F 
scr197 CTCTCTCTCTCTCTGGTGCG R 
SLC25A37 Human 
scr202 ATAGCTGGGAGTATGGCCAC F 
scr203 GTGGTGTAGCTCCGGTAGAA R 
SAF-B Human 
scr206 TAACGGGCTGGAGGAAAACT F 
scr207 CATGTTCCTGAAGCTGCTCC R 
TM9SF2 Human 
scr216 TTGAAACTGGGTCCATGGGA F 
scr217 TCCCCAGAAGCCTTGTTACT R 
β-actin Human 
G345 CCTGG CACCC AGCAC AAT F 
G346 GCCGA TCCAC ACGGA GTACT R 
HOIP=rnf31 Mouse 
scr244 GTGGCCGGGATGTACTACG F 
scr245 CTCTCTTAGCAGCTGGTCCA R 
HOIL=rbck-1 Mouse 
scr248 CGGAGATGAACAGGCTGCTA F 




scr256 TGCCCCATTTCTCCACCAT F 
scr257 CTGCTTTCTCATCCCCACCT R 
β-actin Mouse 
G360 TGACAGCATTGCTTCTGTGTAAATT F 
G361 ATTGGTCTCAAGTCAGTGTACAGGC  R 
IL-1α Mouse 
scr260 CAAGATGGCCAAAGTTCGTGAC F 
scr261 GTCTCATGAAGTGAGCCATAGC R 
IL-6 Mouse 
scr264 AGGATACCACTCCCAACAGACCT F 
scr265 CAAGTGCATCATCGTTGTTCATAC R 
CCL4 Mouse 
scr276 CAACACCATGAAGCTCTGCG F 
scr277 GCCACGAGCAAGAGGAGAGA R 
CCL5 Mouse 
scr272 CCAATCTTGCAGTCGTGTTTGT F 
scr273 CATCTCCAAATAGTTGATGTATTCTTGAAC R 
ICAM-1 Mouse 
scr268 GGCATTGTTCTCTAATGTCTCCG F 
scr269 CCGCTCAGAAGAACCACCTTGG R 
VCAM-1 Mouse 
scr270 TACTCCCGTCATTGAGGATATTGG F 
scr271 CTCCTTCACACACATAGACTCC R 
TNF-α Mouse 
scr274 GGCAGGTCTACTTTGGAGTCATTGC F 
scr275 ACATTCGAGGCTCCAGTGAA R 
GAPDH Mouse 
scr278 TGTGTCCGTCGTGGATCTGA F 
scr279 CCTGCTTCACCACCTTGTTGAT R 
 
ID: primer identification reference with “G” designed by Grigory Ryzhakov and “scr” 
by Solene Rolland; Ori: orientation; F: forward; R: reverse 
 
4.2.4 Primers for amplification of open reading frames (ORFs) 
Gene ID Sequence RE Ori 
ALG12 
scr109 GGCCGGACATGTCAGCTGGAAAGGGGTCATCAG PciI F 
scr110 GGCCGGGCGGCCGCTCAGGACGGCCGGGGGAGC NotI R 
EMC6 
scr111 GGCCGGACATGTCAGCCGCGGTGGTGGCCAAGC PciI F 
scr112 GGCCGGGCGGCCGCTCAGTAGACGTGCACCATG NotI R 
TM9SF2 
scr113 GGCCGGCGTCTC/ACATGTCAGCGAGGCTGCCGGTGTTG BsmBI+PciI F 




scr115 GGCCGGACATGTCAGGGTCGGCCTTTGAGCGGG PciI F 
scr116 GGCCGGGCGGCCGCCTAGTGGGGCTCCTGGCTC NotI R 
FIP1L1 
scr117 GGCCGGACATGTCGGCCGGCGAGGTCGAGCGCC PciI F 
scr118 GGCCGGGCGGCCGCCTATTCTGCAGGTGTAGCT NotI R 
SRSF10 
scr119 GGCCGGACATGTCCCGCTACCTGCGTCCCCCCA PciI F 
scr122 GGCCGGGCGGCCGCTCAGTGGCCACTGGACTTA NotI R 
CASP4 
scr123 GGCCGGACATGTCAGCAGACTCTATGCAAGAGA PciI F 
scr124 GGCCGGGCGGCCGCTCAATTGCCAGGAAAGAGG NotI R 
CASP8 
scr128 GGCCGGACATGTCAGACTTCAGCAGAAATCTTT PciI F 
scr127 GGCCGGGCGGCCGCTCAATCAGAAGGGAAGACA NotI R 
SAF-B 
scr130 GGCCGGACATGTCAGCGGAGACTCTGTCAGGCC PciI F 
scr131 GGCCGGGCGGCCGGAGACGTCAGTAGCGGCGAGTGAAG BsmBI+NotI R 
ID: primer identification reference; RE: restriction enzyme for which the restriction 
site is underlined; Ori: orientation; F: forward; R: reverse 
 
 
4.2.5 Primers for generating sgRNAs 


















































































































































































































scr139 AAACGACTGGTCTCAACATCCTCC R 
ID: primer identification reference; Ref: symbol by which they were referred as 
during experiments, if they are strikethrough, it means that the plasmid failed 
transformation and therefore was not used in validation experiment; Ori: orientation; 
F: forward; R: reverse 
 
The amplified fragments from human cDNA were then digested with restriction 
enzymes in order to create overhangs and were ligated into the backbone: 












ID Plasmid description Resistance 
SR08 M6P.Blast.NtermFLAG.GSDMD blasticidin 
SR09 M6P.Blast.GSDMD.CtermFLAG blasticidin 
MW724 M6P.pac.NtermFLAG.CASP4-WT puromycin 
MW738 M6P.pac.NtermFLAG.CASP4-K19E puromycin 
MW739 M6P.pac.NtermFLAG.CASP4-C258A puromycin 
SR10 M6P.Blast.NtermGFP.ALG12 blasticidin 
SR11 M6P.Blast.NtermGFP.GSDMD blasticidin 
SR12 M6P.Blast.NtermGFP.TM9SF2 blasticidin 
SR13 M6P.Blast.NtermGFP.CASP8 blasticidin 
SR15 M6P.Blast.NtermGFP.SRSF10 blasticidin 
SR17 M6P.Blast.NtermGFP.EMC6 blasticidin 
SR18 M6P.Blast.NtermGFP.CASP4 blasticidin 
SR21 M6P.Blast.NtermGFP.SAFB blasticidin 
JN141 M6P.pac.Otulin-WT puromycin 
JN145 M6P.Blast.NtermGFP.Otulin-WT blasticidin 
CE009 M6P.Blast.NtermGFP.Lysenin-W20A blasticidin 
F1032 M6P.Blast.NtermGFP.HOIL-WT blasticidin 
F1035 M6P.Blast.NtermGFP.Sharpin-WT blasticidin 
F1034 M6P.Blast.NtermGFP.HOIP-WT blasticidin 
JN110 M6P.Blast.NtermGFP.HOIP-T360A blasticidin 
JN70 M6P.Blast.NtermGFP.HOIP-Ν294 blasticidin 
JN71 M6P.Blast.NtermGFP.HOIP-Ν438 blasticidin 
JN164 M6P.Blast.NtermGFP.HOIP-Ν438-R375A blasticidin 
JN136 M6P.Blast.NtermGFP.HOIP-Ν438-T360A blasticidin 
JN73 M6P.Blast.NtermGFP.HOIP-ΔN294 blasticidin 
JN74 M6P.Blast.NtermGFP.HOIP-ΔΝ438 blasticidin 
JN85 M6P.Blast.NtermGFP.HOIP-ΔΝ527-R646W blasticidin 
JN78 M6P.Blast.NtermGFP.HOIP-ZnF blasticidin 
JN79 M6P.Blast.NtermGFP.HOIP-UBA blasticidin 
JN81 M6P.Blast.NtermGFP.HOIP-ZnF1 blasticidin 
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JN89 M6P.Blast.NtermGFP.HOIP-ZnF2 blasticidin 
JN82 M6P.Blast.NtermGFP.HOIP-ZnF1+2 blasticidin 
JN83 M6P.Blast.NtermGFP.HOIP-ZnF3 blasticidin 
JN84 M6P.Blast.NtermGFP.HOIP-ZnF2+3 blasticidin 
JN57 M6P.Blast.NtermGFP.Nemo blasticidin 
BR295 M6P.Blast.NtermGFP.Optineurin-WT blasticidin 
BR294 M6P.Blast.NtermGFP.Optineurin-E478G blasticidin 
JN158 M6P.Blast.NtermGFP.Optineurin-N555 blasticidin 
JN138 M6P.Blast.NtermGFP.Optineurin-F177S-D286N-L493S blasticidin 
JN139 M6P.Blast.NtermGFP.Optineurin-D474N blasticidin 
JN167 M6P.Blast.NtermGFP.Optineurin-N522-S473A-L494S blasticidin 
JN130 M6P.Blast.NtermGFP.Optineurin-(424-510) blasticidin 
JN159 M6P.Blast.NtermGFP.Optineurin-(424-510)- S473A blasticidin 
BR256 M6P.Blast.NtermGFP.p62-WT blasticidin 
BR274 M6P.Blast.NtermGFP.p62-N166 blasticidin 
BR280 M6P.Blast.NtermGFP.p62-ΔN165 blasticidin 
JN183 M6P.Blast.NtermGFP.p62-K7A-D69A blasticidin 
BR385 M6P.Blast.NtermGFP.p62-D337A-W338A-L341A blasticidin 
BR262 M6P.Blast.NtermGFP.p62-DDDW335-338AAAA blasticidin 
BR260 M6P.Blast.NtermGFP.p62-F406V blasticidin 
BR261 M6P.Blast.NtermGFP.p62-L417V blasticidin 
BR299 M6P.Blast.NtermGFP.p62-F406V-L417V blasticidin 
BR298 M6P.Blast.NtermGFP.p62-PB1+LIR blasticidin 
BR296 M6P.Blast.NtermGFP.p62-ΔPB1-ΔUBA blasticidin 
JN64 M6P.Blast.NtermGFP.NDP52-WT blasticidin 
JN65 M6P.Blast.NtermGFP.NDP52-L374A blasticidin 
JN68 M6P.Blast.NtermGFP.NDP52-D439K blasticidin 
JN69 M6P.Blast.NtermGFP.NDP52-V136S blasticidin 
JN170 M6P.Blast.NtermGFP.NDP52-ΔSKICH -V136S blasticidin 
JN171 M6P.Blast.NtermGFP.NDP52-ΔSKICH -V136S-L374A blasticidin 
ID: plasmid identification reference with BR=Ben Ravenhill, CE=Cara Ellison, 
JN=Jessica Noad, MW=Michal Wandel, SR=Solene Rolland; RE: restriction enzyme; 
WT: wild-type; ZnF: zinc-finger. 
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Apart from Lysenin, all the above plasmids code for the expression of human 
proteins. 
These proteins were all ligated into the same plasmid backbone: M6P (Fig.1).  
 
 
Figure 1: M6Pblast-GFP vector plasmid map 
MMLV long terminal repeats (LTRs) enable integration of the plasmid sequence into the host 
cell genome. The gene of interest is inserted between PciI and NotI (all single restriction sites 
are labelled in red). AmpR – Ampicillin resistance, Blast – Blasticidin resistance, Ori – origin 
of replication, IRES – Internal ribosome entry site, GFP – Green fluorescent protein. 
 
Even though most of them show N-terminal tag GFP and blasticidin as antibiotic 




























4.4 siRNAs  
4.4.1 Dharmacon pools 
They were used for the validation of some candidates form the screen (pools of 4 
human siRNAs from Dharmacon). 
All sequences are given in the table below in the sense (5’ → 3’) orientation 










































































































































4.4.2 Other siRNAs 
Target Species Sequence 
HOIP Mu 5’-GACCCUAACUGCAAGGUGA-3’ 
HOIL Mu 5′-ACACGUCACUCAACCCACA-3’ 
Sharpin Mu 5′-CUUUCAUCAAUGCCUCAAA-3’ 






PART II - METHODS 
4.5 Cell lines and pathogenic strains 
In the experiments undertaken in this thesis, the following cell lines and pathogens 
(bacteria or parasites) were used in a containment level 2 laboratory. 
 
4.5.1 Cell lines 
*MEF, fibroblast cell line derived from mouse embryonic tissue, kindly provided by 
C. Sasakawa. 
*HeLa, epithelial cell line derived from human cervical carcinoma cells; obtained 
from European Collection of Authenticated Cell Cultures.  
*HCT116, epithelial cell line derived from human colon cells; obtained from 
European Collection of Authenticated Cell Cultures. Used as an alternative non-
phagocytic human epithelial cell line to HeLa cells. 
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*HEK-293ET, epithelial cell line derived from human embryonic kidney cells; 
obtained from European Collection of Authenticated Cell Cultures. Used for viral 
production (retroviruses and lentiviruses) and often referred to as “293ET” only. 
*Sharpin-cpdm and corresponding WT MEFs, mouse embryonic fibroblast cell line 
encoding spontaneous frameshift mutation in the Sharpin gene and wild-type 
littermates, kindly provided by H. Walczak.  
*HOIL (-/- and corresponding WT) MEFs, mouse embryonic fibroblast cell line 
knockout in the RBCK1 gene using the CRISPR-Cas9 technology and its 
corresponding wild-type control, kindly provided by H. Walczak. 
*HOIP (-/- and corresponding WT) MEFs, mouse embryonic fibroblast cell line 
knockout in the RNF31 gene using the CRISPR-Cas9 technology and its 
corresponding wild-type control, kindly provided by H. Walczak. 
*HFF, fibroblast cell line derived from human foreskin cells; obtained from ATCC 
(ATCC® SCRC-1041™). Used for growth and culture of Toxoplasma gondii and also 




4.5.2 Bacterial strains 
*Salmonella enterica serovar Typhimurium (S.Typhimurium), strain 12023, provided 
by Dr David Holden, Imperial College London. Wild-type non-fluorescent or stably 
expressing BFP, GFP, mCherry were used for infection of non-phagocytic cells 
(HeLa and MEF cells, mostly). 
*Escherichia coli (E.coli), strain MC1061: used for plasmid production. 
*Escherichia coli (E.coli), strain BL21: used for protein expression. 
 
 
4.5.3 Parasitic strains 
Toxoplasma gondii, type I (RH) and type II (PRU), kindly given by Eva Frickel, 
Francis Crick Institute London. Both strains stably expressing Td-tomato were used 





4.6 Molecular cloning techniques 
4.6.1 RNA extraction 
The monolayer of HeLa or MEF cells was lysed using the RLT Plus buffer 
complemented with 2-β-mercaptoethanol (Merck, M6250) in proportion of 10μL for 
1mL of buffer. RNA was then extracted from the cells using the RNeasy Plus Mini 
Kit (Qiagen), following the manufacturer’s instructions. RNA concentration was 
measured on a NanoDrop (Thermo) and the RNA was used to make cDNA either 
directly or was frozen at -80°C for subsequent use. 
 
 
4.6.2 Making cDNA 
cDNA libraries or cDNA samples were synthesised from RNA extracted from HeLa 
and MEF cells (wild-type, knockout or knock-down) using the SuperScript III 
Reverse Transcriptase Kit (Invitrogen) and Oligo(dT) from New England Biolabs 
(NEB). Reaction mix 1 which contained 500ng of RNA, 1μL of 50μM Oligo(dT), 
5μL of 2mM dNTPs, and 2μL of distilled water was incubated at 65°C for 5 minutes 
in a Veriti™ 96-Well Thermal Cycler (Applied Biosystems) for denaturation. The 
mixture was then snap-cooled on ice. Reaction mix 2 contained 0.5μL of the 
SuperScript Reverse Transcriptase, 4μL of buffer, 1μL of DTT (all three reagents 
provided in the kit) and 1.5μL of distilled water. Reaction mix 2 was added to the 
cooled mix 1 and the mixture was incubated in the thermal cycler, first at 50°C for 60 
minutes for reverse transcription, and then at 75°C for 10 minutes for heat 
inactivation of the enzyme before holding at 4°C. 
 
The cDNA generated from particular cell lines was used to assess the mRNA level by 
qPCR (using a 1:15 dilution of cDNA) and stored at -20oC. The resulting cDNA 
libraries were stored at -80oC and carried on into PCRs to generate DNA fragments of 





4.6.3 Polymerase Chain Reaction (PCR) 
The reactions were carried out either in tubes (200μL-PCR tubes, eppendorf, CAT # 
0030124332) closed with lids or in 96-well plates (96-Well PCR Plate_Semi-Skirted, 
STARLAB, CAT # I1402-9710) sealed with adhesive PCR plate foil (ThermoFisher 
Scientific, CAT # AB0626). 
The runs were programmed, set up and performed on a Veriti™ 96-Well Thermal 
Cycler (Applied Biosystems) or a Techne Prime Thermal cycler. 
 
PCR was used to amplify genes of interest from existing plasmids or from cDNA. 
Primer pairs (see paragraph 4.2 “Primers”) were designed to include appropriate 
flanking sequences containing the desired DNA restriction enzyme sites directly 
adjacent to 15-20 complementary nucleotides to the 5’ (Forward) or 3’ (Reverse) end 
of the gene of interest. DNA restriction sites were added to enable cloning of the 
amplified gene in a mammalian or bacterial expression vector. 
PCR fragments were synthesised using KOD Hot Start polymerase kit (Merck 
Millipore). A 50μL-reaction contained 1X buffer for KOD polymerase, 0.2mM of 
each deoxynucleoside triphosphate (dNTP), 1.5mM MgSO4, 100pM each of forward 
and reverse primers, template DNA (50ng of plasmid or 1:15 dilution of cDNA) and 
0.02U of KOD polymerase. Sometimes, particularly for more difficult reactions, 5% 
DMSO were added to the reaction mix. Standard cycling conditions were as follows: 
initial DNA denaturation and polymerase activation for 2min at 94°C followed by 
cyclical DNA denaturation (94°C, 20s), primer annealing (55-60°C, 10s) and 
extension (70°C, 30s/kb of DNA). These cycles were repeated 18 times for plasmid 
DNA before a final extension period of 7min at 70°C and final cooling to 4°C. 
 
Following the reaction, all PCR products were purified using the QIAquick PCR 
purification kit (Qiagen) according to the manufacturer’s protocol. 
 
Several PCRs were also necessary to amplify and generate samples for sequencing 
from DNA extracted from samples isolated during the screen (see paragraph 4.9 
“Samples for the screen”). In this case, primers were designed differently (see 





4.6.4 DNA digestion and ligation 
4.6.4.1. DNA digestion 
Restriction enzymes from NEB were used to digest PCR products and plasmids to 
generate overhangs for ligation. Digest reactions contained 0.5μL of each restriction 
enzyme, 2μL of appropriate 10X NEBuffer (NEB) and approximately 1μg of DNA. 
The total reaction volume was made up to 20μL by adding distilled water. Digest 
reactions of PCR products were incubated at 37°C for 1h30min. Backbone vectors – 
where the insert will be cloned into – were incubated at 37°C for 1h for digestion and 
were then dephosphorylated by adding 1.5μL of alkaline phosphatase (1000U/mL, 
Roche) and by incubating for an additional 30min at 37°C. The dephosphorylation 
removes the phosphate groups at the 5’ end of the backbone preventing its self-
ligation. Incubation were performed by putting samples in a 37°C-waterbath.  
5μL of loading buffer (10mM EDTA, 30% glycerol, 0.05% Orange G (Sigma)) were 
added to each digestion product. The digestion products were then run at 85V for 
20min in TAE buffer (20mM acetic acid, 1mM EDTA, 40mM Tris (pH 7.6)) on a 
1.5% (w/v) low melting point agarose gel (Nusieve GTG, Lonza or UltraPure agarose, 
Invitrogen) containing SYBR Safe (Life Technologies) for DNA visualisation. DNA 
bands were visualised using a blue light transilluminator. Bands observed at the 
desired size were excised and incubated at 70°C for the time required for the agarose 
to melt, before ligation. 
 
For the generation of sgRNA to validate some of the genes in the ‘hit’ list from the 
screen, 2.5μg of the gRNA backbone (#1862) were digested for 2h at 37°C with 
1.5μL of enzyme BbsI and 3μL of NEB Buffer 2.1 in a 30μL reaction. The linearised 
product was purified using Qiagen purification kit and eluted in 40μL. 1.5μL of BbsI 
and 4μL of NEB Buffer 2.1 were added and the second digestion reaction was carried 
on for 2h at 37°C, before adding 4μL of alkaline phosphatase (1000U/ml, Roche). The 





4.6.4.2. Ligation of DNA fragments 
To create new plasmids, digested DNA fragments (both insert and dephosphorylated 
backbone vector) with compatible overhangs were ligated. A 25μL ligation reaction 
contained 1μL of digested and dephosphorylated backbone vector and 4μL of digested 
DNA insert from the melted agarose samples along with 2.5μL of 10X T4 DNA 
ligase buffer (NEB), 2.5μL of ligation additives (1mM ATP, 10mM DTT), 0.5μL of 
20mg/mL BSA (NEB), and 0.5μL of T4 DNA ligase (400000U/mL, NEB) in 14μL of 
distilled water. Reactions were incubated at room temperature for at least 2h before 
the ligated products were transformed into competent bacteria. 
 
For the generation of sgRNA plasmids, sense and antisense oligos for each gene were 
designed to exhibit the overhangs for the ligation already. First, 0.5μL of each oligo 
was incubated separately for 1h at 37°C with 2.5μL of NEB Buffer 4, 2.5μL of 
ligation additives (1mM ATP, 10mM DTT), 0.5μL of BSA and 2.5μL of T4 
polynucleotide kinase (PNK) in 17μL of water. For each gene, the two reactions 
corresponding to the sense and antisense oligos were then combined and incubated for 
5min at 95°C. The paired oligo mixtures were slowly cooled to room temperature. 
In 16μL of water, 1μL of purified, digested and dephosphorylated backbone (#1862), 
2.5μL of 10X ligation buffer, 2.5μL of ligation additives, 0.5μL of BSA and 0.5μL of 
T4 DNA ligase were added to 2μL of the cooled annealed oligo pair. The ligation 




4.6.5 Transformation into competent bacteria 
E.coli (MC1061) 
For a freshly ligated plasmid, 50μL of E.coli strain MC1061 was added to 4.5μL of 
ligation mixture. The bacterial mix was incubated on ice for 30min followed by heat-
chock for 5min in a water bath at 37°C.  
In the case of a plasmid rescue, 0.5μL of the plasmid to be rescued were mixed with 
10μL of E.coli strain MC1061. The bacterial mix was incubated on ice for 5min and 




In both cases, 50μL of the bacterial solution were then plated on agar, supplemented 
with either ampicillin (TYE+AMP) or the appropriate antibiotic, and the plates were 
incubated overnight at 37°C to obtain single resistant colonies. 
 
 
4.6.6 Plasmid purification 
Depending on the scale of the bacterial culture and the expected growth and 
purification yields, two different methods were used to purify plasmids. 
4.6.6.1. Qiagen kit 
Single colonies of transformed resistant bacteria were grown overnight in a shaking 
incubator (220rpm at 37°C), in 5mL of LB medium supplemented with either 
ampicillin (100μg/mL) or the appropriate antibiotic. Plasmids from the 5mL of 
bacterial culture were purified using the QIAprep spin miniprep kit (Qiagen) 
according to the manufacturer’s protocol. Plasmid concentrations were measured on 




4.6.6.2. Cesium Chloride (CsCl) maxi-prep 
Packaging (pCMV delta R8.2 – lentiviral or pMD-OGP – retroviral) and envelope 
(pMD- VSV-G) plasmids were needed in large quantities (several μg), as they were 
necessary to produce viruses. Hence the need to scale-up the production and 
purification of these three plasmids. 
Three solutions were prepared for this protocol:  
Maxi1 was a 2L solution of 10mM EDTA, pH8 (40mL of 0.5M EDTA in water);  
Maxi2 was always prepared fresh and was a solution of 0.2M NaOH, 1%SDS (180mL 
of water with 10mL of 4M NaOH and 10mL of 20%SDS);  
Maxi3 was a solution of 5M KOAc, pH4.7 (500g of KOAc with 300mL glacial HOAc 
topped up with water to 2L).  
 
Single colonies of transformed resistant bacteria were grown overnight in a shaking 
incubator (220rpm at 37°C), in 2mL of LB medium supplemented with ampicillin 
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(100μg/mL). The next day, these 2 mL were transferred into a 1L flask of LB 
complemented with ampicillin (100μg/mL). Bacteria were grown overnight to reach 
saturation. The bacterial suspension was then spun down for 30min at 5krpm at 4°C to 
pellet the cells. The cell pellet was resuspended in 40mL of Maxi1, before adding 
80mL of Maxi2 followed by 40mL of Maxi3 to lyse the cells. The sample was spun 
down for 10min at 5krpm at 4°C to pellet the debris. The supernatant (150mL) was 
poured into a 250mL bottle, which was then filled with isopropanol to precipitate 
DNA. The precipitate was pelleted by centrifugation for 5min at 5krpm and 4°C. The 
bottle was carefully drained, and its walls were rinsed gently with 70% ethanol to dry 
them out. The DNA pellet was re-suspended in 4mL 10mM EDTA, before adding 
5.5g of CsCl followed by 0.1mL of 1% Triton X-100. After the salt dissolved, 0.5mL 
of 10mg/mL ethidium bromide was added. This new solution was spun down for 
10min at 10krpm. The supernatant was transferred into sealed tubes and centrifuged 
overnight at 60krpm. 
After centrifugation, the solution featured three bands between the pellet (RNA) and 
the supernatant (proteins). The middle band was taken out using a syringe equipped 
with a needle since the top band contained genomic DNA and the lower band 
contained plasmid DNA. To extract the content of the isolated middle band, 10mL of 
n-butanol saturated with 1M NaCl were added to the isolated band. Butanol was 
aspirated in a trap containing NaOH in order to destroy ethidium. After extraction, 
10mL of 5M ammonium acetate and 20mL of 95% ethanol were added before 
centrifugation for 10min at 10krpm. The pellet was washed with 70% ethanol and let 
to dry before it was re-suspended in TE buffer. 
 
 
4.7 Nucleic acids quantification and analysis 
4.7.1 Quantitative PCR (q-PCR) 
qPCR reactions were run in a 96- or 384-well plate format. In both cases, the ViiA 7 
Real-Time PCR System (ThermoFisher Scientific) was used to perform the 
quantifications. The parameters were set on Comparative and Fast Analysis using 
SYBR Green Standard Reagents and included a Melt Curve. Wells were assigned 
based on which primer sets (Target) and sample type (Sample) they were. Usually, 
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conditions were as follows: the initial denaturation (95°C, 5min), was followed by 35 
cycles of denaturation (95°C, 30s) and extension (60°C, 45s). The Melt Curve 
analysis was done between 65°C and 95°C. 
 
 
4.7.1.1. Analysis of mRNA levels 
Total RNA from cells was isolated and purified using the RNeasy Plus Mini Kit 
(Qiagen). This extracted RNA was then converted into cDNA using the SuperScript 
III reverse transcriptase kit (Invitrogen) (see paragraph 4.6.2 “Making cDNA”). Gene 
expression was quantified using 6μL of cDNA (1:15 dilution in distilled water), 2μL 
of each primer at 2μM concentration, and 10μL of SYBR Green Reagent (Applied 
Biosystems). Primer pairs were designed to amplify the gene of interest (see 
paragraph 4.2.3 “Primers used for qPCR”) and selected based on a few trials in a 
previous experiment testing amplification. Primers were chosen so that the Ct value 
was as low as possible and so that the melting curve showed only one discreet peak 
(specific amplification). Each sample was amplified with primers for the gene of 
interest and for β-actin and/or GAPDH as control genes. All samples were run in 
duplicates. Relative amounts of cDNA were calculated using the ΔΔCt method, which 
normalises cDNA levels to the gene chosen as reference (β-actin or GAPDH) and 
makes it possible to compare gene expression in between cell lines. 
 
 
4.7.1.2. Precise quantification of amplified DNA sequences 
Before submitting samples to sequencing, the concentration of amplified sequences 
from DNA extracted from cells was determined using qPCR. The Kapa SYBR Fast 
kit was used; ROX and primer mixes were added to the Master Mix to prepare the 
new Master Mix, according to the manufacturer’s recommendation. A 20μL reaction 
contained 4μL of sample, 10μL of Master Mix, 2μL of primer mix and 0.4μL of ROX 
(or 12.4μL of the new Master Mix) with 3.6μL of distilled water. Along with 
standards and water, samples were run in triplicates and at five different dilutions: 
1:100 / 1:10,000 / 1:50,000 / 1:100,000 / 1:1,000,000. 
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Results were analysed using averaged Ct values from the three replicates. Standards 





After quantification, DNA samples were submitted to sequencing analysis in order to 
identify the sequences present and to get a measure of their representation. 
The gRNA library was sequenced within the LMB using a MiSeq. The three sub-
libraries were mixed in a 18:18:1 ratio as they supposedly contained 90,000, 90,000 
and 5,000 guides respectively, making up a sample with a final concentration of 4nM. 
Sample preparation was then carried out following several Illumina preparation 
guides before analysis (see paragraph 4.8.2.3 “MiSeq sequencing and analysis”). 
The samples isolated from the screen were however sent to the Genomics Facility in 
the CRUK, Cambridge for analysis on a HiSeq, not available at the LMB. Because 
samples isolated from different batches of screened cells were barcoded (see 
paragraph 4.9.2 “gRNA amplification and sample barcoding”), two samples were 
submitted at the same time to be analysed in one lane. They were mixed to get to a 
final concentration of 4nM with equal representation of the two samples (see 
paragraph 4.9.3 “Quantification and submission for sequencing”). 
 
 
4.8 The gRNA library 
Human Two Plasmid Activity-Optimized CRISPR Knockout Library was made 
available by David Sabatini and Eric Lander (Addgene # 1000000095) and was 
delivered as three sub-pools (hL1nC9, hL2nC9 and hL3nC9) containing 
approximately 90x, 90x, and 5x 103, respectively. 
 
4.8.1 Transformation and purification 
4.8.1.1. Transformation in Ultra electrocompetent E.coli 
This protocol was adapted from the EnduraTM Comptetent Cells “Transformation 




Each sub-pool from the gRNA library was transformed and purified individually. For 
each sub-pool, 1μL of plasmid DNA was mixed with 25μL of electrocompetent cells 
in an electroporation cuvette (0.1cm gap, Flowgen Bioscience) on ice. The 
electroporation was carried out at 1.8kV for 5ms. Immediately after the pulse, 975μL 
of warmed Recovery Medium (provided with the electrocompetent cells) were added 
to the cuvette to resuspend the cells. This 1mL-mixture was then transferred to a 
culture tube and placed in a shaking incubator (220rpm, 37°C) for 1h. 
 
For each sub-library, 10 bioassay plates (Nunc™ Square BioAssay Dishes, 
ThermoFisher) had been prepared with LB agar complemented with ampicillin. They 
were pre-warmed at 30°C for about 30min. The incubated mix was diluted by adding 
9mL of LB medium. 100μL were taken out, of which 50μL were directly spread onto 
a small LB+AMP agar plate, while the remaining 50μL were used to make three serial 
1:10 dilutions, which were also plated. Then, around 1mL of the initial mix was 
spread on each of the 10 agar plates. The 10 culture and 4 counting plates were put 
overnight in an incubator at 30°C. 
Plated serial dilutions were used to estimate the number of total colonies grown on the 
10 bioassay plates. For example, counting 50 colonies on dilution plate IV would 
translate to 107 colonies in total for the whole culture (after accounting for all the 
dilution steps (4) and the total number of plates (10)). The transformation gave the 
following numbers of colonies for each sub-pool: 
A 1000-fold coverage is commonly referred to as the minimum acceptable threshold 
for the purification and use of the library without the risk of losing diversity and 
representation. Therefore, each bioassay plate was washed, and colonies harvested 
with 30mL of LB medium.  
 
 
Sub-library Number of colonies Number of guides Fold coverage 
hL1nC9 1.6x108 90x103 1778 
hL2nC9 1.8x108 90x103 2000 
hL3nC9 7.0x106 5x103 1400 
 
 234 
4.8.1.2. Plasmid purification 
For each bioassay plate, the 30mL bacterial solution was pelleted down by 
centrifugation. Plasmids were purified using a column from the HiSpeed MaxiPrep kit 




4.8.2.1. Single digests 
Purified plasmids were digested with either BamHI, MluI or PciI, all single cutters in 
the plasmid map. 10μL-digestion reactions were set-up as follow: 2.5μL of purified 
plasmid was mixed with 1μL of NEB Buffer 3.1, 6μL of distilled water and 0.5μL of 
the desired restriction enzyme (BamHI, MluI or PciI). Samples were incubated for 1h 
at 37°C before being loaded on a 1% agarose gel containing 1:10000 SYBR Safe 
DNA gel stain. The gel was run at 85V for 25min. Bands were revealed using a blue 
light transilluminator. Bands were observed at the size expected for the linearised 
form of the plasmid. 
 
 
4.8.2.2. GATC sequencing 
Samples from the purified sub-pools were sent to GATC for sequencing with primers 
designed to amplify sequences in the backbone (PCR2, M13FP and scr16 (in the U6 
promoter)). Primer scr15, however, was designed to amplify the gRNA sequence as it 
complemented the beginning of the gRNA scaffold. Sequencing with scr15 did not 




4.8.2.3. MiSeq sequencing and analysis 
The purified sub-libraries were sequenced using the MiSeq available at the LMB to 
check for coverage and compare the gRNA distribution to the reference (sequencing 
data from the initial pool, provided by the supplier). First, purified plasmids were 
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amplified by PCR; primers were designed to flank sequences with specific Illumina 
adapters (both forward and reverse primers) and a specific barcode (contained in the 
reverse primers) allowing the identification of each sub-library, because the three sub-
libraries were mixed and run as a single sample. After PCR, individual amplified sub-
libraries were loaded on a 2% low melting point agarose gel for 1h30 at 85V. Bands 
of the desired size were melted and purified using QIAquick Gel Extraction Kit 
(Qiagen) according to the manufacturer’s protocol except for the melting step which 
was performed without QB Buffer. Following purification, samples were quantified 
by quantitative 
polymerase chain reaction 
(qPCR). The Kapa SYBR 
Fast kit was used; ROX 
and primer mixes were 
added to the Master Mix. 
A 20μL reaction contained  
 4μL of sample, 12.4μL of the complemented Master Mix and 3.6μL of distilled 
water. Along with standards and water, samples were run in triplicates and at 4 
different dilutions: 1:10,000 / 1:50,000 / 1:100,000 / 1:1,000,000. 
 
 After analysis using Microsoft Excel, the sub-library concentrations were determined 







To respect the ratio in terms of numbers of gRNAs in the different sub-libraries, 
samples were mixed 18:18:1 respectively to get a final sample at 4nM. This mix was 
then prepared for sequencing following the “MiSeq Reagent Kit Reagent Preparation 
Guide”, the “MiSeq System Denature and Dilute Libraries Guide” and the “MiSeq 
System Guide” (documents 15034097 Rev.B, 15039740 v01 and 15027617 v01, from 
Illumina). The mixture was denatured, diluted further to 10pM and 15% PhiX at 






hL1nC9 28.8 1.6 
hL2nC9 18.3 1.3 
hL3nC9 16.1 1.2 
 
 236 
from the small genome of the bacteriophage PhiX. It helps mitigate sequencing in the 
case of unbalanced and/or low-diversity libraries.  
The sample was run on the MiSeq (available at the LMB) using the information from 




Workflow Generate FASTQ 
 
Application MiSeq FASTQ Only 
 




Reads  75  
 
    
Sample_ID Sample_Name I7_Index_ID index 
lib1 hL1nC9 op19 TTAATCAG 
lib2 hL2nC9 op7 CATGCTTA 
lib3 hL3nC9 op17 TCCTTGGT 
 
The three sub-libraries were deconvoluted from the PhiX and demultiplexed 
(segregation of the sequences based on their barcode to recreate the sub-libraries) to 
be analysed separately if needed. Consequently, three files containing all sequences 
present in the three sub-pools, were generated from BaseSpace. Sequences were 
trimmed according to the expected gRNA size, selected following readability criteria, 
counted and finally aligned to the reference list using programming in R. 
 
 
4.8.3 gRNA design 
To validate some of the candidate genes in the ‘hit’ list from the screen, additional 
gRNAs were generated. gRNA sequences were designed using the online tool CHOP 
CHOP (http://chopchop.cbu.uib.no/) to target early exons in the gene of interest 
considering the different isoforms. BbsI overhang sequences were added to both the 
sense and antisense strands. The gRNA backbone did not contain the Cas9 protein and 
the insert site was located between two BbsI restriction sites. 
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First, 2.5μg of the gRNA backbone (#1862) were digested for 2h at 37°C with 1.5μL 
of enzyme BbsI and 3μL of NEB Buffer 2.1 in a 30μL reaction in distilled water. The 
linearised product was purified using Qiagen purification kit and eluted in 40μL. 
1.5μL of BbsI and 4μL of NEB Buffer 2.1 were added and the second digestion 
reaction was carried on for 2h at 37°C, before adding 4μL of alkaline phosphatase 
((1000U/ml), Roche). The reaction was incubated for another hour at 37°C before gel 
purification. 
Sense and antisense oligos for each gene were designed to exhibit the overhangs 
ready for the ligation. First, 0.5μL of each oligo was incubated separately for 1h at 
37°C with 2.5μL of NEB Buffer 4, 2.5μL of ligation additives (1mM ATP, 10mM 
DTT), 0.5μL of BSA and 2.5μL of T4 polynucleotide kinase (PNK) in 17μL of water. 
For each gene, the two reactions corresponding to the sense and antisense oligos were 
then combined and incubated for 5min at 95°C. The paired oligo mixtures were 
slowly cooled to room temperature. Finally, 1μL of purified, digested and 
dephosphorylated backbone (#1862), 2.5μL of 10X ligation buffer, 2.5μL of LA, 
0.5μL of BSA and 0.5μL of T4 ligase in 16μL of water were added to 2μL of the 
cooled annealed oligo pair. The ligation mixture was left overnight at room 
temperature before being transformed into competent bacteria. 
 
 
4.9 Samples for the screen 
After each round of selection in the genetic screen, some cells were set apart and 
grown alongside the others which were carried over to the next round. The selected 
cells were grown and, at various stages in the selection process, they were trypsinised, 
pelleted and frozen. 
 
 
4.9.1 DNA extraction and purification 
Frozen pellets were thawed, and DNA extraction was carried out using the DNeasy 
Blood & Tissue Kit (Qiagen, CAT #69506), following manufacturer’s instructions 





4.9.2 gRNA amplification and sample barcoding 
The extracted DNA was processed following a series of PCRs in order to prepare the 
sample for sequencing analysis. 
 
4.9.2.1. qPCR0: checking for primer binding 
The first step was run on a qPCR machine but was not intended as a sample 
quantification as such. qPCR0 was performed to test and to ensure that the chosen 
primers for PCR1 in fact bind and amplify sequences in the purified DNA. In the case 
of inhibition of amplification, primer pairs would be changed and tested again. This 
preliminary experiment also indicated whether a diluted sample was needed or if the 
initial concentration were sufficient; if any saturation were noticed, samples would be 
diluted in order to be able to amplify the sequences. 
A 20μL qPCR0 included 9.8μL of (diluted) DNA, 0.1μL of each primer (reverse and 
forward) at a concentration of 100μM and 10μL of SYBR Green Master Mix (Applied 
Biosystems). Each sample (purified DNA at decreasing concentrations) was run in 
duplicate along with some negative controls, which contained water instead of DNA. 
On the amplification plot, all samples showed products being synthesised in a time-
dependent fashion. The melt curve appeared less clean as in the control samples and a 
low melting point product was initially detected; however, it was subsequently shown 
that this was an artefact originating from the Master Mix used. All the actual samples 
had a clear and single peak on the melt curve, suggesting that fragments were being 
amplified and that those amplification products were pure. 
 
The melt curve was recorded to assess the amplification and purity of the samples. All 
samples were amplified and the melt curve (Fig.2, blue lines) showed a single peak at 
79C for the different sample concentrations, meaning that the amplified products 
were identical in sequence length and were not contaminated; the presence of a 
contaminant would show another peak on the melt curve.  
In this example (Fig.2), control samples (water, in red) also provided a peak on the 
melt curve. There was some sample contamination such as traces of DNA that had 
been amplified or primers that reacted or oligomerised. However, this peak for the 
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water samples was at 73C and was very distinct from the 79C peak for the samples. 
A replicate experiment was conducted following the same protocol, this time using an 
unopened water bottle; it was found that this also provided a peak at 73C. 
Interestingly, Paul Monis published a comparison of SYT09 and SYBR Green (Monis 
et al., 2005) finding SYT09 less inhibitory to PCR and more reproducible for DNA 
melting curves than SYBR Green. It was therefore thought that the SYBR Green 
Master Mix was the source of this extra feature. A comparison experiment was done 
in P. Kozik’s laboratory with EvaGreen (Biotium) and then the peak at 73C was not 




Figure 2: qPCR0 as a test for the use of PCR1 primers  




The observation that the samples, primers, and conditions tested all produced a single 
product validated the use of the primers for PCR1. 
 
 
4.9.2.2. PCR1: first amplification 
The goal in this reaction was to amplify gRNA sequences above the rest of the 
genomic DNA, which constitute only background noise in the analysis. Only a limited 
number of cycles was performed, since PCR2 also further amplified the desired 
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gRNA sequences. PCR1 primers were designed to bind to common part from the 
gRNA backbone on each side of the desired sequence (Fig.3A). 
To preserve the diversity and the distribution of gRNA in the samples, a large number 














0 370 6.0 2.22 288 5μg 
3 340 3.5 1.19 266 5μg 
1 349 3.1 1.08 288 4μg 
2 230 1.5 0.345 192 4μg 
 
Reducing the amount of DNA going through amplification significantly increases the 
risk of losing some sequences, consequently introducing a random bias on both the 





Figure 3: amplifications of DNA fragments for sequencing of the gRNAs 
(A) PCR1 primers bind to the U6 promoter (forward) and the cPPT/CTS sequence (reverse) 
which are quite distant from the gRNA sequence itself; but PCR2 primers (B) bind right 
before the variable part of the gRNA sequence (forward) and still in cPPT sequence but closer 
to the gRNA. Primers for PCR1 and PCR2 do not overlap. The amplified fragment after 
PCR2 (C) contains the whole gRNA sequence flanked by P5 and P7 Illumina adapters, 






PCR1 reactions were set-up in 100μL (total) in order to reduce the number of plates to 
run. Each well contained 5mg of genomic DNA diluted in 76μL of water, 1μL of 
dNTP mix (25mM each, from 100mM individual dNTPs solution, Sigma-Aldrich, 
CAT # DNTP100-1KT), 0.5μL of each primer at 100μM concentration, 20μL of 
Herculase Buffer and 1μL of Herculase (Herculase II Fusion DNA Polymerase, 
Agilent Technologies, CAT # 600675).  
Master mixes of Herculase Buffer, dNTP and primers were prepared and dispensed 
accordingly. Samples were put in the block at 95°C and the cycling conditions were 
as follows: initial DNA denaturation and polymerase activation for 1min at 95°C 
followed by cyclical DNA denaturation (95°C, 30s), primer annealing (55°C, 30s), 
and extension (70°C, 30s). These cycles were repeated 18 times before a final 
extension period of 10min at 72°C and cooling to 4°C. 
 
In order to keep the diversity of the gRNA represented in the samples, 90μL were 
taken out of each well and were combined together by sample. This was based on the 




4.9.2.3. qPCR1: determination of the number of cycles for PCR2 
The qPCR1 reaction was not a quantification but was used to determine the number of 
cycles needed in PCR2. Each sample was run at three different concentrations: non-
diluted sample, 1:5 and 1:25 dilutions. Water samples were run alongside as controls. 
All samples were run in triplicates. 20μL reactions contained 2μL of (diluted) PCR1 
product, 0.5μL of each PCR2 primer and 17μL of SYBR Green Master Mix. 
The threshold cycle – Ct value – (now standardized by the MIQE guidelines as 
quantification cycle (Cq)) of the least concentrated sample gave the number of cycles 
for PCR2, if below 20. 
 
The melt curve (Fig.4) showed a single peak for all the concentrations and in both 
samples tested, which demonstrated the purity of the amplified fragments in 
comparison with the water control where no product was detected. The amplification 
plot and, more particularly, the cycle threshold (Ct) values (the number of cycles 
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necessary for the fluorescent signal to exceed background, i.e. where exponential 
amplification can be reliably detected) were studied carefully. The Ct value of the 
PCR1 products were similar between sample dilutions, which is counterintuitive as a 
drop of Ct value is expected with less diluted samples; this result suggests qPCR 
saturation or inhibition. However, Ct values were significantly lower than the Ct value 
of the water sample (set by default at the maximum number of cycles run during the 
experiment, which was 40). For both cell batches – ‘- cells’ and ‘3+ cells’ – the Ct 
values were evaluated to be around 32. This was considered too high compared to 
regular values (Aird et al., 2011; Kebschull & Zador, 2015; Bevan et al., 1992); either 
samples might be too diluted or the qPCR might not be working. 
 
 
Figure 4: qPCR1 was used to mimic PCR2 conditions to determine the number 
of PCR2 cycles required 
Melt curves (left panel) and amplification plots (right panel) of samples from ‘- cells’ and ‘3+ 
cells’ (cells submitted to none or three rounds of enrichment respectively) are shown here as 






qPCR1 was set up to mimic PCR2 cycling conditions and the number of cycles was 
set up to 40 for qPCR1. Ct values obtained for the different samples were relatively 
high (30) compared to those one can expect (20) in such experiment. Two test 
PCR2 reactions were run side-by-side, set for either 20 or 30 amplification cycles. 
PCR2 products of those two test experiments were run on a gel. In both conditions, 
products were synthesised and bands on the gel were at the expected size (350bp) for 
the fragment. 
The amount of cycles performed in PCR2 should be kept to a minimum so as not to 
change the distribution and representation of the gRNAs in the samples. Over-
amplification could introduce a bias if sequences were to be amplified at different 
rates; this would result in a sample that was no longer representative of the initial cell 
population. To reduce the risk of overamplification and/or misrepresentation, 20 
cycles were performed in PCR2. 
 
 
4.9.2.4. PCR2: second amplification with barcodes and Illumina adapters 
PCR2 is a nested PCR within the PCR1 product. PCR2 could therefore be performed 
on the crude product from PCR1 since there was no overlap between PCR1 and PCR2 
primers (Fig.3B). However, PCR2 primers are significantly longer than PCR1 primers 
because PCR2 was an extra amplification of the sample. PCR2 also allowed the 
addition of the Illumina adapters and the barcodes to the sequences; PCR2 primers 
hence contained complementary sequences to bind the fragments flanked by Illumina 
adapters, which enabled the sequencing. A barcode was also attached on the reverse 
primer to allow the identification of different samples submitted together as a mix for 
sequencing. 
 
A PCR mix was prepared with 20μL Herculase Buffer, 1μL dNTPs (mix with 25mM 
each), 58μL distilled water, and 1μL of Herculase. To this, 10μL of PCR1 product and 





PCR2 conditions were very similar to PCR1, since samples were put in the block at 
95°C under the following cycling conditions: initial DNA denaturation and 
polymerase activation for 1min at 95°C followed by cyclical DNA denaturation 
(95°C, 30s), primer annealing (53°C, 30s), and extension (72°C, 30s). These cycles 
were repeated 17 times before a final extension period of 10 min at 72°C and cooling 
to 4°C. 
Samples which were treated once with Lipofectamine2000 only (‘- cells’) or 
submitted to three rounds of enrichment (‘3+ cells’) were tested with their specific 
primer pairs (reverse primers contained distinct barcodes to allow segregation of the 
different cell batches during data analysis). 
PCR2 products were then loaded on a 2% low melting point agarose gel 
complemented with SYBR Safe DNA gel stain (Fig.5). Samples were run in TBE 
buffer at 90V for 1h on ice. Bands of around 360 nucleotides were extracted and 
purified using the QIAquick Gel Extraction Kit (Qiagen) following manufacturer’s 
instructions. The purified PCR2 products (Fig.3C) were then precisely quantified 
before submission to sequencing analysis. 
 
Figure 5: Isolation of PCR2 samples  
1.5% low melting point agarose gels were used to purify PCR2 products before gel extraction. 
Gels for both ‘- cells’ and ‘3+ cells’ samples are shown. Forward primer (FS mix) mix was 






4.9.3 Quantification and submission for sequencing 
4.9.3.1. qPCR 
Sample concentration was determined by qPCR. The KAPA SYBR Fast Kit was used, 
mixing 12.4μL of pre-mix containing Master Mix, primer mix and ROX, 3.6μL of 
water, and 4μL of either the samples or the standards or water, to make up a 20μL 
reaction. 
The ViiA 7 Real-Time PCR System (ThermoFisher Scientific) was set on 
Comparative and Fast Analysis using SYBR Green Standard Reagents and including 
a Melt Curve. Wells were assigned based on which primer sets (Target) and the 
sample type (Sample) they were. Conditions were as follows: the initial denaturation 
(95°C, 5min), was followed by 35 cycles of denaturation (95°C, 30s), and extension 
(60°C, 45s). The Melt Curve analysis was performed between 65°C and 95°C. 
The melt curve plot (Fig.6A) showed that, as expected, the sample melting 
temperature was distinct from that of the standards. Furthermore, melt curves 
exhibited a single peak, indicating that the amplified samples contained sequences of 
the same length as was required. Standards were samples of known concentrations 
and their amplification (Fig.6B) was fairly robust because the triplicates always 
overlapped and the differences in the Ct values (cycle number for which the 
amplification overcome a certain threshold: red line) between the constant dilutions 
remained identical. A standard curve (Fig.6C) was built with the Ct values of the 






Figure 6: Precise quantification of samples by qPCR  
The melt curve (A) shows the two batches of amplified sequences (in blue and pink) 
compared to the Standards. Amplification curves (B) were plotted for each standard with their 
triplicates, and Ct values were used to make a calibration curve (C) to determine DNA 




NanoDrop (Thermo) and Qubit Fluorometric Quantitation could be used as additional 
methods but these were not as reliable or precise as qPCR. 
 
 
4.9.3.2. Preparation of the sample for sequencing 
Samples were mixed together, taking into account their individual concentrations, to 
achieve 50/50 mix in terms of amount – quantity of DNA sequences. Complying to 
the Genomics Core (CIGC) Illumina sequencing service requirements, samples were 





4.10 Cell culture 
Apart from HFF cells, all cells were cultured in Iscove's Modified Dulbecco's 
Medium (IMDM, Gibco) supplemented with 10% (v/v) FCS and 30μg/ml gentamycin 
(Sigma). This medium is commonly referred as G30 medium in the laboratory. HFF 
cells were cultured in Dulbecco's Modified Eagle’s Medium (DMEM, Gibco) 
supplemented with 10% (v/v) FCS and 10μg/ml gentamycin (Sigma). Cell lines were 
kept in incubators maintaining constant growth conditions (37°C and 5% CO2). All 
cells in the culture room were regularly tested for Mycoplasma. Cells were never 
passaged for longer than 6 months. 
 
 
4.10.1 IFN-γ treatment 
Human and mouse cell lines were incubated with IFN-γ overnight before the 
experiment: 
*HeLa cells were treated with 2ng/mL human IFN-γ (R&D systems) 




Control samples were always prepared, irrespective of which agent was transfected. 
The transfection reagent was added in the same amount but with only Opti-MEM 
(Gibco) instead of the Opti-MEM mix containing LPS or siRNA. 
 
4.10.2.1. LPS transfection 
In a 96-well plate, 1.103 HeLa cells were seeded per well while in a 24-well plate they 
were seeded to be 70-80% confluent on the following day. HeLa cells were grown 
overnight in G30 medium with half the wells primed with human IFN-γ. S. 
Typhimurium LPS (Sigma) was diluted in water to a concentration of 1mg/mL, 
aliquoted, and frozen before use. LPS and Lipofectamine2000 (Invitrogen) were 
separately mixed in Opti-MEM (Gibco) before combining them and the mix was 











LPS OptiMEM Total 
added to the 
well 
containing 
96-well 0.2 10 1.5 10 20 100 
24-well 1.0 50 3.0 50 100 500 
 
Unless otherwise stated, the medium was replaced with fresh medium in all the wells, 
5h post-transfection. Cells were analysed the day following the transfection. 
 
 
4.10.2.2. Bacterial lysates 
Bacterial lysates (prepared as described in paragraph 4.11.1.2 “Bacterial lysates”) 




siRNAs were transfected into cells to knock down genes of interest, to deplete the 
encoded proteins and thereby study their role in the context of different assays. HeLa 
or MEF cells were seeded in 24- or 6-well plates to be confluent at either 72h or 48h 
post siRNA transfection, respectively. The siRNAs (Dharmacon pools or Silencer 
Select) were resuspended and diluted in distilled water at a working concentration of 
6μM. The transfection reagent RNAiMax and the siRNA were mixed separately in 
Opti-MEM and, after 5min incubation at room temperature, both preparations were 
combined. The mixture was then incubated at room temperature for 15min before 














siRNA OptiMEM Total 
added to the 
well 
containing 
24-well 1.0 25 1.0 25 50 500 
6-well 4.0 100 4.0 100 200 2000 
 
For the 24-well plates, assays were performed directly in the same plate 72h following 
siRNA transfection. Cells cultured in 6-well plates were trypsinised and seeded in the 




4.10.3 Viral work 
Viruses were used as a means to eventually express genes of interest into cell lines. 
Two different types of viruses were used, depending on whether the parental 
backbone encoding the gene of interest was a retrovirus or a lentivirus. 
Protocols for lentiviral production and transduction were determined after several 
steps of optimisation (Fig.7). To produce lentiviral particles, two packaging plasmids 
(namely R8.2 and psPAX) were tested and the transfection of 293ET cells was 
optimised by comparing three different transfection reagents: PEI, 
Lipofectamine2000, and TransIT-LT1. Batches of lentiviral supernatant were 
compared by transducing HeLa cells in the same conditions but using lentiviruses 
produced with one of the three transfection reagents mentioned and either of the two 
packaging plasmids. Using the packaging plasmid R8.2 gave significantly higher 
titers than using the psPAX packaging plasmid (Fig.7A). In the case of R8.2, Trans-
IT gave the best titer, reaching 100% GFP-positive cells with a 1:10 virus dilution 
while, for the same dilution, Lipofectamine2000 and PEI successfully transduced 85% 
and 65% of the cells, respectively. 
The transduction method was optimised by transducing HeLa cells with lentiviral 
particles expressing GFP. Cells were centrifuged for 2h either in the presence or 
absence of polybrene – a chemical agent that neutralises the charge repulsion between 
virions and sialic acid on the cell surface. Transduction efficiency was assessed by 
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flow cytometry, where the percentage of GFP-positive cells in the population was 
measured. The addition of polybrene helped increasing the transduction efficiency 
from 55% for a 1:10 dilution of virus to 100% (Fig.7B).  
 
 
Figure 7: Viral supernatants are produced with R8.2 and transduced with 
polybrene 
(A) 293ET were transfected to produce viruses using psPAX (left) or R8.2 (right) as 
packaging plasmids. In both cases, three transfection reagents: PEI, Lipofectamine 2000 and 
TransIT-LT1 were tested. (B) Viruses obtained with R8.2 and TransIT-LT1 were transduced 
into HeLa cells testing the requirement of polybrene. Viruses produced expressed GFP and so 




Based on these preliminary experiments, TransIT was chosen as the transfection 
reagent for lentiviral production, R8.2 was used as the packaging plasmid, and 




The final protocols used in all experiments were as follows: 
 
4.10.3.1. Viral production 
i. Retroviral production 
Retroviruses were produced using HEK293-ET cells seeded at about 50% confluency 
in 6-well plates in 2mL of medium the day before their transfection. The transfection 
mix contained (for a 6-well format): 1.4μg of retroviral gag/pol plasmid (pMD-OGP), 
140ng of viral capsid protein plasmid (pMD-VSVG), 1.4μg of proviral M6P plasmid 
encoding for the gene of interest and 9μL of TransIT-LT1 transfection reagent (Mirus, 
MIR2300) in 200μL of Opti-MEM (Gibco). The transfection mix was incubated at 
room temperature for 10-15min before adding it to the well. 
At 16-18h post-transfection, 1mL of medium supplemented with 3% BSA was added 
to each well. Retroviruses were harvested by collecting the supernatants at 48h post-
transfection, aliquoted, and either used directly to transduce cells or stored at -20°C. 
 
ii. Lentiviral production 
Lentiviruses were produced using HEK293-ET cells seeded at about 50% confluency 
in 6-well plates in 2mL of medium the day before their transfection. The transfection 
mix contained (for a 6-well format): 1.4μg of lentiviral gag/pol/tat/rev packaging 
plasmid (pCMV-ΔR8.2), 140ng of envelope plasmid (pMD-VSVG), 1.4μg of plasmid 
encoding for the gene of interest and 9μL of TransIT-LT1 transfection reagent (Mirus, 
MIR2300) in 200μL of Opti-MEM (Gibco). The transfection mix was incubated at 
room temperature for 10-15min before adding it to the well. 
At 16-18h post-transfection, 1mL of medium supplemented with 3% BSA was added 
to each well. Lentiviruses were harvested by collecting the supernatants at 48h post-
transfection, aliquoted and either used directly to transduce cells or frozen at -20°C. 
 
 
4.10.3.2. Viral transduction 
Transduction enabled the generation of cell lines stably expressing the proteins of 
interest. HeLa or MEF cells were seeded at approximately 60% confluency in 24-well 
plates in 500μL of medium the day before transduction. Retroviral or lentiviral 
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supernatants were either thawed or used directly upon collection after centrifugation 
at 18000g for 2min in order to pellet cell debris. Appropriate volumes of virus-
containing supernatants, determined by preliminary titration, were diluted in 500μL 
IMDM complemented with 10% FCS, 30μg/ml gentamycin, and 1μg/mL polybrene 
(SantaCruz) before being added to the wells. Cells were centrifuged at 1800rpm for 
2h at room temperature before incubation at 37°C, 5% CO2. At either 48h or 72h 
following transduction, transduced cells were expanded and selected with the 
appropriate antibiotics: puromycin (1μg/mL), blasticidin (5μg/mL), or hygromycin 
(250μg/mL) depending on the resistance present on the plasmid. Selected cells were 
then expanded further, used in experiments, and/or frozen down for further use. 
 
 
4.11 Pathogenic strains 
4.11.1 Bacteria 
4.11.1.1. Salmonella enterica serovar Typhimurium (strain 12023) 
Single colony cultures were grown overnight at 37°C in a shaking incubator in LB 
medium supplemented with 50μg/ml ampicillin for strains constitutively expressing 
fluorescent markers (mCherry and BFP). Overnight S.Typhimurium cultures were 
sub-cultured (1:33 – 150μL of culture in 5mL fresh medium) in fresh LB plus 
appropriate antibiotics, for an additional 3.5h before infection.  
Cells were grown in an antibiotic-free IMDM medium complemented with 10% FCS 
(G0 medium) for at least 2h prior to infection. In 24-well plates, cells were infected 
with 20μL of bacterial sub-culture per well for 15-20min at 37°C. After the initial 
infection period, cells were washed twice with warm PBS and the medium was 




4.11.1.2. Bacterial lysates 
Experiments were done transfecting lysates from different mutants of S. 
Typhimurium, presenting various lengths of LPS chains. Single colony cultures of 
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Salmonella enterica serovar Typhimurium (strain 12023 – WT, ΔrfaL, ΔrfaI, ΔrfaF, 
ΔrfaG/Q) were grown overnight at 37°C in a shaking incubator in LB medium. OD 
was measured and adjusted to 1 by adding PBS to reach a final volume of 
approximately 8mL. Samples were centrifuged at 44krpm for 4min. Bacterial pellets 
were resuspended in 1mL PBS. Samples of 500μL were boiled at 90°C on the heat-
block for either 10min or 20min and were thoroughly vortexed. Boiled samples were 
then spun down at 13krpm for 15min in order to pellet down denatured proteins. 
Supernatants were collected, aliquoted and either used directly to transfect cells or 
frozen at -20°C. 
 
 
4.11.2 Toxoplasma gondii 
Toxoplasma gondii was grown using HFF cells. Both strains (RH and PRU) were 
passaged into new flasks every 2-3days to keep them alive and growing. T.gondii-
containing HFF cells were scraped in their growth medium, harvested and cells were 
lysed through a 10mL syringe equipped with a needle. The type I strain (RH) 
replicates faster than the type II (PRU), and PRU parasites do not survive outside cells 
contrary to RH. That is why for passaging them every 2 days, 200μL of PRU and 
175μL of RH were usually added to the fresh flasks of confluent HFF cells. 
To infect MEF cells, 1mL of T.gondii was transferred into a new HFF flask 24h 
before the scheduled infection to have enough parasites for either killing or 
microscopy assays. On the day of infection, T.gondii-containing HFF cells were 
scraped in their growth medium, harvested, and cells were lysed through a 10mL 
syringe equipped with a needle. T.gondii were counted and pelleted down at 1700rpm 
for 7min before being re-suspended at the correct concentration in G10 DMEM. 50μL 
were added in 24-well plates, whereas only 10μL were added in 96-well plates. 
Infected plates were spun down at 1500rpm for 5min to synchronise infection. 
 
For looking at recruitment by microscopy, coverslips in 24-well plates were infected 
for 1h at a ratio T.gondii to cell number of 4:1 for type II strain (PRU) or 2:1 for type 
I strain (RH). For killing experiments, cells seeded in 24-well plates were infected 
with a ratio of 1:1 T.gondii to cells for 1h before being washed with PBS and cells 




For quantification of variations in mRNA levels of various cytokines upon T.gondii 
infection, cells were seeded in 24-well plates, primed with IFN-γ overnight and 
infected with a ratio of 1:1 T.gondii (PRU) to cells for 1h. Cells were then washed 
with PBS and lysed at 24h post-infection. mRNA was extracted and purified before 
reverse transcription and analysis by qPCR using primers designed against several 
cytokines (see paragraph 4.7.1.1 “Analysis of mRNA levels”). 
 
 
4.12 Detection methods 
4.12.1 Protein detection and analysis 
4.12.1.1. Sample preparation 
A lysis buffer containing 150mM NaCl, 20mM Tris pH 7.4, 0.5% (v/v) Triton-X 100, 
and protease inhibitors, was prepared on ice. Cells from a confluent 6-well were lysed 
with the lysis buffer and scraped from the well on ice. The mixture was then 
centrifuged at 13krpm for 10min at 4°C in order to pellet cell debris. Protein amounts 
in supernatants were quantified by using Pierce 660nm Protein Assay (ThermoFisher) 
and protein concentrations were calculated comparing absorbances against samples 
containing known concentrations of BSA in buffer. Sample protein concentrations 
were then equalised with lysis buffer before adding 4X Laemmli buffer (40mM Tris 
pH 6.8, 8% (w/v) SDS, 40% (v/v) glycerol, 0.15% (v/v) bromophenol blue, 5% (v/v) 
β-mercaptoethanol) and incubated for 5min at 95°C. 
 
 
4.12.1.2. SDS PolyAcrylamide Gel Electrophoresis (SDS-PAGE) 
Samples were loaded into SDS-PAGE NuPAGE Novex 4-12% Bis-Tris pre-cast gels 
(Life Technologies) along with a sample from the Precision Plus Protein Prestained 
Standard (Bio-Rad), which provides a protein size ladder for reference. Gels were run 
in MES buffer (Formedium) at 165V, 300mA for 45min. Gels were then analysed 





4.12.1.3. Coomassie blue staining 
Directly after electrophoresis, gels were immersed in Instant Blue (Expedion) protein 
stain. They were heated up for 20s in the microwave to accelerate the chemical 
reaction and enable prompt revelation of the proteins. They were then incubated for 
30min at room temperature on an orbital shaker before being extensively washed with 




Samples were transferred from gels onto PVDF membranes using the Trans-Blot® 
TurboTM transfer system (BioRad) for 7min at 1.3A. Membranes were washed with 
TBS-T (100mM Tris-HCl pH 7.4, 150mM NaCl, 0.1% (v/v) Tween-20) and then 
blocked in 5% (w/v) dried milk powder (Marvel) in TBS-T for at least 1h at room 
temperature on the orbital shaker. After washing the membranes several times with 
TBS-T to remove the milk, membranes were incubated in an appropriate primary 
antibody solution – dilution made in 2% (w/v) BSA in TBS-T supplemented with 
0.1% (w/v) of azide – for either 1-3h at room temperature on the orbital shaker or 
overnight at 4°C on the rotator depending on the antibody. Membranes were 
subsequently washed 3-4 times with TBS-T before incubation with secondary HRP-
conjugated antibody – diluted in 5% (w/v) dried milk powder (Marvel) in TBS-T – for 
1h at room temperature on the shaker. Following the final incubation, membranes 
were washed 3-4 times in TBS-T. To visualise the proteins, the membranes were 
incubated for 1min in Amersham Enhanced Chemiluminescence (ECL) detection 









After incubation with ECL detection reagent, membranes were either transferred to an 
X-ray cassette and exposed to X-ray film (FUJI or Wolflabs) or visualised using a 
ChemiDocTM MP imaging system (BioRad). In both cases, exposure time was 
adjusted according to signal intensity. 
 
 
4.12.2 Plate reader 
4.12.2.1. Luminescence 
The cell viability assay CellTiter Glo (CellTiter-Glo® 2.0 Cell Viability Assay, 
Promega) was used to measure and quantify the proportion of cells still alive after 
LPS transfection. Assays were performed in 96-well plate (Corning® 96 Well TC-
Treated Microplates, Sigma) where 1.103 cells were seeded per well (unless otherwise 
stated). Cells were grown in G30 medium overnight, and on the next day, they were 
transfected with LPS (see paragraph 4.10.2.1 “LPS transfection”). At 5h post-
transfection, the medium in the wells was aspirated and replaced with fresh medium. 
Cells were only analysed on the following day (i.e. 24h post-transfection).  
 
The CellTiter Glo reagent was added in equal volume to the volume of medium 
already present in the well (usually 50+50μL). It reacted with ATP; the luminescence 
signal was therefore proportional to the number of cells still alive in each well. Plates 
were incubated at room temperature on the shaker for 15-20min. 90μL of the mix 
were then transferred into an opaque white 96-well plate (Nunc™ F96 MicroWell™ 
White Polystyrene Plate, ThermoFisher Scientific) to be run on a PHERAstar FS plate 
reader (BMG LabTech) in order to measure luminescence intensities in the wells. The 
reader settings were as followed: focal height of 9.7mm, 1 multichromatic, the gain of 
the optic module LUM plus was set at 2400; measurements were taken every second 
using a top optic. 
 
Luminescence signals were then compared between conditions but no absolute 
quantification was performed, since a calibration – measure of the luminescence 





4.12.2.2. Absorbance  
During the sample preparation for protein analysis, cells were first lysed (see 
paragraph 4.12.1.1 “Sample preparation”). Then the protein levels were quantified 
adding 150μL of the Pierce 660nm Protein Assay (ThermoFisher) reagent to 3μL of 
the unknown sample in a 96-well plate (Corning® 96 Well TC-Treated Microplates, 
Sigma). The calibration curve was built by adding 150μL of the Pierce reagent to 6μL 
of BSA solutions at known concentrations. All samples were done in duplicates. The 
absorbance of each well was measured on a PHERAstar FS plate reader (BMG 
LabTech) set-up for detection, at the discrete wavelength of 600nm. Settling time was 
0.5s and 22 flashes were performed per well. These absorbance values were used for 




4.12.3 Flow cytometry 
All data acquired on the various flow cytometers were transferred and analysed using 
the FlowJo software (see paragraph 4.12.3 “Flow cytometry”). 
 
4.12.3.1. Isolation of individual clones 
Some experiments required cells that were derived from a single mother cell. In order 
to grow these populations, cells were sorted through a cell sorter (Beckman Coulter 
MoFlo High Speed Cell Sorter) in a 96-well plate containing G30 medium, 
complemented with penicillin and streptomycin in order to minimise the risk of 
contamination. Cell colonies were grown in the 96-well plate until it became visible 
for selection and expansion. 
 
 
4.12.3.2. PI staining for assessing cell survival 
Cells were seeded in 24-well plates for the experiments. The day after LPS 
transfection, cells were washed with PBS, trypsinised, centrifuged and re-suspended 
in 200μL of 100μg/mL of PI (ThermoFisher) in PBS. Samples were transferred into a 
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flat-bottom 96-well plate which was run on the Eclipse flow cytometer (Sony 
Biotechnology) for detection at 700nm of unstained (red-negative) cells; that is, alive 
cells, in a given volume of 150μL. Aspirating and hence analysing the same volume 
for all samples allowed cells numbers to be compared between different conditions. 
 
 
4.12.3.3. Staining for MHC Class I receptor to check Cas9 activity 
Cells stably expressing Cas9 were transduced with lentiviruses encoding for a gRNA 
targeting the beta-2 microglobulin (β2M) gene. β2M is a major component of the 
MHC class I receptor and efficient knockout of the β2M gene should therefore result 
in a decrease (and eventually an absence) of MHC class I receptors on the outer 
membrane of transduced cells. To check whether Cas9 was efficient, the transduction 
of the β2M gRNA was used as an indicator. Several days (clearly stated in Fig.14 of 
Chapter 2) after β2M-gRNA transduction, cells were stained by incubating them first 
with a primary murine antibody against MHC class I receptor and then with a 
secondary antibody fluorescently labelled (Alexa 488) recognising mouse IgG. Cells 
expressing only Cas9 should be stained while cells transduced with both Cas9 and the 
guide should not. 
 
Cells were trypsinised and resuspended in 1%BSA in PBS, incubated with primary 
antibody (1:50) for 30min, washed and then incubated with secondary antibody 
(1:500) for 20min. Cells were washed again and resuspended in 1% BSA in PBS for 
the analysis on the Eclipse flow cytometer (Sony Biotechnology). The secondary 
antibody was equipped with an Alexa488 fluorophore and the detection was 
performed at 525nm. 
 
 
4.12.3.4. T.gondii assays  
Flow cytometry was used to determine relative rates of T.gondii entry (both strains) in 
different MEF-derived cell lines. These assays also showed whether those cells had 
the ability to restrict replication of the parasites and provided a relative estimate of 
cell death upon infection. Prior to analysis, cells (see paragraph 4.11.2 “Toxoplasma 
gondii”) were trypsinised and fixed in 4% (w/v) paraformaldehyde (PFA) in PBS for 
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15 minutes in FACS tubes (Corning™ Cluster Tub, Fisher Scientific) before the 
reaction was quenched by diluting in FACS buffer (2% BSA (w/v) in PBS). Samples 
were centrifuged and were all re-suspended in 400μL of FACS buffer. 200μL of the 
re-suspension were loaded into U-bottom 96-well plates and run on an LSRII SORP 
flow cytometer (BD BioScience). The following settings were used for the analysis of 
cells infected with Td-tomato-expressing T.gondii: FSC=150V; SSC=270V, YG-
582=380V. The plate was run, mixing samples three times at 180μL/sec and 
aspirating 150μL of sample with a flow rate of 2.5μL/sec, before washing with 200-




For microscopy analysis, cells were seeded and grown on glass coverslips within 24-
well plates or in specific 96-well plates with transparent bottom and black walls. After 
the experiment (usually infection), cells were washed with PBS and then fixed with 
4% (w/v) paraformaldehyde (PFA) for 15min at room temperature. Fixed cells were 
then washed twice with PBS before overnight incubation in 1M glycine in PBS at 4°C 
to quench the PFA. Coverslips could be stored in these conditions before being either 
stained or directly mounted. In the latter case, coverslips were washed in PBS and 
then in water before mounting them on glass slides using ProLong Gold Antifade 
Mountant (Sigma). Quantitative analyses (counting) were performed on a Zeiss 
AxioPlan upright fluorescence microscope (100x 1.3 numerical aperture oil 
objective), with at least 100 events being counted per coverslip. 
 
Pictures were taken on a Zeiss 780 inverted confocal microscope (63x 1.4 numerical 




Coverslips of fixed cells stored at 4°C in 1M glycine in PBS were washed with PBS. 
An immunofluorescence buffer (IF Buffer) containing 2% BSA and 0.1% saponin in 
PBS was prepared. Coverslips were incubated for 30min at room temperature in the 
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dark with 300μL of IF Buffer in order to permeabilise and block the cells. Cells were 
washed with PBS and were incubated with the primary antibody diluted appropriately 
(see table 4.1.2.1 “Primary antibodies”) in IF Buffer, for 1-2h in the dark at room 
temperature. Cells were then washed in IF Buffer, incubated with secondary antibody 
and Hoechst, also diluted at the required concentrations (see table 4.1.2.2 “Secondary 
antibodies”) in IF Buffer, for 1h in the dark at room temperature. For antibody 
incubations, coverslips were transferred onto a Parafilm® M (Sigma) sheet where 
20μL drops of the antibody mix were set up. The parafilm sheet displaying the 
coverslips was incubated on a wet paper towel in a dark box. Dilutions of antibodies 
were made in IF Buffer as saponin permeabilise the cells in a reversible fashion. 
 
Following the two incubations, coverslips were washed with IF Buffer, then PBS, and 
finally water before being mounted on glass slides using ProLong Gold Antifade 




4.12.4.2. High content p65 translocation assay (kindly performed by Dr. 
Claudio Pathe) 
NF-κB signalling is triggered in response to bacterial infection. Its activation results 
in the nuclear translocation of the protein p65, one of the complex subunits. TNF-α 
(1:2000, final concentration) was used as positive control for the activation of the NF-
κB signalling pathway and hence the translocation of p65. 
 
Fixed cells were stained with p65 antibody. An immunofluorescence buffer (IF 
Buffer) containing 2% BSA and 0.5% Triton in PBS was prepared. Coverslips were 
incubated for 10min at room temperature in the dark with 300μL of IF Buffer in order 
to permeabilise and block the cells. Triton permanently permeabilises the cells. 
Antibody staining could then be done in PBS supplemented with 2% BSA. After 
permeabilisation and blocking, cells were washed with PBS and incubated with the 
rabbit polyclonal p65 antibody diluted 1:1000 in buffer for 1-2h in the dark at room 
temperature. Cells were then washed in buffer, incubated with secondary antibody 
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and Hoechst both diluted at the required concentrations in buffer (see table 4.1.2.2 
“Secondary antibodies”), for 1h in the dark at room temperature. 
Images were acquired in high content manner using a wide-field Nikon HCA 
(20x/0.75numerical aperture air objective) equipped with a sCMOS camera and 
supplemented with an automated stage. 
 
 
4.13 Analysis methods 
4.13.1 Sequencing data 
4.13.1.1. Sequencher 
This software was used to generate a consensus sequence for fragments submitted to 
GATC sequencing with several primers. It was possible to revert to experimental data, 
therefore the sequences were processed and trimmed as desired. Chromatograms were 




This software was used to compare sequenced fragments with references, which could 
be either DNA or protein sequences. It was primarily used to check plasmids and 
single-point mutations in genes of interest. MacVector also allowed annotations of 




Sequencing data of the gRNA library (MiSeq) or samples from the screen (HiSeq) 
were demultiplexed, meaning that the sequences originating from either the three sub-
libraries or the two samples submitted in the same line could be respectively 
segregated according to the barcode they carried. Sequences were trimmed to remove 
extra base pairs on either side of the actual gRNA sequence. These gRNA sequences 
were aligned to the list of gRNAs provided as a reference to be identified, counted 
and related to a gene. 
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In the case of the gRNA library, the representation was assessed by looking at the 
number of distinct gRNA sequences present in the sample and the distribution of their 
frequency. 
Concerning the samples from the screen, each sgRNA received a number 
corresponding to its occurrences in each sample to calculate their enrichment ratio. 
These numbers were used by all the algorithms to rank the genes and first consider the 
results in a sgRNA-based manner. Several ranking methods were explored to analyse 
the results from the screen and are presented below: 
 
 
i. MaGECK  
The model-based analysis of genome-wide CRISPR/Cas9 knockout (MaGECK; Li et 
al., 2014) first normalises data to correct for differences due to library size and read 
count distribution. sgRNAs are individually ranked based on their p-value. The p-
value is generated by the calculation of the enrichment of each guide in terms of 
counts over the number of counts in the control condition (reference). Genes are 
finally ranked based on sgRNA rankings considering the skew to the uniform null 
model. 
Unlike MaGECK, redundant siRNA activity (RSA) was first designed to 
accommodate and analyse data from siRNA screen. 
 
ii. RSA 
The RSA method (König et al., 2007; Birmingham et al., 2009) ranks and calculates 
p-value for genes based on their guides’ distribution of enrichment compared to 
results obtained by chance. 
 
iii. “5th guide” and Fisher’s and Wilcoxon tests 
This method takes all sgRNAs and rank them based on their enrichment value, which 
is defined as the ratio of read counts between the condition tested and the control. 
Since the genome-wide gRNA library targeted each gene with ten guides, it was 
decided that the 5th guide (median) would be a good indicator of the gene’s 




Fisher’s and Wilcoxon tests (Prabhakaran, 2016-2017) were used to calculate p-
values – representation of the dispersion of the 10 sgRNAs for each gene – on this 
ranking and to generate volcano plots of the genes overall enriched (blue) or depleted 
(dark green) in the screen.  
  
 
4.13.2 Flow cytometry 
FlowJO was used to generate dot plots, histograms, and tables from the analysed 
samples. Gates were drawn first segregating out the debris from the cells and then 
according to several fluorescent markers. Tables could feature numbers or 
percentages of cells in those different sub-populations, as well as either the total, 
average or median intensity of a given population. 
 
 
4.13.3 Blots and gels 
4.13.3.1. Blue light transilluminator 
In cases where gels were prepared with 1.5% or 2% (low-melting point) agarose, the 
mixture was complemented with SYBR Safe (Life Technologies), a DNA gel stain to 
enable visualisation of the DNA products with this light. It was of great help to extract 
desired bands out (see paragraph 4.6.4.1 “DNA digestion”) or to check whether 
products were formed during PCRs. 
 
 
4.13.3.2. ChemiDoc imaging system (Bio-Rad) 
Pictures of SYBR Safe-complemented gels could be taken using the Molecular 
Imager ChemiDocTM XRS+ Imaging System (Bio-Rad). Default settings for SYBR 
Safe stain could be used and gels were loaded and illuminated to allow their 
visualisation. The software allowed brightness, contrast, and exposure to be modified 
prior to printing. 
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The ChemiDocTM MP imaging system (BioRad) could image Coomassie-stained gels 
and ECL-treated PVDF membranes, changing the detection modes according to the 
samples and adjusting the exposure time according to signal intensity. 
 
 
4.13.3.3. Image Lab software 
For precast gels, gels were visualised following double incubation with antibodies, 
using ECL Prime on ChemiDocTM MP Imaging System (Bio-Rad). Settings used were 
‘colorimetric’ for the ladder and ‘chemiluminescence’ for the proteins. Images were 
taken either for a particular exposure time or series of pictures could be defined for a 
longer exposure time. Images were transferred in Image Lab to be processed, cropped, 




4.13.4.1. High-content analysis and counting 
Wells were imaged on a HCA (high content assay) system consisting of a wide-field 
Nikon eclipse Ti with a 20x objective and a fluorescent light source, supplemented 
with an automated stage and plate loader by Prior Scientific. The system was 
configured to take 12 pictures per well. NIS Elements (4.40) was used as acquisition 
and analysis software. 
The analysis pipeline was designed to identify cells infected with T.gondii (Td-
tomato) and/or exhibiting p65 nuclear translocation. Cell nuclei were first recognised 
by Hoechst33342 staining via an intensity threshold. Identified nuclei were then used 
as the origin of each cell. Cell outlines were drawn base on the p65 staining using 
Alexa488. T.gondii was detected by expression of Td-tomato red and only pathogens 
within the cell outlines were defined as intracellular. Finally, p65 localisation to the 
nucleus was determined by using two separate parameters: an intensity threshold was 
set for Alexa488 signal (p65) within the mask of each nucleus and additionally 
Hoechst and Alexa488 signals needed to show positive co-localisation scores 
(Pearson correlation coefficient) for the cell to be considered as positive for p65 





4.13.4.2. ImageJ and Photoshop 
Pictures taken on the microscope were transferred to ImageJ (Schindelin et al., 2012) 
as .lsm files for processing. Individual channels could be split and brightness, 
intensity, and/or contrast were harmonised between samples in order to compare 
them. Layouts were created displaying the merged image along with the constitutive 
channels. 
Adobe Photoshop was used to resize pictures without losing in definition. Windows 
could be drawn as well as zoom-ins of desired areas in the pictures. It was also 
convenient to split the channels and displaying them individually to make figures. 
 
 
4.13.5 Statistical analysis 
GraphPad Prism (version 8.00 for Mac OS X, GraphPad Software, La Jolla California 
USA, www.graphpad.com) was used to handle a great number of analyses with large 
amounts of data. It gave the opportunity to visualise data by creating various types of 
graphs and helped normalise some sets of data or run statistical analyses on certain 
results such as percentages of surviving cells in different knock-down or knockout 
cell lines. 
 
To quantify the significance of the difference between two distinct conditions, a two-
tailed Student’s t-test was used. One-way ANOVAs with Dunnett multiple 
comparisons test were used to perform multiple comparisons. Gaussian distribution 
and equal variance were assumed. Significances are represented on plots and graphs 







The purpose of this thesis was to investigate the role of interferon-gamma (IFN-γ) in 
cell-autonomous immune defence mechanisms against pathogenic infection through 
the study of its involvement in the response against Salmonella enterica serovar 
Typhimurium (Chapter 2) and Toxoplasma gondii (Chapter 3).  
 
Although IFN-γ has a weak antiviral effect, it has demonstrated to be effective in 
prompting defensive responses to eliminate infectious agents through phagocytosis 
and promoting intracellular killing. Furthermore, it can act upon most cell types in 
various body tissues as IFNGR is ubiquitously expressed (Hu & Ivashkiv, 2009). 
Thanks to this, IFN-γ acts on local tissue cells by inducing the expression of ISGs that 
mediate host defence and immune responses. In addition to this, it has important 
effects on the tissue-specific functions of non-immune cells. It also plays an important 
role in tissue homeostasis and pathobiology through its combined effects on tissue 
cells and infiltrating immune cells. 
To emphasise the important role of IFN-γ in antimicrobial defence, it has been noted 
that IFNGR deficiencies lead to increased susceptibility to weakly virulent 
Mycobacteria and to Listeria infections (Roesler et al., 1999). These deficiencies can 
be due to recessive mutations either in the IFGR1 or IFGR2 genes, which respectively 
prevent either the surface expression of the receptor or the expression of the signalling 
chain (Casanova & Ochs, 1999). Research was done to understand the tight regulation 
of its expression considering genetic and epigenetic mechanisms (Aune et al., 2013). 
 
As a result of said research, a number of endogenous and manmade components were 
found to play a part in the regulation of the IFN-γ signalling. For example, in 
unstimulated human CD4+ and CD8+ T lymphocytes, the long noncoding RNA 
(lncRNA) Tmevpg1 is expressed and its pattern of expression during stimulation 
mirrors that of IFN-γ (Vigneau et al., 2003). That lead to the identification of 




Similarly, the antibody Fontolizumab (HuZAF) was developed to bind IFN-γ and 
inhibit the expression of IFN-γ-regulated genes. This called for an investigation on its 
viability as a treatment for autoimmune diseases such as Crohn’s disease, lupus, 
rheumatoid arthritis and multiple sclerosis (Skurkovich, 2003).  
By contrast, some other strategies aiming to stimulate the host immune system 
(immunotherapies) have been considered and are used to treat cancer, autoimmune 
diseases and infections. In addition to vaccines, they include immunomodulators (e.g. 
Thalidomide), interferons, monoclonal antibodies (e.g. Daratumumab, Elotuzumab); 
for instance, recombinant IFN-γ was developed as a treatment for a wide variety of 
clinical indications including cancer, T cell leukemia, tuberculosis (Miller et al., 
2009). 
 
Considering these findings, it is reasonable to suggest that understanding the IFN-γ-
dependent immune pathways is crucial for the development of new drugs against 
microbial infections. This last application is especially important in light of the 
current issue of antibiotic resistance and the severe lack of recent breakthroughs in the 
field. Similarly, pathways targeted for therapeutic intervention in autoimmune 
diseases can be harnessed during malignancy and infectious disease to counteract the 
effect that these conditions have on immune responses. 
 
In the context of infection, multiple cellular processes and protein effectors could be 
targeted. For example, the IFN-inducible GTPase proteins provide host resistance to a 
variety of viral, bacterial, and protozoan pathogens through the sequestration of 
microbial proteins, manipulation of vesicle trafficking, regulation of antimicrobial 
autophagy (xenophagy), execution of intracellular membranolytic pathways and the 
activation of inflammasomes (Pilla-Moffett et al., 2016). More specifically, GBPs are 
IFN-γ-induced GTPases necessary for CASP4 activation in human epithelial cells and 
monocytes during infection with S.Typhimurium or following LPS transfection. 
GBP1 targets cytosolic S.Typhimurium and LPS and recruits GBP2-4 for the 
recruitment and activation of CASP4 (Wandel et al., 2020) but they do not induce 
bacteriolysis (Santos et al., 2020). However, GBP1 also plays a crucial role in 
vacuolar lysis (Haldar et al., 2013; 2015; Fisch et al., 2019a). Deletion of GBP1 
compromises the control of T. gondii in IFN-γ-treated cells in vitro and increases the 
susceptibility of mice to infection (Selleck et al., 2013). 
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The destruction of the SCV or the PV removes the replicative niche for the pathogens, 
exposing them in the cytosol to further mechanisms of defence including 
inflammasome activation and cell death. In conclusion, GBP1 expression could be 
activated to help the host cope with microbial infections. 
 
 
Rationale for the two projects 
The two projects presented in this thesis were motivated by the potential of IFN-γ-
regulated pathways to lead to new antimicrobial therapies. They considered the role of 
IFN-γ, first in the cell death pathway triggered by the presence of cytosolic LPS and 
second, in the involvement of autophagy and the release of cytokines during T.gondii 
infection. 
 
This section states the knowledge in the fields relevant to the two biological questions 
asked in the thesis. The two projects are thereby justified by showing the lack of 
understanding in some areas or the need for identification of new components 
required in signalling cascades. 
 
The project described in Chapter 2 investigated the possibility of binding partners for 
cytosolic LPS that would be involved in the IFN-γ-dependent and LPS-triggered cell 
death pathway. 
It is accepted that the detection of lipopolysaccharide (LPS) is central to host defence 
against Gram-negative bacterial infections and to the pathogenesis of sepsis. 
Extracellular LPS is sensed by Toll-like receptor 4 (TLR4), which induces the 
production of cytokines via the MyD88 and TRIF signalling pathways (Takeuchi & 
Akira, 2010). Cytosolic LPS is detected by the non-canonical inflammasome, which 
controls the activation of CASP-4/−5 in humans and Casp11 in mice (Hagar et al., 
2013; Kayagaki et al., 2013; 2015; Shi et al., 2014; 2015). These caspases cleave the 
cell death effector GSDMD to induce pyroptosis and cytokine release by formation of 
pores in the plasma membrane. In contrast to the activation of other caspases that 
requires their recruitment to multiprotein platforms formed by dedicated sensor and 
adaptor proteins (e.g. DISC, apoptosome and canonical inflammasome), no 
comparable platform has yet been reported for caspase-4/−5 or −11. Instead, their 
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activation appears to involve a new mode of pattern recognition in which caspase-
4/−11 act both as sensor and executor without the need for additional adaptor proteins 
or co-factors (Shi et al., 2014). This model was proposed based on the observation 
that caspases-4/−11 binds the highly hydrophobic lipid A moiety of LPS through their 
CARD (caspase recruitment domain), resulting in their oligomerization and activation 
(Shi et al., 2014). However, since LPS is hydrophobic and normally present within 
bacterial membranes, it is conceivable that cytosolic LPS sensing could require 
accessory factors in analogy to LPS-binding protein (LBP) or cluster of differentiation 
14 (CD14) that are required for TLR4 signalling. LBP binds to LPS-containing outer 
membrane of bacteria and promotes the transfer of LPS onto CD14, which then 
delivers LPS to the MD-2/TLR4 complex (Gioannini et al., 2004; Park et al., 2009). 
Moreover, the presence of cytosolic LPS in IFN-γ-primed human monocytic and non-
monocytic cells leads to the activation by cleavage of GSDMD proteins, followed by 
accumulation of GSDMD pores on the plasma membrane, eventually resulting in cell 
death by pyroptosis (Rathinam et al., 2019).  
 
Experimentation described in Chapter 2 showed that IFN-γ-dependent cell death 
triggered by cytosolic S.Typhimurium can be recapitulated in HeLa cells by 
transfection of LPS. Using this model, a human genome-wide CRISPR screen was 
performed to identify new players in the pathway. 
 
 
Chapter 3 investigated multiple IFN-γ-dependent cell-autonomous immune 
responses against the parasite T.gondii. They included autophagy and the production 
of inflammatory cytokines.  
 
The mechanisms of cell death (e.g. apoptosis or pyroptosis) and autophagy (self-
eating) are interwoven and have been implicated in microbial infections (Nonaka et 
al., 1999; Zychlinsky et al., 1992) and autoimmunity. The recently discovered 
function of autophagy in ATP-dependent generation of engulfment signals and 
heterophagic removal of apoptotic corpses (Qu et al., 2007) hints at a potential role 
for autophagy in the prevention of inflammation and autoimmunity. Said rapid 
removal of apoptotic corpses is critical for the prevention of tissue inflammation 
(Grossmayer et al., 2005) as there is evidence that autophagy-deficient (atg5−/−) 
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embryos exhibit increased inflammation in tissues due to impaired clearance of 
apoptotic cells (Qu et al., 2007). Moreover, the lack of efficient apoptotic cell 
clearance may overcome tolerance to self-antigens and lead to autoimmune diseases 
such as systemic lupus erythematosis (SLE) (Grossmayer et al., 2005). It is therefore 
possible that defective autophagy may contribute to the pathogenesis of SLE or other 
autoimmune diseases. 
 
Autophagy is a conserved cellular degradation process involved in maintaining 
homeostasis and preventing nutritional, metabolic, and infection-mediated stresses. It 
plays a beneficial role during infection by simultaneously degrading pathogens, 
killing infectious agents directly and activating the host’s immune system (Levine et 
al., 2011). Previous work demonstrated that autophagy provides an excellent 
intracellular defence system against bacterial pathogens, including Salmonella 
enterica serovar Typhimurium (Birmingham et al., 2006), Listeria monocytogenes 
(Yoshikawa et al., 2009), and Shigella flexneri (Mostowy et al., 2011).  
Further studies on the process of autophagy in different microbial infections (Levine 
& Kroemer, 2008) could help design and develop novel therapeutic strategies against 
important pathogenic microbes such as Toxoplasma gondii. It can also be argued that 
understanding the host defence mechanisms along with the avoidance strategies 
elaborated by T.gondii could assist the investigation of new treatment and vaccines 
(Liu et al., 2012; Scorza et al., 2003). 
 
The autophagy machinery is composed of and regulated by several cellular, 
membrane-associated or cytoplasmic moieties. The ubiquitinylation cascade, for 
example, plays an important role in signalling and recruiting proteins such as cargo 
receptors that are fundamental for the formation of the autophagosome. LUBAC is 
instrumental to such cascade, as it acts as an E3 ligase and specifically synthesises 
linear Ub chains. Cells that present a LUBAC deficiency are unable to carry out 
autophagy adequately and, as a result, exhibit higher rates of infection.  
For each of the LUBAC subunits (HOIP, HOIL-1 and Sharpin), inherited deficiencies 
have been reported and they all participate to autoinflammation and higher 
susceptibility to infections because it negatively impacts the NF-κB signalling 
pathway. For example, homozygous mutation in the PUB domain of HOIP, the 
catalytic subunit of LUBAC, impairs its expression and destabilises the whole 
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complex (Boisson et al., 2015). Furthermore, loss-of-function and loss-of-expression 
mutations in HOIL-1 cause hereditary disorders, phenotypically characterised by 
auto-inflammation, invasive bacterial infections and muscular amylopectinosis. On 
another note, mice lacking Sharpin (cpdm) develop a spontaneous inflammatory 
syndrome; their cells exhibit decreased NF-κB activation and are more sensitive to 
TNF-induced cell death (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 
2011).  
 
Given the importance of LUBAC in antibacterial response and its role in the 
pathogenesis of multiple inflammatory disorders, its recruitment to T.gondii was 
investigated in Chapter 3. By synthesising linear Ub chains, it drives the autophagy 
machinery; that is why the recruitment of autophagy cargo receptors was also studied. 
 
It should also be noted that impairment of LUBAC stability results differently in 
various cell types: IL-1β-dependent NF-κB activation is compromised in human 
fibroblasts but monocytes are hyperresponsive to IL-1β (Boisson et al., 2012). This 
shows that mutations in the activation pathways of NF-κB can result in aberrant 
cytokine production. The link between LUBAC and the expression and regulation of 
certain cytokines and signalling molecules was therefore further investigated in the 
context of T.gondii infection. When infected with a low‐virulence form of this 
protozoan, normal mice are able to control infection, but develop chronic 
toxoplasmosis. However, IFN‐γR1 (‐/‐) mice are unable to control infection, 
developing a necrotizing hepatitis, and ultimately succumbing to the pathogen. 
Hepatic macrophages in infected IFN‐γR1 (‐/‐) mice produced lower levels of TNF‐α, 
iNOS, and IL‐1β (Deckert-Schluter et al., 1996).  
IFN-γ also induces autophagy through the IRF-1 signalling pathway. Overexpression 
of IRF-1 enhances autophagosome formation and turnover of LC3 protein in human 
liver cancer cells whereas silencing IRF-1 expression blocks IFN-γ-induced 
autophagy (Li et al., 2012).  
 
In addition to the role of LUBAC and autophagy in the immune response against 
T.gondii, the production of cytokines and the requirement for IFN-γ were considered 





New avenues of investigation 
The conclusion that can be inferred from Chapter 2 is that even though there is no 
definitive proof that binding partners of cytosolic LPS could be involved in the IFN-γ-
dependent and LPS-triggered cell death pathway, there is enough evidence to suggest 
said involvement. Further study on the matter is therefore merited. 
Chapter 3 demonstrated the IFN-γ-dependent recruitment of LUBAC and three 
autophagy cargo receptors (NDP52, p62 and Optn) on type II T.gondii in MEF cells. 
However, the precise binding mechanisms have not been established and require 
additional experimentation. Moreover, IFN-γ-induced cytokine production was 
noticed following infection with T.gondii. The activation of proinflammatory 
signalling pathways and the potential role of autophagy during T.gondii infection 
could be investigated further. 
 
 Reconsidering the experimental strategy and the models used 
The investigation of the IFN-γ-dependent, LPS-triggered cell death mechanism used a 
human genome-wide CRISPR screen and was carried out in HeLa cells. Although the 
methodology failed to discover any new players, it was successful in identifying 
known genes in the pathway and generated a list of genes enriched during the 
selection process. 
The identification of transcription factors within this list could lead to the study of 
their targets as potential players in the IFN-γ, LPS-triggered cell death mechanism. 
Some of the transcription factors might be indirectly involved in the pathway by 
either stimulating or repressing genes. For example, LPS activates the expression of 
the transcription factor LPS-induced TNF-α factor (LITAF) that regulates TNF-α 
transcription and STAT6(B). Together, they form a complex that upregulates the 
production of cytokines, such as TNF-α, IL-1α and IFN-γ (Tang et al., 2005). 
Researching these newly identified transcription factors and their target(s) could 
advance the understanding in the field and potentially serve as a platform for the 
discovery of new drugs and therapies. 
 
The results from Chapter 2 also revealed some limitations about the strategy and the 
model used. Transcriptomics could be used to investigate the discrepancies in the cell 
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death percentages observed between not only the different cell lines (see Chapter 2, 
Figure 4) but also within a population of HeLa cells (see Chapter 2, Figure 5). A 
significant differential number of mRNAs from certain genes would identify them as 
actors in the IFN-γ-dependent, LPS-triggered cell death pathway. These genes could 
either inhibit the pathway or be required for it to operate, depending on whether they 
are respectively present or absent in cell lines that do not display the cell death 
phenotype (e.g. 293ET). Performing the screen on a population of HeLa cells 
constitutes a substantial approximation considering that they can be very 
heterogenous (Landry et al., 2013). Transcriptomic analysis comparing the surviving 
cells (see Chapter 2, Figure 5) to the rest of the population might also help identifying 
the genetic reasons for the resistance. 
 
The choice of model organisms also infers a set of constraints. For example, 
S.Typhimurium has been widely used as a model organism to study cell-autonomous 
immunity pathways such as autophagy. However, experiments carried out in Chapter 
3 established new findings in the case of T.gondii infection. These results, 
complemented with data from the literature, demonstrated that ubiquitylation and 
recognition of the pathogens or of the vacuolar membrane were shared characteristics 
during infections with S.Typhimurium or non-virulent type II T.gondii strains in IFN-
γ-primed cells. The mechanisms underlying T. gondii detection depend on the 
virulence of the strains and also on the presence of IFN-γ, reinforcing its essential role 
in cell-autonomous immunity. IFN-γ is indeed required for the LPS-triggered cell 
death pathway and the recruitment of LUBAC and autophagy cargo receptors on type 
II T.gondii.  
 
On another note, the reason(s) for the recruitment of LUBAC and autophagy cargo 
receptors to T.gondii needs to be discovered. These recruitment events might be 
linked to the ATG5-dependent restriction of replication and/or might cause the 
elevated expression of IL-1α or IL-6 in infected cells. To investigate this further, 
autophagy- and LUBAC-deficient cells could be primed with IFN-γ and infected with 
T.gondii. The monitoring of T.gondii replication using plaque assays (Pfefferkorn & 
Guyre, 1984) and the levels of cytokine production measured by ELISA would give 





 Localisation and time-sequence of (recruitment) events following infection 
Results obtained in Chapter 3 were limited and some of them deserve to be followed-
up in future experiments. The use of high-resolution microscopy would be 
instrumental to differentiate extracellular from cytosolic T.gondii. It would also allow 
the identification of the particular targets and binding partners of the LUBAC subunits 
and the three autophagy cargo receptors and their specific localisation (either on the 
PVM or the parasite itself). 
 
In addition to localisation of the recruited protein, the timing of events in the 
signalling cascades seems to be an important issue to address. For example, GAL8 is 
recruited to vacuolar membrane remnants before any LUBAC subunits can access the 
cytosol-invading S.Typhimurium. Moreover, HOIP requires the presence of 
endogenous HOIL-1 to accumulate on cytosolic S.Typhimurium and then recruits 
HOIL-1 and Sharpin (Noad et al., 2017).  
Time-lapse-based microscopy (Velasquez et al., 2019) could be employed to 
investigate the order of recruitments of LUBAC and its constitutive subunits, 
autophagy cargo receptors and GBPs, during T.gondii infections. 
In the case of LPS-triggered cell death in IFN-γ-primed cells, multiple cell death 
mechanisms might be triggered, and their sequence could be resolved by specifically 
inhibiting apoptosis, pyroptosis or necrosis when appropriate. 
 
 
 Investigation beyond redundancy: exploring the multiple layers of immune 
responses 
In both chapters, many new questions about redundancy and cross-talk between 
multiple immune pathways were raised and could be addressed in further 
experiments.  
Multiple complementary strategies could be implemented to identify redundant IFN-
γ-dependent cell death mechanisms triggered by cytosolic LPS. GSDMD- or ATG5-
deficient cells would respectively provide a cellular background devoid of pyroptosis 
or autophagy; these cells could be submitted to LPS transfection after priming with 
IFN-γ. Measure of cell death at different time points could give indications on 
whether pyroptosis and autophagy are both occurring and their respective timings. To 
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investigate potential redundancy with other cell death pathways, the simultaneous 
inhibition of multiple caspases (inflammatory or effector caspases) would disable 
chosen cell death pathways and allow identification of those that are in play. 
 
From an inflammasome-related perspective, it has been demonstrated that rupture of 
the PVM followed by release of T.gondii DNA triggers the AIM2-ASC-CASP8 
inflammasome and results in cell death (Saeij & Frickel, 2017; Fisch et al., 2019b). It 
might be interesting to consider other inflammasomes or study different cell death 
mechanisms such as GSDMD-driven pyroptosis in the case of T.gondii infection. 
Such experimentation would provide additional material to compare host immune 




 The role of microbial effectors 
A more in-depth analysis and comparison of S.Typhimurium and T.gondii effectors 
and their impact on the host immunity and the establishment of the infection would be 
appropriate. 
Following S.Typhimurium infection, the SCV gets coated by host Rab proteins and is 
maintained by the effector SopB that also renders the SCV non-fusogenic (Srikanth et 
al., 2011). Similarly, the T.gondii rhoptries ROP18, ROP5 and ROP17 are discharged 
into the host cytosol and form a complex involved in the formation of the PV (Taylor 
et al., 2006).  
Some other effectors play an important role in virulence. S.Typhimurium produce 
SifA, SSe proteins, SopD2 and PipB2, which are essential for intracellular survival 
(Srikanth et al., 2011). The pseudokinase ROP5 enhances the kinase activity of 
ROP18 (Behnke et al., 2012) making the type 1 T.gondii strain more virulent, because 
ROP18 is highly expressed in these parasites. Strains of T.gondii are differentially 
susceptible to destruction by IRGs (Zhao et al., 2009) and GBPs (Selleck et al., 2013), 
due to active mechanisms of avoidance. Similarly to the mouse system, in IFN-γ-
treated HeLa cells, type 2 and 3 strain parasites are susceptible to ubiquitination, the 
accumulation of the adaptors NDP52 and p62, and the recruitment of LC3 (Selleck et 
al., 2015), a canonical early marker for autophagosomes. Type 1 strain parasites avoid 
this ubiquitination-autophagy recruitment pathway by an unknown mechanism. The 
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accumulation of autophagy adaptors and LC3 leads to engulfment of the PV in host 
membranes and restricted growth of type 2 parasites, although the compartment does 
not fuse with lysosomes (Selleck et al., 2015). 
 
T.gondii modulates its host cell on numerous functional levels. T.gondii was 
previously reported to influence host cellular cell cycle and to dampen host cell 
division. The transmembrane protein GRA7 binds to IRGs and promotes their 
degradation, protecting the parasites against murine immune defence (Alaganan et al., 
2013). ROP16 hijacks the host gene transcription machinery by inducing STAT3 and 
STAT6 via their phosphorylation (Saeij et al., 2007). Likewise, S.Typhimurium have 
evolved effectors to either harm or fool the host and establish infection. SopA mimics 
a human protein and undergoes post-translational modifications. It is then cleaved by 
human CASP3, thereby triggering inflammation. SseL on the other hand acts as a 
deubiquitinase and inhibits the degradation of IkBα, thereby downregulating the 
inflammatory response from the NF-κB signalling pathway. 
 
 
In summary, investigating the roles of IFN-γ and IFN-γ-regulated pathways in the 
context of microbial infections will help gain further understanding about specific 
mechanisms of defence. However, proteins can play several roles in different 
pathways that could be competitive, synergistic or redundant. It is therefore important 
to put the results into perspective and to integrate new discoveries into the wider 
picture of the entire immune system, considering both the innate and the adaptive.  
Finally, such work is also necessary for the development of new treatments that would 
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